Probing the membrane-binding and effector function of Phage Shock Protein A and its homologue Vipp1 by McDonald, Christopher
    1 
  
 
Probing the membrane-binding and effector function 
of Phage Shock Protein A and its homologue Vipp1 
 
 
 
 
Christopher McDonald 
 
 
 
 
 
 
 
Department of Chemistry 
Imperial College London 
Thesis submitted for the degree of Doctor of Philosophy 
April 2015 
    2 
  
Declaration of Originality 
I, Christopher McDonald, declare that this thesis is an original piece of work written entirely 
by myself. All the results detailed arise from my own research unless otherwise stated. Any 
information and conclusions derived from other works has been referenced appropriately. 
   
The copyright of this thesis rests with the author and is made available under a Creative 
Commons Attribution Non-Commercial No Derivatives licence. Researchers are free to 
copy, distribute or transmit the thesis on the condition that they attribute it, that they do 
not use it for commercial purposes and that they do not alter, transform or build upon it. 
For any reuse or redistribution, researchers must make clear to others the licence terms of 
this work 
  
    3 
  
Abstract 
Stress response systems are prevalent throughout all organisms with several functioning to 
maintain the cell envelope. One widely distributed system in bacteria is the Phage Shock 
Protein (Psp) response which is involved in pathogenicity, biofilm and persister cell 
formation. Induced under conditions proposed to cause membrane (often Inner-Membrane, 
IM) stress, the Psp response appears to stabilize the IM and so prevent dissipation of the 
proton motive force. The central component, PspA, is a peripheral IM protein that acts as 
both the effector and negative regulator of the Psp response. PspA has a counterpart Vipp1, 
which functions for chloroplast envelope maintenance and thylakoid biogenesis in plants, 
algae and photosynthetic bacteria. Mechanistic insight into how PspA and Vipp1 undertake 
their respective effector functions is limited but thought to be through their direct 
interactions with cellular membranes.  
Rigorously controlled, in vitro methodologies with lipid vesicles, purified proteins and 
peptides were established and used in this study, providing the first biochemical and 
biophysical characterisation of membrane binding by PspA and Vipp1. Direct membrane 
association of PspA and Vipp1 was shown to occur through their conserved N-terminal 
amphipathic helices. Both proteins are found to sense stored curvature elastic (SCE) stress 
and anionic lipids within the membrane. PspA has enhanced sensitivity for SCE stress while 
Vipp1 partitioning is most sensitive to membranes with a high net-negative charge. 
Experimental data points to alleviation of SCE stress by Amphiphatic Helix (AH) insertions as 
an attractive mechanism for membrane maintenance by PspA and Vipp1.  
Furthermore, by probing PspA’s regulatory role we show that its transcription inhibition, 
though binding to the transcription activator PspF, can be relieved upon bilayer exposure in 
a SCE stress specific manner. The identification of a physical, stress related membrane signal 
suggests a unilateral mechanism that promotes both membrane binding of PspA and a 
stress triggered induction of the Psp response. 
 
  
    4 
  
Acknowledgements 
I would like to thank my supervisors Martin Buck and Oscar Ces for all their help and 
guidance during my time at Imperial College. Their experience and support throughout the 
PhD has been of great benefit providing a significant contribution to the success of my 
research. I would also like to thank the EPSRC and CBC/ICB for funding my research project 
over the last three years. 
Many thanks to Goran Jovanovic for all the cloning work, advice and Psp related discussions 
during the project. Also, Nan Zhang and Pvoilas Udinays for teaching me some of the 
laboratory techniques used in this study.  Thanks to Bonnie Wallace and the rest of her lab 
for all their help with the Circular Dichroism studies and to Harry Low for carrying out the 
EM studies in this work. 
A big thanks to all Buck lab members past and present for making my time in the lab an 
enjoyable one.  In particular I would like to mention Parul Prabhat and Chris Waite who have 
provided many hours of science and non-science related conversation. Finally I would like to 
thank my mum for her proof reading and Annie Simpson for putting up with me whilst I 
wrote this thesis. 
  
    5 
  
Contents 
 
Declaration of Originality .................................................................................................. 2 
Abstract ........................................................................................................................... 3 
Acknowledgements .......................................................................................................... 4 
Contents .......................................................................................................................... 5 
List of Figures ................................................................................................................... 9 
List of Tables .................................................................................................................. 13 
Abbreviations ................................................................................................................. 14 
Amino Acids ................................................................................................................... 17 
 
1. Introduction ............................................................................................................... 18 
1.1 The cell envelope .............................................................................................................. 18 
1.1.1 Composition of the Gram-negative cell envelope ....................................................................... 19 
1.1.2 Cell envelope stress responses .................................................................................................... 23 
1.2 The Phage shock protein (Psp) response ............................................................................ 25 
1.2.1 A brief overview and components of the Psp response .............................................................. 25 
1.2.2 Psp response transcription regulation and the role of PspF ........................................................ 27 
1.2.3 bEBPs and PspF ............................................................................................................................ 30 
1.2.4 PspA negative regulatory function............................................................................................... 33 
1.2.5 Release of the A-F inhibitory co-complex and roles of PspBC ..................................................... 34 
1.2.6 Inducers of the Psp response ....................................................................................................... 36 
1.2.7 PspA and its effector function in the Psp response ..................................................................... 38 
1.2.8 Other members of the Psp response ........................................................................................... 42 
1.2.9 Conservation of the Psp proteins and the response .................................................................... 43 
1.3 Vesicle Inducing Protein in Plastids (Vipp1)........................................................................ 45 
1.3.1 Structure of Vipp1 ........................................................................................................................ 45 
1.3.2 Phylogeny and evolution ............................................................................................................. 47 
1.3.3 Vipp1 function .............................................................................................................................. 48 
1.4 Membrane-protein interactions: a biophysical perspective ................................................ 49 
1.4.1 Polar lipids and the basic architecture of biological membranes ................................................ 50 
    6 
  
1.4.2 Molecular shape, aggregation and spontaneous curvature ........................................................ 52 
1.4.3 Membrane curvature ................................................................................................................... 53 
1.4.4 Membrane stored curvature elastic stress .................................................................................. 54 
1.4.5 Lipid vesicles, positive membrane curvature and lipid packing defects ...................................... 57 
1.4.6 Lamellar mesophases ................................................................................................................... 58 
1.4.7 Biological membranes and the fluid mosaic model ..................................................................... 60 
1.4.8 Peripheral membrane proteins (PMPs) and their membrane interactions ................................. 61 
1.4.9 Cooperation of multiple membrane interactions ........................................................................ 63 
1.5 Project aims...................................................................................................................... 65 
 
Chapter 2: Materials and Methods.................................................................................. 67 
2.1 Materials .......................................................................................................................... 67 
2.1.1 Media ........................................................................................................................................... 67 
2.1.2 Antibiotics .................................................................................................................................... 67 
2.1.3 Buffers .......................................................................................................................................... 67 
2.1.4 Kits ................................................................................................................................................ 69 
2.1.5 Lipids ............................................................................................................................................ 69 
2.1.6 Peptides ....................................................................................................................................... 70 
2.1.7 Bacterial strains and plasmids ..................................................................................................... 71 
2.2 Methods ........................................................................................................................... 72 
2.2.1 Protein, peptide and DNA gels ..................................................................................................... 72 
2.2.2 Protein purification techniques ................................................................................................... 74 
2.2.3 Protein concentration assays ....................................................................................................... 77 
2.2.4 Western blotting .......................................................................................................................... 78 
2.2.5 PspA fluorescent labelling ............................................................................................................ 78 
2.2.6 Anisotropy studies of labelled proteins ....................................................................................... 79 
2.2.7 PspA - PspF interaction assays ..................................................................................................... 79 
2.2.8 HPLC gel filtration ........................................................................................................................ 80 
2.2.9 Lipid vesicle techniques ............................................................................................................... 81 
2.2.10 Protein-Vesicle and Peptide-Vesicle interaction assays ............................................................ 83 
 
Chapter 3 – Developing an approach to study PspA-lipid Interactions ............................. 87 
3.1 Introduction ..................................................................................................................... 88 
3.2 Results and Analysis ......................................................................................................... 89 
    7 
  
3.2.1 Protein purification and functionality studies ............................................................................. 89 
3.2.2 Fluorescent labelling of PspA for single molecule imaging .......................................................... 93 
3.2.3 An alternative approach to monitoring protein-vesicle interactions ........................................ 105 
Discussion and Conclusions .................................................................................................. 118 
 
Chapter 4 – PspA-Membrane Interaction Studies .......................................................... 122 
4.1 Introduction ................................................................................................................... 123 
4.1.1 Anionic lipids as membrane binding determinant? ................................................................... 123 
4.1.2 Membrane binding via the N-terminal amphipathic helix......................................................... 123 
4.2 Results and Analysis ....................................................................................................... 127 
4.2.1 Studying the effects of anionic lipids on PspA binding through lipid extracts .......................... 127 
4.2.2 Binding assays with lipid extract vesicles ................................................................................... 130 
4.2.3 Bilayer-association of PspA to synthetic DPPC and DOPC vesicles ............................................ 132 
4.2.4 Probing vesicle curvature leading to observation of a direct PspA-membrane interaction ..... 134 
4.2.5 Stored curvature elastic stress and PspA binding assays........................................................... 138 
4.2.6 Binding to negatively charged membranes ............................................................................... 142 
4.2.7 Combining stored curvature elastic stress and anionic lipids .................................................... 145 
4.2.8 Membrane binding of PspA mutants ......................................................................................... 147 
4.2.9 Effect of PspA on vesicle stability .............................................................................................. 152 
4.3 Discussion and conclusions ............................................................................................. 155 
 
Chapter 5 – The Vesicle inducing protein in plastids (Vipp1) .......................................... 163 
5.1 Introduction ................................................................................................................... 164 
5.2 Results and Analysis ....................................................................................................... 166 
5.2.1 Protein expression and purification of Vipp1 WT and Vipp1∆ahA ............................................... 166 
5.2.2 Vipp1 secondary and tertiary structure ..................................................................................... 167 
5.2.3 (His)6-Tag cleavage and oligomer formation assays .................................................................. 169 
5.2.4 Vipp1 – PspF interaction assays ................................................................................................. 171 
5.2.5 Vipp1 - membrane binding assays ............................................................................................. 173 
5.2.5 Vipp1∆ahA assays ......................................................................................................................... 182 
5.2.6 Visualisation of SUV bound Vipp1 .............................................................................................. 184 
5.2.7 Binding of Vipp1 to thylakoid membrane lipids ........................................................................ 185 
5.3 Discussion and Conclusions ............................................................................................. 189 
    8 
  
Chapter 6 – Probing the amphipathic helices of PspA and Vipp1 ................................... 193 
6.1 Introduction ................................................................................................................... 194 
6.2 Results and Analysis ....................................................................................................... 198 
6.2.1 Synthetic Peptide Studies .......................................................................................................... 198 
6.2.2 Effects of AH peptides on vesicle stability ................................................................................. 214 
6.3 Discussion and Conclusions ............................................................................................. 221 
 
Chapter 7 – Transcription regulation and in vivo implications ........................................ 228 
7.1 Introduction ................................................................................................................... 229 
7.1.1 PspBC independent induction of the Psp response through the membrane? .......................... 229 
7.1.2 The role of PspA ahB in negative regulation of PspF ................................................................. 230 
7.2 Results and Analysis ....................................................................................................... 231 
7.2.1 Studying the effect of membrane exposure on PspA’s negative regulatory function............... 231 
7.2.2 Repression of PspF’s ATPase functionality by peptides ............................................................. 241 
7.3 Discussion and Conclusions ............................................................................................. 245 
 
Chapter 8 – Discussion .................................................................................................. 249 
8.1 A key role for SCE stress in the induction and effector function of the Psp response? ....... 250 
8.2 Dual membrane signals impart dual Vipp1 maintenance and biogenesis function? ........... 254 
8.3 Future Work ................................................................................................................... 256 
 
Bibliography ................................................................................................................. 259 
Appendix A – Sizing of vesicles via Dynamic Light Scattering .................................................. 279 
Appendix B – PspA and Vipp1 (His)6 tag cleavage and pH vesicle-binding controls .................. 280 
Appendix C – Circular Dichroism spectra of Vipp12-19 with E. coli TLE vesicles and PspA1-40 
peptides ............................................................................................................................... 281 
 
  
    9 
  
List of Figures 
Figure 1.1 The cell envelope of Gram-negative bacteria 19 
Figure 1.2 Energy conservation via oxidative phosphorylation at the Gram-negative IM 22 
Figure 1.3 Working model of the core Psp response 26 
Figure 1.4 The Psp regulon in E. coli 29 
Figure 1.5 Domain organisations of a three domain bEBP and the two domain PspF 31 
Figure 1.6 Transcription activation of the psp regulon 32 
Figure 1.7 Negative regulation of the Psp response by PspA 34 
Figure 1.8 Predicted structure of PspA 39 
Figure 1.9 Negative stain EM studies of PspA oligomerization 40 
Figure 1.10 Conservation of the Psp system 44 
Figure 1.11 Predicted domain organisation and oligomerization of Vipp1 46 
Figure 1.12 Vipp1 high-order oligomeric states and modelled structure 47 
Figure 1.13 General structure of phospholipids and bilayer formation 50 
Figure 1.14 Phospholipids commonly found in biological membranes 51 
Figure 1.15 Phospholipid geometry and spontaneous membrane curvature 53 
Figure 1.16 Defining membrane curvature at a point on the monolayer 54 
Figure 1.17 Lateral pressures acting within a flat monolayer 55 
Figure 1.18 Curvature frustration within a bilayer formed from spontaneously positively or 
negatively curved monolayers 56 
Figure 1.19 Structure of lipid lamellar phases 59 
Figure 1.20 Cooperation of multiple interactions to promote membrane binding 64 
Figure 3.1 Purification of his-tagged PspA WT and PspA1-186 from E. coli 90 
Figure 3.2 Purified PspA proteins SDS-PAGE, immunoblotting and Bioanalyser analysis 91 
Figure 3.3 Purified PspA protein interaction with PspF1-275 and subsequent ATPase inhibition 92 
Figure 3.4 Chemical labelling approach for PspA1-186 94 
Figure 3.5. Disulphide bond formation in PspA1-186 cysteine mutants 97 
Figure 3.6 Visualising fluorescent labelling of PspA1-186 S186C via SDS-PAGE 98 
Figure 3.7 Fluorescence anisotropy of Alexa 488 titrated with PspA1-186 101 
Figure 3.8 Chemical structures of the fluorophores used in this study 102 
Figure 3.9 Non-specific labelling studies with HiLyte 488 103 
Figure 3.10 Alexa Fluor 647 labelling studies 104 
Figure 3.11 Monitoring protein-vesicle binding via co-flotation assays 108 
    10 
  
Figure 3.12 Distribution of PspA WT across fractions from co-flotation assays with and without 
vesicles 109 
Figure 3.13 Native-PAGE based binding assay gives a quantitative measure of                                   
PspA-membrane binding 111 
Figure 3.14 Calculating membrane binding of PspA from the native-PAGE assay 113 
Figure 3.15 Native-PAGE protein-membrane interaction assay negative control with PspF1-275 114 
Figure 3.16 Fluorescent images of NBD-PE labelled vesicles run on a native-PAGE gel 115 
Figure 3.17 Linearity of Sypro Ruby Protein Stained PspA WT 116 
Figure 4.1 N-terminal amphipathic helixes A (ahA) and B (ahB) in PspA 124 
Figure 4.2 Four membrane binding AH’s and the different membrane signals they sense 126 
Figure 4.3 PE, PG and CL biosynthesis pathway from PA in E. coli 128 
Figure 4.4 Mass spectrometry data for E. coli MG1655 WT, cls and pgsA lipid extracts 129 
Figure 4.5 Co-flotation assays of PspA with E. coli lipid extract vesicles 130 
Figure 4.6 PspA binding to vesicles produced from lipid extracts 131 
Figure 4.7 Binding of PspA to DPPC and DOPC vesicles 133 
Figure 4.8 Binding of PspA to DOPC vesicles of differing diameters 135 
Figure 4.9 Probing the ability of PspA bound SUVs to enter the gel matrix 137 
Figure 4.10 Native gels of PspA incubated with vesicles of increasing SCE stress 139 
Figure 4.11 Membrane binding of PspA WT as a function of bilayer SCE stress 140 
Figure 4.12 Linear regression of binding to increased SCE stress vesicles as a function of lipid 
concentration and vesicle composition 142 
Figure 4.13 Native-PAGE gels of PspA incubated with vesicles containing increasing anionic            
lipid content 143 
Figure 4.14 PspA-membrane binding as a function of membrane anionic lipid content 144 
Figure 4.15 PspA-membrane binding as a function of anionic lipid content and SCE stress 146 
Figure 4.16 Membrane binding of PspA1-186 as a function of bilayer SCE stress and binding to               
E. coli TLE vesicles 149 
Figure 4.17 Membrane binding of PspAahA as a function of bilayer SCE stress, anionic lipid       
content and E. coli TLE vesicles 151 
Figure 4.18 Calcein efflux assay probing the effect of PspA WT and PspA1-186 on vesicles 153 
Figure 4.19 Schematic of the relief of SCE stress via lipid chain splay 157 
Figure 4.20 Sequence alignment of PspA from 10 different organisms 160 
Figure 4.21 Roles of E20 and K21 in AH-membrane binding 161 
Figure 5.1 Sequence conservation of PspA and homologue Vipp1 165 
    11 
  
Figure 5.2 Purification of Vipp1 proteins from E. coli 167 
Figure 5.3 Secondary and tertiary structural analysis of Vipp1 168 
Figure 5.4 Gel filtration and (His)6 cleavage gels of Vipp1 proteins 170 
Figure 5.5 Vipp1-PspF1-275 interaction assays 172 
Figure 5.6 Vipp1-membrane binding assays with E. coli TLE vesicles 174 
Figure 5.7 Membrane binding of Vipp1 and PspA as a function of E. coli TLE vesicle         
concentration 175 
Figure 5.8 Membrane binding of Vipp1 WT as a function of bilayer SCE stress 177 
Figure 5.9 Membrane binding of Vipp1 WT as a function of anionic lipid content 179 
Figure 5.10 Membrane binding of Vipp1 as a function of anionic lipids and SCE stress combined 181 
Figure 5.11 Membrane binding of Vipp1ahA to vesicles of varying membrane composition 183 
Figure 5.12 Visualising direct membrane binding of Vipp1 WT to SUVs using the native-PAGE   
binding assay 184 
Figure 5.13 Chemical structures of the most abundant species of MGDG and DGDG in     
synechocystis 185 
Figure 5.14 Vipp1-membrane binding to vesicles containing the galactolipids DGDG and MGDG 187 
Figure 6.1 Conservation of the N-terminal AH of PspA and Vipp1 sequence 195 
Figure 6.2 The sequence and macroscopic properties of N-terminal AHs of PspA and Vipp1         
across species 196 
Figure 6.3 Helical wheel projections of the peptides used in this chapter 199 
Figure 6.4 Circular Dichroism spectra of PspA and Vipp1 ahA peptides 200 
Figure 6.5 Monitoring Vipp11-24-vesicle binding using a sucrose gradient co-floatation assay 202 
Figure 6.6 AH formation of Vipp11-24 with increasing concentrations of E. coli TLE vesicles 203 
Figure 6.7 AH formation of Vipp11-24 with vesicles of different lipid compositions 206 
Figure 6.8 AH formation of Vipp11-24 incubated with vesicles of varying anionic lipid content 207 
Figure 6.9 AH formation of PspA1-24 upon membrane exposure 209 
Figure 6.10 AH formation of PspA1-24 with vesicles of different lipid compositions 211 
Figure 6.11 AH formation of PspA1-24 mutants upon membrane exposure 213 
Figure 6.12 Vesicle rupturing effect of PspA2-19 on E. coli TLE vesicles 215 
Figure 6.13 Monitoring the release of trapped solutes from E. coli TLE vesicle by PspA and           
Vipp1 peptides 216 
Figure 6.14 Effect of PspA and Vipp1 peptides on vesicles with high and low SCE stress 217 
Figure 6.15 Effect of PspA and Vipp1 peptides on anionic lipid vesicle stability 219 
Figure 6.16 Vesicle rupturing effects of Vipp11-24 on 40 % DOPG vesicles 220 
    12 
  
Figure 6.17 Model of membrane disruption by amphipathic helixes 225 
Figure 7.1 Probing PspA’s ability to repress σ54 dependent transcription via an spRNA assay 232 
Figure 7.2 Vesicles relieve transcription repression by PspA through disruption of the                     
PspA – PspF1-275 inhibitory complex 233 
Figure 7.3 Effects of sonicated E. coli TLE, DPPC and DOPC vesicles on transcription relief 235 
Figure 7.4 spRNA production with PspA-vesicles pre-incubation 237 
Figure 7.5 Probing the effect of SCE stress on transcription relief 239 
Figure 7.6 Membrane exposure cannot relieve transcription repression by PspA1-186 241 
Figure 7.7 PspA and Vipp1 peptide effects on PspF1-275 ATPase activity 243 
Figure 7.8 Peptide effects on PspF1-275 ATPase activity as a function of hydrophobicity (A), 
hydrophobic moment (B) and net-charge (C) 244 
Figure 8.1 Model of the PspBC independent induction and effector function of the Psp response      
of E. coli in vivo informed by findings of this study 251 
Figure A.1 Dynamic light scattering data of vesicles used within this study 279 
Figure B.1 Native-PAGE based binding assay controls for PspA and Vipp1 280 
Figure C.1 CD spectra of peptides 281 
 
  
    13 
  
List of Tables 
Table 1.1 Reported inducing conditions of the Psp response in E. coli 37 
Table 2.1 Composition of media used in protein expression 67 
Table 2.2 Antibiotics used in this study 67 
Table 2.3 Composition of buffers used in this study 68 
Table 2.4 Commercially available kits used in this study 69 
Table 2.5 Synthetic phospholipids used in this study 70 
Table 2.6 Lipid extracts used in this study 70 
Table 2.7 Peptides used within this study 71 
Table 2.8 Bacterial strains and plasmids used in this study 72 
Table 2.9 Components of SDS-PAGE gels 72 
Table 2.10 Components of native-PAGE gels 73 
Table 2.11 Components of 20 % sequencing gels 74 
Table 2.12 BenchPro 4100 protocol 78 
Table 2.13 DNA oligonucleotides used in the spRNA assays 86 
Table 3.1 Labelling efficiencies of PspA1-186 proteins with Alexa 488 99 
Table 4.1. Protein to vesicle ratios reached in the calcein efflux assay 154 
Table 5.1 Membrane lipid composition of the four major lipid classes in Synechocystis 186 
Table 6.1 α-helical content of Vipp11-24 and Vipp12-19 peptides with E. coli TLE vesicles 204 
Table 6.2 α-helix content of Vipp11-24 in the presence of vesicles with increasing net negative 
membrane charge 208 
Table 6.3 α-helical content of PspA1-24 and Vipp11-24 peptides with E. coli TLE vesicles 210 
Table 6.4 α-helical content of PspA1-24 and Vipp11-24 peptides incubated with different vesicle 
compositions 211 
Table 6.5 α-helical content of PspA1-24, PspA1-24 V11E and PspA1-24 F4E V11E 214 
 
  
    14 
  
Abbreviations 
(His)6 Hexahistidine-tag 
µH Hydrophobic moment 
AA Amino acid 
ADP Adenosine 5’-diphosphate 
AH Amphipathic Helix 
ahA PspA amphipathic helix A  
ahB PspA amphipathic helix B 
ALPS Amphipathic Lipid Packing Sensor  
APS Ammonium persulphate 
ATP Adenosine 5’-triphosphate 
bEBP Bacterial Enhancer Binding Protein 
BSA Bovine Serum Albumin 
C12E8 Octaethylene glycol monododecyl ether 
CCT CTP:phosphocholine cytidylyltransferase 
CD Circular Dichroism 
CHAPS 3-[(3-Cholamidopropyl)dimethylammonio]-1- 
propanesulfonate 
 
CL Cardiolipin 
CV Column volumes 
DGDG Digalactosyldiacylglycerol 
DLS Dynamic Light Scattering 
DMPC 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
DNA Deoxyribonucleic acid 
DOPC 1,2-dioleoyl-sn-glycero-3-phosphocholine 
DOPE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
DOPG 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol 
DOPS 1,2-dioleoyl-sn-glycero-3-phospho-L-serine 
DPPC 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
DTT Dithiothreitol 
E Core RNAP 
    15 
  
EDTA  
 
Ethylenediaminetetraacetic acid 
eGFP Enhanced GFP 
Em Emission 
EM Electron Microscopy 
Ex Excitation 
FRET Fluorescence Resonance Energy Transfer 
GFP Green fluorescent protein 
H Hydrophobicity 
HD1 PspA helical domain 1 
HPLC High performance liquid chromatography 
HRP Horseradish peroxidase 
IHF Integration Host Factor 
IM Inner Membrane 
Kd Dissociation Constant 
L/P Lipid to protein ratio 
L/P Lipid to peptide ratio 
LC Lamellar crystalline phase 
LUV Large unilamellar vesicles 
Lα Lamellar fluid phase 
Lβ Lamellar gel phase 
MGDG Monogalactosyldiacylglycerol 
MS Mass spectrometry 
Mw Molecular weight 
NADH Nicotinamide adenine dinucleotide (reduced) 
NBD-PE 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-
2-1,3-benzoxadiazol-4-yl) 
OD Optical density 
OM Outer Membrane 
P/L Peptide to lipid ratio 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PE Phosphatidylethanolamine  
    16 
  
PG Phosphatidylglycerol 
PIV Phage protein IV 
PMF  Proton Motive Force 
PS Phosphatidylserine 
Psp Phage shock protein  
r Anisotropy 
RI Relative Intensity 
RPc Closed Complex 
Rpm Revolutions per minute 
RPo Open Complex 
SCE Stored Curvature Elastic 
SCE stress Stored curvature elastic stress 
SD Standard Deviation 
SDS Sodium dodecyl sulphate 
SMI Single molecule imaging 
SN1 Soluble fraction 
SN2 Membrane fraction 
spRNA Small primed RNA 
SQDG Sulfoquinovosyldiacylglycerol 
SUV Small unilamellar vesicles 
TCEP Tris(2-carboxyethyl)phosphine 
TEMED N, N, N’, N’ -Tetramethylethylenediamine 
TLE Total lipid extract 
TM Phase transition temperature 
Tris Tris(hydroxymethyl)aminomethane 
v/v Volume per volume 
Vipp1 Vesicle inducing protein in plastids 
w/v Weight per volume 
WT Wild Type 
Z Net charge 
σ54 Sigma 54 
σ70 Sigma70 
    17 
  
Amino Acids 
 
Amino Acid  
 
Abbreviation Single-Letter Code 
 
Alanine Ala A 
Arginine Arg R 
Asparagine Asn N 
Aspartate Asp D 
Cysteine Cys C 
Glutamate Glu E 
Glutamine Gln Q 
Glycine Gly G 
Histidine His H 
Isoleucine Ile I 
Leucine Leu L 
Lysine Lys K 
Methionine Met  M 
Phenylalanine Phe F 
Proline Pro P 
Serine Ser S 
Threonine Thr T 
Tryptophan Trp W 
Tyrosine Tyr Y 
Valine  Val V 
 
  
    18 
  
1. Introduction 
Chapter 1 presents an introduction to the literature within the main fields of research 
covered in this study. First the structure and functions of the Gram-negative cell envelope 
are introduced (1.1) followed by characterisation of the envelope maintenance Phage shock 
protein (Psp) response (1.2). Current understanding of the functions of effector and 
negative regulator of the response, Phage shock protein A (PspA), is detailed before the 
conservation of the response is presented. In section 1.3 the PspA homologue the Vesicle 
Inducing Protein in Plastids (Vipp1) is introduced and current understanding of its structure 
and function is compared and contrasted with PspA. In section 1.4 an introduction to the 
biophysical and biochemical properties of phospholipid bilayers along with the biophysics 
behind membrane-protein interactions is covered. Finally the aims and objectives of this 
study are outlined in section 1.5. 
 
1.1 The cell envelope 
All cells have a defined boundary. This function is performed by biological membranes, 
acting as a semipermeable barrier by keeping the cellular contents contained while 
selectively allowing nutrients and other substances in and out of the cell. The cell’s 
membrane systems along with other structures that surround and encapsulate the 
cytoplasm are known as the cell envelope. 
Bacteria have evolved highly sophisticated cell envelopes in order to protect the cytoplasm 
from varied and often hostile environments that they encounter while allowing the selective 
uptake of nutrients and excretion of waste. The study of bacterial cell envelopes can be 
traced back to the staining procedure developed by Christian Gram in 1884 (Gram, 1884) 
which resulted in the ability to classify nearly all bacteria into two groups; those that retain 
the stain (Gram-positive) and those that do not (Gram-negative). Unbeknown at the time 
the source of the differing retention of the stain lies in fundamental structural differences 
within the cell envelope. Since then, understanding of both the structure and function of the 
bacterial cell envelope has massively progressed. Initial simplistic models of a 
    19 
  
semipermeable bag have become a complex, dynamic and highly adaptive arrangement of 
phospholipids, proteins, polysaccharides with embedded signalling systems and structural 
scaffolds. The Gram-positive bacterial cell envelope poses a cytoplasmic lipid membrane 
covered with multiple layers of peptidoglycan that is responsible for taking up the crystal 
violet stain used in the Gram test. The Gram-negative cell envelope however is much more 
complex. 
 
1.1.1 Composition of the Gram-negative cell envelope 
The Gram-negative bacterial cell envelope consists of three principle layers; the outer 
membrane (OM), periplasm and the inner membrane (IM) (Figure 1.1). The IM and OM are 
lipid bilayers that act as interior and exterior barriers between the cytoplasm and 
extracellular milieu respectively. Sandwiched in-between is the aqueous periplasmic.  
 
 
Figure 1.1 The cell envelope of Gram-negative bacteria. The IM is a phospholipid bilayer 
containing both peripheral and integral membrane proteins that separates the cytoplasm from the 
periplasm. It is vital for establishing and maintaining the cell’s energy status. Above, the periplasm 
contains proteins and layers of peptidoglycan. The OM’s outer surface is in contact with the 
extracellular milieu and contains lipopolysaccharides, phospholipids and embedded proteins. 
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1.1.1.1 The Outer Membrane (OM) 
The OM is a distinguishing feature of Gram-negative bacteria and the outermost layer of the 
cell envelope. A lipid bilayer, asymmetric in nature, the OM has an inner leaflet consisting of 
phospholipids and an outer layer (which is in contact with the extracellular milieu) 
composed of glycolipids, the majority of which are lipopolysaccharide (LPS) (Kamio and 
Nikaido, 1976).  
LPS’s are comprised of three structural domains; Lipid A, core oligosaccharide and O 
antigen.  Lipid A is a phosphorylated glucosamine disaccharide linked to acyl chains that 
anchor LPS in the membrane (Raetz and Whitfield, 2002). The core oligosaccharide and O 
antigen contain variable polysaccharides that are species specific, some of which are 
responsible for endotoxic shock caused by some Gram-negative bacteria (Raetz and 
Whitfield, 2002). The tight packing of LPS (facilitated by mainly saturated alkyl chains), 
coupled with its non-fluid phase, plays a key role in the barrier function of the OM (Nikaido, 
2003).   
Proteins are also prevalent within the OM and can generally be divided into two classes, 
lipoproteins and β-barrel proteins. Lipoproteins are surface exposed proteins that possess 
acyl chains attached to an N-terminal cysteine residue that insert within the membrane, 
acting as an anchor (Sankaran and Wu, 1994). The E. coli proteome consists of around 100 
OM lipoproteins, the functions of many of which are not known (Weiner and Li, 2008). β-
barrel proteins otherwise known as OMPs are integral OM proteins that form a β-barrel 
conformation via curved beta sheets. The porins are a class of these OMPs that span the OM 
allowing passive diffusion of hydrophilic molecules smaller than 600 Da across the OM 
(Schirmer, 1998).  
Its role as a protective barrier is the only known function of the OM yet it is very effective in 
this respect, essential for survival of bacterial in hostile conditions and inferring higher 
antibiotic resistance than Gram-positive bacteria. 
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1.1.1.2 The Periplasm 
An aqueous domain between the OM and IM, the periplasm contains a high density of 
proteins and as such is more viscous than the cytoplasm (Mullineaux et al., 2006). These 
proteins are involved in substrate transport as well as chemotaxis, envelope biogenesis and 
the respiratory chain. Within the periplasm is also a thin peptidoglycan layer, made up of 
repeating units of the disaccharide N-acetyl glucosamine-N-acetyl muramic acid cross-linked 
by pentapeptide side chains (Vollmer et al., 2008). The peptidoglycan’s main function is to 
confer rigidity to the bacterial cell. 
 
1.1.1.3 The Inner Membrane (IM) 
The IM is the innermost layer of the cell envelope with its inner leaflet in contact with the 
cytoplasm. It is a phospholipid bilayer containing around 15% of all cellular proteins (Lopez-
Campistrous et al., 2005). These proteins are involved in a diverse range of essential cellular 
processes such as energy production, lipid biosynthesis, protein secretion and transport.  
The amphiphilic nature of the phospholipid bilayer and absence of un-gated proteins 
channels means it acts as an effective barrier for both small polar/hydrophobic substances 
and larger molecules. Exchange of molecules between the cytoplasm and periplasm is made 
possible through selective transport across the IM by α-helical integral IM proteins.  
Bacteria lack intracellular organelles and thus many of the processes associated with them 
in eukaryotic cells (such as energy production in the mitochondria) are carried out at the IM. 
Generating the energy used for many cellular processes is a vital function of the bacterial 
IM; utilising the electron transport chain to produce adenosine triphosphate (ATP) from 
adenosine diphosphate (ADP) and an inorganic phosphate (Pi). The electron transport chain 
is the final step in the aerobic respiratory process and where the majority of the ATP is 
produced. In E. coli it is located in the IM and consists of two distinct enzyme types: a 
dehydrogenase that oxidises an electron donor (such as NADH) and a cytochrome oxidase 
responsible for reducing an electron acceptor. It also contains the lipophilic cofactor 
ubiquinone which transfers electrons between the dehydrogenase and oxidase. Oxygen 
usually acts as the electron acceptor (in aerobic conditions), but in its absence other 
substances such as nitrate, nitrite, trimethylamine-N-oxide, dimethyl-sufloxide, and 
    22 
  
fumarate can act as anaerobic electron acceptors through one or more substrate specific 
terminal reductase enzymes. The electron flow from this process results in the ejection of 
protons from the cytoplasm to the periplasm, creating a proton gradient across the IM 
(Figure 1.2). The IM is virtually impenetrable to protons and the resulting membrane 
potential is known as the proton motive force (PMF). ATP synthase (a proton conducting 
channels within the IM) allows ejected protons to flow back through the IM and the energy 
acquired is harnessed by the ATP synthase to produce ATP from ADP and Pi (Mitchell, 1961). 
In E. coli around 4 protons are moved across the IM per molecule of ATP that is made by 
ATP synthase (Steigmiller et al., 2008).  
 
 
Figure 1.2 Energy conservation via oxidative phosphorylation at the Gram-negative IM.  The 
electron transport chain, consisting of dehydrogenase and oxidase enzymes and a lipophilic cofactor 
quinone, oxidises an electron donor (such as NADH) transferring the electrons to the electron 
acceptor O2. A concurrent translocation of protons across the IM results in a H
+ ion gradient 
generating the PMF. ATP synthase allows protons to flow down the electrochemical gradient utilizing 
the kinetic energy to drive synthesise ATP. 
 
The purpose of electron transport is to generate ATP. The chain itself does not directly 
result in ATP production but establishes a PMF from which ATP synthesis is driven. Electron 
transport can progress in broken up membranes to completion, however, an intact 
membrane is required for the generation of the PMF and concurrent production of ATP. 
Maintaining the integrity of the IM is therefore paramount for energy conservation. 
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1.1.2 Cell envelope stress responses  
As outlined above, the cell envelope is the site of a variety of functions, many of which are 
vital for the cell’s viability. It is therefore of paramount importance for bacteria to maintain 
the integrity of the cell envelope and a number of stress response systems have evolved to 
that functional extent. In E. coli the σE, Cpx, Bae, Rcs and Psp responses are current known 
stress responses involved in maintenance, adaptation and protection of the bacterial 
envelope (Raivio, 2005).  This study focuses on the Psp response which will be described in 
detail in Section 1.3. A brief outline of the other four Gram-negative envelope stress 
responses is given below. 
 
1.1.2.1 The SigmaE (σE) response 
The SigmaE (σE) response senses and responds to misfolded OMPs in either the periplasm or 
OM. The response is also observed under high temperature, exposure to ethanol, osmotic 
and oxidative stress. These conditions are thought to result in the inducing misfolded OMP 
signal (Raivio and Silhavy, 1999). Recent investigations have also observed off-pathway 
intermediates in lipopolysaccharide transport and assembly as an activating signal (Lima et 
al., 2013). The σE response is required for viability when exposed to both heat shock and low 
temperatures (Penas et al., 1997), with a major physiological role of maintaining the 
integrity and functions of the envelope. The system consists of the sigma factor σE, α-sigma 
factor RseA, periplasmic protein RseB, and the proteases DegS and YaeL. Under non-
inducing conditions σE is inactivated forming an inhibitory RseA-σE complex localised in the 
IM and reinforced by a periplasmic interaction between RseA and RseB.  Upon induction σE 
is released from the inhibitory complex by two cooperative mechanisms. RseB is titrated 
away from RseA through interactions with intermediates in lipopolysaccharide transport in 
the periplasm causing the RseA-σE interaction to weaken. Concurrently OMPs directly 
activate DegS to proteolytically degrade RseA and release σE (Alba and Gross, 2004, Walsh 
et al., 2003, DeLasPenas et al., 1997, Lima et al., 2013). SigmaE is then free to bind RNA 
polymerase and activate transcription of σE-dependent genes. These targets include 
promoters of envelope folding factor FkpA and degrading factor DegP (Lipinska et al., 1988) 
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to directly combat misfolded OMPs, and the rseABC operon facilitating autoregulation of the 
system (Raivio and Silhavy, 1999).  
 
1.1.2.2 The Cpx system 
The Cpx response is composed of the CpxR response regulator and the CpxA sensor histidine 
kinase along with the periplasmic protein CpxP. The activating signal of the system is IM 
associated aggregates of misfolded proteins. These are caused by over production of 
lipoprotein NIpE, P pili synthesis, cell adhesion and alkaline pH (Snyder et al., 1995, Raivio, 
2014). When in the uninduced state CpxA acts as a phosphatase on CpxR, keeping it inactive 
by preventing phosphorylation. CpxP inhibits activation of CpxA via an unknown mechanism. 
Upon induction CpxP is degraded by DegP de-repressing CpxA autokinase ability, enabling it 
to phosphorylate CpxR. Phosphorylated CpxR then binds to DNA to regulate transcription. 
Genes involved in periplasmic protein folding and degrading, along with peptidoglycan 
metabolic enzymes are upregulated. Envelope-localized protein complexes (pili and flagella) 
are downregulated (Vogt and Raivio, 2012). 
 
1.1.2.3 The Bacterial adaptive response (Bae) pathway 
Similarly to the Cpx response the Bae is a two-component system comprising of a histidine 
kinase sensor and response regulator, BaeS and BaeR respectively (Nagasawa et al., 1993). 
The stress response is induced upon exposure to ethanol, indole, iron and antimicrobials 
(Appia-Ayme et al., 2011). Under inducing conditions IM bound BaeS senses the 
environmental change and transduces the signal to the cell by phosphorylating the 
transcription factor BaeR. This increases the affinity of BaeR for DNA initiating transcription 
of target genes. The response activates expression of 8 genes including those encoding for 
transporters, a periplasmic protein, and both BaeS and BaeR (Nishino et al., 2005, Leblanc et 
al., 2011). The system has been shown to play an important physiological role in metal 
homeostasis, particularly with respect to combating high extracellular zinc concentrations 
(Wang and Fierke, 2013). 
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1.1.2.4 The Rcs system 
Implicated in antibiotic resistance (Laubacher and Ades, 2008), the Rcs multicomponent 
phosphorelay modulates gene expression. It is induced by peptidoglycan stress, 
hyperosmotic shock, interactions with solid surfaces and exposure to acidic conditions 
(Majdalani and Gottesman, 2005, Majdalani et al., 2002). Inducing signals are sensed by the 
OM lipoprotein RcsF or by the IM sensor kinase RcsC resulting in phosphorylation of the 
cytoplasmic response regulator RcsB (Castanie-Cornet et al., 2006, Takeda et al., 2001). 
RcsB-RcsB and RcsB-RcsA dimers regulate expression of target genes including those 
encoding the colonic acid synthesis pathway and the genes rprA, osmC and ftsZ. 
Transcription of flhDC the master regulator of flagella is repressed (Soutourina and Bertin, 
2003, Francez-Charlot et al., 2003, Laubacher and Ades, 2008).  
 
1.2 The Phage shock protein (Psp) response 
The Phage shock proteins (Psp) response is a widely distributed and highly specialised stress 
response reacting to IM stresses subjected to the cell. Discovered in Peter Model’s 
laboratory while investigating filamentous phage f1 infection of E. coli (Brissette et al., 
1990), the term Phage shock protein response arose from the observed up-regulation of a 
25 KDa protein upon phage infection. This protein was named Phage shock protein A (PspA). 
Over the last two decades there has been great progress in characterising the Psp response, 
notably in respect to regulation, induction and expression of the system. However, 
determining exactly how the Psp response acts to maintain the integrity of the IM has yet to 
be established and thus forms the basis of this study. This section gives a brief overview of 
the response followed by a more comprehensive look at transcription, regulation, induction, 
effector function and conservation of the system. 
 
1.2.1 A brief overview and components of the Psp response 
One of the more complex envelope stress responses, the Psp response has found to be 
conserved in a number of Gram-negative bacteria but is predominantly studied in E. coli and 
Yersinia enterocolitica. In E. coli (which this study focuses on) the response primarily consists 
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of the effector and negative regulator PspA, integral membrane signal transducer proteins 
PspB and C and the transcriptional activator protein PspF. Proteins PspD, PspE and PspG are 
also part of the response but their precise functions are as yet not known. The genes coding 
for PspA, B, C, D and E lie on the psp operon (Brissette et al., 1991), expression of which is 
σ54 dependent and controlled by PspF (Weiner et al., 1995, Jovanovic et al., 1996). Under 
non-inducing conditions PspA binds to PspF forming a negative regulatory PspA-PspF co-
complex. This prevents PspF from activating transcription of the psp operon (Dworkin et al., 
2000). Exposure to inducers such as heat and osmotic shock, envelope protein 
mislocalization and proton ionophores (Joly et al., 2010b) are sensed by integral membrane 
proteins PspB and PspC resulting in an interaction with PspA (Darwin, 2012). This disrupts 
the PspA-PspF inhibitory complex and allows free PspF to activate transcription of the psp 
operon resulting in the upregulation of effector protein PspA. Then, PspA forms high-order 
oligomers that are capable of directly binding the IM, maintaining its integrity and 
preventing PMF dissipation (Yamaguchi et al., 2010, Kobayashi et al., 2007, Kleerebezem et 
al., 1996). Figure 1.3 provides a basic schematic of the Psp response in E. coli.  
 
 
Figure 1.3 Working model of the core Psp response.  The schematic presents the current 
understanding of the main interactions of proteins PspA, B, C and F upon induction of the Psp 
response. (1) IM experiences Psp inducing stress causing damage to its integrity and dissipation of 
the PMF. (2) Membrane stress is sensed by PspB and PspC. They sequester PspA to the membrane, 
disrupting the PspA-F inhibitory complex activating expression of the psp operon. (3) Upregulated 
PspA forms large oligomers that bind to the IM maintaining its integrity and restoring the PMF.  
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1.2.2 Psp response transcription regulation and the role of PspF 
The Psp response is strictly controlled at various regulatory levels. Since the expression of 
stress response proteins is only required under specific conditions, a range of specific 
mechanisms have evolved to ensure their genes are expressed only when required. 
Transcription regulator PspF plays a key role in activation of the Psp response through its 
regulatory effects on the psp operon via interaction with PspA and 54. 
 
1.2.2.1 Bacterial transcription 
Gene expression consists of two major steps: first the transcription of coding DNA into 
messenger-RNA (mRNA), followed by the translation of mRNA into proteins. It is the first of 
these steps where control of gene expression predominantly occurs. In particular, initiation 
of transcription is highly regulated in bacteria by the action of transcription factors upon 
RNA polymerase. These transcription factors can act positively or negatively and often 
influence steps leading to formation of the open promoter complex, from which de novo 
RNA synthesis can occur. 
Within bacteria, DNA is transcribed to RNA through the highly regulated transcription 
process involving the multi-subunit RNA polymerase (RNAP) protein. RNAP binds to the DNA 
promoter sequences catalysing DNA melting and resulting in the transition from a double-
stranded DNA promoter complex (the closed complex RPc), to an open transcriptionally 
active complex (the open complex RPo), followed by RNA synthesis. Bacterial RNAP core 
enzyme (E) consists of five conserved subunits: 2 α, β, β’ and ω, with an additional 
dissociable unit known as a sigma () factor. The  factor is responsible for recognition of 
specific promoter sequences by the holoenzyme (-RNAP). Sigma factors can be classified 
into two structurally unrelated families: 70 and 54 families. E. coli possesses seven sigma 
factors six of which (70(D), 24(E), 28(F), 32(H), 38(S) and 19(Fecl)) fall into the 70 family. The 
other  factor, 54(D), is part of the 54 family (Paget and Helmann, 2003). 
The 70 family sigma factors have four conserved regions, a shared transcription mechanism 
and recognise promoter sequences 10 and 35 base pairs upstream of the transcription start 
site. The family can be divided into four sub groups on the basis of gene structure and 
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function. Group 1 contains primary sigma factors essential for cell growth. In E. coli 70 is the 
primary sigma factor, constitutively expressing house-keeping genes under control of the -
35 TTGACA and -10 TATAAT promoters. Group 2 sigma factors (38(S) in E. coli) control 
transcription in the stationary phase but are dispensable for cell viability. The group 3 sigma 
factors (32(H) and 28(F) in E. coli) are more distantly related to 70 usually activating regulons 
in response to a specific signal. Finally, group 4 sigma factors (24(E) and 18(Fecl) in E. coli) 
carry out extracytoplasmic functions (Paget and Helmann, 2003). 
Expression of the psp operon in E. coli is controlled by 54(D) the only member of the 54 
family. The 54 family sigma factors differ in their primary sequence, promoter recognition, 
and transcription activation mechanism to the 70 family. First identified due to its role in 
nitrogen metabolism, 54 binds to the -24 (GG) and -12 (GC) consensus sequence (Morett 
and Buck, 1989). Regulation of σ70-dependent transcription often occurs at the level of 
RNAP recruitment. The σ70-RPc complex is short-lived and it either dissociates from the 
promoter or spontaneously isomerises to form the σ70-RPo. However, 
54 dependent 
transcription is mechanistically different. The rate-limiting step is not RPc formation but 
rather the subsequent isomerisation to the RPo. Sigma 54 requires the service of a bacterial 
enhancer binding protein (bEBP) to catalyse the formation of the RPo via bEBP ATP-
hydrolysis. Notably bEBPs usually form self-associated active hexameric complexes that bind 
upstream (typically 80-200 base pairs) of the 54 promoter to an upstream activation 
sequence (UAS) (Buck et al., 2000, Reitzer and Schneider, 2001).   
 
1.2.2.2 The psp regulon 
In E. coli the psp regulon consists of seven genes. Five genes lie on the afore-mentioned psp 
operon coding for the proteins PspA, B, C, D and E; the expression of which is directed by 
the 54 dependent pspA promoter. Adjacent to this is the pspF gene expressed from a 
divergent 70 promoter. The pspG coding sequence is separated from the psp operon with a 
separate 54 promoter (Joly et al., 2010b). The PspA promoter has two UASs located 80 and 
120 base pairs upstream of the transcription start site that are recognised and bound by 
PspF. Crucially these UASs overlap with the pspF 70 promoter sequence resulting in 
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autogenous negative regulation of pspF expression and therefore its production occurs at a 
consistently low intracellular level (Jovanovic et al., 1996, Jovanovic et al., 1997). Located 78 
base pairs upstream of the transcription start site, pspG possesses only one UAS (Lloyd et 
al., 2004). A binding site for the Integration host factor (IHF) between the promoter 
sequences and UAS’s of pspA and pspG facilitates DNA looping when IHF is bound. This 
enables UAS bound PspF to interact with the RPc (Dworkin et al., 1997). A schematic of the 
regulon can be seen below in Figure 1.4. 
 
 
Figure 1.4 The Psp regulon in E. coli. The psp operon coding for Psp proteins A-E lies adjacent to 
the pspF gene. Between the two opposing coding strands reside the pspA 54 promoter, IHF binding 
site and UAS’s required for 54 dependent transcription.  The divergent pspF 70 promoter overlaps 
with the UAS binding sites of PspF resulting in negative autogenous regulation of pspF expression. 
The PspG gene, upstream of the psp operon, contains only UAS II located 78 base pairs upstream of 
the 54 dependent transcription start site.    
 
Within the psp operon a possible transcription termination site (by means of an inverted 
repeat of 7 nucleotides) between pspA and pspB has been identified. This could account for 
the large amount of PspA produced upon induction compared to the downstream proteins 
(Brissette et al., 1991).  It is also worth noting that in E .coli, the termination codon for pspB 
(TAA) partially overlaps with the initiation codon of pspC (ATG) resulting in possible 
cotranslation. This is hypothesised to aid protein complex formation (Brissette et al., 1991). 
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Recent In silico analysis identified an amplification of this overlap to 10 nucleotides in 
Shewanella baltica. In Sodalis glossinidius a single gene is present in the place of pspB and 
pspC predicted to be a two domain chimera with one pspB and one pspC domain (Huvet et 
al., 2011). 
 
1.2.3 bEBPs and PspF 
With the psp operon under the control of a 54 promoter, a bEBP is required for expression 
of the gene products. This role is fulfilled by PspF acting as an AAA+ ATPase. Typically  AAA+ 
ATPases convert chemical energy from ATP into a biological output, generally via the 
creation of a mechanical force (Patel and Latterich, 1998). The bEBPs all contain a conserved 
200 amino acid (AA) region known as the AAA+ core containing seven conserved motifs (C1-
C7) (Morett and Segovia, 1993). C3 is where 54 is bound via a GAFTGA motif. ATP is bound 
and hydrolysed using Walker A and B motifs respectively resulting in the remodelling of 54 
for RPo formation. In addition to the central AAA+ ATPase domain, most bEBPs contain two 
extra domains: an N-terminal regulatory domain and a DNA-binding domain at the C-
terminus. The regulatory domain regulates the AAA+ domain, while the DNA-binding 
domain recognises the target promoters UAS ensuring specificity of the activator (Batchelor 
et al., 2008). The central AAA+ domain is strictly conserved across all bEBPs, however, they 
may lack the regulatory domain, DNA binding domain or both. 
 PspF is a 37 kDa, 330 residue cytoplasmic bEBP that lacks a cis-acting, N-terminal regulatory 
domain. It therefore relies on the trans-acting factor PspA to negatively-regulate the activity 
of the core AAA+ domain (Elderkin et al., 2002, Elderkin et al., 2005). Residues 1-275 make 
up the catalytic AAA+ domain containing the conserved C1-C7 motifs of bEBPs (see Figure 
1.5). The DNA-binding domain (residues 292-325) is a helix-turn-helix structural motif that 
uniquely recognises the UASs of the PspA and PspG promoters, binding and activating 54 
dependent transcription of the psp genes (Jovanovic et al., 1996, Jovanovic et al., 1999, 
Lloyd et al., 2004). 
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Figure 1.5 Domain organisations of a three domain bEBP and the two domain PspF.  The 
schematic diagram shows the three specific domains of bEBPs: the N-Terminal regulatory domain, 
central AAA+ domain (with conserved C1-C7 motifs shown) and C-terminal DNA-binding domain. 
PspF is a group IV bEBP due to lack of a cis-acting regulatory domain instead being regulated in trans. 
 
For PspF to hydrolyse ATP (providing the mechanical force to form the RPo) and hence 
activate transcription, it must oligomerize to form a catalytically active hexamer 
(Schumacher et al., 2004). Although the full nature of the self-association pathway is not 
known, hexamer formation is found to be concentration dependent and favoured in the 
presence of ATP and ADP (Joly et al., 2006, Schumacher et al., 2006). This PspF hexamer is 
able to interact with the 54-RNAP closed complex (RPc) via the GAFTGA sequence located 
within Loop 1. This motif only becomes exposed and thus able to bind the RPc within the 
ATP bound state, reverting back to a buried conformation when ADP is bound (Rappas et al., 
2006). Figure 1.6 shows the mechanism for expression of PspF through σ70 transcription and 
the role this plays in transcription of the psp operon. 
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Figure 1.6 Transcription activation of the psp regulon. Two types of sigma factor (σ70 and σ54) 
interact with a common RNAP core enzyme forming distinct holoenzymes that both play a role in 
transcription of the regulon. The σ70-RNAP can bind the pspF promoter (when PspF is not bound to 
either UAS) spontaneously forming the open promoter complex. σ54-RNAP bound to the psp operon 
promoter sequence requires the bEBP PspF to hydrolyse ATP catalysing formation of the RPo. 
    33 
  
1.2.4 PspA negative regulatory function 
The lack of a regulatory domain means PspF is unable to independently curtail its catalytic 
AAA+ ATPase activity in cis. This leads to constitutively active ATPase if not kept in check by 
external factors. PspA acts as this factor, negatively regulating PspF in trans by binding to 
the PspF hexamer and in so doing preventing ATP hydrolysis. As both the master effector 
and negative regulator, PspA has a dual and pivotal function in the Psp response. PspA, is a 
25.5 kDa peripheral IM protein able to reside in both a soluble and membrane-bound form 
(Kleerebezem and Tommassen, 1993). A basal level of PspA expression in the uninduced 
state is sufficient to bind PspF forming an inhibitory co-complex comprising of six PspA and 
six PspF subunits. This inhibitory co-complex is still able to interact with 54 but lacks full 
ATPase functionality so formation of the RPo and transcription of the psp operon is 
prevented (illustrated in Figure 1.7). Thus, in the uninduced state of the response this PspA-
PspF inhibitory co-complex prevails, keeping psp gene expression in check until inducing 
stresses are sensed. Upon induction the PspA-PspF complex is disrupted and free PspF 
activates transcription of the psp operon. The surface-exposed tryptophan residue at 
position 56 of PspF is a key binding determinant of this interaction, with a W56A mutant 
losing its PspA binding ability, resulting in unregulated PspF activity (Elderkin et al., 2005).  
Although rather an elegant regulatory system, having PspA employed as both the effector 
and negative regulator of the response leads to an interesting question.  One would think 
that the resulting upregulation of a negative-regulator after induction would result in 
prompt reformation of the PspA-PspF inhibitory complex and thus a rapid auto shut-off 
effect. Somewhat paradoxically, this is clearly not the case as continued production of pIV 
results in concurrent elevated expression of PspA (Model et al., 1997). At present no 
experimental evidence answers this question, however, the possibility of a conformational 
change of PspA or PspF upon induction creating an unfavourable PspA-PspF interaction has 
been suggested (Darwin, 2005). 
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Figure 1.7 Negative regulation of the Psp response by PspA. In the absence of PspA, binding of 
hexamer PspF to the RPc is followed by ATPase induced DNA melting. This results in a constitutively 
transcriptionally active RPo. The presence of PspA imparts transcriptional control upon the system by 
binding PspF and forming an inhibitory 6:6 co-complex. The PspA-PspF complex does not prevent 
interaction between PspF and the RPc but inhibits ATPase by PspF. Adapted from (Joly et al., 2010b). 
 
1.2.5 Release of the A-F inhibitory co-complex and roles of PspBC 
Although it is known that sensing of inducing signals results in the disruption of the PspA-
PspF inhibitory co-complex, how this is achieved is a complex and not completely elucidated 
mechanism. Under a number of inducing conditions (including secretin pIV overproduction), 
the integral membrane proteins PspB and PspC are known to play a crucial role in sensing 
and transducing the stress signal to PspA resulting in PspA-PspF inhibitory complex 
disruption (Weiner et al., 1991). However, under other inducing conditions (such as heat 
shock), PspB and PspC appear to be less important (Kleerebezem et al., 1996) implicating 
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the existence of at least two stress activated signalling pathways that result in transcription 
of the psp operon.  
Integral IM proteins PspB and PspC are both expressed from the psp operon. PspC is a 119 
AA, polytopic transmembrane protein with a cytoplasmic N-terminal domain of around 40 
residues and periplasmic (or possibly cytoplasmic (Darwin et al., 2012)) C-terminal domain 
of 55 residues (Jovanovic et al., 2010). At a markedly shorter 74 residues PspB has an N-
terminal membrane insertion with a C-terminal cytoplasmic region.  PspB and PspC have 
been shown to form a complex in cells possibly by an interaction within the trans-
membrane region (Jovanovic et al., 2010). Interestingly overexpression of PspC alone and 
both PspC and PspB concurrently result in induction of the Psp response, but overexpression 
of PspB alone has no inducing effect (Maxson and Darwin, 2006). In an E. coli ∆pspF strain 
PspC overexpression reduced the PMF, however, no observable reduction was seen with 
overexpression of PspBC (Jovanovic et al., 2010). This has led to the postulation that the 
PspBC complex acts as an antitoxin-toxin pair where PspB counteracts the negative effects 
of PspC (Brown and Shaw, 2003). 
 Direct communication between PspBC and PspA has been strongly implicated in a number 
of studies. It is thought to be responsible for relief of PspA-PspF negative regulation under 
PspBC dependent inducing conditions. Protein-protein interactions between PspA–PspC and 
PspB–PspC have been identified in a bacteria two hybrid system (Jovanovic et al., 2006, 
Adams et al., 2003). PspA–PspB interactions have only been observed in the presence of 
PspC, suggesting a central role for PspC in signal transduction to PspA. The C-terminal 
domain of PspC contains a putative leucine zipper motif. Interaction of PspC with PspA is 
abolished when this region is deleted. Also, a leucine zipper mutation of PspC limits 
induction of the Psp response in both E. coli and Y. enterocolitica (Jovanovic et al., 2010, 
Gueguen et al., 2009).  
The specific signal (or signals) sensed by PspBC is (are) not known, however, a change in the 
chemical or physical properties of the membrane upon stress is a leading candidate since no 
evidence for a regulatory phosphor-relay involving PspA and PspF has been obtained. It has 
been shown under microaerobic growth conditions that the ArcAB system contributes to 
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induction of the Psp system in a PspBC-dependent manner. Therefore two or more signals 
may be responsible for PspBC dependent induction in certain cases (Jovanovic et al., 2009).  
1.2.6 Inducers of the Psp response 
Mislocalisation of the pIV secretin encoded by filamentous phage infection was the first 
observed inducing signal of the Psp response (Brissette et al., 1990, Russel and Kazmierczak, 
1993). The pIV protein forms the OM multimeric exit channel region of the phage export 
pathway (Russel, 1994). Mislocalisation of this structure within the IM results in induction of 
the Psp response. Some bacterial OM secretins of the type II and type III secretion system 
such as PulD and OutD exhibit structural homology with pIV and also induce the Psp 
response when mislocalised within the IM (Possot et al., 1992, Russel and Kazmierczak, 
1993). The overexpression of the OM secretin YscC in Y. enterocolitica also induces the Psp 
response (Darwin and Miller, 2001). It seems likely that misloclaisation of multimeric OM 
proteins within the IM is responsible for mounting the system. 
However, a number of other inducing signals unrelated to OM secretin mislocalization have 
been observed since.  Documented inducers of the Psp response in E. coli can be seen in 
Table 1.1 illustrating the wide range of stimuli that the Psp response reacts to.  Many of 
these conditions have found to illicit the Psp response across other organisms where the 
system is conserved. Novel conditions have been documented for a number of species, such 
as alkaline shock (pH 9) in B. subtilis and macrophage infection in s. enterica (Wiegert et al., 
2001, Eriksson et al., 2003). 
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Conditions Target/effect References 
Filamentous phage infection Energy generation (Brissette et al., 1990) 
Lytic phage infection Energy generation (Poranen et al., 2006) 
Secretin production (pIV, PulD, YscC, OutD) Energy generation (Darwin and Miller, 2001) 
Late stationary growth phase at pH9 Cell envelope 
(Weiner and Model, 
1994) 
Media downshifts Energy generation 
(Model et al., 1997, 
Weiner and Model, 1994) 
Ionophores - Protonophores Energy generation (Becker et al., 2005) 
Overexpression of ATP synthase from 
thermophilic Bacillus PS3 in E. coli 
Energy generation 
(Kobayashi et al., 2007) 
Contact-dependent growth inhibition  
Cell envelope, energy 
generation 
(Aoki et al., 2009) 
Verapamil, dibucaine 
Abolish PMF and decrease 
intracellular ATP conc. 
(Andersen et al., 2006) 
Addition of CORM-3 [Ru(CO)3Cl(glycinate)] 
Inhibits bacterial aerobic 
respiration 
(Davidge et al., 2009) 
Biofilm formation 
Cell envelope; energy 
generation 
(Beloin et al., 2004) 
Persister cells 
Multidrug tolerance, biofilm 
formation 
(Keren et al., 2004b) 
Ethanol, Methanol (5%, 10%)  
Cell envelope, fatty acid 
composition 
(Brissette et al., 1990) 
Hydrophobic organic solvents  Cell envelope (Kobayashi et al., 1998) 
Hyperosmotic shock (sucrose, NaCl) Cell envelope (Bidle et al., 2008) 
Extreme heat shock (48-50 C) Cell envelope (Brissette et al., 1990) 
Sodium azide, CCCP, Sec mutants, Tat mutants, 
YidC mutants 
Block of protein secretion 
(DeLisa et al., 2004) 
Free fatty acids; fatty acid elongation mutant 
(fabl) 
Cell envelope; disorder 
phospholipids  
(Kleerebezem et al., 
1996) 
Diazaborine, cerulenin 
Cell envelope; Inhibition of 
phospholipid biosynthesis 
(Bergler et al., 1994) 
Globomycin 
Cell envelope, inhibited 
processing of lipoproteins 
(Bergler et al., 1994) 
Lipoprotein Llp mislocalization 
Cell envelope, energy 
generation 
(Robichon et al., 2003) 
Overexpression of mislocalized OM porins 
mutant (LamB PhoE) 
Cell envelope, energy 
generation 
(Carlson and Silhavy, 
1993, Kleerebezem et al., 
1996) 
Overexpression of YedR Cell envelope (Bury-Mone et al., 2009) 
rpoE mutants  
Cell envelope, energy 
generation 
(Egler et al., 2005) 
Divalent metal chelator TPEN Energy generation (Sigdel et al., 2006) 
Lack of HSP synthesis (
32
 mutants) 
Prolonged Psp response 
under stress 
(Brissette et al., 1991, 
Weiner et al., 1991) 
Low level expression of CobS from salmonella 
and archaea  
Metabolism, coenzyme B12 
synthesis 
(Maggio-Hall et al., 2004) 
Overexpression of PspC (and PspBC) Loss of psp-negative control 
(Maxson and Darwin, 
2006) 
Overproduction of PspF Activation of psp promoters (Jovanovic et al., 1996) 
Overproduction of ArcA or ArcB Activation of PspBC sensors (Jovanovic et al., 2009) 
 
Table 1.1 Reported inducing conditions of the Psp response in E. coli. 
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It can be seen that over the years a plethora of inducing conditions for the Psp response 
have been identified. The likely existence of a unifying signal manifested by all the inducers 
listed in Table 1.1 has been suggested by many studies, but as yet has not been identified. 
Several studies have indicated that dissipation of the PMF may act as the inducing signal 
(Darwin, 2005, Darwin, 2007). This was supported by the fact that many inducing conditions 
of the Psp response affect the PMF and that PspA (effector protein of the system) is able to 
suppress proton leakage In Vitro (Kobayashi et al., 2007). This also suggested a possible PMF 
regeneration function of the system. However, it has recently been shown that dissipation 
of the PMF alone is not sufficient to induce the Psp response in E. coli (Engl et al., 2011). The 
continual induction of Psp in pIV-producing cells also supports the case for an inducing 
signal other than PMF dissipation. It is likely that an upstream signal that precedes a drop in 
the PMF may be responsible for induction of the response. As described earlier, PMF 
generation occurs across the gram-negative IM and thus stress and/or damage to the IM 
can result in disruption of the PMF. Many, if not all of the inducing conditions affect the 
integrity of the IM. A resulting chemical or physical change in the IM may therefore be the 
inducing signal that is sensed. 
 
1.2.7 PspA and its effector function in the Psp response 
1.2.7.1 PspA structure 
The effector and biological function of the Psp response is arguably the most important, yet 
least well understood aspect of the system. As earlier mentioned, PspA is a vital component 
in the Psp response acting as both a negative regulator and major effector. Induction of the 
Psp response results in significant upregulation of PspA expression with cellular amounts 
increasing over 100-fold (Lloyd et al., 2004). This is achieved through PspF activated, σ54 
dependent transcription of the psp operon. A transcription termination site between pspA 
and pspB results in stochastic dissociation between the chromosome and the transcriptional 
machinery. Thus, PspA expression is markedly increased compared with PspB, C, D and E 
(Joly et al., 2009). 
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The peripheral IM protein PspA consists of 222 AAs. No experimental high resolution 
structural data for the protein fold is currently available, but in silico analysis has predicted a 
highly helical coiled-coil structure (Dworkin et al., 2000). This is also observed in a predicted 
structural model of PspA obtained from the I-TASSER server (Zhang, 2008) shown in Figure 
1.8B. Using structural alignments and coiled-coil structural prediction programs, four 
putative helical domains (HD1-HD4) were identified within the protein (Elderkin et al., 2005) 
(Figure 1.8A). HD 1-3 are required for PspF binding and subsequent repression of ATPase 
activity, while the presence of all 4 helical domains is necessary for high-order oligomer 
formation (Joly et al., 2009, Elderkin et al., 2005).  
 
 
Figure 1.8 Predicted structure of PspA. (A) Schematic showing the four predicted alpha helical 
domains (HD1 to HD4) of PspA obtained using the COILS program (Elderkin et al., 2005). (B) 
Predicted structure of PspA obtained using the I-TASSER structure prediction software coloured from 
blue (amino terminal) to red (carboxy terminal). Location of the initial residue from each predicted 
helical domain in part A is labelled on the model. 
 
1.2.7.2 Oligomerization and its link to effector function 
Purified PspA (in the absence of PspF) has been found to form high-order oligomers over 1 
MDa in weight. When visualised in separate low resolution electron microscopy (EM) 
studies two different structures were observed. Hankamer et al. (2004) reported an 
oligomeric ring with 9-fold rotational symmetry, an outer diameter of 20 nm, inner diameter 
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of 9.5 nm and height of 8.5 nm. When correlated with a size exclusion chromatography 
mass of 1023 kDa it was proposed each symmetrical domain consisted of 4 PspA units giving 
a 36-mer. Standar et al. (2008) found hollow, prolate spheroidal, scaffold-like particles 
around 30-40 nm in diameter with a clathrin-like surface pattern. Images of the observed 
structures found in each study are shown in Figure 1.9 below. The difference in apparent 
structures may be attributed to the variation in detergent used between the studies and the 
methods of size fractionation employed prior to EM imaging. 
 
 
Figure 1.9 Negative stain EM studies of PspA oligomerization. (A) Top and side view of PspA 
oligomeric rings, with nine-fold rotational symmetry (Hankamer et al., 2004). Class averages of the 
single particle projections are shown on the left panels with surface-rendered views shown on the 
right. (B)  Survey (top) and close-up (bottom) view of single and bipartite PspA scaffold-like 
oligomers (Standar et al., 2008). 
 
In vivo single molecule imaging (SMI) and photobleaching studies with a GFP-PspA fusion 
protein bound at the IM also indicated the presence of high-order oligomers of varying 
stoichiometry (Lenn et al., 2011, Engl et al., 2009). In vitro fragmentation approaches have 
shown that high-order oligomerization of PspA is dependent on the presence of all four 
putative helical domains. However, fragments with N and C-terminal domain deletions form 
low-order oligomer with PspA1-186 (HD1-3) and PspA68-222 (HD2-4), producing a dimer and 
hexamer respectively (Joly et al., 2009).  
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The PspA high-order oligomer has been implicated in the effector function of the protein 
with in vitro experiments showing its ability to supress proton leakage (Kobayashi et al., 
2007). In the same experiment monomer PspA was unable to achieve the same feat, 
suggesting that a change in oligomeric state may be required for a shift to the effector 
function. 
 
1.2.7.3 Sub-cellular localisation and membrane association 
Early sub-cellular localisation experiments showed PspA evenly distributed between the 
cytoplasm and the IM (Brissette et al., 1990), demonstrating membrane binding properties. 
More recent studies have backed this up using single molecular imaging and cellular 
fractionation to show binding of PspA to the IM of E. coli and Yersinia enterocolitica (Engl et 
al., 2009, Yamaguchi et al., 2010). The latter of these studies found PspA changed from 
predominantly cytoplasmic to IM associated under stress-inducing conditions. Also 
identified were two distinct mechanisms by which PspA associates with the IM; one PspBC 
dependent (possibly responsible for regulatory effects) and another PspBC independent 
(with suspected physical implications) (Yamaguchi et al., 2010). Direct binding between 
PspA and phospholipids within the bilayer may be responsible for the PspBC independent 
IM association and has been shown in vitro using vesicles and purified PspA. Membrane 
binding by PspA was observed with vesicles containing the anionic lipids 
phosphatidylglycerol (PG) and phosphatidylserine (PS) (Kobayashi et al., 2007). Although PS 
is not very abundant (<1 %) in the E. coli IM, PG is a major species contributing 15-20 % mole 
fraction of the membrane phospholipid content thus presenting a realistic in vivo binding 
target. 
Studies employing single molecular imaging in combination with fluorescently tagged PspA 
have provided an increased special and temporal understanding of PspA’s sub-cellular 
localisation. Two classes of membrane associated PspA are observed; static complexes 
located within the polar regions of the cell, and highly mobile lateral complexes (Engl et al., 
2009). The dynamics and distribution of these two subclasses changes upon pIV induced 
stress. When uninduced PspA predominantly localises in polar regions (≈ 90 %), however, 
under stress PspA was predominantly found as slow moving lateral complexes (Mehta et al., 
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2013, Jovanovic et al., 2014d). These findings implicate two functional classes of membrane 
associated PspA; static polar complexes involved in regulation of the system via PspBC 
interaction (PspB and PspC have polar localisation (Mehta et al., 2013)), and dynamic lateral 
complexes involved in PspA’s effector function (Engl et al., 2009). 
Current knowledge of the mechanism by which PspA associates with the IM is limited, but 
some light has been shed on this area by recent study undertaken by Jovanovic et al 
(Jovanovic et al., 2014b). Two putative amphipathic helixes (α-helixes possessing a 
hydrophilic and hydrophobic face) at the N-terminus of PspA were identified; one from 
residues 2-19 (designated as ahA) and another from residues 25-42 (designated as ahB). A 
PspA mutant with an in-frame deletion of ahA (PspA∆ahA) lost membrane binding ability. 
Membrane association was also lost with a PspA V11E mutant, where a polar residue is 
introduced to the hydrophobic face of ahA. It was therefore proposed that the ahA of PspA 
is responsible for a direct membrane interaction via insertion of the hydrophobic face of the 
amphipathic helix (AH) into the membrane (Jovanovic et al., 2014b).  
 
1.2.8 Other members of the Psp response 
The majority of research in the field has focused on proteins involved in the core functioning 
system of PspABC and F, hence, functional knowledge of PspD, E and G along with the role 
they play in the Psp response is limited. PspD has been identified as a peripheral IM bound 
protein dispensable for induction of the Psp response but having possible effector functions 
(Jones et al., 2003, Jovanovic et al., 2006). PspE is a periplasmic rhodanese enzyme with no 
known regulatory or effector function (Adams et al., 2002). PspG is predicted to be an 
integral IM protein (Lloyd et al., 2004) and effector of the response but does not play an 
apparent role in transcription regulation. Overexpression of PspG upregulates genes 
involved in microaerobic and anaerobic respiration (Jovanovic et al., 2006), but its role in 
the response is yet to be established. 
The two component ArcAB system (a master regulator controlling the switch from aerobic 
to anaerobic respiration and fermentation (Malpica et al., 2006)) has been found to impart a 
major contribution to propagating the induction signal of the Psp response under 
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microaerobic conditions (Jovanovic et al., 2006). Direct protein-protein interactions 
between the sensor-kinase ArcB and PspB enhance the level of psp expression upon pIV 
production. In aerobic and anaerobic conditions the ArcAB system does not appear to play a 
significant role (Seo et al., 2007). 
 
1.2.9 Conservation of the Psp proteins and the response 
Since the initial discovery of the Psp response in E. coli, knowledge of its phylogeny and 
conservation across organisms has increased dramatically. This is especially the case within 
the last decade aided by the rise of powerful bioinformatics tools to trace evolutionary and 
conservatory traits. Experimental data documenting functioning Psp systems has been 
complimented with in silico genomic analysis to show that the psp regulon is highly 
conserved across Gram-negative bacterial and has been found in all three domains of life. 
Analysis by Darwin probing for at least two adjacent psp genes identified putative Psp 
systems in Gamma-, Delta- and Alpha-proteobacteria (Darwin, 2005). PspA, B, C and F were 
always conserved, however, conservation of PspD, E and G was limited (see Figure 1.9A). 
This lead to the proposal that PspABCF constituted the minimal functioning system (Darwin, 
2005). Later In silico work studying the evolution of the Psp response has shown a further 
increase in its conservation (Huvet et al., 2011, Huvet et al., 2009). Results suggested that 
the Psp response evolved around a core mechanism (proposed to contain only PspA and 
PspF), with additional genes co-opting into the system over time to enhance the sensing, 
signalling and effector functionalities (Huvet et al., 2011). Sampling all the bacterial species 
present in the NCBI database in 2010, 127 species were identified as containing orthologues 
of at least two Psp proteins (Including ArcAB) with 25 species possessing all 9 proteins (see 
Figure 1.10). A high level of Co-conservation between PspA and PspF was identified along 
with signs of correlated evolution of the two genes (unseen for any other components of 
the Psp response), consistent with a PspA-PspF minimal functioning system. 
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Figure 1.10 Conservation of the Psp system. (A) Putative Psp systems identified using E. coli 
TBLASTN searches. Identification was on the basis of having at least two adjacent psp genes in a 
completed bacterial genome sequence. (B) Graph showing the number of Psp and Arc orthologues 
identified in 699 analysed bacterial genomes. (C) Pie chart of the 129 organisms containing more 
than one orthologue showing the distribution of multiple protein conservation from 2 to all 9 
proteins. Figure adapted from (Darwin, 2005, Joly et al., 2010b).  
 
Psp systems with multiple protein orthologues have been identified in numerous organisms. 
Homologs of PspA alone have also been identified that have distinct functions and operate 
as part of different systems. In Bacillus subtilis the PspA homologue LiaH is a member of the 
LiaR response, expressed upon exposure of the cell to alkaline conditions (Wolf et al., 2010). 
Hyper saline conditions in Haloferax volcanii also upregulate expression of a PspA 
homologue (Bidle et al., 2008). But perhaps the most interesting and functionally diverse 
homologue of PspA is the Vesicle inducing protein in plastids (Vipp1). 
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1.3 Vesicle Inducing Protein in Plastids (Vipp1) 
First described in 1994 as a protein located in the chloroplast of Pisum sativumn (Li et al., 
1994), Vipp1 is highly conserved in both cyanobacteria and high order plants. Vipp1 contains 
an N-terminal region homologous to PspA, with a number of studies drawing parallels in 
their structures, oligomerization and function. The proteins share a common origin and, as 
some cyanobacteria possess genes coding for both PspA and Vipp1, it is thought that Vipp1 
has evolved from PspA by gene duplication (Westphal et al., 2001). While Vipp1, like PspA, 
has been implicated in membrane integrity maintenance (Zhang et al., 2012), additional 
functionality in thylakoid biogenesis has also been observed. This section examines Vipp1’s 
structure and function with comparison to that of PspA. 
 
1.3.1 Structure of Vipp1 
Vipp1 shares a common N-terminal core structure with PspA referred to as the ‘PspA 
domain’ consisting of around 220 residues (Westphal et al., 2001) (shown in Figure 1.10A). 
PspA and Vipp1 from all organisms show certain conservation in primary AA sequence 
within this PspA domain, yet the level of conservation is not high even within the same 
organism. In Synechocystis sp. PCC 6803 only 30% sequence identity and 50% sequence 
similarity between the two proteins is seen (Bultema et al., 2010). Conservation of 
secondary and tertiary structure within the PspA domain is evident as spectroscopic 
measurements and in silico predictions for Vipp1 indicate a purely α-helical coiled-coil 
structure, similar to that of PspA (Fuhrmann et al., 2009a, Bultema et al., 2010). Vipp1 does 
however have an extra C-terminal region containing an unordered coil spacer followed by 
short α-helical domain (around 30 residues in length). It has been suggested that this region 
is responsible for the proteins differing functions (Westphal et al., 2001). To ensure the 
import of the cytosolic-translated Vipp1 proteins into the chloroplasts of algae and plants, 
an N-terminal transit peptide is present in these organisms. Its removal after translocation 
means it has no bearing on the mature protein and is therefore not considered in structural 
or functional studies (Li et al., 1994).  
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Figure 1.11 Predicted domain organisation and oligomerization of Vipp1. (A) Schematic of 
Vipp1 from Synechocystis showing residues 1-222 (that share sequence homology with PspA) and an 
additional 45 AA C-terminal region consisting of a linker region and extra helical domain (labelled 
HD5). (B) Schematic illustrating the formation of Vipp1 oligomeric rings from intermediate dimers, 
tetramers and string-like structures. (C) Rings have the potential to aggregate forming double rings 
and, in some cases, rod-like structures. Figure adapted from (Vothknecht et al., 2012). 
 
Vipp1, like PspA, forms high-order homo-oligomeric rings. Studies of Arabidopsis and 
Synechocystis Vipp1 oligomers show ring structures with molecular masses up to 2 MDa, 
possessing 12-17 fold internal rotational symmetry (Aseeva et al., 2004, Fuhrmann et al., 
2009a). The EM images and structure models are shown in Figure 1.12. Ring assembly is 
independent of the extra C-terminal Vipp1 domain (Aseeva et al., 2004) and appears to be 
preceded by formation of string like structures from Vipp1 monomers, dimers or tetramers 
(see Figure 1.11B). When assembled the outer diameters of the rings vary from 25 nm to 33 
nm with a uniform height of 22 nm (Fuhrmann et al., 2009a). Individual Vipp1 rings have 
been shown to stack together forming barrel-like, double-ring structures in two separate 
studies (Aseeva et al., 2004, Fuhrmann et al., 2009a). Rod-like, multiple-ring stacking 
structures have also been observed after in vitro refolding experiments of Chlamydomonas 
reinhardtii Vipp1 (Liu et al., 2007). 
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Figure 1.12 Vipp1 high-order oligomeric states and modelled structure. (A) Class-averages of 
projection maps with imposed rotational symmetries of the 6 forms of Vipp1 oligomeric ring 
observed by (Fuhrmann et al., 2009a) in EM studies. The degree of rotational symmetry (n) of each 
ring is given in the bottom right corner of each projection. (B) Side view of double-ring structures 
observed in the same study. (C) Top and tilted-views of a modelled Vipp1 oligomeric ring with 15-
fold symmetry, images from (Bultema et al., 2010).  The oval shows one tetramer unit composed of a 
dimer of dimers. 
 
1.3.2 Phylogeny and evolution 
Phylogenetic analysis of Vipp1 shows it is found exclusively in cyanobacteria and 
chloroplasts and likely has a prokaryotic origin. While plants contain only Vipp1, many 
cyanobacterial genomes have both pspA and vipp1 genes, indicative of a requirement for 
both proteins. The vipp1 and pspA genes can be found adjacent to each other in some 
cyanobacterial genomes (separated by 162 bp in Anabaena sp. PCC 7120 (Kaneko et al., 
2001)). It has been suggested that Vipp1 has evolved in cyanobacteria from PspA by gene 
duplication (Vothknecht et al., 2012). Passage of vipp1 to plants then occurred via the 
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cyanobacterial endosymbiotic event, with pspA either absent in the original endosymbiont, 
or lost in the plant lineage shortly after. 
 
1.3.3 Vipp1 function 
After the initial observation of a chloroplast localised protein, inclinations of Vipp1’s 
function first came from the observations by Kroll et al. (2001). A large decrease in Vipp1 
expression (due to a mutated promoter region) in an Arabidopsis thaliana was found to be 
deleterious to thylakoid membrane formation (Kroll et al., 2001). Concurrently a similar 
phenotype for a vipp1 depletion mutant in Synechocystis was described as having a loss of 
thylakoid membrane content and structure (Westphal et al., 2001). These findings in two 
independent systems lead to a consensus that Vipp1 plays a vital role in thylakoid 
biogenesis. Recent work, where the first fully segregated null mutant was constructed, 
found that Vipp1 was essential for the biogenesis of photosystem I but not thylakoid 
membranes. This casts doubt on a vital thylakoid biogenesis role (Zhang et al., 2014). 
Indeed, a decrease in the Photosystem I: Photosystem II ratio and drastic effect on 
photosynthetic complexes has also been observed in Vipp1 depletion strains in other 
studies. This implicated a role in photosystem I biogenesis (Fuhrmann et al., 2009b, Gao and 
Xu, 2009). Normal thylakoid biogenesis is dependent upon the assembly of photosystem I so 
this may go some way to explain the initial observation of Vipp1’s role in biogenesis.  
In the last couple of years it has emerged that Vipp1 plays a role in the maintenance of 
membrane envelopes, significantly, a function that is shared with PspA. Vipp1 can directly 
bind membranes, and in chloroplasts is associated with the inner-envelope along with the 
thylakoid membranes (Zhang, 2012). In cyanobacteria a cytoplasmic membrane and 
thylakoid membrane localization is observed (Srivastava et al., 2005, Fuhrmann et al., 
2009a). This membrane binding appears to locally stabilise bilayer structures, maintaining 
membrane integrity in both chloroplasts and cyanobacterial thylakoid membranes 
(Vothknecht et al., 2012). This is observed in Zhang et al. (2012), an Arabidopsis vipp1 
deletion mutant had balloon-like, swollen chloroplasts relating to osmotic stress but 
expression of Vipp1 rescues the aberrant morphology.  
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Investigations into relief of protein export saturation by PspA found that expression of 
Synechocystis Vipp1 in an E. coli ∆pspA strain prevented blockage of protein translocation, 
an activity similar to that of PspA (DeLisa et al., 2004). Arabidopsis Vipp1 was also able to 
maintain the PMF in an E. coli ∆pspA mutant (Zhang et al., 2012), suggesting that Vipp1 
could functionally replace bacterial PspA. The converse does not seem possible as the PspA 
endogenously present in a Synechocystis ∆Vipp1 depletion strain is unable to compensate 
for the deficiency in Vipp1 (Gao and Xu, 2009, Fuhrmann et al., 2009b).  
Like PspA, the membrane binding function of Vipp1 has been attributed to an N-terminal 
AH. Deletion of residues 1-21 in Arabidopsis thaliana Vipp1 resulted in loss of association 
with pea chloroplast IM vesicles in vitro (Otters et al., 2013). The same deletion mutant also 
lost the ability to form high-order oligomers, leading to the assumption that Vipp1 
oligomerization may be a prerequisite for membrane association (Otters et al., 2013). 
 
1.4 Membrane-protein interactions: a biophysical perspective 
Integral IM proteins, traversing the membrane via a hydrophobic alpha helix, have been 
estimated to constitute around 18 % of the E. coli proteome (Horler et al., 2009). 
Lipoproteins, anchored into the membrane via acyl chains contribute another 2% (Juncker 
et al., 2003). These estimates can be obtained as the nature of the membrane interaction 
for each is well characterised due to their well-defined, easily identifiable and conserved 
structural motifs. However, a rational estimation of the peripheral membrane proteins 
(PMPs) within an organism is currently not possible due to the wide range of membrane 
interaction mechanisms and the vast array of structural motifs that are responsible for 
them. 
This study aims to elucidate the features that promote membrane-binding of the PMPs PspA 
and Vipp1 and the mechanisms by which this is achieved. This section therefore examines 
the general properties of lipid bilayers and biological membranes along with mechanisms of 
PMP association with the membrane. 
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1.4.1 Polar lipids and the basic architecture of biological membranes 
The lipid bilayer is the basic structure of all biological membranes, the core component of 
which are polar lipids. Though the chemical structure and distribution of polar lipid species 
within different biological membrane vary, all are amphipathic molecules consisting of a 
hydrophilic (or polar) head group and hydrophobic (or nonpolar) tail. This amphipathic 
character causes spontaneous aggregation in solution with one such adopted conformation 
being the lipid bilayer, consisting of two lipid monolayers lying back to back. In an aqueous 
environment the hydrophilic heads reside on the outside of the bilayer, maximising their 
contact with water while the hydrophobic tails are shielded from water on the inside of the 
structure (Figure 1.13).   
 
 
Figure 1.13 General structure of phospholipids and bilayer formation. (A) General chemical 
structure of a phospholipid with a polar head containing a polar motif (denoted by x) bound to a 
phosphate group. A glycerol linker connects this to the fatty acid nonpolar tails, consisting of 
saturated (in this case) or unsaturated hydrocarbon chains. (B) The simplified depiction of 
phospholipids within this thesis. (C) Structure of a lipid bilayer formed in an aqueous solution. 
 
Phospholipids are the most abundant class of polar lipids found within Gram-negative 
bacteria and most biological membranes. They are composed of two distinct fatty-acid acyl 
chains esterified to the sn-1 and sn-2 hydroxyl groups of a glycerol-3-phoshpate, with a 
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specific polar head group attached to the sn-3 position. The structures of the major head 
groups found in biological membranes with their common names and two letter 
abbreviations are shown in Figure 1.14. Due to the negative charge on the phosphate group, 
positively charged head groups result in a neutral zwitterionic phospholipid; neutral head 
groups give an anionic phospholipid. The lack of net positively charged phospholipids means 
biological membranes usually have a net negative or neutral charge. Zwitterionic 
phosphatidylethanolamine (PE), anionic phosphatidylglycerol (PG) and dianionic cardiolipin 
(CL), make up around 75%, 20% and 5% of the IM phospholipid content of E. coli 
respectively (Foss et al., 2011). 
 
 
Figure 1.14 Phospholipids commonly found in biological membranes.  The general chemical 
structure of a phospholipid along with the structure of the varying head groups found in biological 
membranes (ionisation states shown are at pH7), their common name and their two letter 
abbreviation. 
 
Just as the structure of the polar head groups of phospholipids vary within biological 
membranes, so too do the fatty acid chains. Both the length and saturation of the tails 
differs between (and even within) phospholipids, imparting key membrane properties such 
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as packing densities, intrinsic curvature and fluidity. Chains range in length from C14 to C24 
(but predominantly C14 – C18) and nearly exclusively they contain an even number of carbons 
due to synthesis from acetyl-CoA adding two carbon units at a time. Hydrocarbon chains can 
be saturated, mono-unsaturated and poly-unsaturated. The degree of bulk unsaturation of 
fatty acid chains within a membrane is of paramount importance in order to maintain the 
membrane’s fluidity. Phospholipid polar head groups and fatty acid chains relate directly to 
their packing confirmations and, hence, the physical properties of biological membranes 
(Snape et al., 2014).  
  
1.4.2 Molecular shape, aggregation and spontaneous curvature 
One can see that by varying both polar head and acyl chain type, a vast array of distinct 
phospholipid species are available to nature. Biological membranes exploit this, containing 
complex but tightly controlled phospholipid mixtures in order to ensure a bilayer stability 
and fluidity, appropriate to the membrane’s functionality as a barrier and as a host 
environment for membrane proteins. Despite this diversity, when considering aggregation, 
one can generally describe the packing of a lipid in contact with an aqueous environment 
based on their shape. This shape is given by the packing parameter ρ (Israelachvili, 1991) 
which is based on the ratio of the cross sectional area between the polar head and acyl 
chains: 
 
𝜌 =
𝜐
𝑎0𝑙𝑐
  Equation 1.1 
 
Where 𝜐 is the molecular volume of the hydrocarbon chains, 𝑎0 is the surface area of the 
head group and 𝑙𝑐 is the length of the chains. The geometries defined by the packing 
parameter give rise to spontaneous curvature upon aggregation, illustrated in Figure 1.15. 
When ρ < 1, generally due to large head groups with short, unsaturated or single chained 
tails, lipids are cone shaped and are classed as type I lipids. These lipids spontaneously form 
positive curvature away from the aqueous environment upon aggregation. A packing 
parameter > 1 occurs with lipids that have small head group cross sectional areas relative to 
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that of the chains (e.g. unsaturated chains which cause the tails to splay). This results in an 
inverse-cone shaped, type II lipid that possess negative spontaneous curvature towards the 
aqueous environment. Type I and II lipids are non-bilayer lipids due to their preference for 
assembly into non-bilayer phases, such as hexagonal structures (Hoff, 1995). However, type 
0 lipids are bilayer lipids, spontaneously assembling into planar lamellar structures with no 
curvature in aqueous solutions. Type 0 lipids are cylindrical in shape with a packing 
parameter of 1. 
 
 
Figure 1.15 Phospholipid geometry and spontaneous membrane curvature.  The three shapes of 
lipid categorised by their packing parameter p. Type I lipids are cone shaped and assemble into 
positively curved membranes. Type 0 lipids exhibit no curvature due to their cylindrical shape and 
type II lipids are inverted cones, giving spontaneous negative curvature upon assembly.  
 
1.4.3 Membrane curvature 
As described, each lipid type will form a different spontaneous curvature upon its 
association, the magnitude of which must somehow be described. Membrane curvature is 
defined by the principle curvatures c1 and c2, which are obtained from the reciprocal of the 
two perpendicular radii of a curved surface (Figure 1.16). The mean curvature (H) and 
Gaussian curvature (K) are derived from the sum and product of the principle curvatures 
respectively (see Figure 1.16). A flat surface has both zero mean and Gaussian curvature, 
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while a cylindrical surface will have positive mean curvature but zero Gaussian curvature. 
Gaussian curvature will only be non-zero when both principle curvatures are non-zero, and 
so this can only happen when in conjunction with a compensating membrane deformation. 
 
 
Figure 1.16 Defining membrane curvature at a point on the monolayer.  Equations are given for 
the principle curvatures c1 and c2 where R1 and R2 are the two perpendicular radii of a curved surface 
(shown on left), the mean (H) and Gaussian curvature (K). 
 
1.4.4 Membrane stored curvature elastic stress 
Within a monolayer the lateral pressure acting upon it varies as a function of depth 
(illustrated in Figure 1.17) and can reach several hundred atmospheres (Marsh, 2007). 
Steric, electrostatic and hydration interactions cause repulsive headgroup forces while 
thermally driven collisions in the chain region also add to the repulsive force. These are 
balanced by a strong inward pressure due to the hydrophobic effect trying to limit the 
contact between the hydrocarbon tails and water at the interface (Templer et al., 1998).  
 
    55 
  
 
Figure 1.17 Lateral pressures acting within a flat monolayer. Isotropic lateral pressure (π(z)) as a 
function of depth (z) shown. Figure adapted from (Templer et al., 1998). 
 
Measuring the lateral pressure as a function of bilayer depth (known as the lateral pressure 
profile) directly is not possible using current experimental methods. However, modelling has 
been undertaken by Cantor (Cantor, 1999a, Cantor, 1999b), and indirect methods such as 
2H-NMR (Gawrisch and Holte, 1996) and use of fluorescent probes (Templer et al., 1998) 
have also been documented. The shape of the lateral pressure profile shown in Figure 1.17 
varies depending upon the phospholipid compositions of the monolayer and so can be 
directly related to phospholipid geometry. Unsaturation of acyl-chains increases the 
outward chain pressure, an effect that is more dramatic when double bonds are close to the 
headgroup (Cantor, 1999a). Also, computational experiments suggest inverse-conical type II 
lipids reduce the positive pressure in the headgroup region with a concurrent pressure 
increase in the acyl-chain area compared with cylindrical type 0 lipids (van den Brink-van der 
Laan et al., 2004). 
Although the lateral pressure at any one point is rarely zero, for a monolayer at equilibrium, 
if all the lateral pressures π(z) acting across it are summed up then the net lateral stress will 
be equal to zero: 
 
∫ 𝜋(𝑧)𝑑𝑧 = 0  Equation 1.2 
 
Biological membranes are lipid bilayers and as such the constituent monolayers are 
constrained to lie back to back, flat against each other. If both monolayers possess no 
intrinsic curvature (e.g. composed of type 0 lipids) then bilayer formation will be 
    56 
  
spontaneous and little energy will be stored within the membrane. However, when 
monolayers containing positive or negative spontaneous curvature are held flat within a 
bilayer they are forced to adopt an unfavourable conformation. This results in the 
accumulation of torque energy stored within the bilayer (Figure 1.18).  
 
 
Figure 1.18 Curvature frustration within a bilayer formed from spontaneously positively or 
negatively curved monolayers. Monolayers come together and are forced to lie flat (driven by the 
hydrophobic effect) despite intrinsic curvature resulting in torque energy stored within the 
membrane. 
 
The torque (𝜏) acting upon a monolayer when it is constrained to lie flat is given by the first 
moment of the stress profile: 
 
 
𝜏 = − ∫ 𝜋(𝑧)𝑧𝑑𝑧 = −2𝑘𝑐0  Equation 1.3 
 
 
Where 𝑘 is the bending rigidity of the monolayer and 𝑐0is the spontaneous curvature of the 
monolayer. For 𝜏 to be equal to zero, 𝑐0 must also be zero and in this case there is no torque 
stored within the monolayer, within a bilayer this is very rarely the case. A monolayer with a 
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propensity to form positive or negative curvature will result in a torque tension being 
applied to the bilayer formed by these lipids. The magnitude of this torque tension energy is 
dictated by the degree of spontaneous curvature within the monolayer and is termed stored 
curvature elastic (SCE) stress. Thus, increasing the amount of Type II (conical) lipids in a 
bilayer composed of Type 0 lipids will increase the SCE stress. This results in the bilayer 
expanding laterally and the lipid head group area increasing above its favoured value 
exposing the hydrocarbon chains to the aqueous environment. 
Increasing the SCE stress in a bilayer results in a concurrent elevation in the total free 
energy of the membrane. The total free energy of a system consisting of lipid assemblies 
and water molecules (𝑔𝑡𝑜𝑡) can be given as: 
 
 
𝑔𝑡𝑜𝑡 = 𝑔𝑐 + 𝑔𝑝 + 𝑔𝑖𝑛𝑡𝑒𝑟 Equation 1.4 
 
 
Free energy (𝑔𝑡𝑜𝑡) is equal to the sum of membrane curvature elasticity (𝑔𝑐), packing of the 
hydrocarbon chains (𝑔𝑝) and the interactional forces (𝑔𝑖𝑛𝑡𝑒𝑟) such as electrostatic 
contributions and hydration forces (Shearman et al., 2006). 
 
1.4.5 Lipid vesicles, positive membrane curvature and lipid packing defects 
The most commonly used model membrane system for in vitro studies of protein-
membrane interactions are lipid vesicles. This is because they structurally resemble many 
cellular membrane systems and are compatible with a wide range of biochemical assays. 
Most studies use unilamellar vesicles which are composed of a single spherical lipid bilayer, 
as such the inner monolayer experiences negative curvature while the outer possesses 
positive curvature. The degree of curvature is dependent on the vesicle size. For a spherical 
vesicle, c1 and c2 are both equal to the reciprocal of the vesicles radius, thus mean curvature 
increases linearly as vesicle size decreases while Gaussian curvature increases exponentially. 
While SCE stress occurs when Type II (conical) lipids are forced to lie flat in a bilayer, an 
equivalent phenomenon arises when a monolayer containing Type 0 (cylindrical) lipids is 
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forced to adopt positive (or negative) curvature. Therefore, with vesicles composed of type 
0 lipids the SCE stress within the outer (and inner) monolayer increases as the vesicle size 
decreases. For large unilamellar vesicles (R > 50 nm) membrane curvature is minimal in 
comparison to the effect of lipid packing parameters and bilayers can essentially be 
considered flat. But, for small unilamellar vesicles (SUVs) (R < 50 nm) curvature effects are 
larger and the resulting strain on the outer leaflet is significant. 
The consensus is that the increased curvature strain leads to lipid packing defects. These are 
geometric imperfections in the bilayer where, to accommodate high curvature, exposure of 
the hydrophobic interior of the membrane to the aqueous solvent occurs (Cui et al., 2011). 
The number of these defects within a monolayer increases with positive curvature (Hatzakis 
et al., 2009) (thus smaller vesicles poses a higher density of packing defects). Interestingly, 
similar lipid packing defects are observed in flat bilayers that contain Type II lipids 
(Vamparys et al., 2013) indicating that increased SCE stress within a bilayer may manifest in 
packing defects. It has recently been shown that combining Type II lipids and positive 
curvature has a cumulative effect on the number of defects (Vanni et al., 2014). From the 
current literature it appears that lipid packing defects are directly related to the concept of 
membrane bending energy resulting from curvature frustration within a monolayer. Packing 
defects have been implicated as sites for association of PMPs. This occurs trough insertion 
of hydrophobic moieties between the exposed chains (Vanni et al., 2014, Hatzakis et al., 
2009).  
 
1.4.6 Lamellar mesophases  
Lipids self-assemble into a range of different phases depending on their chemical structures 
and external variables including temperature, pressure and water content. Broadly speaking 
these phases can be organised into two generalized categories, lamellar and non-lamellar 
phases. Biological membranes are usually lamellar bilayers. 
The lamellar phases are separated into the fluid (Lα), gel (Lβ) and crystalline or subgel (LC) 
phase depending on the lipid head-group and fluidity of the lipid chains. At very low 
temperatures most phospholipids form the LC phase which has both short-range and long-
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range order restricting any movement. As the temperature increases a phase transition to 
the Lβ phase occurs where chains are still ordered but the lipid molecules are able to rotate 
around their axis. Further temperature elevation allows transition into the Lα phase where 
chains are fully mobile and lipid molecules can readily laterally diffuse within the membrane 
(Cevc, 1993). The different lamellar phases are shown in Figure 1.19. 
 
 
Figure 1.19 Structure of lipid lamellar phases. The crystalline or subgel (Lc), gel (Lβ), tilted gel (Lβ’) 
and fluid (Lα) lamellar phases.  
 
At physiological conditions phospholipid bilayers are nearly always in a fluid (Lα) or gel (Lβ) 
state. Because of this, the Lβ-Lα transition is arguably the most biologically relevant phase 
transition and a major energetic event in lipid bilayers. It results in a large increase in lipid 
surface area and specific volume (Nagle, 1980). The phase transition temperature (Tm) is 
predominantly determined by the phospholipid’s hydrocarbon chains. Longer chains and 
higher degrees of saturation lead to higher transition temperatures as more energy is 
required to overcome the increased van der Waals force between them (Koynova and 
Caffrey, 1994). As such, in a single lipid type bilayer, phospholipids with unsaturated (or 
short saturated) chains generally form fluid (Lα) phases but those with long saturated chains 
tend to be in the gel (Lβ) phase. Saturation has much greater effect on Tm than the chain 
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length, for example,  going from 18:0 to 16:0 PC the Tm changes by 14 °C  (55 to 41 °C) while 
the Tm of 18:0 and 18:1 (9Z) PC differ by 72 °C  (-17 to 55 °C) (Jost and Griffith, 1982). 
 
1.4.7 Biological membranes and the fluid mosaic model 
While a model bilayer is portrayed as flat and symmetrical, this is seldom the case in 
biological membranes which are commonly described as a two-dimensional surface which 
spans three-dimensional space. With undulating surfaces, diverse lipid mixtures and 
asymmetrical leaflets one can appreciate their complexity before even considering the 
biophysical effects of the embedded membrane proteins, lipid mesophases and micro-
domains.  
Lipid species and compositions vary between different organisms, cell types and organelles;  
yet in 1972 Singer et al. described biological membrane using the fluid mosaic model 
providing a shared physical structure (Singer and Nicolson, 1972). This model has been the 
central paradigm of membrane biology since and describes the membrane as a two-
dimensional liquid in which phospholipids and integral membrane proteins diffuse easily. 
Observations regarding the non-uniform lateral and transmembrane organization of 
phospholipids in membranes have led to the model being updated to account for the 
resulting ordered micro-domains known as lipid rafts (Tenchov and Koynova, 1985, 
Mouritsen and Jorgensen, 1995). Lipid rafts have been characterised in vitro as micro-
domains (enriched in species such as cholesterol, sphingomyelin, saturated phospholipids 
and sphingolipids) that exist in the liquid-ordered phase (Lo), immiscible with the fluid phase 
(Pike, 2006). However, detection in vivo is problematic due to technical difficulties and as 
such their presence in cellular membranes is still debated (Munro, 2003, Silvius, 2005). 
Nevertheless IM proteins have been found to specifically partition into the liquid ordered 
(Lo) phase and it has been suggested that rafts play a role in intracellular trafficking and 
signal transduction (Salaun et al., 2005, Brown and London, 1998). 
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1.4.8 Peripheral membrane proteins (PMPs) and their membrane interactions 
It has become increasingly apparent that association of PMPs with the surface of cellular 
membranes is essential for wide ranging cellular functions. These include maintaining cell 
structure, signal transduction cascades, formation of transport vesicles and lipid metabolism 
pathways. Membrane association by PMPs may be as simple as a bimolecular interaction 
with a transmembrane protein or specific lipid head group species, or can be though non-
specific protein-membrane interactions. When in the cytosol, PMPs are surrounded by 
bilayers but to undertake their intended function targeted association to particular areas or 
types of membrane is normally required. To achieve this sensitivity a few general 
mechanisms have been identified.  
As mentioned above, protein association can occur through recognition of a specific lipid 
species within the membrane. Exploiting selectivity to a minor lipid species, enriched in 
particular membrane areas or under certain conditions, can provide targeted association. 
This type of sensing is exploited by PH and C1 protein domains which directly bind to 
phosphoinositides (PI) and diaglycerol respectively (Harlan et al., 1994, Oancea et al., 1998). 
PMPs can also use a kinetic trapping approach where a weak, non-specific anchor motif 
allows reversible association to all membrane regions. In the targeted membrane region the 
domain undergoes a molecular change that causes a substantial decrease in the dissociation 
rate. This can involve the addition of a second lipid modification such as those seen for H- 
and Nras guanosine triphosphate-binding proteins (Rocks et al., 2005). Finally proteins can 
recognise one or more membrane physiochemical parameter such as membrane charge 
density, SCE stress or curvature. 
Electrostatic protein-membrane interactions, governed by membrane charge density, are 
largely dependent on the bulk anionic lipid content of the membrane. In eukaryotes, PS is 
generally the major anionic lipid species yet, in Gram-negative bacteria PG and CL 
predominate. Anionic lipids rarely distribute evenly within cellular membrane (for example 
in E. coli the major anionic lipid species PG and specifically CL have been found to be 
concentrated in the polar regions of cells (Oliver et al., 2014)), thus electrostatics can affect 
the localization of PMPs.  Proteins that sense these anionic lipids usually contain a cluster of 
surface exposed positively charged AA residues as the lipid binding domain. Proteins such as 
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cytochrome c, non-receptor tyrosine kinase Src and Myristoylated alanine-rich C-kinase 
substrate (MARKS) protein all utilize an electrostatic component in binding (Murray et al., 
2002). Interestingly, MinD and MinE in E. coli have recently been shown to preferentially 
bind anionic lipids in vivo leading to suggestions that the membrane binding of both has an 
electrostatic component (Vecchiarelli et al., 2014). 
SCE stress due to increased conical lipid content in the membrane has been shown to be a 
key determinant in many protein-membrane interactions and can regulate protein insertion, 
folding and function. The channel-forming peptide alamethicins increased conductance 
states positively correlates with elevated SCE stress and Rhodopsin association with the 
membrane is facilitated by increased non-bilayer PE content (Botelho et al., 2002). Protein 
Kinase C and phospholipase A2 activity is augmented with an increase in SCE energy 
(Senisterra and Epand, 1993, Stubbs and Slater, 1996, Cornell and Arnold, 1996). Finally 
CTP:phoshocholine cytidylyltransferase (CCT) activity is modulated by SCE stress (Attard et 
al., 2000). The study proposed that the insertion of hydrophobic regions such as the apolar 
face of an AH into the membrane acts as a wedge reducing some of the SCE stress. Recent 
work suggests that this PMP association is at sites of lipid packing defects that are induced 
by the SCE stress (Vamparys et al., 2013). 
Membrane curvature is also sensed by a number of PMPs with the two major sensors being 
BAR domains and ALPS motifs. BAR domains are a crescent shape that sense, induce or 
stabilize membrane curvature (Bigay and Antonny, 2012). It is proposed that the entire 
concave face of the BAR domain adheres to the membrane through multiple electrostatic 
and hydrophobic interactions. In this nature, the concave face can act as a sensor for a 
complimentary convex membrane as this will allow the most binding interactions to be 
satisfied. AHs can also sense membrane curvature. The ALPS motif binds preferentially to 
curved surfaces (Drin et al., 2007), although they are more a sensor of the membrane stress 
resulting from curvature rather than only geometry specific. Binding is proposed to be 
through lipid packing defects (1.4.4) and ALPS motifs can also bind flat membranes 
containing conical lipids. 
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1.4.9 Cooperation of multiple membrane interactions 
It is often the case that in isolation a single lipid-binding domain is not sufficient to cause 
membrane partitioning of PMPs. However, by utilizing multiple membrane interactions in 
the same protein (or oligomer), a higher affinity, multivalent membrane binding interactions 
can occur. Indeed, many proteins use a combination of weak binding motifs to achieve 
targeted membrane association to one or more membrane property (McLaughlin and 
Aderem, 1995).  
Cooperative membrane binding can occur through interactions by multiple domains of the 
same protein. Multiple clusters of surface exposed positively charged residues can enhance 
an electrostatic interaction. For example, combinations of weak membrane binding domains 
with different membrane targets can lead to so called ‘coincidence detection’ where bilayer 
association only arises when both signals are present at the same membrane location (see 
Figure 1.20). This behaviour is observed with the Sorting nexin 1protein where a PX and BAR 
domain lead to specific targeting of highly curved membrane regions containing PI (Carlton 
et al., 2004). The cooperating domains do not all have to associate directly with the bilayer 
and some may interact with integral membrane proteins. Many G proteins associate with 
the membrane through insertion of a lipidated region into the bilayer and a protein-protein 
interaction with integral G protein-coupled receptors (Qin et al., 2011). Sometimes the same 
domain can also simultaneously bind two targets acting as a ‘coincidence detector’, for 
example, some PX domains have been shown to bind both PA and PI (Lemmon, 2008).  
Oligomerization of PMPs can also have a significant effect on binding through a similar 
effect of multivalent interactions. Multivalence is seen with the PH binding domain (specific 
to PI) of Dynamin. In a monomeric form the protein has a kd for PI containing membranes in 
the mM range but, upon dimerization, membrane affinity increases with the kd decreasing 
to the µM range (Klein et al., 1998). The membrane binding energies of each monomer in 
the oligomer will be additive and in this respect oligomerization can have a significant effect 
on membrane interactions. If the membrane-binding domain of the monomer is weak then 
only the oligomeric form may be able to associate with the bilayer (see Figure 1.20 for 
schematic representation). The yeast sorting nexins Vps5 and Vps17 are examples of this, 
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only being recruited to PI containing membranes when part of a multivalent complex 
(Seaman and Williams, 2002). 
 
 
Figure 1.20 Cooperation of multiple interactions to promote membrane binding. Schematic 
representing the enhanced membrane affinity of binding domains through oligomerization and 
multi-domain and single domain cooperation.  
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1.5 Project aims 
A number of outstanding issues surround the mechanistic basis of the Psp response which is 
driving current research in the field. Although regulation and induction of the response is 
relatively well characterised, the same cannot be said for the signal origin and the 
mechanism by which the upregulation of PspA expression maintains the integrity of the IM 
(preventing dissipation of the PMF). Interactions between PspA and the IM are regarded as 
a pivotal part of the mechanism of action, however, the precise biochemical and biophysical 
nature of these protein-lipid interactions is yet to be established. Recent studies on Vipp1 
have shown that the homologue of PspA also plays a role in membrane maintenance, but 
again the means by which it achieves this is unknown. Removing the putative N-terminal AH 
region of both proteins prevents membrane association, suggesting PspA and Vipp1 may 
utilize the same membrane binding mechanism as part of their protective functionalities 
(Jovanovic et al., 2014b, Otters et al., 2013). 
This study aims to address the uncertainties surrounding PspA and Vipp1 membrane 
association and the related effector functions by using purified proteins and model 
membranes to probe for determinants of the interactions in vitro. This approach allows for 
rigorous control of the chemical and biophysical properties of the membrane to identify the 
specific membrane signals sensed by PspA and Vipp1. 
Monitoring transient protein-lipid interactions is not a straight forward process and as such 
significant refinement of an existing assay, or development of a new method is often 
required. Previous in vitro studies of PspA-membrane interactions have been limited to 
basic co-sedimentation assays providing no quantitative data on partitioning. Obtaining a 
more effective method for probing PspA-membrane interactions was therefore the initial 
aim of this study. Chapter 3 details the process leading to the development of a rapid 
quantitative assay for application in the later work.  
With suitable protein-membrane interaction assay established a detailed analysis of PspA’s 
bilayer association properties can be investigated in Chapter 4. Assays will be undertaken 
varying the lipid composition to identify the membrane signals sensed by PspA and provide 
the first quantitative insights on bilayer association. Monomer/dimer PspA1-186 can be used 
to probe the effects of high-order oligomerization on membrane partitioning and PspAahA 
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mutant lacking the putative N-terminal AH can provide the first in vitro evidence of its role 
in bilayer association. 
After characterisation of PspA’s membrane binding properties, Chapter 5 will expand the 
study to Vipp1 and its membrane-binding properties. Vipp1 has been found to bind both E. 
coli and pea chloroplast lipids, however, the specific nature of the interaction is unknown.  
Using synthetic lipids Vipp1’s bilayer partitioning will be probed providing the principal 
study of the protein’s sensitivity to membrane composition. Comparison of the resulting 
data with that of PspA will reveal the similarities and differences in membrane sensing of 
the two proteins and provide information on their relative bilayer affinities.    
Following on from the results of Chapters 4 and 5, which strengthen the evidence for 
membrane association through the putative N-terminal AHs of PspA and Vipp1, Chapter 6 
aims to show a direct interaction between this region and the membrane. Once observed, 
the binding properties of the isolated regions can be studied using peptides with an aim to 
identify AH traits such as helical folding upon membrane association. The availability of 
purified PspA and Vipp1 peptides also present opportunities to probe the effect that their 
association has on the membrane. Isolated peptide concentrations much higher than the 
full length proteins can be achieved in solution mimicking the levels seen in cells when the 
response in activated.  
Finally, in Chapter 7 the role of the membrane on PspA’s negative regulatory function is 
investigated. Disruption of the PspA-PspF inhibitory complex (through PspA being 
sequestered to the membrane via PspB and PspC) is thought to be the major mechanism of 
releasing negative control following the inducing signal. However, the induction of the Psp 
response can also occur in the absence of PspB and PspC when the plasma membrane stress 
is severe. We hypothesised that PspBC independent induction may be a result of direct 
PspA-membrane interactions. By using transcription assays and native-PAGE band shift 
assays incorporating vesicles, the association and activity of the A-F inhibitory complex can 
be monitored as a function of membrane composition. Together this data can make a 
significant impact on the current understanding of PspA’s and Vipp1’s properties along with 
their associated effector functions.  
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Chapter 2: Materials and Methods 
2.1 Materials 
2.1.1 Media 
Media used for bacterial growth was prepared in accordance to Table 2.1. The weighed dry 
components were mixed first before addition of dH2O immediately prior to autoclaving.  
 
Medium Composition 
LB (Luria Bertani Broth) 10 g/L peptone, 5 g/L NaCl, 5 g/L yeast extract 
LA (LB agar) 10 g/L peptone, 5 g/L NaCl, 5 g/L yeast extract, 18 g/L 
agrose 
 
Table 2.1 Composition of media used in protein expression. 
 
2.1.2 Antibiotics 
Antibiotic stock solutions were prepared by dissolving antibiotic salt in solvent to the 
desired concentration followed by filter sterilisation. Stocks were stored at -20 °C and added 
to media when required at the following concentrations: 
Antibiotics Stock solution 
Final 
Concentration 
Ampicillin 50 mg/mL in dH2O  50 mg/L 
Kanamycin 50 mg/mL in dH2O  50 mg/L 
Chloramphenicol 25 mg/mL in ETOH 25 mg/L 
 
Table 2.2 Antibiotics used in this study. Compositions of stock solution and final concentrations 
used during inoculation are given. 
2.1.3 Buffers 
The compositions of the buffers used in this study can be seen in Table 2.3. All buffers were 
prepared with dH2O and filtered through a 0.2 µm membrane before use unless stated 
otherwise. 
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Buffer Composition Used For 
PspA Resuspension 
Buffer 
100 mM Tris-HCl pH 7.5, 50 mM NaCl, 75 
mM NaSCN, 5 % (v/v) glycerol  
Protein purification (cell 
pellet resuspension) 
PspA Assay Buffer 
20 mM Tris-HCl pH 7.5, 200 mM NaCl, 75 
mM NaSCN, 0.005 % (w/v) CHAPS†, 5 % (v/v) 
glycerol 
 Assay buffer for PspA 
and related proteins 
PspA Extraction 
Buffer 
100 mM Tris-HCl pH 7.5, 500 mM NaCl, 75 
mM NaSCN, 1% (w/v) CHAPS  
Protein purification 
(solubulization of  
membrane fraction) 
PspA Purification 
Buffer A 
100 mM Tris-HCl pH 7.5, 500 mM NaCl, 75 
mM NaSCN 
Protein Purification 
PspA Purification 
Buffer B 
100 mM Tris-HCl pH 7.5, 500 mM NaCl, 75 
mM NaSCN, 1 M imidazole 
Protein Purification 
Vipp1 Assay Buffer  
20 mM Tris-HCl pH 7.5, 200 mM NaCl, 75 
mM NaSCN, 5 % (w/v) glycerol  
Assay buffer for Vipp1 
and related proteins. 
PspF Resuspension 
Buffer 
25 mM Tris-HCl pH 7.5, 500 mM NaCl, 5 % 
(w/v) glycerol 
Protein purification (cell 
pellet resuspension) 
PspF Assay Buffer 
20 mM Tris-HCl pH 7.5, 200 mM NaCl, 5% 
(w/v) glycerol 
Assay buffer for PspF1-275 
and related proteins 
PspF Buffer A 
20 mM Tris-HCl pH 7.5, 500 mM NaCl, 5% 
(w/v) glycerol  
Protein Purification 
PspF Buffer B 
20 mM Tris-HCl pH 7.5, 500 mM NaCl, 5% 
(w/v) glycerol, 1 M imidazole 
Protein Purification 
PBS Buffer 
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.8 mM KH2PO4, pH 7.4 
Peptide studies and lipid 
extraction 
STA Buffer 
25 mM Tris-acetate, pH 8.0, 8mM Mg-
acetate, 10 mM KCl, 3.5 % (w/v) PEG 6000 
spRNA assays 
ATPase Buffer 
25 mM Tris-HCl pH 8.0, 100 mM KCl, 10 mM 
MgCl2, 1 mM DTT 
ATPase assays 
TM Buffer  10 mM Tris-HCl pH 8.0, 10 mM MgCl2 DNA duplex formation 
 
Table 2.3 Composition of buffers used in this study.† CHAPS stands for 3-[(3-
Cholamidopropyl)dimethylammonio]-1-propanesulfonate. Buffers containing CHAPS were filtered 
prior to addition of CHAPS to prevent excess foaming. ‡ DTT stands for DL-Dithiothreitol. 
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2.1.4 Kits 
The following kits were used in this study: 
Kit Producer Used 
QIAprep® Spin Miniprep Kit Qiagen Purification of plasmid DNA 
DC Protein Assay Bio-Rad Determining protein concentration  
Westar Supernova Cyanagen 
Western Blotting - Chemiluminescent 
Detection of HRP Conjugates  
Agilent Protein 230 Kit Agilent Determining protein concentration  and purity 
 
Table 2.4 Commercially available kits used in this study. 
 
2.1.5 Lipids 
2.1.5.1 Synthetic phospholipids 
Synthetic phospholipids used within this study are listed in Table 2.5. All lipids were 
purchased in powder form and stored at -20 °C. Once the vials of supplied phospholipid 
were opened the powder was dissolved in chloroform within clear glass vials to give a stock 
solution of between 1-10 mg/mL. Vials were sealed and wrapped with Parafilm to prevent 
any water vapour from entering and stored at -20 °C. 
Phospholipid Abb. Formal Name Company 
Phosphatidylcholine  PC   
PC(14:0/14:0) DMPC 1,2-ditetradecanoyl-sn-glycero-3-
phosphocholine 
Avanti 
PC(16:0/16:0) DPPC 1,2-dihexadecanoyl-sn-glycero-3-
phosphocholine 
Sigma 
PC(18:1(9Z)/18:1(9Z)) 
DOPC 1,2-di-(9Z-octadecenoyl)-sn-glycero-
3-phosphocholine 
 
Avanti/ 
Sigma 
Phosphatidylethanolamine  PE   
PE(18:1(9Z)/18:1(9Z)) DOPE 1,2-di-(9Z-octadecenoyl)-sn-glycero-
3-phosphoethanolamine 
Sigma 
PE(16:0/16:0) – NBD 
Labelled 
NBD-PE 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(7-nitro-2-
1,3-benzoxadiazol-4-yl) 
Invitroge
n 
Phosphatidylglycerol PG   
PG(18:1(9Z)/18:1(9Z)) DOPG 1,2-di-(9Z-octadecenoyl)-sn-glycero-
3-phospho-(1'-rac-glycerol)  
Avanti 
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Phosphatidylserine    
PS(18:1/18:1(9Z)) DOPS 1,2-di--(9Z-octadecenoyl)-oleoyl-sn-
glycero-3-phospho-L-serine 
Sigma 
Cardiolipin CL   
CL(1'-
[14:0/14:0],3'[14:0/14:0]) 
CL 
1,1',2,2'-tetramyristoyl cardiolipin  
Avanti 
 
Table 2.5 Synthetic phospholipids used in this study. 
 
2.1.5.2 Lipid extracts 
Lipids extracted from organisms that were used within this study are listed in Table 2.6. 
Purchased extracts were in powder form and handled as described above in 2.1.5.1. Lipids 
extracts from this work were obtained by growth of the desired strains in LB before 
extraction via an adapted Bligh-Dyer technique (see 2.2.9.4). 
Organism/ Extract  Composition (major phospholipids) Source 
E. coli Total lipid extract 
(TLE) 
PE: 57.5% (w/w),  PG: 15.1 %, CA: 9.8 %, 
Unknown: 17.6 % 
Avanti 
E. coli WT lipid extract See mass spec data (chapter 4) This work 
E. coli cls lipid extract See mass spec data (chapter 4) This work 
E. coli pgsA lipid extract 
See mass spec data (chapter 4) 
 
This work 
Soy PC PC(18:2): 63.0 %, PC(16:0): 15.9 %, PC(18:1): 
11.4 %, PC(18:3): 5.7%, PC(18:0): 3.7 % 
Avanti 
MGDG (Plant) 
MGDG (18:3/16:3): 66.8 %, MGDG (18:3/18:3): 
14.1 %, MGDG (18:2/16:3): 12.9 %, MGDG 
(18:2/18:3): 3.2 %, MGDG (16:1/18:3): 3.0 % 
Avanti 
DGDG (Plant) 
DGDG (18:3/18:3): 44.5 %, DGDG (18:3/16:3): 
21.3 %, DGDG (18:2/18:3): 10.7 %, DGDG 
(18:3/16:0): 9.7 %, DGDG (18:2/16:3): 7.0%, 
DGDG (18:3/16:1): 6.9% 
Avanti 
 
Table 2.6 Lipid extracts used in this study. 
 
2.1.6 Peptides 
Peptides were purchased from Insight Biotechnology and supplied in powder form at ≥95 % 
purity (confirmed via HPLC).  The peptides used in this study along with their amino acid 
sequences and suppliers stated purity can be seen in Table 2.7. 
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Name # Residues Amino Acid Sequence Purity (%) 
PspA2-19 18 GIFSRFADIV NANINALL 95.14 
PspA1-24 24 MGIFSRFADI VNANINALLE KAED 95.78 
Vipp12-19 18 GLFDRLGRVV RANLNDLV 96.01 
Vipp11.24 24 MGLFDRLGRV VRANLNDLVS KAED 95.43 
PspA25-47 23 PQKLVRLMIQ EMEDTLVEVR STS 96.68 
PspA1.40 40 
MGIFSRFADI VNANINALLE KAEDPQKLVR 
LMIQEMEDTL 
95.56 
PspA1-24 V11E 24 MGIFSRFADI ENANINALLE KAED 95.68 
PspA1-24 F4E 
V11E  
24 
MGLEDRLGRV VRANLNDLVS KAED 95.16 
 
Table 2.7 Peptides used within this study. Number of residues, amino acid sequence and supplied 
purity (determined by HPLC) is shown.  
 
2.1.7 Bacterial strains and plasmids 
Bacterial strains and plasmids used in this study are listed in Table 2.8 below: 
Strain or 
plasmid 
Relevant characteristics Reference 
Strain     
MG1655 WT  CGSC# 7740 
MVA115 
MG1655 cls (Cardiolipin synthase)  
MG1655 cls::kan (kanr) 
(Jovanovic et al., 
2014c) 
UE54 
MG1655 pgsA 
(Phosphotidylglycerophosphate synthase)  
MG1655 lpp-2 ara714 rcsF::mTn10cam 
pgsA::kan (camr, kanr) 
(Shiba et al., 2004) 
 
BL21 
E. coli cells designed for high-level 
expression of non-toxic recombinant 
proteins. IPTG regulated expression of T7 
RNA polymerase 
Laboratory collection 
Plasmid     
pSLE18 A pET28b+ harbouring PspA
 
WT (kan
r
) (Elderkin et al., 2002) 
pSLE PspA1-186 pET28b+ harbouring PspA
1-186
 (kan
r
) (Elderkin et al., 2005)  
pET28-AahA pET28b+ harbouring PspA
ahA
 (kan
r
) 
(Jovanovic et al., 
2014b) 
pPB1  pET28b+ harbouring PspF
1-275 
(kan
r
) (Bordes et al., 2003) 
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pGJ98 pET28b+ harbouring VIPP1
WT 
(kan
r
) This work 
pGJ99  pET28b+ harbouring VIPP1
ahA 
(kan
r
) This work  
 
Table 2.8 Bacterial strains and plasmids used in this study. 
 
 
2.2 Methods 
2.2.1 Protein, peptide and DNA gels 
2.2.1.1 SDS – Polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein samples were mixed in an equal volume of 2X Laemmli Buffer (Sigma) and heated at 
95 °C for 5 minutes (min) to denature protein samples. Samples were loaded on 10 % or 
12.5 % resolving polyacrylamide SDS gels with a 4.5 % stacking phase in a Tetra Cell system 
(Bio Rad) with low range SDS-PAGE standards (Bio Rad) used as markers. Gels were run in 1x 
Tris/SDS/Glycine running buffer (National Diagnostics, 25 mM Tris, 192 mM glycine, 0.1 % 
(w/v) SDS) at 180 volts (V) for 60 min and stained with Coomassie Brilliant Blue solution or 
Sypro ruby protein stain (Bio Rad). The components and volumes of solutions required per 
polyacrylamide gel can be seen in the Table 2.9. 
 
Component 
Resolving Stacking 
10 % 12.5 % 4.5 % 
Solution I (ProtoGel® (National Diagnostics) 30 
% w/v Acrylamide) 
1.65 mL 2.05 mL 0.3 mL 
dH2O 2.1 mL 1.7 mL 1.2 mL 
Solution II (1.5 M Tris-HCl, pH 8.8, 0.3 % SDS) 1.25 mL 1.25 mL - 
Solution III (0.5 M Tris-HCl, pH 6.8 0.4 % SDS) - - 0.5 mL 
10 % APS solution 50 µL 50 µL 20 µL 
TEMED (Sigma) 2 µL 5 µL 2 µL 
 
Table 2.9 Components of SDS-PAGE gels. 10 % APS prepared by dissolving 1g Ammonium 
perulphate (Sigma) in dH2O to give a total volume of 10 mL. TEMED (N,N,N;N-tetramethyl-
ethylenediamine) added immediately before casting to initiate polymerisation. 
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2.2.1.2 Tris-Tricine gels 
Tris-Tricine gels were used for analysis of the peptides discussed in Chapter 6. Peptide 
samples were mixed with an equal volume of 2x Tris-Tricine sample buffer (200 mM Tris-
HCl, pH 6.8, 2 % (w/v) SDS, 40 % (v/v) glycerol, 0.04 % (w/v) Coomassie Brilliant Blue G-250, 
2 % (v/v) β-mercaptoethanol (added fresh)) and heated for 5 min at 95 °C. Samples were 
loaded onto a 16.5 % Tris-Tricine precast gel (Bio Rad) in a Tetra Cell system with Broad 
Range SDS protein standards (NEB) used as markers. Gels were run in 1x Tris-Tricine running 
buffer (100 mM Tris, 100 mM Tricine, 0.1 % (w/v) SDS) for 120 min at 100 V. 
2.2.1.3 Native - Polyacrylamide gel electrophoresis (Native PAGE) 
Protein samples were mixed with 5x Native gel sample buffer (250 mM Tris-HCl (pH 7.4), 50 
% (v/v) glycerol, 0.5 mg/mL bromophenol blue) and loaded into the wells of a 
polyacrylamide gel. 8 cm X 10 cm gels in a Tetra Cell were used for PspA-PspF interaction 
assays while 18 cm X 10 cm gels in an OmniPAGE system (Geneflow) were used for protein-
membrane interaction assays (composition and volumes of one polyacrylamide gel for each 
system can be seen in Table 2.10 below). The gels were run in a Tris/Glycine buffer (National 
Diagnostics, 25 mM Tris, 192 mM glycine, pH 8.3) at 90 V for 70 min and then stained with 
Coomassie Brilliant Blue solution or Sypro ruby protein stain. The components and volumes 
of solutions required per polyacrylamide gel can be seen in Table 2.10. 
 
Component 
Tetra Cell  omniPAGE  
4.5 %  7 %  9 %  5 % 7 % 
Solution I 0.75 mL 1.1 mL 1.5 mL 2.5 mL 3.3 mL 
dH2O 3.75 mL 3.4 mL 3 mL 11 mL 10.2 mL 
10x Tris/Glycine Buffer 0.5 mL 0.5 mL 0.5 mL 1.5 mL 1.5 mL 
10% APS solution 50 µL 50 µL 50 µL 150 µL 150 µL 
TEMED 5 µL 5 µL 5 µL 15 µL 15 µL 
 
Table 2.10 Components of native-PAGE gels. Amounts listed make one gel, 10% APS solution and 
TEMED were added immediately before casting. 
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2.2.1.4 Sequencing gel 
Sequencing gels were used to separate α-32p GTP from the spRNA (UpGGG) product in 
spRNA synthesis assays. Samples were mixed with 3x Formamide Stop dye (6 mg 
bromophenol blue, 6 mg xylene octanol, 1.6 mL 250 mM EDTA, 20 mL deionized formamide) 
and heated at 95 °C for 5 min. The samples were loaded onto a 20 % sequencing gel and run 
for 32 min at 300 V in an MBI TV200 gel system. Components and volumes required per gel 
can be seen in Table 2.11.  
Component 20% 
UreaGel System Concentrate 12 mL 
UreaGel System Diluent  1.5 mL 
10x Tris/Glycine Buffer 1.5 mL 
10 % APS 150 µL 
TEMED 15 µL 
 
Table 2.11 Components of 20 % sequencing gels. UreaGel system concentrate and UreaGel System 
Diluent were purchased from National diagnostics. 
 
2.2.2 Protein purification techniques 
2.2.2.1 Plasmid isolation 
Plasmids were purified from a 5 mL overnight culture grown in LB using a QIAprep Spin 
Miniprep Kit (Qiagen). The process was undertaken according to the manufacturers 
guidelines, the plasmid was eluted in a final volume of 50 µL of dH2O and stored at -20 °C 
2.2.2.2 Preparation of chemically competent cells 
Two mL of overnight cultures were used to inoculate 200 mL of LB and incubated at 37 °C 
with shaking until an OD600 of 0.6 was reached. Cells were then harvested by centrifuging 
(4000 rpm, 4°C, 15 min). The cell pellet was re-suspended with 50 mL of cold 0.1 M MgCl2 
solution and left on ice for 20 min. The solution was again centrifuged and cell pellet re-
suspended with 50 mL cold 0.1 M CaCl2 and left on ice for 20 min. The cells were collected 
via another round of centrifugation and re-suspended in 2 mL of 0.1 M CaCl2 (18% (v/v) 
glycerol), separated into 20 µL aliquots and stored at -80 °C for future use. 
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2.2.2.3 Transformations 
The plasmids used in this work are listed in Table 2.8. Mutations introduced were verified by 
sequencing (by Goran Jovanovic) and the expression of the corresponding PspA mutant 
proteins tested using Western blotting and the PspA antibodies. 
A 20 µL aliquot of BL21 competent cells was left to defrost on ice for 15 min. 2 µl of the 
required plasmid was then mixed with the cells and the solution was left on ice for a further 
45 min. Cells were heat-shocked at 42 °C for 2 min before being placed back in ice for 
another 2 min. 150 µL of LB was added to the solution and it was left at 37 °C for 30 min. 
The solution was spread onto an LA plate containing the appropriate antibiotic to select for 
the plasmid of interest and colonies left to grow overnight at 37 °C. A single colony was 
picked, re-streaked on fresh LA plate and again incubated overnight at 37 °C. 
2.2.2.4 PspA and Vipp1 protein expression 
A colony of transformed competent cells was selected from an LBKAN plate, added to 20 mL 
of LBKAN and left to grow overnight at 37 °C. The culture was added to 1 L of LBKAN and left at 
37 °C with shaking until OD600 reached 0.6, at which point the culture was placed in an ice 
bath and cold shocked for 30 min. Protein expression was induced via addition of IPTG to 
give a final concentration of 0.1 mM in the culture and incubated at 30 °C with shaking for 3 
h. Centrifugation of the culture (4000 rpm, 4 °C, 15 min) was used to harvest the cells which 
were then re-suspended in 20 mL PspA resuspension buffer and stored at -20 °C. 
2.2.2.5 PspF1-275 expression 
The expression procedure for was the same as per PspA however after induction of 
expression with 0.5 mM IPTG the culture was incubated at 25 °C for 3 h. Post centrifugation 
the cells were re-suspended with PspF resuspension buffer and stored at -20 °C. 
2.2.2.6 Cell lysis and protein purification 
Cell solution from protein expression was put on ice and once defrosted one tablet of EDTA 
free protease inhibitor cocktail (Promega) was added to the solution. Cells were lysed using 
two cycles of sonication (20 min, 2 s pulse length, 40 % amplitude on ice). The resulting 
soluble and insoluble cell debris was separated via centrifugation (12,000 rpm, 4 °C, 30 min) 
and the supernatant was stored at 4 °C, For PspF1-275 and soluble fraction (SN1) purifications 
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this supernatant was used for further purification. For PspA and Vipp1 membrane fraction 
(SN2) purifications 12mL of PspA extraction buffer was added to the insoluble cell debris 
and this was then left at 4 °C for 3 h with shaking. The solution was then centrifuged (18,000 
rpm, 4 °C, 45 min) and the resulting supernatant containing the solubilised membrane 
fraction of the proteins was used for further purification.   
2.2.2.7 Nickel affinity chromatography 
Purification of the solubilized protein fraction was by Ni-chelate affinity chromatography at 
25 °C using Ni2+ charged 5 mL HiTrap (GE) columns and an AKTA FPLC system. The protein 
was loaded onto the column using a 50 mL superloop followed by column washing with 
PspA Buffer A and PspA Buffer A + 30 mM Imidazole to remove nonspecifically bound 
protein. The (His)6-tagged Protein was eluted by an imidazole gradient (0 to 1 M over 40 min 
at 1 mL/min flow rate) with 1mL fractions collected. Fractions showing absorption at 280 nm 
on the FPLC were analysed via SDS-PAGE for presence of protein. Fractions found to contain 
desired protein at the highest concentration were pooled and dialysed in 10,000 MWCO 
dialysis membrane (Spectrum Laboratory) for 4 h in PspA assay buffer (20 mM Tris-HCl (pH 
7.5), 200 mM NaCl, 75 mM NaSCN, 0.005 % (w/v) CHAPS, 5 % (v/v) glycerol) with two buffer 
changes. Post dialysis the solution was separated into 1 mL aliquots and centrifuged (14,000 
rpm, 5 min, 4 °C) to remove any precipitate.  
2.2.2.8 (His)6-tag cleavage 
All purified PspF1-275 along with PspA and Vipp1 samples used for controls were subjected to 
(His)6-tag cleavage using a Thrombin Cleavage Kit (Novagen). The purified protein was mixed 
with 10x thrombin cleavage buffer and of biotinylated thrombin and left for 4 h at 25 °C 
with gentle shaking. Equal amounts of Ni-NTA agrose beads (Quigen) and streptavidin 
agarose beads (Novagen) loaded on a 10 mL column was used to remove cleaved (His)6-tags 
and biotintylated thrombin. Samples were analysed by SDS-PAGE to monitor cleavage. The 
cleaved sample was dialysed against protein storage buffers to remove the thrombin 
cleavage buffer. 
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2.2.3 Protein concentration assays 
2.2.3.1 Proteins – DC assay 
Protein concentration was determined via the DC Protein Assay (Bio-Rad), a reaction similar 
to the Lowry assay but with more rapid colour development. BSA standard solutions were 
prepared (concentrations from 0.075 mg/mL to 1.75 mg/mL) and 5 µl of protein samples 
and standards were pipetted into the microtiter plate in triplicate. 25 µL of reagent A (an 
alkaline copper tartrate solution) was added to each well followed by addition of 200 µL of 
reagent B (a dilute Folin reagent). The plate was gently agitated for 30 s to mix the reagents 
and then left covered for 30 min at 25 °C to allow for colour development. The colourimetric 
change was measured at 750 nm using an absorbance plate reader (BMG Spectrostar Nano) 
and protein concentration was determined by calibration with the BSA standards.  
2.2.3.2 Bioanalyzer analysis 
An Agilent 2100 bioanalyzer was also used to determine the concentration and purity of 
proteins. The Agilent Protein 230 kit designed for the sizing and analysis of proteins 
between 14-230 kDa was used. The assay was undertaken according to the manufacturer’s 
instructions.  
2.2.3.3 Peptides and proteins for Circular dichroism  
Accurate determination of peptide and protein concentrations is required for Circular 
Dichroism studies. The DC assay results vary slightly from protein to protein and therefore a 
microbiuret procedure(Goa, 1953) was used for quantification. 50 µL protein/ peptide 
samples and BSA standard solutions (concentrations from 0.2 mg/mL to 1 mg/mL) were 
pipetted into the microtiter plate in triplicate. 250 µL of 3 % (w/v) NaOH and 10 µL of 
Benedict’s Reagent was added to each well and the plate was gently agitated for 30 s to mix 
the reagents. The plate was left covered for 15 min at 25 °C to allow for colour 
development.  The absorbance at 330 nm was measured using an absorbance plate reader 
(BMG Spectrostar Nano) and protein concentration was determined by calibration with the 
BSA standards. 
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2.2.4 Western blotting 
Samples for western blotting were first subjected to SDS-PAGE as described above. After 
electrophoresis the gel were equilibrated in transblot buffer (10 mM Tris base, 100 mM 
glycine, 10 % (v/v) methanol) for 10 min. Resolved proteins within the PAGE gel were 
transferred onto a methanol-activated-ImmunoBlot PVDF membrane (Bio Rad) using a 
Trans-Blot Semi-Dry Transfer Cell (Bio Rad) at 100-130 mA for 60 min. Protein transfer onto 
the membrane was confirmed by staining with Ponceau S (Sigma). The processes of 
blocking, washing and incubation with primary and secondary antibodies was performed 
overnight using a BenchPro 4100 Western Processing System (Invitrogen) the protocol for 
which is given in Table 2.12 below. An Anti-PspA primary antibody at 1:1000 dilution (Jones 
et al., 2003) and Goat-Anti-Rabbit-HRP (GE) secondary antibody at 1:5000 dilution was used 
for PspA detection. Following the procedure proteins were detected using the Westar 
Supernova Western Blotting Kit (Cyanagen) and imaged using a GelDoc and ChemiDoc 
imagining system. 
Step Time (min) 
Blocking 5 % (w/v) milk powder (Marvel) in TBS 60 
Washing in TBSTT (2X) 10 (2X) 
Washing in TBS  10 
Primary antibody incubation (in TBS + 5 % (w/v) 
milk powder) 
720 
Washing in TBSTT (2x) 10 (2X) 
Washing in TBS 10 
HRP conjugated Secondary antibody incubation 
(in TBS + 5 % (w/v) milk powder)  
60 
Washing in TBSTT 10 (5X) 
 
Table 2.12 BenchPro 4100 protocol. 
 
2.2.5 PspA fluorescent labelling 
All solutions containing dye were kept out of contact of light whenever possible with 
reaction vessels columns, and eluted fractions wrapped in foil. PspA cysteine mutants were 
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concentrated to around 100 µM via centrifugation (3,500 rpm, 4 °C) in an Amicon Ultra unit 
(MW cut off 3500 Da). A two fold molar excess of TCEP-NaOH (pH 7.5) was added to the 
protein solution and left for 30 min. An excess of dye (Alexa 488/647 maleimide (Invitrogen) 
or Hilyte 488 maleimide (Invitrogen) dissolved in DMSO) was then added slowly with stirring 
and allowed to react over varying periods of time and temperatures. Labelled protein was 
then separated from free dye by passing the reaction solution through a column loaded with 
2 mL of Ni-NTA agarose solution and washing with 4 CV of PspA Buffer A and 4 CV PspA 
Buffer A + 3 % 1 M imidazole. The bound protein was then eluted via passing 4 CV of PspA 
Buffer B through the column with the eluent being collected in 1 mL fractions each of which 
was analysed by SDS-PAGE for presence of protein. Fractions found to contain protein were 
dialysed overnight in PspA assay buffer and then concentrated to around 200 µL. Quantities 
of protein and labelling efficiency were calculated via UV-Vis spectroscopy. 
2.2.6 Anisotropy studies of labelled proteins 
Alexa 488 or Alexa 647 maleimide dissolved in DMSO was added to a 500 µL solution of PBS/ 
BSA (0.3 mg/mL)/ Tween20 (0.05 % (v/v)) to give a final concentration of 34 nM in solution. 
100 µL was added to a cuvette and the fluorescence anisotropy of the dye was calculated by 
a Fluoro-max 3 fluorometer. PspA1-186 protein solution was titrated into the cuvette to give 
known final concentrations of protein between 1 – 60 µM. After each titration the 
anisotropy was calculated at 2 min intervals until the value remained constant. Titrations 
continued until anisotropy value did not increase further. 
 
2.2.7 PspA - PspF interaction assays 
2.2.7.1 Native-PAGE band-shift assay 
Reactions were carried out in a total volume of 15 µL in the PspA final assay buffer. 5 µM 
PspF1-275 was incubated with increasing amounts of PspA (from 1.25 µM – 10 µM) at 21 °C 
for 15 min. Samples were then subjected to Native-PAGE analysis on a 4.5 % gel with the 
proteins visualised by Coomassie or Sypro ruby protein staining. 
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2.2.7.2 NADH-coupled ATPase 
The steady-state ATP hydrolysis activity of PspF1-275 in the presence of proteins and peptides 
was measured in real-time using an NADH-coupled regeneration system (Norby, 1988). The 
rate of steady state ATP hydrolysis is proportional to the decrease in NADH (which absorbs 
at 340 nm). The enzymatic reactions operating in the assay are shown; 
 
 
Where; Pi, inorganic phosphate; PEP, phosphoenolpyruvate; PK, pyruvate kinase; Py, 
pyruvate; LDH, lactate dehydrogenase; La, lactate. ATPase activity was measured at 37 °C in 
a final volume of 100 µL containing: 25 mM Tris-HCL (pH 8.0), 100 mM KCl, 10 mM MgCl2, 1 
mM DTT, 1 mM NADH, 10 mM phosphoenolpytivate, 10 U/mL pyruvate kinase, 20 U/mL 
lactate dehydrogenase, 50 mM ATP, PspF1-275 (0-5 µM) and peptides (10 – 500 µM). 
Absorbance at 340 nm was monitored every minute using a BMG Omega microplate reader. 
 
2.2.8 HPLC gel filtration 
Prior to gel filtration, 50 µL samples in running buffer (20 mM Tris HCl pH 8.0, 50 mM NaCl, 
15 mM MgCl2) were centrifuged (18,000 g, 5 min) to remove any particulate matter. The 
samples were then transferred into 200 µL crimp autosampler vials and placed in the 
refrigerated autosampler of a Surveyor HPLC system (Thermo Scientific). A Yarra SEC-S3000 
column (Phenomenex) fitted with Security Guard (Phenomenex) guard column was used 
within a column oven (Phenomenex) maintained at a temperature of 8 °C. For each run 15 
µL of sample was injected into the column with a flow rate of 1 mL/min and pressure limit 
set at 3000 psi. The detector was set to monitor UV absorbance at 280 nm and broad 
spectrum absorbance to identify protein content of the eluent. Each sample was run 3 
times. A ladder for mass comparison was obtained by running a mixture of the following 
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globular proteins: Carbonic anhydrase (29 kDa), BSA (66 kDa), β-amylase (200 kDa), 
Apoferritin (443 kDa) and Thyroglobulin (669 kDa).  
 
2.2.9 Lipid vesicle techniques 
2.2.9.1 Preparation of lipid films for hydration 
Lipid chloroform stocks were mixed in 1.5 mL glass vials to the desired proportions giving a 
total lipid mass between 2-5 mg. The chloroform was evaporated under a stream of dry 
nitrogen and left on a freeze dryer overnight to remove any residual solvent. Once removed 
from the freeze dryer the vial was promptly sealed, wrapped in parafilm and stored at -20 °C 
ready for hydration 
2.2.9.2 Lipid Vesicle Preparation via Extrusion 
Aqueous buffer (typically PspA or Vipp1 assay buffer for protein based assays and PBS for 
peptide assays) was added to the glass vial containing the dry lipid film to give a lipid 
concentration of 7 µM. In order for the lipids to hydrate the solution was left for 1 h with 
intermittent vortexing and maintained at a temperature above the TM of the lipids used. The 
solution was freeze-thawed five times to disrupt LMV suspensions via alternate 
submergence in liquid nitrogen and a water bath at 37 °C. The solution was then passed 
through a Mini-Extruder (Avanti) containing a nucleopore membrane (50-400 nm depending 
on required vesicles size) 21 times. For lipid compositions with TM above 25 °C the extruder 
was heated to 5 °C above the TM using a heating block prior to extrusion and maintained at 
that temperature throughout the extrusion process. Vesicles were used immediately or 
stored at 4 °C and used within 72 h of production. 
2.2.9.3 Lipid vesicle preparation via sonication 
Aqueous buffer (typically PspA or Vipp1 assay buffer) was added to the glass vial containing 
the dry lipid composition to give a lipid concentration of 7 µM. The solution was left for 1hr 
with intermittent vortexing in order for the lipids to hydrate and maintained at a 
temperature above the TM of the lipids used. The solution was sonicated using a VC-50 2mm 
Microtip (Sonics) probe for 10 min (pulse length 10 s, 5 s pause, 50 % amplitude). Reduced 
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opacity of the sample post sonication is an indication of vesicle formation and thus samples 
that were still cloudy were exposed to subsequent rounds of sonication (up to 3 total). The 
samples were then centrifuged at 10,000 g for 5 min to sediment any metal fragments from 
the sonication process and transferred to clean microcentrifuge tubes. Vesicles were used 
immediately or stored at 4 °C and used within 72 h of production. 
2.2.9.4 E. coli lipid extraction 
E. coli WT, cls and pgsA mutant strains were grown in LB at 37 °C to an OD600 of 1.5 and the 
cells were harvested by centrifugation for 10 min at 3000 g. The cell pellet was re-
suspended in 4 mL of PBS buffer and transferred to a Teflon lined centrifuge bottle. Lipids 
were extracted using the Bligh and Dyer method. Briefly, to the suspension 5 mL of 
chloroform was added followed by 10 mL methanol resulting in a single phase extraction 
mixture. After 1 min of thorough shaking the mixture was incubated at 25 °C for 20 min, 
followed by centrifugation at 3000 g for 15 min. The resulting supernatant was transferred 
to a clean centrifuge tube and then by addition of a further 5 mL chloroform and 5 mL 
methanol a two-phase Bligh-Dyer extraction mixture was created. Centrifugation as above 
resolved the phases and the lower phase was collected, washed with 19 mL of pre-
equilibrated neutral upper phase and solvent from the resulting lower phase was 
evaporated under a stream of nitrogen. Residual solvent was removed by lyophilisation 
overnight. Dry lipid powder was weighed, placed in glass vials and dissolved in chloroform to 
give lipid stocks at 5 mg/mL. Stocks were stored at -20 °C. 
2.2.9.5 Lipid mass spectrometry (Performed with Dr Tony Postle) 
1 mL of 50 % (v/v) MeOH, 50 % (v/v) DCM solution was added to 10 µg of lipid extract and 
vortexed until the lipid had dissolved. 100 µL of this solution was taken and added to 1 mL 
of MS solvent (66 % (v/v) MeOH, 30% (v/v) DCM, 3 % (v/v) H2O and 1 % (v/v) Conc NH3).  
300 µL of the resulting solution was then taken for analysis via mass spectrometry using a 
Xevo TQ Quadrapolar machine. Positive and Negative ion scanning was undertaken using a 
collision energy of 30 EV or 4 EV. Processing of mass spectrum was performed with the 
MassLynx V3.3 software. 
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2.2.9.6 Characterization of vesicles via Dynamic Light Scattering 
To ensure homogeneity the size and distribution of vesicles produced via sonication and 
extrusion were characterised via dynamic light scattering (DLS). 0.8 mL of vesicle sample 
was pipetted into a quartz cuvette that had been thoroughly washed with 0.2 µM syringe 
filtered dH2O. A Delsa
TMNano C particle analyser (Beckman Coulter) was used to detect 
scattered light at a 165° angle and analysed using a log correlator over 100 accumulations. 
All DLS runs were undertaken in triplicate.  
2.2.9.7 Phospholipid quantification via phosphorous assay 
The phospholipid concentration within lipid extracts and the concentration of vesicles after 
gel filtration was estimated via phosphorous detection through an acidic digestion. The 
method used is adapted from Rouser et al. (Rouser et al., 1970) and is briefly as follows. 
Samples in clean glass tubes were lyophilized for 12 h to completely remove the solvents. 
Concentrated perchloric acid (70 %, 0.65 mL) was added to each sample and heated at 180 
°C for 30 min. Once cooled 3.3 mL of water was added to each tube followed by 0.5 mL 
Ammonium molybdate solution (2.5 % (w/v) in dH2O) and 0.5 mL Ascorbic acid solution (10 
% (w/v) in dH2O). Samples were briefly votexed before each addition. The tubes were then 
heated at 100 °C for 5 min then allowed to cool. The OD of each sample was measured at 
800 nm and phosphorous content was calculated from a standard curve produced from a 
KH2PO4 standard solution. 
 
2.2.10 Protein-Vesicle and Peptide-Vesicle interaction assays 
2.2.10.1 Native-PAGE based protein-membrane binding assay 
A Native-PAGE based assay was used to probe protein-membrane binding. Generally, 
samples containing 10 µM purified protein were incubated with increasing amounts of lipid 
vesicles (0.25 – 5 mM lipid concentration) for 15 min at 25 °C in a total reaction volume of 
10 µL. 5x Native loading dye (250 mM Tris-HCl (pH 7.4), 50 % (v/v) glycerol, 0.5 mg/mL 
bromophenol blue) was added to the samples before loading onto a polyacrylamide native 
gel. The samples were run for 80 min at 90 V at 25 °C. Gels were stained with Sypro Ruby 
protein stain and band visualised using a phosphorimager. The Intensity of the proteins 
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bands was quantified using AIDA image analyser. During electrophoresis unbound protein is 
free to run through the gel matrix while vesicles bound protein is unable enter. By using 
SYPRO Ruby Protein gel stain (linear staining intensity for PspA (Berggren et al., 2000)), 
integration of the stained PspA band gives a quantitative measure the free protein present. 
Comparison between the intensity of a PspA without vesicles, (AV) standard and PspA + 
vesicles (A+V) samples gives a relative amount of vesicle-bound protein. 
2.2.10.2 Peptide vesicle dye efflux Assays 
Reconstitution of calcein into sealed vesicles - A 50 mM calcein buffer was prepared by 
addition of 0.62 g of calcein powder (Sigma) to 15 mL of a solution containing 2 mL 10x PBS 
buffer and 13 mL dH2O. Calcein was dissolved by gradual addition of 1 M NaOH until 
complete dissolution and a pH of 7.5 had been reached. The solution was then topped up to 
20 mL with dH2O. Lyophilised lipids at a concentration of 7 mM were hydrated in calcein 
buffer and vesicles were prepared as earlier described via extrusion or sonication. Free dye 
was separated from encapsulated dye via gel filtration. G50 Sephadex (0.4 g, Sigma) was 
soaked for a minimum of 3 h in 10 mL elution buffer (1X PBS buffer + 0.5 M sucrose) then 
packed in a disposable 5 mL polypropylene column (Thermo Scientific).  300 µL of the 
prepared vesicle solution was added to the top of the column, allowed to enter the column 
matrix by gravity flow and followed by 600 µL of elution buffer with the subsequent eluent 
discarded as waste. Then a further 1 mL of elution buffer was added and the eluent 
containing calcein encapsulated vesicles was collected as the sample of interest, vortexed to 
ensure thorough mixing and stored at 4 °C. Vesicle concentration was determined via the 
phosphorous assay. 
 
Calcein efflux assay- Samples of 150 µL calcein encapsulated vesicles (1 mM lipid conc.) 
were pipetted into a microtiter plate and a baseline fluorescence was measured using a 
BMG Fluorostar Omega (Ex 485 nm, Em 520 nm) for 30 min to determine if any background 
dye leakage was occurring from vesicles. Desired peptides (generally 1 µM stock solution) 
were titrated into the samples (2 – 80 µL) and the plate was agitated for 30 s to ensure 
complete mixing. Flourescence was then monitored for 60 min with a reading taken every 2 
minutes. Further peptide additions were made before all of the vesicles were burst by 
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addition of 1 µL, 0.2 M Octaethylene glycol monododecyl ether (C12E8) (Sigma) and 
fluorescence measured to give a value for a complete dye release event.  
2.2.10.4 Sucrose gradient centrifugation 
100 µL (20 µM) protein was incubated with 50 µL, (3.5 mM) vesicles for 15 min at 25 °C. 
Samples were then carefully layered on top of a 4.9 mL 0-30 % sucrose gradient in PspA 
Buffer (pH 7.8) in thin walled polypropylene centrifuge tubes. Samples were subjected to 
centrifugation (160,000 g, 16 h, 4 °C) using a Beckman SW 55 Ti swingout rotor. 0.5 mL 
fractions of decreasing density were obtained by piercing the bottom of the tube with a 
clean syringe needle and collecting the eluent in microcentrifuge tubes. The fractions were 
analysed via SDS-PAGE on a 12.5 % gel and protein was visualised with Sypro ruby protein 
staining. The recovery of vesicles after centrifugation was monitored with vesicles 
containing 0.5 % NBD-PE and measuring fluorescence of the collected fractions using a BMG 
Omega fluorescent plate reader. 
2.2.10.5 Small primed RNA assay (spRNA) 
To produce the -10 -1/WT nifH promoter probe used in this assay oligonucleotide WVC3 and 
WVC7 (sequences and function described in Table 2.13) were mixed in 1x TM Buffer (10 mM 
Tris-HCl pH 8.0, 10 mM MgCl2), heated to 95 °C for 5 min and then cooled gradually to allow 
DNA duplex formation. The spRNA assay was performed in 10 µL of STA buffer (25 mM Tris-
acetate, pH 8.0, 8 mM Mg-acetate, 10 mM KCl, and 3.5% (w/v) PEG 6000). 100 nM Eσ54 
(reconstituted using a 1:5 ratio of E: σ54) and 20 nM promoter nifH probe were incubated at 
25 °C for 5 min to allow RNAP-σ54-DNA complex formation. Addition of 4 mM dATP (for 
PspF ATPase) and a further 5 min incubation was followed by protein mix (containing the 
desired amounts of PspA, PspF1-275 and vesicles) and a final 30 min incubation at 37 °C. 
spRNA (UpGGG) synthesis was initiated by addition of a mix containing 4 µCi [α-32P] GTP, 
0.5 mM UpG and 100 µg/mL heparin followed by 37 °C incubation for 20 min. The reaction 
was quenched via addition of loading buffer and analyzed on a 20 % denaturing gel, 
visualized and quantified using a Fuji FLA-5000 Phosphorimager. 
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Oligo Sequence (5’-3’) Function 
WVC 3 
ACATGAATGCGCAACAGCATGCGCGCCCAGGGC
TGATCTGCAAAAGTCGTGCCAGCCGTCTGAAATA
AAACTACTCGCTTTCTTTC 
nifH promoter, Template 
strand from -68 to +20 
WVC 7 
GAAAGAAAGCCGAGTAGTTTTATTTCAGACGGCT
GGCAGACTTTTGCACtcgactaaagGGGCGCGCAT
GCTGTTGCGCTTCATGT 
NifH promoter, non-
template strand from -68 
to +20 mismatch from -10 
to -1 
 
Table 2.13 DNA oligonucleotides used in the spRNA assays. 
 
2.2.10.6 Peptide floatation assay 
Peptides (50 - 200 µM) and vesicles (0.5 – 1.5 mM) were incubated in PBS buffer for 15 min 
at 25 °C in a total volume of 300 µL. The solution was adjusted to 30 % (w/v) sucrose via 
addition of 200 µL 75 % (w/v) sucrose solution in PBS buffer. The solution was transferred to 
a polycarbonate centrifuge tube and carefully overlaid with 400 µL PBS buffer containing 25 
% (w/v) sucrose solution followed by 100 µL PBS buffer creating a density gradient. The 
samples were then subjected to centrifugation at 75,000 rpm (240,000 g) in a Beckman TLA-
100.2 rotor for 2 h at 4 °C. Five fractions were collected sequentially from the bottom of the 
centrifuge tube using a syringe. Presence of peptides was determined via analysis of 
fractions on a Tris/Tricine 16.5 % SDS-PAGE gel (Bio Rad) and visualised with sypro ruby 
protein staining.  
2.2.10.7 Circular Dichroism 
Proteins were dialysed into a 20 mM Tris-HCl (pH 7.8) buffer and syringe filtered through a 
0.2 µM membrane with their final concentration determined via the microbiuret method. 
Peptides were dissolved in 20 mM Tris-HCl (pH 7.8) buffer at 2 mg/ml. Vesicles were also 
prepared in the same buffer. Cylindrical demountable cells with path lengths of 0.01 and 
0.005 cm were used with sample volumes of 25 and 16 µL respectively. Cells were placed in 
an Aviv 62DS with the temperature maintained at 25 C and scanned between 180 and 280 
nm with three repeats. Buffer only baselines were subtracted from the sample scans and 
files were processed using the CDtool software (Lees et al., 2004). 
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Chapter 3 – Developing an approach to study PspA-lipid 
Interactions 
 
Overview 
In order to study the interactions between a peripheral membrane protein and the 
membrane in vitro one must first obtain the purified protein components, deploy a relevant 
model membrane system and establish a reproducible and functioning protein-membrane 
binding assay.  This chapter details the preliminary investigations undertaken to establish in 
vitro methods for studying the IM binding function of PspA. Using a number of initial 
approaches, appropriate methodologies are identified that will allow the detailed study of 
direct PspA-membrane interactions throughout the proceeding work. A direct interaction 
between purified PspA and the membrane of E. coli TLE vesicles was observed using a 
sucrose gradient co-floatation assays and the native-PAGE based binding assay developed in 
this chapter. The quantitative data obtained from the native-PAGE assay allows for an 
estimation of the membrane coverage by PspA to be 28 %. 
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3.1 Introduction  
Principally biological systems are enormously complex and rather few are described in 
mechanistic detail to include genetic, biochemical and biophysical study. This is certainly the 
case for the Psp response. While a plethora of signalling pathways and protein interactions 
have been identified (Joly et al., 2010a), mechanistic insight into the effector function of the 
response still remains lacking. A general consensus is that envelope maintenance by PspA 
occurs through protein-IM interactions facilitated via either: other IM proteins (e.g. PspBC, 
MreB), a direct PspA-lipid interaction or both (Kobayashi et al., 2007, Yamaguchi et al., 
2013). However, creating a sufficiently defined, isolated and active system in vivo to gain 
detailed biochemical and biophysical information into the processes is challenging due to 
roles of PspBC in upstream signalling and the enormous complexity of cell envelope. 
Reconstituting components of the system at reduced complexity in rigorously controlled 
extracellular environments has proved vital for understanding the regulation of the Psp 
response at a molecular level (Burrows et al., 2010, Elderkin et al., 2005, Joly et al., 2009). 
Studies using in vitro experimental techniques to probe the effector function of the 
response are comparatively sparse because of the involvement of the membrane. This has 
left many aspects of characterisations lacking within the Psp response, especially regarding 
the biophysical aspects of the system.  
This study aims to redress this imbalance of understanding and provide detailed insights 
into membrane association of PspA that cannot be readily, perhaps ever, fully resolved 
using in vivo methodologies alone. The group has had recent success using in vivo single 
molecular imaging (SMI) studies to map the special and temporal distribution of PspA when 
undertaking its regulatory and effector function (Jovanovic et al., 2014b, Engl et al., 2009). 
The initial aim of the project was to complement these studies in vitro, using fluorescently 
labelled PspA in combination with SMI to observe the proteins localisation on the 
membrane under a number of different conditions.  
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3.2 Results and Analysis 
3.2.1 Protein purification and functionality studies 
For any in vitro protein studies, purification of the target protein is the first step. Purification 
methodologies for PspA WT and its fragments have previously been established by the 
group (Elderkin et al., 2005) and were used in this study. The purified PspA proteins were 
analysed to determine concentration and purity, before functionality studies were 
undertaken to confirm that the purification process has had minimal impact on their native 
behaviour. 
 
3.2.1.1 Purification of PspA proteins 
Wild type PspA (PspA WT) and PspA lacking HD4 (PspA1-186) (see Figure 1.8), along with 
PspA1-186 E82C and PspA1-186 S186C variants (for fluorescent labelling studies) made up the 
initial PspA purifications. After transformation of the relevant plasmid into chemically 
competent E. coli BL21 cells, protein expression was induced by addition of IPTG. After cell 
lysis the overexpressed PspA is reported to be distributed equally between the soluble and 
insoluble fraction (Brissette et al., 1990). Previous in vitro studies with PspA have reported 
low yields using the soluble fraction for purification. Protein extraction from the insoluble 
fraction with detergent was much more successful for purification (Dworkin et al., 2000). N-
terminally histidine tagged proteins were purified from the insoluble membrane fraction via 
extraction with 1% CHAPS and Nickel-affinity chromatography. CHAPS was used as it is a 
non-denaturant so it can liberate membrane bound PspA in its native conformation. Its 
small micelle molecular weight (6150 Da) and high CMC (6-10 mM) also facilitate removal 
from samples by dialysis. PspA proteins eluted from the nickel column at a concentration of 
around 300 mM Imidazole. Typical SDS-PAGE gels showing the protein content of eluted 
fractions can be seen in Figure 3.1. 
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Figure 3.1 Purification of his-tagged PspA WT and PspA1-186 from E. coli. Coomassie stained SDS-
PAGE gels showing the protein content of eluted fractions from nickel chelation chromatography 
(fraction number along the bottom of each image, L denotes protein ladder). Gels from the 
purification of PspA WT (A), PspA1-186 (B), PspA1-186 S186C (C) and PspA1-186 E82C (D) are shown. 
 
After dialysis of fractions containing purified protein, the concentrations of each preparation 
were determined via the DC protein assay (BioRad) using BSA standards. PspA WT 
precipitated during dialysis due to its low solubility in aqueous solutions. This limited the 
concentration of the protein to around 20 µM in PspA assay buffer (concentrations between 
15-26 µM were obtained within 6 separate PspA WT preps during the study). The other 
proteins had no such solubility issues their final concentrations were as follows: PspA1-186 - 
42 µM, PspA1-186 E82C – 36 µM, PspA1-186 S186C – 128 µM. Ten microliters of each purified 
PspA preparation was run on SDS-PAGE and can be seen in Figure 3.2A. Immunoblotting was 
also undertaken with PspA WT and PspA1-186 (see Figure 3.2B). Samples were analysed on an 
Agilent 2100 Bioanalyzer in order to determine the purity of each preparation and all were 
found to be over 85% pure (see Figure 3.2C for the PspA1-186 electropherogram).  
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Figure 3.2 Purified PspA proteins SDS-PAGE, immunoblotting and Bioanalyser analysis. (A) 
Coomassie stained, 12.5% SDS-PAGE gel showing purified PspA proteins after dialysis. 10 µL protein 
sample in each lane (B) 12.5% SDS-PAGE gel of proteins analysed via Western blotting with anti-PspA 
antibodies. PspA WT and PspA1-186 in lanes 1 and 2 respectively. Negative controls PspF1-275 and 
Vipp1 WT are in lanes 3 and 4. (C) Electropherogram of purified PspA1-186  between 14-55 kDa from 
the Agilent 2100 Bioanalyzer. PspA1-186 peak is labelled and peaks at 4.5 and 7 kDa are from the 
lower marker. Concentrations of proteins (in ng/µL) in each peak calculated from the integral of the 
peak area are given on the graph. 
 
3.2.1.2 Functionality studies with PspF1-275 
To confirm that our purified PspA proteins retained their native functions in vitro, PspA-PspF 
functionality assays were undertaken. PspA binds to PspF forming a 6:6 inhibitory co-
complex. Formation of this co-complex can be visualised via a native-PAGE band shift assay 
(Elderkin et al., 2002). The subsequent repression of PspF’s ATPase activity can be measured 
via an NADH-coupled ATPase assay (Joly et al., 2012). (His)6-PspF1-275 (lacking the DNA 
binding domain but active for PspA binding an ATPase) was purified followed by His-
cleavage giving a 95% pure, 150 µM stock used for functionality assays.  
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Figure 3.3 Purified PspA protein interaction with PspF1-275 and subsequent ATPase inhibition. 
(A) Native-PAGE band shift assay showing PspA1-186 variants (10 µM) co-complex formation with 
PspF1-275. Increasing concentrations of PspF1-275 in lanes 7-10 and 11-14 are 1:1, 1:2, 1:3 and 1:5 
molar ratios of PspA:PspF1-275 (B) Band shift assay with PspA WT (10 µM) and PspF1-275. (C) ATPase 
activity of PspF1-275 incubated with purified PspA proteins at a 1:1 molar ratio measured via the 
NADH-coupled assay. 
 
As can be seen in Figure 3.3A and 3.3B, all the purified PspA proteins were able to form a 
visible PspA-PspF1-275 co-complex about half way down the native gel. PspA1-186 has a high 
affinity for PspF1-275 with a near complete complex formation at a 1:1 molar ratio (Figure 
3.3A, lane 3). At a 1:1 molar ratio of PspA WT : PspF1-275 the co-complex could be seen but a 
significant amount of the PspF1-275 band still remains, indicative of PspA WT having a lower 
affinity for PspF1-275 than PspA1-186 (Figure 3.3B, lane 5). This is in agreement with previous 
studies where it was reasoned that PspA1-186 may form a tighter complex due to its 
increased homogeneity compared with PspA WT (Elderkin et al., 2005). The PspA1-186 S186C 
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and PspA1-186 E82C mutants had a similar affinity for PspF1.275 as PspA1-186 indicating that the 
point mutations do not have any effect of PspA1-186:PspF1-275 co-complex formation 
(compare lanes 3, 7 and 11 in Figure 3.3A).  
All the purified PspA proteins were also able to inhibit the ATPase activity of PspF1-275 in the 
NADH-coupled assay. As can be seen in Figure 3.3C at a 1:1 molar ratio of PspA1-186 to PspF1-
275 the ATPase activity of PspF1-275 dropped to 41% that of PspF1-275 alone. PspA WT had less 
of an inhibitory effect but still resulted in a reduction of ATPase activity to 69% of PspF1-275 
alone. These results again align with the literature where similar trends was observed (Joly 
et al., 2009) and could be due to PspA1-186 having an increased affinity for PspF1-275. Psp1-186 
S186C’s inhibitory effect is very similar to PspA1-186 and thus the point mutation does not 
have an effect on activity. Interestingly the PspA1-186 E82C has around a 40 % reduction in 
inhibitory activity compared with PspA1-186 and PspA1-186 S186C. The reason for this is not 
immediately obvious, however, it is possible that residue E82 may form a stabilising 
electrostatic interaction with PspF1-275 that lost upon its substitution. Equally the di-sulfide 
dimer that is formed by some of the PspA1-186 E82C (see Figure 3.5) may be unable to 
interact with PspF1-275 due blockage of the PspF1-275 binding site. 
 
3.2.2 Fluorescent labelling of PspA for single molecule imaging 
GFP fusion proteins are extensively used in in vivo cell imaging due to their biological 
compatibility and ability to be expressed in biological environments (Tsien, 1998). However, 
they have limitations; primarily the large size of GFP (27 kDa, 2 kDa larger than PspA) which 
can have an effect on the function of the fused protein (Sahoo, 2012). The eGFP-PspA 
fluorescent fusion protein has been shown to maintain both PspA’s membrane binding and 
effector functions to a certain extent but not to comparable levels of PspA WT (Engl et al., 
2009). Synthetic fluorophores are much smaller (usually <1000 Da) whilst possessing greater 
photostability and higher quantum yields than GFP. This makes them a preferable option for 
fluorescence in vitro studies, where cell toxicity and difficulties establishing a specific link 
between the target protein is not an issue (Sahoo, 2012). For these reasons chemical 
labelling of PspA was chosen as a preferable approach for the investigation. 
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There are a number of methods to covalently attach chemical probes to specific amino 
acids. For single molecule imaging (SMI) studies a technique that provides a site specific, 
singly labelled protein is required. For this reason conjugation of a maleimide fluorescent 
dye to a cysteine residue within the protein was chosen as the preferred approach. 
Maleimides are selectively reactive towards the thiol in cysteine residues below pH 8 
(Reaction scheme shown in Figure 3.4A). High specificity and reactivity of cysteine residues 
helps achieve a good labelling efficiency and their infrequent occurrence within proteins 
avoids issues of multiple labelling’s (Tyagarajan et al., 2003, Brinkley, 1992).   
 
 
Figure 3.4 Chemical labelling approach for PspA1-186 (A) Mechanism for the conjugation of 
cysteine to a maleimide fluorescent dye. (B) Predicted structure of PspA1-186 using the I-TASSER 
structure prediction software. Locations of the E82C and S186C substitutions are indicated. 
 
PspA1-186 was used as a starting point for initial labelling studies as its membrane binding 
function is preserved (Jovanovic et al., 2014b), yet significantly increased concentrations 
and yields can be obtained compared with PspA WT (see 3.2.1.1). As PspA1-186 (along with 
PspA WT) does not contain any native cysteine residues, introduction of a cysteine via site-
directed mutagenesis allowed specific positioning of the dye. The location of the cysteine 
within the protein must be carefully considered in order to gain a high labelling efficiency 
whilst not interfering with the proteins native structure and function. A C-terminal S186C 
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substitution of PspA1-186 was made. This region is predicted (via I-TASSER (Zhang, 2008)) to 
provide good solvent accessibility and is the opposite end to the putative N-terminal binding 
motif (Jovnovic et al., 2014). An internal E82C mutant was also created as this residue was 
again predicted to have high solvent accessibility and be part of an unstructured linker 
region between two α-helixes (I-TASSER, see Figure 3.4B). 
   
3.2.2.1 Labelling Reactions with Alexa 488 
Alexa Flour 488 (Invitrogen) was chosen as the flourophore for these studies due to its 
compatibility with our imaging system, high fluorescence quantum yield and high 
photostability. Alexa Flour 488 maleimide (Alexa 488) conjugated proteins have also been 
used in a number of in vitro protein-membrane interaction studies (Ramadurai et al., 2010, 
Basu et al., 2010).  
Initial labelling reactions were undertaken via the incubation of PspA1-186 S186C with tris(2-
carboxyethyl)phosphine (TCEP) for 30 min at 25 C to reduce any disulphide bonds between 
proteins. High TCEP to protein ratios have been found to adversely affect labelling (Han and 
Han, 1994) and so SDS-PAGE studies were undertaken with the DTT reducing agent replaced 
with increasing TCEP to determine the smallest excess required. A two-fold molar excess of 
TCEP over the protein was sufficient for complete disulphide bond reduction (see Figure 
3.5B) so this amount was used in labelling reactions. 
After incubation with TCEP, a ten-fold molar excess of Alexa 488 was added and the mixture 
was incubated at 21 C for 2h with shaking. The pH was regularly checked to ensure it was 
below pH 8, above which maleimides are prone to hydrolysis rendering them nonreactive 
(Ishii and Lehrer, 1986). Protein was separated from free dye via nickel-affinity 
chromatography and a clear orange protein solution was observed, indicative of 
fluorescently labelled PspA. Labelling efficiency was calculated via measuring absorbance at 
280 nm and 495 nm, using Equation 3.1 to calculate protein concentration, then Equation 
3.2 to give the moles of dye bound per mole of protein ratio (𝑀𝐷𝑦𝑒 ∶  𝑀𝑃𝑟𝑜𝑡𝑒𝑖𝑛).  
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𝑃𝑟𝑜𝑡𝑒𝑖𝑛 𝐶𝑜𝑛𝑐. (𝑀) =
𝐴280−(𝐴495 × 0.11)
𝜀𝑝𝑟𝑜𝑡𝑒𝑖𝑛
  Equation 3.1 
 
Where A280 is the absorbance at 280 nm, A495 the absorbance at 495 nm and εprotein is the 
molar extinction coefficient of the protein (5,500 cm-1 M-1 for PspA cysteine mutants). 
 
 
𝑀𝐷𝑦𝑒 ∶  𝑀𝑃𝑟𝑜𝑡𝑒𝑖𝑛  =
𝐴495
𝜀𝑑𝑦𝑒 ×𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑐𝑜𝑛𝑐.(𝑀)
  Equation 3.2 
 
Where 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑐𝑜𝑛𝑐. Is calculated from Equation 3.1, A495 the absorbance at 495 nm and         
εdye is the molar extinction coefficient of the dye (71,000 cm
-1 M-1 for Alexa Flour 488). As 
there is only one labelling site per protein, multiplying 𝑀𝐷𝑦𝑒 ∶  𝑀𝑃𝑟𝑜𝑡𝑒𝑖𝑛 (calculated in 
Equation 3.2) by 100 provides a percentage labelling efficiency for the reaction. Using the 
initial method a labelling efficiency of only 12 % was obtained for the PspA1-186 S186C 
mutant. In order to undertake SMI studies using the conjugate this efficiency needed 
improving otherwise only a small proportion of the protein used would be visualised.  
 
3.2.2.2 Optimisation of the labelling reaction 
Conditions of the dye labelling reaction were varied with an aim of increasing the labelling 
efficiency. Perhaps surprisingly, the first marked increase was observed when TCEP was 
omitted from the reaction, resulting in 20 % labelled PspA1-186 S186C (see Figure 3.6 for SDS 
and fluoresce images of labelling reaction). It was noted that after undertaking the reaction 
in the presence of TCEP an orange precipitate formed in the reaction vessel which was not 
seen in the absence TCEP. SDS-PAGE analysis of the precipitate showed the presence of 
PspA1-186 S186C. The precipitate must have also included Alexa 488 due to its orange colour. 
It was hypothesised that the presence of TCEP was inducing the formation of fluorescently 
labelled protein aggregates (possibly due to a reduction in solubility), adversely effecting 
labelling efficiency. Replacing TCEP with other reducing agents such as DTT or β-
mercaptoethanol was not a viable alternative as their sulfhydryl groups react with 
maleimides (Getz et al., 1999). However, SDS-PAGE under non-reducing conditions (see 
Figure 3.5) showed significant amounts of monomer PspA1-186 S186C (40 %). This indicates 
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that disulphide bond formation between proteins is not complete thus a substantial 
labelling efficiency may be attained without a reducing agent.  
 
 
Figure 3.5. Disulphide bond formation in PspA1-186 cysteine mutants. Monomer bands represent 
proteins with no disulphide bond formation and dimer bands are indicative of a disulphide bond 
between two proteins. (A) Non-reducing SDS-PAGE of PspA1-186 and cys mutants. (B) Effect of TCEP 
on reduction of dimers of PspA1-186 S186C. 
 
Attempts at increasing the 20 % labelling efficiency of PspA1-186 S186C were undertaken by 
varying the dye incubation time and temperature. Increasing the incubation time to 18 h 
and the incubation temperature to 25 °C resulted in the highest labelling efficiency at 38 %. 
SDS-PAGE under non-reducing conditions (to prevent cleavage of protein-maleimide bond) 
followed by fluorescent imaging (488 nm Ex, 532 nm Em) was used to visualize labelled 
proteins. Subsequent Coomassie staining allowed visualisation of all protein bands within 
the gel (see Figure 3.6).  
In the non-reducing SDS-PAGE assay PspA1-186 E82C was found to exhibit significantly less 
disulphide bond formation with only around 10 % of the protein found as a dimer (see 
Figure 3.5A). Thus, PspA1-186 E82C may be a more attractive target for labelling under non-
reducing conditions (due to a higher proportion of reactive monomer). This was indeed the 
case with the labelling reaction of PspA1-186 E82C (25 °C, 18 h) giving an 11 % increase in 
labelling efficiency of 49 %. Table 3.1 shows the labelling efficiencies of the proteins under 
various conditions. 
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Figure 3.6 Visualising fluorescent labelling of PspA1-186 S186C via SDS-PAGE. Total protein (via 
Coomassie staining) and fluorescence (488 nm Ex, 532 nm Em) images of the product of the Alexa 
488 labelling reaction. 1. 25 °C, 18 h – 38 % labelling efficiency, 2. 25 °C, 2 h – 20 % labelling 
efficiency, 3. 21 °C, 2 h, with TCEP – 12 % labelling efficiency. 
 
3.2.2.3 Non-specific protein labelling  
Although a labelling efficiency of 49 % would be sufficient for SMI studies, Figure 3.6 
highlights a possible issue which required consideration. One can see that the monomer 
PspA1-186 S186C bands in the total protein stain correlate with bands seen in the florescence 
image confirming successfully labelled protein. However, surprisingly the dimer band is also 
shown to fluoresce, indicating the presence of a labelled dimer. These dimers are formed 
due to disulphide bonds between cysteine residues. With only one cysteine residue on each 
protein, a dimer should have no available site for maleimide dye conjugation. The 
observation of these fluorescent dimers may be indicative of a non-specific dye-protein 
interaction. Because of this observation, it was felt necessary to use PspA1-186 in the labelling 
reaction as a negative control. Containing no cysteine residues, PspA1-186 should not be able 
to covalently bind the fluorophore. However, a labelling reaction with PspA1-186 for 18 h at 
25 °C resulted in a 20 % labelling efficiency. It is therefore apparent that non-specific 
protein-dye interactions are a factor and contribute to the total labelling efficiency of the 
cysteine mutants.  
Non-specific labelling is highly undesirable due to uncertainty with respect to number of dye 
molecules per protein and their localization. Attempts to remove the non-specifically 
labelled dye by extensive dialysis proved unsuccessful. Also, assay conditions aimed at 
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minimising the non-specific interaction (increasing the salt concentration, amount of CHAPS 
and a lower excess of maleimide dye (Tyagarajan et al., 2003)) had little effect on the 
proportion of non-specifically labelled protein (see Table 3.1).  
 
Labelling Conditions 
Labelling Efficiency (%) 
PspA1-186 S186C PspA1-186 E82C PspA1-186 
2 h, 25 °C, TCEP (200 µM) 11 ND ND 
2 h, 25 °C 20 ND ND 
18 h, 4 °C 30 ND 18 
18 h, 25 °C 38 49 20 
18 h, 25 °C, 5x Alexa 488 excess 28 32 13 
18 h, 25 °C, Increased CHAPS† 48 61 29 
1 8 h, 25 °C, High Salt Conc.‡ ND 29 17 
 
Table 3.1 Labelling efficiencies of PspA1-186 proteins with Alexa 488. Reactions were undertaken 
with 100 µM protein and a ten-fold molar excess of Alexa 488 flour® C2 maleimide unless otherwise 
stated. † CHAPS in the reaction increased from 0.005 % to 0.1 %. ‡ NaSCN increased from 75 mM to 
225 mM. 
 
3.2.2.4 Probing non-specific labelling via fluorescence anisotropy 
With non-specific binding proving to be a persistent issue, fluorescence anisotropy studies 
were undertaken to establish the strength of the interaction and allow calculation of a 
binding constant. Fluorescence anisotropy measurements give information on the molecular 
orientation and mobility of a flourophore. Changes in anisotropy can be correlated to 
binding events (Teale, 1984).  
Fluorescence anisotropy is the phenomenon where by the emission of light from a 
fluorophore has unequal intensities along different axes of polarization. When polarised 
light is applied to a group of randomly orientated fluorophores in solution, excitation will 
occur in those whose absorption transition dipoles are aligned with the electric vector of the 
incident light. If the fluorophore is fixed in position then the fluorescence emission will be 
polarized within a particular range of angles to the applied light. However, molecular 
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rotation that occurs during the lifetime of the excited state leads to a depolarisation on the 
emission dependent on the degree of rotation (Senear et al., 1998). The extent of 
polarization of fluorescence is defined in terms of the anisotropy with a higher degree of 
fluorescence polarization resulting in a higher anisotropy value. Fluorescence anisotropy (r) 
is given by Equation 3.3. 
 
 
𝑟 =  
𝐼𝑉− 𝐼𝐻
𝐼𝑉+2𝐼𝐻
   Equation 3.3 
 
 
Where 𝐼𝑉 and 𝐼𝐻 are the intensities of vertically and horizontally polarized fluorescence 
emission (following excitation with vertically polarized light). Anisotropy (r) is given as a 
value between -0.5 and 1, if all fluorescence is polarized parallel to the orientation of 
excitation then r = 1, if all fluorescence is polarized perpendicular to the orientation of 
excitation then r = -0.5 and if fluorescence is unpolarized then r = 0.  
Small molecules rotate faster than larger ones. As such, an unbound fluorophore will give a 
lower anisotropy value than one bound to a macromolecule due to increased emission 
depolarization. We could therefore utilize the technique to investigate the strength of non-
specific binding by Alexa 488 to PspA1-186 via measuring fluorescence anisotropy as a 
function of protein concentration. Free dye in solution was titrated with increasing amount 
of PspA1-186, a plot of the anisotropy values can be seen in Figure 3.7 
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Figure 3.7 Fluorescence anisotropy of Alexa 488 titrated with PspA1-186. Alexa 488 at 30 nM in 
solution (PBS / BSA 0.5 mg/mL / Tween 20 0.05 %). Curve shown was fitted to the equation; 
 𝑟 = 𝐴𝑓 + (𝐴𝑏 − 𝐴𝑓) × (𝑥 𝐾𝑑 + 𝑥⁄ ). Calculated parameters along with standard error shown. 
 
It can be seen from Figure 3.7 that addition of PspA1-186 increases the anisotropy of Alexa 
488, therefore protein-dye association must be occurring. Anisotropy continued to increase 
after each titration until saturation is reached at a protein concentration of around 30 µM. 
The dissociation constant (Kd) can be calculated by curve fitting the data to equation 3.4: 
 
 
𝑟 = 𝐴𝑓 + (𝐴𝑏 − 𝐴𝑓) × (𝑥 𝐾𝑑 + 𝑥⁄ )  Equation 3.4 
 
  
Where 𝑟 is anisotropy, 𝑥 is protein concentration, 𝐴𝑓 is anisotropy when 𝑥=0, 𝐴𝑏 is 
anisotropy at saturation and 𝐾𝑑 is the apparent dissociation constant (Ciccia et al., 2007). 
The calculated parameters can be seen in Figure 3.7 with the plot giving a good fit to the 
calculated curve (R2 of 0.99). The Kd for the non-specific association of Alexa 488 and PspA1-
186 was calculated to be 41.1 µM. As the concentrations of dye and protein used in our 
labelling assays are significantly higher than the calculated Kd, the persisting issues of non-
specific binding are not surprising. 
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3.2.2.5 Effects of changing the fluorophore 
To try and eliminate non-specific binding, Alexa 488 was substituted with a different 
fluorophores. It was thought that the differing chemical structure could prevent an 
interaction with PspA. Alexa 488 has a net negative charge which has been shown in some 
cases to cause nonspecific electrostatic interactions. These can be overcome by using a 
neutral fluorophore (Mahmudi-Azer et al., 1998). Therefore HiLyteTM 488 (HiLyte 488) was 
chosen, due to its neutral charge and compatibility with our available imaging equipment 
(which uses a 488 nm excitation laser). Alexa Fluor® 647 (Alexa 647) was also used as its 
significantly different structure may prevent a protein interaction (see Figure 3.8). Dyes 
were purchased as maleimides so as to specifically label our cysteine mutants.  
 
 
 
Figure 3.8 Chemical structures of the fluorophores used in this study.  Structure for Alexa Fluor 
488 and HiLyte Fluor 488 were obtained from (Jungbauer et al., 2009) and Alexa Fluor 647 from 
(Irani et al., 2012). 
 
Labelling reactions with HiLyte 488 were undertaken first as, if successful, the labelled 
protein could be used in our imaging setup with a 488 nm laser line (Alexa 647 requires 594 
or 633 nm laser lines). Use of TCEP in the labelling reactions again lead to formation of an 
orange precipitate and thus it was omitted from the procedure. Three different conditions 
were used to compare nonspecific interactions of HiLyte 488 with Alexa 488. As can be seen 
in Figure 3.9A, HiLyte 488 gave the highest level of nonspecific labelling throughout.  
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Figure 3.9 Non-specific labelling studies with HiLyte 488. (A) Calculated labelling efficiencies with 
PspA1-186 for Alexa 488 and HiLyte 488. 100 µM protein with a ten-fold molar excess (1 mM) of dye 
was used. (B) Fluorescence image (Ex 475 nm, Em 532 nm) of the non-denaturing SDS-PAGE gel 
containing products from the 18 h, 25 °C, labelling reaction with HiLyte 488 (HY) and Alexa  488 (AL). 
(C) Fluorescence anisotropy of HiLyte 488 with increasing PspA1-186. 30 nM dye in solution (PBS / BSA 
0.5 mg/mL / Tween 20 0.05 %). Curve was fitted as per Figure 3.7 and calculated parameters with 
standard error values are shown. 
 
Anisotropy studies with HiLyte 488 (Figure 3.9C) gave a Kd of 9.26 µM showing that HiLyte 
488 actually has a higher nonspecific affinity for PspA1-186. From these results it is clear that 
HiLyte 488 exacerbates the nonspecific binding issue. The increased hydrophobicity of the 
dye might be responsible for this as studies have noted an increase in nonspecific 
interaction concurrent with flourophore hydrophobicity (Zanetti-Domingues et al., 2013).  
Finally, nonspecific interactions of PspA1-186 with Alexa 647 were investigated. These 
labelling reactions resulted in very low nonspecific binding typically around 0-4 %. Also, use 
of TCEP did not result in any precipitate therefore the reducing agent could be incorporated 
into labelling reactions. This lead to a dramatic increase in labelling efficiency of the PspA1-
186 S186C mutant, resulting in 76 % labelling efficiency being achieved (2 h, 25 °C) (see Figure 
3.10). The PspA1-186 negative control had 3 % labelling efficiency under the same conditions, 
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over 25-fold less labelling than the cysteine mutant, thus non-specific interactions are rather 
insignificant with Alexa 647. Interestingly the PspA1-186 E82C mutant only gave a modest 8 % 
labelling efficiency in the reaction, possibly due to steric clashes between the protein and 
the dye near the cysteine residue.  
 
 
Figure 3.10 Alexa Fluor 647 labelling studies. (A) Calculated labelling efficiencies of PspA1-186 and 
cys mutants with Alexa 647. 100 µM protein with a ten-fold molar excess (1 mM) of dye was used. 
TCEP used in two-fold molar excess when specified. (B) Flourescence image (Ex 635 nm, Em 665 nm) 
of the non-denaturing SDS-PAGE gel containing products from the 2 h, 25 °C, TCEP labelling reaction 
shown in (A). (C) Fluorescence anisotropy of Alexa 647 with increasing PspA1-186, and PspA1-186 S186C. 
Dye was 30 nM in solution (PBS / BSA 0.5 mg/mL / Tween 20 0.05 %). Curve was fitted as per Figure 
3.7 (𝐴𝑏 was estimated to be 0.18 for PspA1-186 as binding saturation could not be reached 
experimentally) and calculated Kd shown. 
 
A 73 % specifically labelled PspA1-186 S186C – Alexa 647 preparation is definitely suitable for 
SMI studies. Unfortunately, the imaging facilities available to us did not have the required 
laser line for excitation of the fluorophore. Initial native-PAGE and ATPase assays of the 
conjugate were undertaken to probe its functionality with respect to interaction with PspF1-
275.  The results showed that PspA1-186 S186C – Alexa 647 behaves similarly to PspA1-186 in 
respect to its ability to inhibit ATPase by PspF1-275. However, it was unable to form the 
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defined PspA1-186-PspF1-275 complex seen in native-PAGE interaction assays (data not 
shown). Apparently the dye labelling causes a weakening of the complex. 
 
3.2.3 An alternative approach to monitoring protein-vesicle interactions 
Due to the numerous difficulties that arose during the fluorescent labelling studies, other 
approaches for observing a PspA-membrane interaction were investigated. Previous in vitro 
studies into association of PspA with the membrane used sucrose gradient co-flotation 
assays (Kobayashi et al., 2007). Due to the techniques relative simplicity, and the availability 
of an established protocol, it was chosen as an initial method to probe direct binding of 
PspA to a range of lipid bilayers. A native-PAGE based binding assays was also established to 
rapidly and quantitatively monitor PspA-membrane interactions across a range of protein 
concentrations and lipid vesicle compositions.  
Both assays require the production of unilamellar vesicles from phospholipids in order to 
form a model membrane upon which the interactions can be studied. Formation and 
characterisation of the vesicles used in this study is detailed in section 3.2.3.1 below. 
 
3.2.3.1 Vesicle production 
The vast majority of our current knowledge of protein-lipid interactions and their associated 
mechanisms have come from the study of model membranes. A number of biomimetic 
systems are used for such purposes, nonetheless, lipid vesicles are the most widely used 
tool. Lipid vesicles structurally resemble many cellular membrane compartments, containing 
a lipid bilayer structure. They are suitable for a wide variety of biochemical assays including 
sucrose gradient co-flotation assays (Zhao and Lappalainen, 2012). In this study unilamellar 
vesicles, composed of a single lipid bilayer, were produced principally via extrusion 
(sonication was occasionally used). 
Throughout the work, vesicles were produced with varying lipid compositions but the same 
principles of formation were applied throughout.  Small unilamellar vesicles (SUVs) with a 
diameter < 50 nm were produced via sonication. Their small diameter results in a high 
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degree of membrane curvature making them inherently unstable while size distributions are 
often quite varied. Extrusion was used to produce large unilamellar vesicles (LUVs) with 
diameters between 100-500 nm (determined by the pore size of the polycarbonate filter 
used). LUVs possess less membrane curvature and are more homogeneous in size 
distribution than SUVs. As such, LUVs were used for membrane binding assays in order to 
minimize the variables in size distribution and the effects of curvature on binding (Mui et al., 
2003). Sonicated SUVs were produced only to assay the effect of membrane curvature on 
binding and to show direct vesicle-binding within the native-PAGE assay. 
After vesicles were produced, their size distribution was characterised via dynamic light 
scattering (DLS).  The intensity of scattered light plotted against the particle diameter for the 
vesicles used in this study is shown in Appendix A. For LUVs, the phospholipid concentration 
of selected samples was checked before and after extrusion via a phosphate assay to ensure 
that lipids were not being retained by the nitrocellulose membrane. None of the samples 
tested exhibited any significant reduction in phospholipid concentration after extrusion. We 
can thus be confident that all phospholipids are successfully passing through the membrane. 
Initial studies to show binding of PspA to lipid-bilayers used E. coli total lipid extract (E. coli 
TLE) vesicles, as they contain the same diverse lipid composition and concentrations of the 
E. coli cells they were extracted from. This allows the study of binding to vesicles with a 
similar distribution of lipids found in in vivo studies of PspA in E. coli (Foss et al., 2011).  
 
3.2.3.2 Sucrose gradient co-flotation assays 
Ultracentrifugation can be utilized to separate vesicle-bound and unbound protein via either 
co-sedimentation or co-flotation assays. Co-sedimentation is based on the principle that 
when exposed to sufficient g force the vesicles, along with any bound protein, will sediment. 
Any unbound protein remains in the aqueous buffer. Co-sedimentation is the faster and 
more versatile of the two methods, however, proteins that form oligomers will often 
sediment in the absence of vesicles (Zhao and Lappalainen, 2012). As PspA forms high-order 
oligomers this technique is unsuitable.  
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Co-flotation assays use a density gradient within the solution to separate unbound protein 
from vesicles and any associated protein. Particles sediment at a position in the centrifuge 
tube where the density of the gradient is equal to that of the particle. This is their isopycnic 
point. Previous studies with PspA have shown its isopycnic point in a sucrose gradient is 
around 25-35 % (w/v) sucrose. Vesicles are comparatively more buoyant, sedimenting at 0-
10% (w/v) sucrose (Standar et al., 2008, Kobayashi et al., 2007). Therefore, after 
centrifugation in a 0-30 % (w/v) linear sucrose gradient PspA should sediment in the 
bottom, higher density, fractions. Vesicles and associated proteins will be found in the lower 
density fractions at the top of the gradient. Fractions collected of each level can be 
analysed. Protein found in lower density fractions is indicative of being vesicle bound (see 
schematic shown in Figure 3.11A). 
The assay was undertaken with PspA WT (10 µM) incubated with E. coli TLE  vesicles (2.5 
mM lipid conc) before being loaded on top of a 0-30 % (w/v) sucrose gradient and subjected 
to centrifugation. A negative control containing PspA WT and buffer only was also 
undertaken. After centrifugation, ten fractions were collected and analysed for protein via 
12.5 % SDS-PAGE (stained with SYPRO Ruby Protein Gel Stain). The results of the assay can 
be seen in Figure 3.11B. In the PspA WT alone sample, protein was only found in the bottom 
three, high density, fractions. However, in the sample where PspA WT was incubated with 
vesicles, some protein was also detected in fractions 7 and 8. These are collected from an 
area of lower density, around the region where vesicles are expected to sediment, and thus 
appears to be membrane bound.  
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Figure 3.11 Monitoring protein-vesicle binding via co-flotation assays. (A) Schematic (figure 
adapted from Kobayashi et al., (2007), (B) Collected fractions of PspA, with and without vesicles 
analysed via SDS-PAGE and SYPRO staining. Starred fractions indicate those found to contain 
vesicles. Assay used 10 µM PspA incubated with 2.5 mM, 100 nm, E. coli TLE vesicles. (C) 
Sedimentation profile of E. coli TLE vesicles labelled with 0.5 % NBD-PE (monitored via fluorescence 
emission at 515 nm). 
 
To confirm the location of E. coli TLE vesicle sedimentation, a vesicle preparation was doped 
with 0.5 % of the fluorescent lipid NBD-PE and incorporated into the coflotation assay. 
Fractions were again collected but this time analysed for vesicles via fluorescence emission 
at 515 nm (see Figure 3.11C). As expected, vesicles were found to sediment in the lower 
density fractions. Fluorescence was only detected in fractions 7, 8, 9 and 10 of the gradient.  
The assay was repeated and consistently showed bound PspA in lower density fractions with 
the vesicles (predominantly fractions 7, 8 and 9), along with the unbound PspA in the high 
density fractions. The results from this co-flotation assay clearly show that PspA WT is 
binding to E. coli TLE vesicles. However, only a small proportion of the total PspA in each 
assay was found to bind the vesicles. As SYPRO Ruby is a quantitative protein stain 
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(Berggren et al., 2000), the relative amounts of PspA in each fraction can be determined 
from the intensity of the protein band in each fraction on the SDS-PAGE gel. The average 
distribution of PspA WT from three repeat assays (with and without vesicles) is shown in 
Figure 3.12. It can be seen that bound PspA is a small fraction of the total PspA in the assay. 
Over three assays an average of 20 % of the total PspA was found bound to vesicles. Even 
smaller amounts of bound PspA was observed by Kobayashi et al in similar assays 
(Kobayashi et al., 2007). The amount of PspA that was found to bind the membrane also 
varied quite significantly from assay to assay, despite the same experimental conditions. 
Binding of 10 µM PspA WT to 2.5 mM TLE vesicles ranged from 6 – 29 %. Increasing the 
concentration of lipid vesicles (from 2.5 - 4 mM) did not appear to correlate with a 
reproducible increase in PspA-membrane binding. These findings cast doubt on co-flotation 
as a quantitative assay to measure levels of membrane association of PspA to vesicles. 
However, it is apparent that qualitatively the assay is sufficient to confirm that the purified 
PspA used in this study possesses direct lipid-bilayer binding properties.  
 
 
Figure 3.12 Distribution of PspA WT across fractions from co-flotation assays with and 
without vesicles. Percentage distributions of PspA across fractions (obtained from quantification of 
SYPRO stained PspA bands) alone (top) and with E. coli TLE vesicles (bottom). 10 µM PspA and 2.5 
mM lipid vesicles were used. Values given are the average from 3 repeats.  
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The membrane binding of truncated PspA1-186 was not able to be probed using this assay as 
PspA1-186 alone was found to sediment at around 15-5 % (w/v) sucrose, similar to that of the 
vesicles. The lower buoyant density for PspA1-186 may be due to its inability to form high-
order oligomers, instead existing as a monomer/dimer in solution (Joly et al., 2009). 
 
3.2.3.3 Developing a Native-PAGE based binding assay 
A native-PAGE based assay using electrophoresis to separate vesicle-bound from unbound 
PspA was also used to investigate binding. It allows for visualisation and quantification of 
unbound protein. Therefore, if the starting amount of PspA is known, membrane-binding 
can be calculated from the decrease in free PspA. Such a depletion assay is described below. 
 
3.2.3.3.1 Assay principles and initial binding measurements 
Samples containing a uniform amount of PspA are pre-incubated with increasing 
concentrations of E. coli TLE vesicles. The samples are then loaded on a 4.5 % native-PAGE 
polyacrylamide gel. During electrophoresis unbound PspA is free to run through the gel 
matrix. Vesicle bound PspA is unable enter the gel due to the large size of the protein-
vesicle co-complex exceeding the gel pore size (Holmes and Stellwagen, 1991).  By using 
SYPRO Ruby, integration of the stained PspA band gives a quantitative measure the free 
protein present. Comparison between the intensity of the PspA without vesicles band, and 
PspA with vesicles samples gives the relative amount of vesicle-bound protein. A schematic 
of the assay can be seen in Figure 3.13A, with the SYPRO stained native-PAGE gel of PspA 
WT with increasing titrations of E. coli TLE vesicles shown in Figure 3.13B. As PspA’s affinity 
for the membrane is unknown a broad range of vesicle concentrations was initially used 
from 100 µM to 5 mM phospholipid (0.25 mM – 5 mM only shown in Figure 3.13B). Lane 1 
of Figure 3.13B contains the PspA WT only standard upon which the intensity the protein-
vesicle samples will be gauged. Lane 7 is a negative control containing only 5 mM vesicles 
(the highest concentration used within the assay). As can be seen, no staining is observed in 
lane 7 and thus we can be confident that any signal observed is only due to protein. Lanes 2-
6 contain the assay samples of 10 µM PspA incubated with increasing vesicle 
concentrations. The red boxes shown in Figure 3.13B indicate the regions that were 
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quantified in each lane. It is important the areas of these integrated regions remain the 
same and incorporate the whole area in which PspA was detected in lane 1 so the intensity 
decrease can be accurately compared.  The integrated region in Lane 7 is used as a 
background, subtracted from the values to account for the uniform background staining of 
the gel. 
 
 
Figure 3.13 Native-PAGE based binding assay gives a quantitative measure of PspA-
membrane binding. (A) Schematic detailing the assay procedure. (B) Image of a typical vesicle 
titration, SYPRO stained native gel (image shown is 10 µM PspA titrated with 100 nm, TLE vesicles). 
Boxed areas signify signal integrated regions and % band intensity compared to without vesicles 
(lane 1) is shown for each lane. 
 
As can be seen from Figure 3.13B, adding TLE vesicles to the sample results in a reduction in 
the relative intensity of the stained protein band compared with the PspA alone standard.  
Increasing the vesicle concentration in the sample corresponds with a decreasing PspA band 
intensity. The signal titrates down to around 10 % that of the PspA standard at a lipid 
concentration of 2.5 mM (see lane 5 of Figure 3.13B). The assay was repeated using 3 
separate vesicle preparations and the trend was found to be reproducible.  
For follow up studies, the range of lipid concentrations used was reduced to between 0.25 
nM – 2.5 mM where a range of binding levels should be observed. As the results are being 
treated quantitatively, great care was taken when loading the native gel to ensure the entire 
sample entered the wells. Despite this diligence, seemingly anomalous results for individual 
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samples in a titration series were occasionally obtained from the assay (around 5 % of all 
samples run). In these cases the intensity of the PspA band strayed significantly from the 
norm (possibly due to physical discontinuities of the gel matrix or occasional precipitation of 
unbound PspA). Due to the pivotal importance of the PspA standard it was run at least in 
duplicate within each gel (usually in the far-left and far-right hand lane). This limited the 
possibility of an anomalous result being incorporated into binding calculations. If intensities 
significantly varied between the standards the samples were rerun. 
A plot of the relative intensity (where the intensity of the PspA standard is set to 1) of the 
free PspA WT band as a function of vesicle concentration from the assays is shown in Figure 
3.14A. As can be seen, the decrease in intensity is initially rapid up to 1.5 mM lipid 
concentration where the signal saturates. The decrease in signal intensity can be 
corresponded to an increase in PspA-membrane binding preventing the protein from 
entering the gel matrix. By using equation 3.5, the percentage membrane-bound PspA can 
be calculated from the relative intensity of the free PspA band. 
 
 
% 𝑃𝑠𝑝𝐴 𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒 𝑏𝑜𝑢𝑛𝑑 = (1 − 𝑅𝐼) × 100   Equation 3.5 
 
 
Where RI is the relative intensity of the free PspA band (where the intensity of the PspA 
alone standard is set as 1). Figure 3.14B shows PspA WT membrane binding to E. coli TLE 
vesicles as a function of vesicle concentration calculated using this equation.  
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Figure 3.14 Calculating membrane binding of PspA from the native-PAGE assay. (A) Relative 
intensity (RI) of the PspA band from the native-PAGE assay (PspA alone standard is set to 1) as a 
function of vesicle concentration. Plot is from 3 repeats using different vesicle preparations, error 
bars show are SD. (B) Graph showing the percentage of PspA vesicle-bound,  calculated via equation 
3.5 from the same experimental data used in 3.14A.  
 
3.2.3.3.2 Controls 
Using the native-PAGE technique, assumptions were initially made that must be 
experimentally addressed before it can be confirmed that the decreasing intensity signal is 
because of protein-membrane interactions. The method is indirect as we are not directly 
observing a protein-membrane interaction but inferring one from a reduction in the 
quantity of unbound protein. It could therefore be argued that the intensity decrease is due 
to factors unrelated to membrane-binding; such as vesicles clogging the pores of the gel, 
preventing unbound protein from entering. To address these issues, controls incorporating 
PspF1-275 into the assay were undertaken. PspF1-275 does not interact with membranes 
(Mehta et al., 2014) so a decrease in the intensity of the free protein band should not be 
observed upon vesicle addition. As expected, the intensity of the PspF1-275 bands remained 
similar despite addition of vesicles to the sample (see Figure 3.15). From this result it is 
apparent that the decrease in PspA signal cannot be attributed to vesicles blocking the gels 
pores or preventing proteins from entering it altogether. Rather, a selective protein-vesicle 
interaction is occurring to account for the depletion of free PspA signal when vesicles are co-
incubated prior to gel electrophoresis.  
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Figure 3.15 Native-PAGE protein-membrane interaction assay negative control with PspF1-275. 
SYPRO stained gel image of the assay undertaken with 10 µM PspF1-275. Red boxes indicate the 
integrated regions with the % intensity with respect to the protein alone sample (lane 2) shown.  
 
To confirm that vesicles are unable to run into the gel matrix, E. coli TLE vesicles were doped 
with 0.5 and 2 % mole fraction of the fluorescent lipid NBD-PE (1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl)) and then subjected to 
electrophoresis under the same conditions used in the assay. The gel was then fluorescently 
imaged (pre and post washing with dH2O) in order to visualise vesicles. 4.5 % gels from both 
the Geneflow and Bio-Rad systems were used with the results shown in Figure 3.16. Before 
washing, a large amount of fluorescence is observed in the wells containing labelled vesicles 
(lanes 2 and 4 of Geneflow gel and lanes 2 and 3 of Bio-Rad gel). However it is clear the 
vesicles have not been able to freely run through the gel matrix, due to the lack of 
fluorescence intensity. After washing with dH2O, the majority of the fluorescence was 
removed from the gel leaving only a small amount of NBD-PE visualised just below the well. 
It is possible that the minimal remaining fluorescence could be due to vesicles at the very 
bottom of the size distribution being able to enter the gel, very slowly running through the 
matrix. The fluorescence present after washing appears to be concentration dependent as 
reducing the vesicle concentration reduces the signal (evident in lanes 2 and 3 of the Bio-
Rad gel in Figure 3.16).   
Within the native-PAGE binding assay, a slight increase in protein density at the very top of 
the gel is sometimes observed with high vesicle concentrations. This may be due to protein 
bound to the vesicles, at the bottom end of the size distribution, being able to enter the gel 
matrix (further evidence for this in Chapter 4). Although the intensity of this signal was 
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minimal compared with the whole protein band (around 5 % of total), integration of the 
protein band in all native-PAGE assays was undertaken from just below the well to avoid its 
incorporation. 
 
 
Figure 3.16 Fluorescent images of NBD-PE labelled vesicles run on a native-PAGE gel. 100 nm 
E. Coli TLE vesicles doped with 0, 0.5 and 2.0 % NBD-PE, run on 4.5 % gels using both the Geneflow 
and Bio-Rad systems are shown. Gels were run at 100 V for 75 min and were imaged both 
immediately after electrophoresis and after the gel had been washed with dH2O.  
 
Finally, controls to confirm linear staining intensity of PspA WT with SYPRO Ruby were 
undertaken. The stain has been shown to have a linear dynamic range between 1-1000 ng of 
protein for BSA, while other proteins have shown linearity at concentration of 2500 ng and 
above (Berggren et al., 2000, Berggren et al., 2002). The amount of PspA loaded on the 
native-PAGE assay in Figure 3.14 was around 2500 ng, which exceeds the stated linear 
dynamic range of some proteins. It was therefore deemed appropriate to test the linearity 
of PspA up to this quantity. Amounts ranging from 0.25-2.5 µg of PspA WT were run on a 
4.5% Native-PAGE gel and SYPRO stained. The intensity of each stained band was plotted 
against protein quantity with the results shown in Figure 3.17.  
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Figure 3.17 Linearity of Sypro Ruby Protein Stained PspA WT. (A) Decreasing amounts of PspA 
WT stained with Sypro Ruby Protein Stain after native-PAGE. Red boxes indicate the areas from 
which intensity of each lane was integrated. (B) The intensity of integrated bands plotted against the 
amount of PspA WT from 3 separate gels. Set 1 and 2 are with a background subtracted and set 3 is 
raw data. R2 values for the linear regression are as follows; Set 1 – 0.991, Set 2 – 0.973, Set 3 0.975. 
 
It can be seen from Figure 3.17B that SYPRO staining of PspA WT does appear to show have 
a linear dynamic range between 0.25 and 2.5 µg with all three plots showing a linear trend 
(R2 values from linear regression all over 0.97). An increased linear dynamic rage above 1000 
ng could be attributed to the relatively diffuse nature of the PspA WT band. It would follow 
that as the area covered by PspA WT is more diffuse, the linear staining is extended at the 
top end of the range as the protein concentration per area is less than that of a focused 
band. This could also explain why detection of PspA WT below a load of 0.1 µg (100 ng) was 
not possible. Protein bands over 10 ng are usually detectable using SYPRO ruby (Butt and 
Coorssen, 2013), however, the diffuse nature of the PspA WT band may make the staining 
indistinguishable from the background. Although the trend is linear, a reduced R2 value 
compared with those observed in the literature is observed, where values are typically 
around 0.99 (Butt and Coorssen, 2013, Berggren et al., 2002). Again this may be due to the 
diffuse PspA WT band on the gels resulting in slightly less sensitivity. 
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 3.2.3.3.3 Calculating the PspA membrane coverage 
Using the data obtained from the native-PAGE binding assay, we can calculate the 
percentage of PspA membrane coverage. If the concentration of PspA and vesicles in a 
sample is known, membrane coverage can be calculated using Equation 3.6. 
 
% 𝑣𝑒𝑠𝑖𝑐𝑙𝑒 𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒 =
𝐶𝑃𝑠𝑝𝐴 ×𝐴𝑃𝑠𝑝𝐴 ×𝐵𝑃
𝐶𝑣𝑒𝑠 ×𝐴𝑣𝑒𝑠
 × 100   Equation 3.6 
 
Where 𝐶𝑃𝑠𝑝𝐴 is the concentration of PspA, 𝐴𝑃𝑠𝑝𝐴 is the surface area per PspA in contact with 
the membrane, 𝐵𝑃 is the proportion of PspA membrane bound (0-1) , 𝐶𝑣𝑒𝑠 is the 
concentration of vesicles and 𝐴𝑣𝑒𝑠 is the surface area per vesicle. The concentration of PspA 
WT in all the samples was 10 µM. Previous EM measurements have shown that the circular 
faces of the 36-mer PspA oligomeric ring have surface areas of around 314 nm2, equating to 
8.7 nm2 per PspA monomer (Hankamer et al., 2004). From DLS measurements the E. coli TLE 
vesicles have an average diameter of 85 nm, thus a surface area of 22,698 nm2. Vesicles 
were made at a 6.6 mM (5 mg/mL) lipid concentration, dividing this by the number of lipid 
molecules per vesicle (𝑁𝑣𝑒𝑠) gives the vesicle concentration (𝐶𝑣𝑒𝑠). 𝑁𝑣𝑒𝑠 is calculated via 
Equation 3.7. 
 
𝑁𝑣𝑒𝑠 =  
(4𝜋(
𝑑
2
)
2
+4𝜋(
𝑑
2
−ℎ)
2
)
𝑎
  Equation 3.7 
 
Where 𝑑 is the diameter of the vesicle (85 nm), ℎ is the bilayer thickness and 𝑎 is the 
average area occupied per lipid. E. coli TLE is a complex lipid mix so parameters for ℎ and 𝑎 
have not been experimentally calculated. However, studies on simpler E. coli model 
membranes have reported a bilayer thickness of 4.0 nm and lipid area of 0.65 nm2 (Pandit 
and Klauda, 2012). Using these values gives an 𝑁𝑣𝑒𝑠 of 63,576 which results in a 𝐶𝑣𝑒𝑠 of 103 
nM for the E. coli TLE vesicle stock solutions that were made. 
The percentage membrane coverage by PspA WT can now be calculated using equation 3.6. 
Using the average value for membrane-binding of PspA WT at 0.5 mM lipid concentration of 
57 % (a point where binding is relatively linear), the percentage vesicle coverage of PspA WT 
was calculated to be 28.2 %.  This value is assuming that PspA binds the membrane face 
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down in its oligomeric ring conformation (i.e. the circular face lies flat on the membrane). 
Although it seems most likely conformation, unfortunately, no experimental data regarding 
binding orientation is available. If the binding is side on or through a different conformation 
such as the clathrin like structures observed by Standar et al. (2008), then the membrane 
coverage will differ. For example, if membrane binding of PspA is though the 36-mer 
oligomer but via a side-on orientation, membrane coverage would be around 15 % (8.5 nm 
ring height X 20 nm diameter results in each oligomer occupying around 45 % less 
membrane surface area).  
 
 
Discussion and Conclusions 
The work undertaken in this chapter provides a solid platform to study the membrane 
association of PspA using purified, defined components. Purified PspA proteins and vesicles 
have both been produced and characterised, before being used in two binding assays that 
confirmed a direct PspA-membrane interaction. The techniques can be used to probe the 
binding of PspA as a function of vesicle composition in an aim to identify specific lipid 
binding determinants. PspA mutants can also be used to gain an insight into the role that 
specific domains play in membrane binding.  
Although the initial approach aiming to use SMI to study PspA’s effector function was 
halted, the dye-labelling studies outlined provide a strong starting point, from which, future 
studies can utilise SMI techniques to study PspA in vitro. It is clear that non-specific PspA-
dye interactions cannot be easily avoided when using Alexa 488 and HiLyte  488. This makes 
them unsuitable for use in SMI studies with PspA. The fluorescein derived, conjugated 
aromatic backbone shared by the two dyes (Figure 3.8) may be responsible for the 
nonspecific interactions through hydrophobic interactions with the protein (Andersson et 
al., 1971, Zanetti-Domingues et al., 2013). PspA contains a number of hydrophobic regions 
(Jovanovic et al., 2014b) and its low solubility would suggest some of these are surface 
exposed, presenting a target for non-specific dye binding. It follows that fluorescein derived 
dyes of similar structure would also be expected to exhibit significant nonspecific binding 
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and their use should be avoided in any future labelling studies. Non-specific binding was 
significantly reduced by using Alexa 647 resulting in a PspA1-186-Alexa 647 conjugate with 
high labelling efficiency and specificity. The dye has a chemically and structurally distinct 
structure from the others investigated (Figure 3.8), which is probably responsible for 
mitigating the nonspecific interactions. Continuation of this line of study would involve 
initial SMI assays using vesicles and the PspA1-186-Alexa 647 conjugate aiming to characterise 
protein-membrane interactions. Photobleaching could potentially reveal the number of 
PspA molecules per complex bound to the vesicles (Lenn et al., 2011), and the distributions 
of such complexes across the vesicle surface could be probed. Labelling of full length PspA 
would follow with careful consideration of cysteine position to avoid interference of both 
high-order oligomerization and membrane-binding.   
Using sucrose gradient co-flotation and the Native-PAGE based assays, binding between 
PspA WT and E. coli TLE vesicles was observed. This asserts the principle that PspA can 
interact directly with the membrane (not just via PspBC) shown previously in vivo 
(Yamaguchi et al., 2010) and in vitro (Kobayashi et al., 2007). While at this stage the specific 
membrane signals sensed by PspA remain ambiguous, the assays provide a platform for 
their identification using targeted lipid compositions and PspA variants.  
A possible explanation for the low and inconsistent levels of binding observed in the co-
flotation assay may be due to a large dissociation constant (Kd) of the PspA-vesicle complex. 
Although a PspA-membrane kd has not been experimentally calculated, in vivo research 
suggests the affinity of PspA for the cells inner-membrane is not especially high (as PspA can 
be found in cytoplasmic and membrane fractions). Studies on direct membrane association 
of PspA in Y. enterocolitica observed membrane association exclusively via PspBC at low 
levels of PspA; direct membrane association is only seen when PspA was overexpressed 
(Yamaguchi and Darwin, 2012). This is consistent with the in vitro co-flotation studies 
carried out both in this work and by Kobayashi et al (2007), where low levels of membrane-
binding are also observed. Compared with co-flotation assays, the native-PAGE based 
membrane-binding assay shows a higher level of membrane association of PspA WT to E. 
coli TLE vesicles. This variance may be due to both methods being non-equilibrium binding 
assays disfavouring a re-association of PspA with the vesicles, in combination with the 
different time scales of the two experiments. Pre-incubation of protein and vesicles achieves 
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an initial binding equilibrium in the assays. However, both centrifugation and 
electrophoresis methods work by separating free protein from the vesicle environment over 
a time period. During this time the rate of protein-vesicle association is less than the 
protein-vesicle dissociation rate. In the co-floatation assay the centrifugation period is much 
longer than the electrophoresis time in the Native-PAGE assay (16 h as opposed to 1 h), 
which will give rise to more total dissociated PspA. This may be compounded by the larger 
sample volumes used in co-floatation assays having a detrimental effect on re-association as 
the vesicle concentration is effectively diluted (due to layering a binding reaction on the 
large sucrose cushion). Loading the sample in a well on the native-PAGE assay has a caging 
effect, maintaining the vesicle concentration and making re-association of any dissociated 
PspA relatively favourable in comparison to co-floatation assays. The non-equilibrium 
nature of the experiments may also explain why membrane-binding does not exceed around 
90% of the total PspA in the native-PAGE assay (i.e. saturation of the PspA band intensity 
decrease caused by vesicles is around 10 % that of a PspA alone sample). However, it must 
be that > 90 % of PspA is competent for vesicle binding. 
The native-PAGE based assay employed in this chapter appears to be an effective technique 
to probe protein-membrane interactions and could be used different lipid compositions and 
PspA mutants. The majority of protein-membrane binding results presented in Chapters 4 
and 5 originate from the native-PAGE based technique due to a number of advantages it 
possesses over the co-floatation method. Both assays provide very clear indications of 
binding of PspA to vesicles. However, the higher throughput and quantitative nature of the 
native-PAGE assays make it preferable for probing protein-vesicle interactions in a 
comparative study, using multiple lipid compositions and proteins. Controls have been 
undertaken to show linearity of the SYPRO stain with PspA and to ensure that vesicles do 
not block protein from entering the gel. Data presented in the Chapter 4 shows a direct 
binding interaction between PspA and SUVs within the assay, supporting the method 
further. During electrophoresis vesicles are exposed to a maximum electric field strength of 
8 V cm-1, well below the level at which vesicles become unstable (Gao et al., 2010, Pysher 
and Hayes, 2004, Correa and Schelly, 1998). Use of capillary gel-electrophoresis (200 V cm-1 
field strength) to probe protein-vesicle interactions is an established method based on 
similar principles (Owen et al., 2005). Although the assay is an indirect method, as protein-
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membrane binding is inferred from loss of free protein, the use of co-floatation assays to 
directly confirm PspA-vesicle binding in selected experiments substantiates the approach. 
After using the native-PAGE technique for PspA, it was found that a similar assay had been 
undertaken to monitor the protein-membrane interaction between PMPs and vesicles in a 
recently published study (Garnier et al., 2012). The work probed the binding of AnxZ55 to 
anionic lipid vesicles. AnxZ55 was incubated with increasing concentrations of vesicles, 
before being subjected to native-PAGE. Similar to our study, intensity of the Anxz55 band 
decreased with increased vesicle concentration. A similar technique has also been used to 
investigate DNA-vesicle binding interactions (Gershon et al., 1993). DNA fragments were 
incubated with increasing vesicle concentrations before being loaded on a 1.5 % agarose gel 
and subjected to electrophoresis. The gel was stained by exposure to ethidium bromide and 
a decrease in stain intensity proportional to vesicle concentration was attributed to an 
increase in DNA-vesicle binding.  
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Chapter 4 – PspA-Membrane Interaction Studies 
 
Overview 
In this chapter the membrane binding assays established in Chapter 3 are first used to probe 
membrane association as a function of lipid composition. This leads to the identification of 
two specific membrane signals sensed by PspA: stored curvature elastic (SCE) stress and 
anionic phospholipids. Independent increases in both the SCE stress and the net negative 
charge of the membrane promote association of PspA, however, increasing the membrane 
negative charge dampens the SCE stress sensitivity. Two PspA mutants are then studied to 
provide information on the roles that the N-terminal amphipathic helix (AH) and high-order 
oligomers play in PspA-membrane association. Removal of the N-terminal AH of PspA was 
found to significantly reduce bilayer association in both a SCE stress and anionic lipid specific 
manner, showing its critical importance in membrane binding. The monomer/dimer PspA1-
186 was still able to bind the membrane, therefore high-order oligomerization of PspA prior 
to membrane association is not absolutely required for binding. Finally, experiments using a 
dye efflux assay to probe the stability of the vesicle after the addition of PspA, reveal that 
membrane partitioning of the protein does not have any destabilising effect on the vesicles. 
From the data in this chapter, a binding mechanism is proposed where by interfacial 
insertion of the hydrophobic face of PspA’s N-terminal AH into the membrane allows nearby 
phospholipid chains to splay, reducing the stored torque tension within the bilayer. This 
interaction is modulated by electrostatic interactions between anionic lipids and the 
negative residues on the polar face of the AH. 
  
    123 
  
4.1 Introduction 
4.1.1 Anionic lipids as membrane binding determinant? 
PspA’s effector function is directly linked to IM association of the high-order oligomer 
(Kobayashi et al., 2007, Yamaguchi et al., 2010). In this respect, identifying one or more 
membrane signals that are responsible for the proteins recruitment is crucial in 
understanding the PspA mediated effector function of the Psp response. PMPs often use a 
combination of weak binding motifs for membrane association as opposed to domains that 
recognise a specific polar head group (McLaughlin and Aderem, 1995). Currently there is no 
definite consensus on the nature of these signals, however, a few studies have implicated a 
crucial role for anionic lipids (see section 1.4.1).  
Previous In vitro studies have shown a binding interaction between purified PspA and 
vesicles containing PG and PS, leading to the proposal that the anionic nature of these lipids 
facilitate binding through electrostatic interactions (Kobayashi et al., 2007). Binding 
between vesicles containing only the neutral lipids PE and PC were not observed. The 
anionic CL also showed no PspA binding. This may be considered surprising due to CLs net 
negative charge and similar head group structure to PG. Recently, in vivo SMI imaging 
studies have also found a link between anionic lipids and PspA’s behaviour in E. coli; 
Inhibiting biosynthesis of PG lead to an increase in the diffusion of PspA in lateral regions 
(Jovanovic et al., 2014c). It was suggested this may be due to PspA being less constrained by 
membrane binding to PG. The study also found that, in a mutant unable to synthesise CL, a 
decrease in polar localised PspA (where the most CL resides (Foss et al., 2011)) was seen. 
 
4.1.2 Membrane binding via the N-terminal amphipathic helix 
While elucidation of the membrane signals sensed by PspA is vitally important for 
understanding the mechanisms of its membrane association, so too is identification and 
characterisation of the membrane binding region of the protein. Great progress has been 
made in this respect over the last few years with the identification of a putative N-terminal 
amphipathic helix (AH), which appears to play a key role in membrane association of PspA. 
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Using a protein fragmentation based approach, Jovanovic et al. (2014) found that PspA 
lacking the first helical domain (HD1, residues 1-67) is unable to bind the IM in vivo, 
suggesting HD1 is responsible for membrane association. Analysis of PspA HD1 revealed two 
putative AHs designated ahA (residues 2-19) and ahB (residues 25-42). These AHs are 
separated by a helix breaking proline at position 25 (see Figure 4.1 for AA sequence and 
helical wheel projections of both ahA and ahB). In the study a PspA mutant lacking ahB 
(along with targeted ahB point mutations) lost negative regulatory function but could still 
interact with the IM. However, a mutant lacking ahA retained PspA’s regulatory function but 
crucially was unable to bind the IM. The requirement of ahA for IM binding strongly 
implicates it as being the region of membrane interaction for PspA. An important membrane 
binding motif, numerous AHs have been shown to have lipid binding properties (Drin et al., 
2007, Lee et al., 2005, Bigay et al., 2005, Attard et al., 2000), further supporting the proposal 
of ahA being in part, or fully responsible for the IM binding of PspA. 
 
 
Figure 4.1 N-terminal amphipathic helixes A (ahA) and B (ahB) in PspA. (Top) Residues 1 to 42 
of E. coli PspA with the positions of ahA and ahB identified by Jovanovic et al.(2014). (Bottom) Helical 
wheel projections of ahA and ahB, arrows represent hydrophobic moment of each helix. 
 
4.1.3 Amphipathic Helixes and their membrane binding properties  
An AH is a structural motif common among many proteins. It consists of an α-helix where 
hydrophilic and hydrophobic residues are segregated between the two opposite faces of the 
helix. This amphiphilic nature makes the helix well suited for membrane binding. Upon 
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membrane association, AHs adopt an orientation parallel to the membrane. The 
hydrophobic face inserts into the hydrophobic core of the bilayer and the polar face 
exposed to the external aqueous environment (Mishra and Palgunachari, 1996).  Usually 
AHs are unfolded in solution with helical formation upon membrane binding, however, pre-
folded AHs are also able to interact with bilayers (Seelig, 2004, Drin and Antonny, 2010). 
The ability of AHs to act as membrane curvature sensors has been well documented with 
increased positive curvature often promoting membrane association (Hatzakis et al., 2009, 
Peter et al., 2004). The GTPase activating protein ArfGAP1 is a prime example with a 
membrane curvature sensing AH responsible for COPI coat disassembly from membrane 
vesicles (Bigay et al., 2003).  Bending the membrane increases SCE stress within the bilayer 
causing lipid packing defects that expose the hydrophobic core of the membrane (see 1.4.3 
and 1.4.4). This exposure promotes the insertion of the hydrophobic face of the AH. The 
resulting interaction alleviates some of the lipid packing stress through a ‘wedge’ effect 
(Vanni et al., 2013, Cornell and Taneva, 2006). The lipid packing defects caused by curvature 
result from an increase in membrane torque and as such other properties that induce 
membrane torque also have an effect on the membrane partitioning of AHs. Incorporating 
conical (type II) lipids into a flat bilayer has been found to induce packing defects similar to 
those caused by positive curvature, having the same effect of AH association (Vamparys et 
al., 2013, Vanni et al., 2013). Recent work has also established that combining lipid 
composition and curvature has a cumulative effect on membrane binding of curvature 
sensing AHs (Vanni et al., 2014). However, this is not exclusively the case with the AH of the 
protein DivIVA (involved in bacterial cell division) preferentially binding to membranes with 
negative curvature (Lenarcic et al., 2009). 
While curvature sensing motifs form an important sub-set, many AHs respond to different 
bilayer signals and can even cause remodelling of the membrane. Magainin 2, an 
antimicrobial peptide, is is curvature insensitive but binds to membranes containing anionic 
lipids (Wieprecht et al., 1997, Wieprecht et al., 2000). Other AHs have selectivity for specific 
phospholipid species such as the N-terminal AH of epsin, which has high affinity for 
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) (Lemmon, 2008). Strikingly, high 
concentration of membrane-bound epsin leads to membrane tubulation (Ford et al., 2002). 
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Figure 4.2 Four membrane binding AH’s and the different membrane signals they sense.  
ArfGAP1 binds to positively curved membranes through an amphipathic lipid packing sensor (ALPS) 
motif. DivIVA localises at regions of negative curvature while Magainin 2 binds to bilayers enriched in 
anionic lipids. Membrane association of epsin is specific to the presence of PI(4,50P2). µH is the 
hydrophobic moment of each AH and arrows show its direction on the helical wheel projections. 
 
Clearly AHs play an important role in membrane association of PMPs, however, the binding 
signals they sense vary. With the N-terminal AH of PspA identified as likely being responsible 
for bilayer association, assays can be targeted at revealing the membrane signals its senses 
and the binding mechanism employed.  
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4.2 Results and Analysis 
 
4.2.1 Studying the effects of anionic lipids on PspA binding through lipid extracts 
The first studies investigating PspA-membrane binding with varying membrane composition 
were undertaken using vesicles made from E. coli lipid extracts. Although lipid extracts do 
not allow the strict control of membrane composition that can be achieved using synthetic 
phospholipids, they do benefit from containing the same diverse lipid composition and 
concentrations of the species they are extracted from. This can result in a better indication 
of how the protein will behave with respect to binding the membrane in vivo. 
Within the E. coli IM the major species phosphatidylethanolamine (PE), phosphatidylglycerol 
(PG) and cardiolipin (CL), make up around 75 %, 20 % and 5 % of the phospholipid content 
respectively (Foss et al., 2011). They are produced via the fatty acid biosynthesis pathway all 
originating from phosphatidic acid (PA) (Cronan et al., 2003). Figure 4.3 shows the different 
enzyme catalysed reactions that occur to produce PE, PG and CL from PA. Mutant strains 
targeting these enzymes can be constructed that diminish each of these phospholipids 
(DeChavigny et al., 1991, Nishijima et al., 1988, Miyazaki et al., 1985). Lipid extracts from 
two of these strains (cls and pgsA) were utilized in this study. As they are not commercially 
available, the strains had to be grown and then lipids extracted within the laboratory. 
 
4.2.1.1 E. coli  cls and pgsA mutants 
In order to probe the binding functionality of PspA to natural membranes depleted in 
anionic lipids PG and CL, cls and pgsA mutants were used. The E. coli MG1655 cls strain lacks 
the gene encoding for cardiolipid synthase, the enzyme that catalyses the final step of 
cardiolipin synthesis from CDP-DAG and PG (see Figure 4.3) (Houtkooper and Vaz, 2008). As 
such, cls strains exhibit greatly diminished amounts of CL (trace amounts of CL are still 
observed thought to originate through a side reaction of the enzyme PssA (Nishijima et al., 
1988)). E. coli MG1655 pgsA strain lacks the gene encoding for the enzyme responsible for 
the conversion of CDP-Diglyceride to the PG precursor phosphatidylglycerophosphate. 
Absence of this enzyme prevents synthesis of both PG and CL (as CL is synthesised in turn 
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from PG, see Figure 4.3). An E. coli MG1655 WT strain was also used as a positive control for 
membrane binding without depleted phospholipid content. E. coli TLE purchased from 
Avanti was not used as the control as it is extracted from a different strain (ATCC 11303). 
 
 
Figure 4.3 PE, PG and CL biosynthesis pathway from PA in E. coli. The protein name derived 
from the gene name is given in each step. Figure adapted from (Cronan, 2003). 
 
4.2.1.2 Lipid extraction and characterisation 
E. coli MG1655 WT was initially used to optimise the lipid extraction protocol to obtain 
sufficient phospholipids for vesicle production. Initially studies used a 1 L culture grown to 
OD600 0.8. The lipids were extracted using a process based on the Bligh and Dyer method 
(Bligh and Dyer, 1959). After extraction only 1.1 mg of dried lipid was obtained, insufficient 
for vesicle production. To increase the yield, a 2 L culture grown to OD600 1.5 was used 
resulting in 7.1 mg of lipid, sufficient for vesicle production. E. coli MG1655 cls and pgsA 
lipid extractions under the same conditions produced 6.5 and 9.2 mg of dried lipids 
respectively.  
Before vesicle production, the lipid extracts were analysed via mass spectrometry to confirm 
the reduction of CL and CL+PG in the cls and pgsA strains respectively (Undertaken in 
collaboration with Tony Postle (University of Southampton)). CL was not identified in any of 
the samples. This was most likely due to difficulty of detection and the short time available 
for data collection. PE and PG were identified and the spectra are shown in Figure 4.4. 
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Figure 4.4 Mass spectrometry data for E. coli MG1655 WT, cls and pgsA lipid extracts. 
Negative ion ES mass spectrum for lipid extracts between 660 – 755 m/z. Major peaks corresponding 
to phospholipid species are identified with the structure of the most abundant species given. 
 
Peaks in the spectra were assigned with reference to previously published data on the 
complete assignment of PE and PG peaks found in wild type E. coli (Oursel et al., 2007). As 
can be seen in Figure 4.4 the mass spectra for the WT and cls lipid extract contains two 
major peaks corresponding to PG 16:1/16:0 and PG 16:0/18:1 at m/z 719 and 747 
respectively. These peaks are absent in the spectrum for the pgsA mutant strain, with only 
peaks corresponding to PE apparent. This confirms the absence of PG within the sample.  
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Vesicles were prepared from the lipid extracts via extrusion (100 nm filters) and 
characterised using DLS (see Appendix A). Interestingly, the stability of the pgsA vesicles was 
considerably lower than the WT and cls vesicles. Vesicles were characterised every 24 hours 
for 7 days via DLS and calcein dye leakage assays with WT and cls vesicles having the same 
size distribution and showing minimal dye leakage throughout. On the other hand, pgsA 
vesicles had ruptured after only 24 hours, showing complete dye leakage and a visible lipid 
aggregation at the bottom of the sample (data not shown). This is probably due to the 
increased non-bilayer lipid content of the pgsA vesicles with PE being the only major lipid 
species in the extract. Due the instability of pgsA mutant lipid extract vesicles, all binding 
assays were undertaken on the same day as vesicle production. 
 
4.2.2 Binding assays with lipid extract vesicles 
The binding of PspA to the lipid extract vesicles was studied via the native-PAGE and co-
floatation assays. Figure 4.5 shows the SYPRO stained SDS-PAGE gels from the co-floatation 
assay for PspA WT incubated with the three lipid extract vesicles. With PspA WT found in 
the low density fraction for all three extracts (where vesicles sediment), it can be seen that 
PspA appears to bind the vesicle membrane irrespective of the loss of CL and PG.  
 
 
Figure 4.5 Co-flotation assays of PspA with E. coli lipid extract vesicles. SYPRO stained SDS-
PAGE gels of collected fractions of PspA WT with and without lipid extract vesicles. 15 µM PspA WT 
incubated with 100 nm vesicles (2.5 mM lipid conc.). WT vesicles – E. coli Wild Type lipid extract, cls 
vesicles – diminished CL, pgsA vesicles - diminished PG and CL. 
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The native-PAGE based assay was used to show PspA binding to vesicles of all three lipid 
extracts (Figure 4.6A). The loss of intensity was correlated with PspA-membrane binding 
using Equation 3.5 and shown graphically in Figure 5.6B.  While PspA appears to have the 
highest affinity for vesicles produced from WT lipid extract, vesicles from the cls and pgsA 
strains are both able to bind a significant amount of PspA, with complete membrane binding 
to vesicles at a 2.5 mM lipid concentration.  
 
 
Figure 4.6 PspA binding to vesicles produced from lipid extracts.  (A) Native gels from titration of 
each set of vesicles into 10 µM PspA. Percentage intensities of vesicle containing bands with respect 
to PspA alone bands are shown under each lane (B) Graph showing the degree of PspA-membrane 
binding obtained from the native-PAGE method. Error bars show the SD from three replicates. 
 
From the co-floatation and native-PAGE assays there is no doubt that PspA is able to bind 
vesicles of all three lipid extracts. However, the comparative quantitative results between 
extracts provided by the native-PAGE assay must be treated with caution as the purity of the 
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lipid extracts has not been experimentally determined. Potential for error also arises when 
calculating lipid concentrations as the distribution of lipids within the extracts is not 
accurately known.  
With previous studies on PspA (Kobayashi et al., 2007) observing binding only to PG out of 
the major E. coli phospholipid species, one might expect similar if not higher levels of PspA 
binding to cls vesicles compared with WT as PG levels increase (Cronan, 2003) (PG is the 
precursor to CL thus is not dissipated by CL synthesis in a cls mutant). The experimental data 
shows the level of PspA binding to the cls mutant and WT strains is similar. This suggests 
that concentrations of PG within the membrane that are higher than native amounts do not 
promote increased bilayer association of PspA. The more surprising result from these assays 
is the significant binding of PspA to pgsA vesicles. Binding without PG and CL implies that 
native concentrations of anionic lipids are not absolutely required for PspA-membrane 
binding. However, one cannot rule out anionic lipids being the only membrane binding 
determinant from this data alone as phosphatidylserine (PS) is still present in all strains as a 
minor lipid species (Raetz, 1976). PspA has been shown to bind vesicles containing PS in 
vitro (Kobayashi et al., 2007) and therefore the binding observed in pgsA vesicles may be PS 
mediated. However, it is clear that high ionic lipid content is not a requirement for PspA-
membrane binding. 
 
4.2.3 Bilayer-association of PspA to synthetic DPPC and DOPC vesicles 
Investigations using synthetic phospholipids to produce vesicles were undertaken. This 
allows for enhanced control over the biophysical properties of the membrane with both 
lipid head and tail groups being selected for. It also avoids potential sources of error using 
lipid extracts (unknown sample purity and ambiguous lipid composition) that can 
compromise quantitative measurements of PspA’s membrane binding.  To assess the affinity 
of PspA for neutral membranes, vesicles composed of 1,2-dihexadecanoyl-sn-glycero-3-
phosphocholine (DPPC) and 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) were used. 
Both are bilayer forming lipids (so can be used to produce vesicles unlike PE which is a non-
bilayer lipid) possessing a choline head group, which is non-native to E. coli (and most 
bacterial) membranes but is highly abundant in eukaryotic organisms (Chen et al., 2009). PC 
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phospholipids have a net neutral charge containing both a positively and negatively charged 
group (as does PE). DOPC and DPPC differ only in their acyl chains, yet, this results in a 
significant physical changes of the vesicles. DPPC has two saturated 16 carbon chains while 
DOPCs 18 carbon chains are monounsaturated with a 9Z double bond. This leads to differing 
phase transition temperatures (TM).  DPPCs TM is 41 °C and DOPCs TM is -17 °C resulting in 
the lipids being in the gel (Lβ) and fluid phase (Lα) respectively at room temperature (Rawicz 
et al., 2000). As such, binding of PspA to neutral PC vesicles in both the fluid and gel phase 
could be investigated using the native-PAGE based assay (results show in Figure 4.7). 
Vesicles were prepared via extrusion though a 100 nm membrane above the TM 
temperature for each species (25 °C for DOPC and 45 °C for DPPC). 
  
 
Figure 4.7 Binding of PspA to DPPC and DOPC vesicles. (A) native-PAGE based assay gel with 10 
µM PspA and increasing conc of 100 nm extruded DPPC vesicles. The intensity of each lane with 
respect to the PspA only band (lane 1) is shown (B) Graph showing the percentage of membrane 
bound PspA with increasing concentrations of DPPC vesicles. Data from three repeats using different 
vesicle preparations are presented. (C) as (A) but using DOPC vesicles. (D) as (B) with DOPC vesicles. 
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From Figure 4.7 it can be seen that PspA is able to bind both DPPC and DOPC vesicles, the 
first time PspA has been shown to directly associate with a neutral bilayer. Anionic 
phospholipids therefore cannot be the only binding determinant for direct PspA-membrane 
interactions. When membrane association is plotted in Figure 4.7B and 4.7D it appears that 
PspA has a higher affinity for DOPC than DPPC vesicles, with a higher average binding at all 
lipid concentrations. Significant variation in binding between different vesicle preparations 
was observed for DPPC vesicles (see Figure 4.7B). This may be due to the instability of the 
DPPC vesicles when they are used below their TM, causing fusion and aggregation (Cevc, 
1991) resulting in inhomogeneous samples. 
Fluidity of the E. coli IM is actively regulated by changes in the acyl chain structure to 
maintain the Lα phase (Lindblom et al., 2002). Here, direct binding by PspA to a neutral 
bilayer in the Lα phase is observed. Clearly, membrane properties other than anionic lipids 
must be responsible for this association. 
 
4.2.4 Probing vesicle curvature leading to observation of a direct PspA-membrane 
interaction 
Many PMPs have been shown to preferentially bind the membrane in locations of high 
curvature (Peter et al., 2004, Taylor and Roseman, 1995, Hatzakis et al., 2009). To ascertain 
if the binding of PspA is modulated by membrane curvature, different sized DOPC vesicles 
were produced via extrusion though 50, 100 and 200 nm filters and sonication to obtain a 
range of curvatures (as membrane curvature is inversely proportional to vesicle radius). 
Sonication of DOPC produces SUVs with an average diameter < 50 nm (Lapinski et al., 2007). 
DLS experiments to size the preparation used in this assay gave an average diameter of 29 
nm with size distribution between 21 and 60 nm (Figure 4.8B).  Extrusion should create LUVs 
with diameters similar to that of the pore size they are extruded through. However, DLS 
results from the 50, 100 and 200 nm preparations showed similar average sizes of 74, 89 
and 109 nm respectively. There was also significant overlap in size distribution between the 
3 different vesicle sets (also observed in other studies (Hatzakis et al., 2009)). Due to the 
similar sizes of the extruded vesicles, it was decided that the best chance of resolving any 
reliable differences in binding due to vesicle diameter would be from comparison of the 200 
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nm extruded (109 nm ave diameter) LUVs and sonicated (29 nm ave diameter) SUVs. Equal 
concentrations of SUVs and LUVs were added to 10 µM PspA WT and loaded on adjacent 
lanes on the native-PAGE gel. The resulting SYPRO stained image is presented in Figure 4.8.   
 
 
Figure 4.8 Binding of PspA to DOPC vesicles of differing diameters.  (A) Gel from the native-
PAGE based assay with 10 µM PspA and increasing concentration of DOPC LUVs (200 nm extruded) 
and SUVs (sonicated). Red boxes indicate the area of intensity integration for each lane. The 
intensity of each box with respect to the PspA only band (lane 1) is shown. Lanes with titrations of 
SUVs show the appearance of a new protein band at the top of the gel attributed to SUV bound 
PspA. (B) DLS data of SUV and LUV vesicles produced via sonication and extrusion. Plot shows the 
size distribution from both vesicle preparations characterised two hours after production. 
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After staining, a new PspA band was observed at the top of each lane containing SUVs (see 
lanes 3, 5, 7 and 9 in Figure 4.8). This could be attributed to the either a change in 
oligomeric state of PspA, or a PspA-vesicle co-complex small enough to enter the gel matrix 
(facilitated by the SUVs smaller diameter). To ensure the correct integration areas it is vital 
to determine the nature of this band as either free or vesicle-bound PspA. Interestingly, the 
observation of a similar high gel retardation band was observed using a native-PAGE based 
assay to monitor the interactions between 50 nm vesicles and the protein Anx5ZZ (Garnier 
et al., 2012). The bands were ascribed to vesicle bound protein entering the gel matrix but 
no further experiments were documented to confirm this was the case.   
Controls undertaken in the previous chapter using NBD-PE labelled 100 nm vesicles (see 
Figure 3.16) found a low level of vesicles at the very top of some lanes. It was stated that 
this was likely due to some vesicles at the bottom end of the size distribution being just 
small enough to enter the native gel matrix. As the sonicated SUVs have a much smaller 
average size, a higher proportion should be able to enter the matrix. However, due to the 
net neutral charge of DOPC vesicles they should not be drawn into the gel alone. Any bound 
PspA will give the protein-vesicle co-complex a net-negative charge. This will cause it to run 
through the gel if small enough. Furthermore, observation of the high gel retardation band 
was a unique to SUVs vesicles in Figure 4.8. The band was therefore deemed most likely to 
be caused by vesicle bound PspA and not a new PspA oligomeric form. Follow-up 
experiments were undertaken to confirm this was the case. 
To ascertain if sonicated vesicles are able to run through the gel matrix used in the binding 
assays, they were labelled with NBD-PE and subjected to native-PAGE. Sonicated vesicle 
preparations of DOPC + 0.2% NBD-PE and DOPC/DOPG 8:2 + 0.2 % NBD-PE (anionic DOPG 
used to give the vesicle a net negative charge as would be the case with PspA bound) were 
run on a 4.5 % native gel and fluorescently imaged (Figure 4.9A). As expected, fluorescently 
doped DOPC vesicles did not enter the gel due to their net neutral charge. However, the 
DOPC/DOPG vesicles are drawn into the gel matrix due to their net negative charge. 
Although the majority of these fluorescently labelled SUVs were observed residing in the 
wells some were small enough to run through the gel, shown by the bands in the right hand 
panel of Figure 4.9A.  
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Figure 4.9 Probing the ability of PspA bound SUVs to enter the gel matrix. (A) Fluorescence 
image of SUVs (composed of DOPC + 0.2 % NBD-PE and DOPC/DPOPG 8:2 + 0.2 % NBD-PE) run on a 
4.5 % native-PAGE gel for 75 min at 100 V. (B ) Fluorescence image before and after SYPRO Ruby 
staining of sonicated DOPC/DPOPG 8:2 + 0.2% NBD-PE SUVs run with and without 10 µM PspA WT. 
 
The data presented in Figure 4.9A shows that sonicated SUVs are able to run through the gel 
matrix alone. But, if the new PspA band observed in Figure 4.8 is due to a protein-vesicle co-
complex, the surface bound PspA will lead to an increased diameter which could affect 
migration (the PspA oligomer has a height of 8.5 nm (Hankamer et al., 2004)). To explore 
this issue, PspA WT (10 µM) was incubated with increasing concentrations of the sonicated 
DOPC/DOPG 8:2 +0.2 % NBD-PE SUVs and run in the native-PAGE assay next to vesicle only 
samples (Figure 4.9B). Adding PspA to the SUVs still results in an observable smear in the gel 
but it is a noticeably closer to the well (compare lanes 1-4 and 6- 9 in Figure 4.9B), running 
to a similar level as the new protein band observed in Figure 4.8. This observation follows 
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the logic that PspA binding to the SUVs increases the particle diameter, causing migration 
within the gel to slow. To check PspA is able to interact with labelled vesicles, the gel was 
stained with SYPRO ruby to visualise the protein; the resulting image is shown in Figure 4.9B 
lanes 5’ to 9’. The PspA signal (seen in lane 5’ of Figure 4.9) is titrated away with increasing 
SUV concentration indicating binding to the vesicles.  
Taken together, these results strongly implicate a PspA-vesicle co-complex being 
responsible for the high running band observed in Figure 4.8. When using sonicated SUVs 
we are therefore observing a direct PspA-vesicle binding interaction, with the appearance of 
the new band representing the co-complex. The area occupied by this band must therefore 
be ignored when considering the areas to integrate in Figure 4.8 (see red boxed area). 
After integration of the bands in Figure 4.8A, it appears that PspA has a higher affinity for 
the SUVs than LUVs (see intensity values given in Figure 4.8A). These initial results suggest 
that PspA’s membrane binding may be modulated by membrane curvature. However, due 
to the range of size distributions (and therefore curvatures) in the vesicle preparations and 
the complications caused by SUVs running through the gel, it was felt the assay in its current 
state could not provide a reliable readout on the effect of membrane curvature on PspA 
binding. The biophysical nature of curvature driven membrane association of AHs is linked 
to curvature-induced lipid packing defects caused by increased stored curvature elastic 
(SCE) stress within the membrane (Cui et al., 2011, Drin and Antonny, 2010). It is therefore 
possible to control curvature based interactions by modulation of the membrane lipid 
composition (Vamparys et al., 2013, Vanni et al., 2013). By moving to study binding as a 
function of SCE stress within the native-PAGE assay, we can use LUVs to circumvent the 
issues of SUV running into the gel. 
 
4.2.5 Stored curvature elastic stress and PspA binding assays 
The binding affinity of PspA for vesicles as a function of SCE stress within the bilayer was 
probed using net-neutral vesicles of differing phospholipid compositions. SCE stress occurs 
when lipids are forced to adopt unfavourable packing conformations (see Chapter 1.4.4). 
Increased SCE stress within a membrane caused by constituent monolayers with negative 
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spontaneous curvature can promote protein association through hydrophobic cavities 
caused by lipid packing defects (Vanni et al., 2013).  By using LUVs composed of binary 
mixtures of 1,2-ditetradecanoyl-sn-glycero-3-phosphocholine (DMPC), DOPC and 1,2-di-(9Z-
octadecenoyl)-sn-glycero-3-phosphoethanolamine (DOPE), we can produce vesicles with 
different magnitudes of SCE stress. DMPC is a type I lipid, DOPC is a type 0 lipid and DOPE is 
a type II lipid resulting in positive, zero and negative spontaneous curvature of the species 
respectively. Using DOPC as a base lipid and adding the other two species from Mole 
fractions of 0.4 DMPC to 0.4 DOPE, the SCE stress within the vesicle bilayer monotonically 
increases (Kirsten et al., 2013).  
Extruded LUVs were prepared from five lipid compositions possessing increasing levels of 
SCE stress (4:6 DMPC/DOPC, 2:8 DMPC/DOPC, DOPC, 2:8 DOPE/DOPC and 4:6 DOPE/DOPC). 
The vesicles were characterised via DLS to ensure uniform size distributions (see Appendix 
A) and then incorporated into the native-PAGE based binding assay. PspA WT (10 µM) was 
incubated with the same concentration of each vesicle composition before running in 
adjacent lanes on native-PAGE. The free PspA bands were integrated and analysed as 
described previously. The resulting SYPRO stained native gels using 0.5 and 1 mM lipid 
concentration are show in Figure 4.10. 
 
 
Figure 4.10 Native gels of PspA incubated with vesicles of increasing SCE stress. SYPRO stained 
native gels after incubation with vesicles (0.5 mM and 1 mM lipid conc.) of increasing SCE stress. 
Vesicles in each lane are as follows; Lane 2 - 4:6 DMPC/DOPC, lane 3 - 2:8 DMPC/DOPC, lane 4 - 
DOPC, lane 5 - 2:8 DOPE/DOPC and lane 6 - 4:6 DOPE/DOPC. Red boxes indicate integrated regions 
and intensity of each lane with respect to PspA alone band (lane 1) is shown. 
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Both the gels shown in Figure 4.10 seem to show a correlation between increased 
membrane binding by PspA and SCE stress. The intensity of the free PspA band decreases as 
SCE stress within the vesicles increases due to increasing negative spontaneous curvature of 
the constituent monolayers. This is most noticeable for 1 mM lipid concentrations where 
the free PspA band intensity goes from 88 % to 28 % as the SCE stress within the vesicles 
increases. Before further assays were undertaken, controls were performed to check that 
the increased binding observed for vesicles containing DOPE was not due to the pH of the 
running buffer causing the vesicles to be negatively charged (see Appendix B for gels). Once 
it was established that this was not the case, the assays were repeated. Vesicles from 0.25 
to 2.5 mM lipid concentration were used to see if the trend was conserved across different 
concentrations. The binding graphs obtained from the lane integrations of these gels are 
presented in Figure 4.11. 
 
 
Figure 4.11 Membrane binding of PspA WT as a function of bilayer SCE stress. (A) Bar graph of 
the membrane binding of PspA WT (10 µM) to vesicle of increasing SCE stress at 0.5 and 1.5 mM 
lipid conc. (B) Scatter plot of membrane binding as a function of vesicle concentration for each of the 
vesicle compositions probing SCE stress. Points shown are the average of three repeats. 
 
It is clear from both Figure 4.11A and 4.11B that for these vesicle compositions, PspA 
membrane binding is promoted by increased SCE stress. The magnitude of affinities 
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between the lipid compositions is significant; at 0.5 mM lipid concentration PspA exhibited 
over a four-fold binding increase between DMPC/DOPC 4:6 and DOPE/DOPC 4:6 vesicles 
(see Figure 4.11A). As can be seen from Figure 4.11B, increasing vesicle concentration 
increases binding to all vesicle compositions up to saturation, nonetheless, the SCE trend is 
still preserved. For the DOPE/DOPC 4:6 vesicles (possessing the most SCE stress), binding 
saturation of PspA WT occurs at 2 mM lipid concentration. This is only slightly higher than 
for E. coli TLE vesicle where the signal saturates at around 1.5 mM (see section 3.2.3.3.1). By 
contrast, less than 50 % of the PspA WT is bound to the DMPC/DOPC 4:6 vesicles at 2.5 mM 
lipid conc. 
Inspecting Figure 4.11B further, it appears that membrane binding of PspA WT is initially 
linearly concentration dependent for all vesicle compositions. No major deviations from 
linearity are seen until around half the PspA is membrane associated. Figure 4.12A shows 
the linear regression for the first three vesicle concentration in Figure 4.11B. Using the lines 
of best fit on Figure 4.12A and Equation 3.6, the percentage membrane coverage by PspA 
WT for each vesicle composition was calculated. Experimental values for both the area 
occupied per lipid (a) and the bilayer thickness (h) from previous studies of DMPC, DOPC 
and DOPE were used (Attard et al., 2000, Marsh, 2013). The average diameter for the 
vesicles, calculated via DLS, was 130 nm. The membrane coverage of PspA WT (assuming 
face on binding of a 36-mer oligomer (Hankamer et al., 2004)) for each vesicle composition 
in order of increasing SCE stress was as follows; 3.7 %, 5.3 %, 8.0 %, 11.9 % and 15.4 %. In 
bilayers with low SCE stress, membrane coverage by PspA is very low with less than 1/25th 
of the bilayer covered. By contrast, with vesicle containing high levels of SCE stress the 
coverage by PspA approaches that of 1/6th of the membrane. 
In similar SCE stress binding assays, the membrane association of Rab5a was found to 
increase monotonically with the addition of DOPC to DMPC or DOPE to DOPC (Kirsten et al., 
2013). To see if the relationship is similar for PspA, linear fitting of the membrane binding 
data at 0.5 mM and 1.5 mM lipid concentration (from Figure 4.11A) was undertaken and 
show in Figure 4.12B. There does appear to be a linear correlation between membrane 
binding and the mole fraction of DMPC and DOPE. This is most noticeable at a 0.5 mM lipid 
concentration where an R2 value of 0.994 was given. At 1.5 mM lipid conc the fitting strayed 
    142 
  
slightly with an R2 of 0.961. Linear regression of binding at 0.25 and 1 mM concentration 
was also undertaken (data not shown) with R2 values of 0.981 and 0.976 respectively.  
 
Figure 4.12 Linear regression of binding to increased SCE stress vesicles as a function of lipid 
concentration and vesicle composition.  (A) Linear fits of PspA membrane binding as a function of 
lipid concentration for each vesicle composition between 0.25 and 1 mM. (B) Linear fits of PspA 
membrane binding to DMPC/DOPC and DOPE/DOPC mixtures. Error bars shown are SD . 
 
The data presented shows that within a neutral lipid bilayer, membrane binding of PspA can 
be driven by SCE stress. This is the first time that a biophysically defined membrane stress 
property has been shown to influence PspA binding. However, the calculated membrane 
coverage of PspA by even the vesicles of highest SCE stress (15.4 %) is nearly twice as small 
as the coverage observed for E. coli TLE vesicles (28.2 % see section 3.2.3.3.3). While 
membrane SCE stress clearly plays a significant role in membrane recruitment, it appears 
that other biophysical membrane factors must play also play a role in association of PspA. 
 
4.2.6 Binding to negatively charged membranes 
The membrane association of many PMPs has been shown act through non-specific 
electrostatic interactions (Cho and Stahelin, 2005). At the outset of this study, anionic lipids 
were the only direct membrane binding determinant identified for PspA (Kobayashi et al., 
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2007). Electrostatic binding interactions were evaluated by controlled addition of anionic 
lipids to the system. The major anionic lipids found in the E. coli IM, PG and CL, and the 
minor anionic lipid species PS were all used. Individual addition of PG, CL and PS into neutral 
DMPC/DOPC 4:6 vesicles (chosen due to these vesicles exhibiting minimal SCE stress specific 
binding), at concentrations of 0.5, 2 and 10 % mole fraction were studied. Despite higher 
anionic lipid content in the E. coli IM (around 25 %), concentrations were kept low to 
minimize their contribution to the level of SCE stress within the membrane. The native-
PAGE based assay was used and Figure 4.13 shows the resulting SYPRO stained gels.   
 
 
Figure 4.13 Native-PAGE gels of PspA incubated with vesicles containing increasing anionic 
lipid content. SYPRO stained gels after 10 µM PspA was incubated with DMPC/DOPC 4:6 vesicles (1 
mM lipid conc.) with DOPG, 14:0 CL and DOPS at 0.5, 2 and 10 % mole fractions. Red boxes indicate 
integrated regions and intensity of each lane with respect to PspA alone (lane 1) is shown.  
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For all anionic lipid species and concentrations, the gels in Figure 4.13 show a decrease in 
free PspA from the levels observed for neutral DMPC/DOPC 4:6 vesicles. Thus, it is apparent 
that addition of anionic lipids to neutral DMPC/DOPC 4:6 vesicles has a positive effect on the 
level of membrane binding by PspA. While band intensities slightly decreased when 0.5 % 
anionic lipids were incorporated into the vesicles, more significant effects were observed 
when 2 and 10 % anionic lipids were added (compare neutral vesicles in lane 2 with anionic 
vesicles in lanes 3, 4 and 5 in Figure 4.13). Membrane binding by PspA was calculated using 
Equation 3.5 and shown as a function of anionic lipid content in Figure 4.14. 
 
 
Figure 4.14 PspA-membrane binding as a function of membrane anionic lipid content. Binding 
data calculated from the native-PAGE assay (10 µM PspA WT and 1 mM lipid conc.). Error bars are 
standard error from three repeats using different vesicle preps. 
 
It is obvious from Figure 4.14 that PspA’s binding to the vesicles is increased by all three 
anionic lipid species. Even at 0.5 % mole fraction anionic lipid, a slight increase in binding is 
universally observed with dianionic CL giving the largest increase (possibly due to CL 
potential to act as a dianion). However, at 2 % mole fraction the effect becomes more 
noticeable with over a threefold increase in overall PspA binding compared with the neutral 
DMPC/DOPC 4:6 vesicles seen for PG, CL and PS. Interestingly little difference is observed 
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between 2 % and 10 % mole fraction anionic lipid, with binding for all species varying by less 
than 10 % between concentrations. At the protein and lipid concentrations used, complete 
membrane binding of PspA would cover only 23 % of the vesicles surface area therefore 
membrane saturation itself cannot be the reason for the plateau. It is clear that increasing 
the anionic lipid content does not have a linear relationship on PspA-membrane binding. 
As all three anionic lipids appear to have a similar effect on PspA binding despite having 
different head group chemical structures, it is unlikely that the increase is due to recognition 
of any specific lipid functional group. Non-specific electrostatic interactions between 
positively charged AA residues on PspA and the negative lipids in the bilayer could be 
attributed to the enhanced membrane binding. This agrees with previous studies showing 
the structure of anionic lipids only has a weak effect on this mode of binding (Ben-Tal et al., 
1996).  
 
4.2.7 Combining stored curvature elastic stress and anionic lipids 
With both SCE stress and anionic lipids being identified as factors responsible for direct 
membrane association of PspA, studies probing the cumulative effects of the two 
determinants on membrane binding were undertaken. Vesicles with high levels of SCE stress 
in combination with anionic lipids were produced using DOPE/DOPC 4:6 with 10 % mole 
fraction DOPG. PspA’s membrane binding was then quantified using the native-PAGE assay. 
Vesicles with lipid concentrations of 0.5 mM and 1 mM were used. DOPE/DOPC 4:6 vesicles 
at these concentrations cause significant but not complete PspA binding, so any positive or 
negative modulation in binding caused by the addition of anionic lipids should be observed. 
The resulting gels are shown in Figure 4.15A. The intensity of the PspA band with 
DOPE/DOPC 4:6 vesicles in lane 3 of each gel is similar to those in lane 4 and 5 where 
DOPE/DOPC 4:6 + 10 % DOPG vesicles were used. As such, little difference in the binding of 
PspA to vesicles of high SCE stress with and without anionic lipids is apparent. This data 
implies that there is no cumulative positive effect on PspA’s membrane association of the 
two binding determinants when levels of anionic lipids within the membrane are ≤ 10 %.  
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Figure 4.15 PspA-membrane binding as a function of anionic lipid content and SCE stress.  (A) 
SYPRO stained native gels after 10 µM PspA was incubated with DMPC/DOPC 4:6 vesicles and 
DOPE/DOPC 4:6 vesicles with and without 10 % DOPG. Red boxes indicate integrated regions and 
intensity of each lane with respect to PspA alone band (lane 1) is shown. (B) Binding data calculated 
from the Native-PAGE assay (10 µM PspA and 1 mM lipid conc.) for vesicles with low (DMPC/DOPC 
4:6) and high (DOPE/DOPC 4:6) SCE stress with and without 10% anionic lipid DOPG. 
 
While modulation of binding by anionic lipids at high SCE stress is minimal, addition of 
anionic lipids (≤ 10 % mole fraction) to the membrane is sufficient to promote increased 
membrane binding at low levels of SCE stress. By this nature, anionic lipids have a 
dampening effect on the SCE stress sensing ability of PspA. This can be seen in Figure 4.15B, 
where membrane binding calculated from the native-PAGE assays is shown for low and high 
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SCE stress vesicles with and without 10 % anionic lipid. In the absence of anionic DOPG, the 
difference in membrane bound PspA between high and low SCE stress is an average of 54% 
of the total protein content, dropping to only 28 % when 10 % anionic DOPG is present. This 
reduction in SCE stress sensitivity of PspA with charged membranes suggest that the two 
signals may act in a competitive nature. SCE stress could drive binding in net neutral 
membranes with electrostatic interactions predominating in charged bilayers. 
 
4.2.8 Membrane binding of PspA mutants 
All the membrane binding assays undertaken so far have used wild type PspA (PspA WT). 
While this approach has provided a great deal of information regarding binding as a function 
of bilayer properties and composition, it does not provide information on the protein-
specific binding determinants of PspA. By incorporating PspA mutants into the membrane 
binding assays, this aspect can be addressed. Two PspA deletion mutants were used to 
provide insights into membrane binding of PspA in the absence of high-order oligomer 
formation and the loss of the N-terminal putative AH.  
 
4.2.8.1 PspA1-186 and the effect of high-order oligomer formation 
The effect of the oligomeric state of PspA on membrane binding was probed by using PspA1-
186. The protein comprises of helical domains 1-3 of PspA, lacking helical domain 4 (HD4) 
which is responsible for high order oligomer formation in solution (in the absence of 
membranes) (Joly et al., 2009). PspA1-186 exists as a monomer/dimer that is still able to 
negatively regulate PspF both in vivo and in vitro (Joly et al., 2009, Jovanovic et al., 2014b). 
Interestingly, in vivo PspA1-186 can still bind the IM, however, when it is substituted for PspA 
WT the effector function of the Psp response is lost (Jovanovic et al., 2014b). Therefore, the 
nature of the membrane interactions of PspA WT and PspA1-186 may differ.  Currently there 
is no in vitro data on PspA1-186 – membrane interactions. Using the protein within the 
binding assay will allow for a comparison between direct bilayer interactions of high and 
low-order oligomer PspA. Unfortunately, sucrose gradient co-flotation assays could not be 
used due to sedimentation profile of free PspA1-186 being very similar to that of the vesicles. 
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However, purified PspA1-186 was incorporated into the native-PAGE based assay with the 
previously described lipid compositions to probe for membrane binding as function of SCE 
stress. Figure 4.16 shows the results from assays using vesicle compositions probing for the 
effect of SCE stress along with E. coli TLE.  
It is clear that PspA1-186 is also able to bind vesicles (compare lanes 1 and 7 in Figure 4.16A). 
Therefore, residues 187-222 and high-order oligomer formation of PspA is not required per 
se for bilayer association in vitro. When the free protein band intensity is correlated to 
membrane binding using Equation 3.5, PspA1-186 appears to have a similar affinity for E. coli 
TLE vesicles as PspA WT. Both average around 75 % binding to E. coli TLE vesicles at 1 mM 
lipid conc. (Figure 3.15B). Modulated membrane binding as a function of SCE stress is also 
observed for PspA1-186 with an analogous trend as seen for PspA WT (Figure 3.15B). The 
comparative magnitudes of PspA1-186 and PspA WT membrane association with increasing 
SCE stress is also similar, indicative of preservation of the binding mechanism in the absence 
of HD4. Although average membrane binding of PspA1-186 and PspA WT is comparable, the 
range of values obtained from experimental repeats was noticeably larger for PspA1-186 
(compare error bars for PspA1-186 and PspA WT in Figure 4.16B). A possible explanation for 
this may be due to less individual membrane contacts per interacting unit of the PspA1-186 
monomer/dimer (one/two), compared with the PspA WT high-order oligomer (feasibly up to 
36 in a 36-mer). Multiple interactions may lead to an averaging effect, making the PspA WT 
oligomer less sensitive to minor discrepancies in membrane composition, assay conditions 
and protein purification between assay repeats. The increase in membrane binding 
robustness of the higher-order oligomer could conceivably prove advantageous in vivo due 
to the plethora of environmental conditions the cell is exposed to (especially under stresses 
in which the Psp response is activated).  
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Figure 4.16 Membrane binding of PspA1-186 as a function of bilayer SCE stress and binding to E. 
coli TLE vesicles. (A) SYPRO stained native gel after incubation of PspA1-186 with vesicles (1 mM lipid 
conc.) of increasing SCE stress. Vesicles in each lane are as follows; Lane 2 - 4:6 DMPC/DOPC, lane 3 - 
2:8 DMPC/DOPC, lane 4 - DOPC, lane 5 - 2:8 DOPE:DOPC and lane 6 - 4:6 DOPE/DOPC. Red boxes 
indicate integrated regions and intensity of each lane with respect to PspA1-186 alone band (lane 1) is 
shown. (B) Bar graph of the membrane binding of 10 µM PspA1-186 compared with PspA WT to vesicle 
of increasing SCE stress and E. coli TLE at 1 mM lipid conc. 
 
4.2.8.2 PspAahA, removal of the N-terminal amphipathic helix  
Removal of the putative membrane binding region of PspA was then investigated. PspAahA 
lacks residue 2-19 which make up the putative N-terminal AH (termed ahA). This mutant has 
been shown to lose IM binding functionality in vivo (Jovanovic et al., 2014b). The mutant can 
still interact with both PspF and PspC, playing a role in stress signalling of the response 
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(presumably though an interaction with PspC). High-order oligomer formation is also 
compromised, with the protein running as an apparent monomer in gel filtration studies 
(Jovanovic et al., 2014b). Similarly to PspA1-186, there are no published studies on the in vitro 
membrane binding of PspAahA, hence, using the protein in this study can provide insights 
into association with membranes of controlled biophysical properties.  
PspAahA was expressed and purified similarly to PspA WT, however, after cell lysis both 
soluble (SN1) and membrane (SN2) fractions were subjected to nickel-chelation 
chromatography. As expected, the SN2 purification yielded very little PspAahA (2 mL at <2 
µM conc.), the SN1 fraction resulted in a significantly higher yield (4 mL at 6 µM) and was 
concentrated using 10 kDa spin filters (Amicon) to a stock of 20 µM. Again, co-flotation 
assays were unsuccessful due to the similar sedimentation profiles of PspAahA and vesicles. 
However, the native-PAGE assay could be used. Gels probing for SCE stress and anionic lipid 
binding of PspAahA are shown in Figure 4.17. 
For PspAahA, very little decrease in free protein intensity on the native-PAGE gel is observed 
when incubated with vesicles of any composition. In Figure 4.17 no more than a 12 % 
decrease in band intensity is observed for any vesicle composition, indicating very minimal, 
if any, membrane binding. At the 2.5 mM lipid concentration used, complete membrane 
binding is observed for PspA WT to all compositions used except those with the two lowest 
levels of SCE stress (see Figure 4.11B). Hence, there is clearly a very significant difference in 
membrane binding affinity between the two proteins. This is further highlighted in Figure 
4.17B, where the membrane binding of PspA WT and PspAahA (calculated from native-PAGE 
assay) is compared for E. coli TLE vesicles and those of increasing SCE stress. It is clear that 
membrane binding of PspAahA is significantly impaired but it appears that it is not 
completely abolished. While the intensity decreases are within the range of values that 
could be due to experimental error, small decreases in intensity are consistently observed in 
vesicle samples compared with the PspAahA standard. Therefore, low levels of membrane 
association may still be taking place. When E. coli TLE vesicles over 2.5 mM lipid 
concentration were incubated with PspAahA in the assay, intensities of the free PspAahA 
decreased further. A 35 % reduction in PspAahA band intensity at 5 mM lipid was observed 
(Data not shown). However, decreases in band intensity of the PspF1-275 negative control 
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were also observed above 2.5 mM lipid concentration. Therefore one cannot necessarily 
attribute the observation to a specific residual membrane binding of PspA lacking ahA. 
 
 
Figure 4.17 Membrane binding of PspAahA as a function of bilayer SCE stress, anionic lipid 
content and E. coli TLE vesicles. (A) SYPRO stained native gels after 10 µM PspAahA was incubated 
with vesicle (2.5 mM lipid conc.) of increasing SCE stress (left) and with DMPC/DOPC 4:6 + 10 % 
DOPG, DMPC/DOPC 4:6 + 10 % 14:0 CL and E. coli TLE vesicles (right). Red boxes indicate integrated 
regions and intensity of each lane with respect to PspA alone band (lane 1) is shown. (B) Membrane 
binding of 10 µM PspAahA compared with PspA WT to vesicle of increasing SCE stress and E. coli TLE 
at 1 mM lipid conc. 
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From these results it can be seen that removing the putative N-terminal AH (ahA) of PspA 
greatly diminishes membrane binding of PspA in vitro, agreeing with similar observations in 
vivo (Jovanovic et al., 2014b). This significantly reduced affinity of PspAahA cannot simply be 
attributed to loss of a high order-oligomeric state as PspA1-186 (also an apparent 
monomer/dimer (Joly et al., 2009)) was shown to be able to bind the membrane with similar 
affinity to PspA WT in certain conditions. Thus, it is highly likely that PspA directly interacts 
with the membrane thought its N-terminal AH (ahA). The absence of any modulated binding 
as a function of SCE stress shows that ahA is responsible for this binding determinant, most 
likely though insertion of the hydrophobic face of the AH into the membrane, a binding 
mechanism seen for many other AHs (Drin and Antonny, 2010). 
 
4.2.9 Effect of PspA on vesicle stability 
Previous assays detailed in this chapter have focused on characterising the binding of PspA 
and its mutants to vesicles of varying lipid composition. To ascertain if membrane binding of 
PspA imparts any effects on the stability of the vesicles, a calcein efflux assay was employed. 
The assay uses vesicles encapsulating 50 mM of the fluorescent dye calcein (Ex 495 nm, Em 
515 nm). At this concentration significant collisional quenching (known as self-quenching) 
occurs between calcein molecules so the overall levels of fluorescence intensity are low. If 
the vesicles rupture or pores are formed in the lipid bilayer, the encapsulated calcein will 
diffuse into the assay buffer resulting in a decrease in fluorophore concentration. Self-
quenching reduces and a concurrent increase in fluorescence intensity is observed (Vogt 
and Bechinger, 1999, Andersson et al., 2007). This assay in principle would allow probing of 
an activity of PspA that might help stabilise or repair stressed and damaged membranes. 
Calcein encapsulated E. coli TLE vesicles and DOPE/DOPC 4:6 vesicles were used. 
Fluorescence at 520 nm was monitored for 20 min at 2 min intervals to ensure dye leakage 
was not occurring without protein addition. Both PspA WT and PspA1-186 were then titrated 
in (along with a buffer only negative control) to see if the addition of either induced or 
reduced leakage from the vesicles. This was achieved by monitoring fluorescence at 520 nm 
immediately after each titration and every 2 min thereafter for 20 min. After the titration 
series, 0.2 M octaethylene glycol monododecyl ether (C12E8) to a final assay concentration 
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of 20 mM was added to give a fluorescence value for complete dye release (C12E8 at such a 
molar excess causes complete micellization of the vesicles (Otten et al., 1995)). The 
percentage release of dye for each measurement was calculated using equation 4.3 
 
𝐹 = (𝐹𝑡 −  𝐹0)/(𝐹𝐶 −  𝐹0) × 100  Equation 4.3 
 
Where 𝐹 is the percentage release of fluorescent dye, 𝐹𝑡the fluorescence intensity 
measured, 𝐹0 the fluorescence intensity of the calcein encapsulated vesicles alone and 𝐹𝐶  
the fluorescence intensity after addition of C12E8. The percentage release of fluorescent 
dye plotted as a function of protein concentration for each vesicle composition is shown in 
Figure 4.18. It can be seen that both PspA WT and PspA1-186 have no negative impact on 
vesicle stability up to a concentration of 10 µM PspA WT and 30 µM PspA1-186, as no increase 
in fluorescence is observed upon any protein titration (yet a significant increase is seen 
upon addition of C12E8). The concentration of PspA WT and PspA1-186 could not be 
increased further due to the limited solubility of both proteins. Vesicles were so stable to 
dye release in the assay that any effects of PspA on increasing their stability were not 
observable. 
 
 
Figure 4.18 Calcein efflux assay probing the effect of PspA WT and PspA1-186 on vesicles. 
Graphs showing the percentage fluorescence (of the value measured at complete dye release, 
obtained via addition of 20 mM C12E8) measured over time with titrations of PspA WT and PspA1-196 
indicated. (A) Assay using E. coli TLE vesicles. (B) Assay using DOPE/DOPC 4:6 vesicles. Fluorescence 
was measured every 2 min and traces have been background corrected by subtracting the 
fluorescence from a vesicle and buffer only sample.  
    154 
  
The phospholipid concentration of the specific samples shown in Figure 4.18 after gel 
filtration was not determined. To give an estimate of the concentrations, vesicles of the 
same lipid composition, size and concentration were gel filtered under exactly the same 
conditions. The collected sample’s phospholipid content was analysed via a phosphorous 
assay. The average phospholipid concentration was 1.16 and 1.07 mM for E. coli TLE and 
DOPE/DOPC 4:6 vesicles respectively.  
The estimated vesicle concentrations was calculated using equation 3.7  to be 18.2 nM for E. 
coli TLE and 16.74 nM for DOPE/DOPC 4:6. Hence, we can be confident that with E. coli TLE 
vesicles protein to vesicle ratios up to 549:1 for PspA WT and 1648:1 for PspA1-186 do not 
have a destabilising effect on the calcein encapsulated vesicles. For DOPE/DOPC 4:6 vesicles 
the ratios are slightly higher at 597:1 for PspA WT and 1792:1 with PspA1-186. These results 
with the estimated protein membrane coverage are summarized in Table 4.1. 
 
Vesicle composition 
and average concentration 
Protein monomers per vesicle at  
highest titration 
Maximum membrane 
coverage  for PspA 
WT at (10 µM) PspA WT (10 µM) PspA1-86 (30 µM) 
E. coli TLE (1.16 mM) 549 1648 21 % 
DOPE/DOPC 4:6 (1.07 mM) 597 1792 26 %  
E. coli TLE 5x dilution (0.23 
mM) 
2745 - 105 % 
DOPE/DOPC 4:6 5x dilution 
(0.21 mM) 
2985 - 130 %  
 
Table 4.1. Protein to vesicle ratios reached in the calcein efflux assay. The calculated maximum 
possible membrane coverage for PspA WT is also shown. 
 
For the two original assays we can see that the estimated maximum membrane coverage 
for PspA WT at the highest titration (10 µM) was only 21 % and 26 % for the E. coli TLE and 
the DOPE/DOPC 4:6 vesicles respectively. A theoretical complete coverage of the vesicles by 
PspA (which may affect the vesicle stability) cannot be achieved. In order to get a higher 
excess of PspA, the calcein encapsulated vesicles were diluted five-fold and the assay was 
repeated with a final conc. of 10 µM PspA WT titrated into the sample. Again no calcein 
leakage was observed (data not shown). The protein to vesicle ratio, along with the 
estimated maximum membrane coverage for these experiments is also shown in Table 4.1. 
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4.3 Discussion and conclusions 
The results presented in this chapter provide, for the first time, a detailed insight into both 
the membrane binding signals that cause direct PspA association, along with the properties 
and sequence determinants of the protein that sense them.  Most notably we identify a new 
membrane binding signal for PspA, SCE stress, which promotes bilayer association of PspA. 
Binding to anionic lipids is also observed. The requirement of the N-terminal ahA of PspA tp 
sense both membrane binding signals highlights the importance of this domain. The new 
information gained in this chapter can provide the first detailed characterisation of PspA’s 
direct membrane binding and suggest how the resulting effector function of the response 
might be manifested.  
The binding of PspA to vesicles prepared from lipids extracted from E. coli strains with 
greatly diminished anionic lipids shows that high anionic lipid content is not required for 
bilayer association. Follow up studies using synthetic PC vesicles show that PspA is also able 
to bind net-neutral (zwitterionic) bilayers. It is clear that the previously established anionic 
lipid binding determinant (Kobayashi et al., 2007) cannot be the only signal within the 
membrane that governs PspA association. In the study by Kobayashi et al. (2007) binding of 
PspA to pure PC vesicles was not observed which could be seen as contradicting our 
observations of significant binding to PspA to DOPC vesicles. However, variations in SCE 
stress can rationalise these differences. Kobayashi et al. used PC extracted from soybeans 
which contains a wide distribution of fatty acid chains varying both in length and saturation. 
Our studies used synthetic phospholipids containing only 18:1 (9-cis) fatty acid chains. It is 
likely that PspA possesses no specific affinity for the PC head group with the binding 
differences observed due to the SCE stress profile of the membrane, which will differ 
between the two species. These findings led to investigations of other membrane properties 
that could be responsible for PspA-membrane association and the identification of a SCE 
stress determinant followed.  
Lipid compositions chosen to specifically probe for increased membrane SCE stress were 
incorporated into the native-PAGE based assay. They were found to positively modulate 
PspA association with the membrane. Previous studies of DMPC/DOPC and DOPC/DOPE 
binary systems have found that they exhibit no phase separation (Attard et al., 2000) and 
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the use of zwitterionic lipids eliminates the possibility of electrostatic mediated protein-
membrane interactions. For the DOPC/DMPC vesicle compositions, lipid head groups are 
unchanged and with DOPC/DOPE vesicles chains are unaffected, thus any phospholipid head 
or chain group effects on binding can be ruled out. A dependence on lipid molecular area for 
binding is also inconsistent with the experimental data as the average cross sectional area 
per molecule initially increases from 67 A2 for DMPC (100 %) to 76 A2 for DOPC (100 %) 
(Costigan et al., 2000) and then reduces to 69 A2 for DOPE (60 %) (Kozlov et al., 1994). 
Crucially, the spontaneous curvature changes monotonically from DMPC to DOPC to DOPE 
and consequently, so too does the SCE stress within the bilayer. From DMPC to DOPC 
unsaturation in the acyl chains increases their propensity to splay, causing curvature 
towards the polar head. DOPC to DOPE results in a further desire for negative curvature due 
to the lower hydrophilicity and smaller size of the PE head group (Templer et al., 1998).  
Observations of increased membrane binding in tandem with SCE stress has been shown 
with other PMPs such as CCT and Rab (Attard et al., 2000, Kirsten et al., 2013). Attard et al. 
proposed that insertion of CCTs AH into the membrane interface allows the chains of nearby 
lipids to splay and alleviate some of the SCE energy. Energy is released upon binding of the 
proteins to the membrane, the magnitude of which increases with SCE stress resulting in a 
concurrent increase in partitioning into the monolayer. Our data indicates that PspA’s N-
terminal AH (ahA) could play a similar role in membrane partitioning as deletion of ahA from 
PspA eliminates any SCE stress sensitivity. Maintenance of torque tension stored in 
biological membranes between a critical range of values is necessary to ensure phase 
transitions into a porous state do no occur (Attard et al., 2000). It appears logical that PspA 
could exploit this mechanism to both target areas of the membrane with high levels of SCE 
stress and then, via its insertion, alleviate stress, stabilizing the membrane (Figure 4.19). 
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Figure 4.19 Schematic of the relief of SCE stress via lipid chain splay.  The integration of PspA 
ahA (shown as a cross section) into the membrane allows lipids in close proximity to splay due to the 
geometry of the hydrophobic face. This reduces the stored torque tension within the membrane. 
Adapted from Attard et al., (2000). 
 
May AHs have been shown to possess a higher affinity for membranes with increased 
positive curvature (Drin et al., 2007, Cornell and Taneva, 2006, Hatzakis et al., 2009). 
Probing the effects of curvature on membrane binding of PspA using the native-PAGE based 
assay proved problematic due to migration of the smaller sonicated vesicles into the gel 
matrix. However, parallels can be drawn between the biophysical effects of curvature and 
SCE stress on the membrane. In both cases mismatch between the geometry of the 
phospholipid and the actual curvature of the membrane drives association of targeting AHs 
(Drin and Antonny, 2010). This has been illustrated in studies with the membrane curvature 
sensing proteins ArfGAP1 where addition of conical (type II) lipids to the bilayer had the 
same effect on bilayer association as membrane curvature (Vanni et al., 2013, Antonny et 
al., 1997). Recent in silico studies have shown that both SCE stress and positive curvature 
result in defects in the geometrical arrangement of lipids within the membrane known as 
lipid-packing defects (Vanni et al., 2014, Vamparys et al., 2013). These are proposed to be 
sites of AH insertion. Therefore, as membrane binding of PspA is sensitive to SCE stress one 
might expect that bilayer association will also increase with positive membrane curvature.  
Along with SCE stress, a negatively charged bilayer also appears to play a role in membrane 
binding of PspA; likely due to electrostatic interactions. Electrostatic mediated binding plays 
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a key role in membrane association of many proteins via interactions between anionic lipids 
and positively charged residues (Zhou et al., 1994, McLaughlin and Aderem, 1995). The data 
in this chapter shows the presence of anionic lipids even at low mole fractions promote a 
PspA-membrane binding interaction with vesicles of low SCE stress. This feature is seen for 
all three anionic lipid species used and thus negative charge is expected to be the signal 
sensed by PspA (opposed to recognition of a specific head-group moiety). Many proteins-
membrane interactions through AHs have been shown to have an electrostatic component 
(Jensen et al., 2011, Bartels et al., 2010). As the PspAahA mutant showed a dramatic 
decrease in binding to vesicles containing anionic lipids, it likely that the electrostatic 
component of the membrane interaction also predominantly resides within the PspA ahA 
region. Thus, the binding increase may be due to electrostatic interactions between the 
positive R6 residue on the polar face of ahA and anionic lipids (as this is the only cationic 
residue within ahA residues 2-19). Positive residue K21, which may form part of the N-
terminal AH in the full length protein, is also likely to contribute to electrostatic interactions. 
However, in the absence of ahA is probably not sufficient to cause membrane binding. 
While mole fractions of anionic lipids were intentionally kept low to minimize the effect 
they have on SCE stress of the membrane, we must still consider the SCE stress impact that 
they have. Like DOPC, both DOPG and DOPS are unsaturated phospholipids with a single 9Z 
double bond. Addition of DOPG and DOPS to the DMPC/DOPC 4:6 vesicles will decrease the 
proportion of saturated DMPC chains in the system, leading to an increase in SCE stress. 
Head groups must also be considered and both PG and PS have smaller cross sectional areas 
than PC (Petrache et al., 2004, Murzyn et al., 2005) which will further increase the SCE 
stress. While 14:0 CL has saturated acyl chains, the relatively small headgroup area 
compared to that occupied by its four acyl chains will also increase the SCE stress within the 
membrane (Lewis and McElhaney, 2009). As all three anionic lipids will have a positive effect 
on SCE stress, some of the membrane binding increases could be attributed to this and not 
electrostatic interactions. However, a number of elements in the data strongly support 
electrostatic effects providing the majority of the binding increases observed. Primarily, the 
magnitude of the increase in membrane binding even at low anionic lipid concentrations is 
much larger than would be expected for a purely SCE stress specific change. Also, if the 
binding was SCE stress specific, the membrane association between 2 and 10 % anionic lipid 
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content would be expected to dramatically increase due to the five-fold increase in the 
lipids promoting negative curvature. This is not the case for all three anionic lipids, with 
membrane association remaining relatively static. 
SCE stress and a net negatively charged bilayer both drive the association of PspA to the 
membrane independently; however, the two signals do not appear to have cumulative 
effects on binding. In fact, anionic lipids lead to a dampening of the SCE stress sensing of 
PspA. This is perhaps not too surprising as similar observations have been made with 
membrane binding AHs such as α-synuclein and CCT. Here, a decrease in lipid-packing 
defect sensing ability upon incorporation of anionic lipids into the membrane is also seen 
(Jensen et al., 2011, Chong et al., 2014). It may be useful in future studies to increase the 
anionic lipid content further than 10 % to see if this results in further dampening of SCE 
stress dependent binding.  
A recent study by Chong et al. (2014) has highlighted the importance of the AAs in the 
flanking region of a curvature sensing AH on membrane association. They found that 
increasing the negative charge on unordered AAs flanking the AHs in α-synuclein and CCT 
decreased the binding strength but enhanced the curvature (hence SCE stress) dependence 
of the proteins (Chong et al., 2014). While this chapter focuses on the effect of residues 2-19 
identified as the N-terminal ahA (Jovanovic et al., 2014b), residues 20-24 flanking ahA 
(before the helix breaking P25) may also play an important role in modulating the SCE stress 
sensing of the AH. These five residues in E. coli PspA are ‘EKAED’, a highly charged region of 
one cationic and three anionic AAs. This results in a net negative -2 charge which would be 
expected to increase the SCE stress sensing ability of the AH (Chong et al., 2014). 
Interestingly, these residues are well conserved in PspA within all organisms (especially K21 
and E23), implicating them as being of functional importance (see Figure 4.20).  
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Figure 4.20 Sequence alignment of PspA from different organisms. Alignment uses PspA from 
Escherichia coli Yerssinia enterocolitica, Erwinia piriflorinigrans, Vibrio cholera, Shewanella 
oneidensis, Photobacterium profundum, Idiomarina loihiensis and Desulfovibrio fructosivorans, 
Pleurocapsa minor and Bacillus subtilis (PspA homologue LiAH) . 
 
E20 and K21 seem likely to form part of the N-terminal AH in full length E. coli PspA. In silico 
secondary structure analysis of full length PspA (and also residues 1-24 alone) predict a 
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helical conformation between residues 3 and 21 with high confidence scores (Jones, 1999). 
Incorporation of E20 and K21 into the AH would result in E20 at the top of the polar face 
and K21 residing at the interface between the polar and apolar faces of the AH. Glutamates 
and lysines in these locations have both been shown to promote membrane association of 
AHs. Negatively charged glutamate residues are proposed to interact with positively 
charged choline and ethanolamine groups of lipids (Figure 4.21) (Mishra et al., 1996). For 
lipid interactions, interfacial lysines have a so-called snorkel effect (Mishra et al., 1996). The 
long hydrocarbon side chain can insert between phospholipid acyl-chains and the positively 
charged ammonium head group interacts with the negatively charged lipid phosphate 
groups (see Figure 4.21). In this respect, incorporation of residues E20 and K21 into the 
putative N-terminal AH model would seem appropriate as they are both predicted to be 
helical and should increase membrane avidity of the region.  
 
 
Figure 4.21 Roles of E20 and K21 in AH-membrane binding. Schematic showing the contributions 
of residues 20 and 21 to AH-membrane association. E20 has an electrostatic interaction with the 
positive ammonium head group of PE and PC. K21 hydrocarbon side chain can insert between 
phospholipid acyl-chains and the positively charged ammonium group interacts with the negatively 
charged lipid phosphate groups. 
 
Calcein efflux assays showed that membrane association of PspA WT and PspA1-186 to E. coli 
TLE and DOPE/DOPC 4:6 vesicles did not cause any vesicle leakage at concentrations 
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sufficient for 100 % membrane coverage. This observation does not conflict with the 
proposed membrane maintenance role of PspA in vivo, as clearly further destabilisation of 
the bilayer upon protein binding is undesirable. The assay could be used in future studies to 
probe the stabilising effects of PspA on the membrane by pre-incubating PspA with vesicles 
before exposure to stresses such as heat, ethanol or hyperosmotic conditions. 
Finally, the effect of CHAPS in the assay buffers for binding studies must be considered as it 
is likely itself to associate with the bilayer. This could cause changes in the membranes 
properties we are trying to assay. Obviously, a detergent free system is desirable for 
protein-membrane interaction assays, however, some CHAPS is required to maintain a 
soluble working concentration of purified PspA. CHAPS was used at 0.005 % w/v in solution, 
the lowest concentration possible to maintain a 20 µM stock of soluble and stable PspA 
protein. This equates to a concentration of 80 µM in solution, well below the critical micelle 
concentration (le Maire et al., 2000) and giving a lipid to detergent ratio of 84:1 in the 
vesicle binding assays. This high lipid to detergent ratio is unlikely to result in any substantial 
membrane disruption. Indeed, DLS and dye leakage assays showed that vesicles are stable 
for days in solution at these CHAPS concentrations. The CHAPS will still have a slight effect 
on the SCE stress of the vesicles but, as the concentration is constant for all vesicle 
compositions the SCE stress trends will be maintained. In terms of the anionic lipid assays, 
CHAPS is zwitterionic so should have no effect on the net negative charge of the membrane.  
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Chapter 5 – The Vesicle inducing protein in plastids (Vipp1) 
 
Overview 
In this chapter we use the established membrane binding assays from Chapters 3 and 4 to 
study the interaction between purified cyanobacterial Vipp1 and vesicles, comparing Vipp1 
bilayer association in vitro to that of PspA. Particular emphasis is placed on the putative N-
terminal AH of Vipp1 which has also been proposed as the direct membrane binding region 
of the protein. First, Synechocystis Vipp1 WT and Vipp1ahA (lacking the N-terminal AH) are 
purified using methods similar to those for PspA. Analysis of the protein’s tertiary and 
quaternary structures reveal Vipp1 is predominantly helical and forms high-order oligomers 
akin to PspA, but ATPase assays show that Vipp1 is not able to effectively negatively 
regulate PspF. The membrane binding ability of Vipp1 is probed using sucrose gradient co-
flotation assays and the native-PAGE based assay. This showed that Vipp1 also senses SCE 
stress and ionic lipids, however, the comparative magnitudes differ to that of PspA. Results 
show Vipp1ahA is unable to bind vesicles, hence the N-terminal AH region of Vipp1 appears 
to act similarly to the N-terminal AH of PspA, causing direct membrane association. Finally, 
membrane binding to vesicles containing the galactolipids MGDG and DGDG is assessed, 
showing that a direct Vipp1-membrane interaction is possible with lipid compositions 
mimicking the thylakoid membrane in cyanobacteria. 
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5.1 Introduction 
Vipp1 is a homologue of PspA found in cyanobacteria, algae and plants.  Both proteins share 
a common origin and have retained similarities in structure and function since diverging (see 
section 1.3). Previous research on Vipp1 has predominantly been undertaken in vivo using 
Synechocystis sp. PCC 6803 (as a model cyanobacterium), or Aribidopsis thaliana (as a model 
plant) (Vothknecht et al., 2012). The comparative study presented in this chapter uses Vipp1 
from Synechocystis sp. PCC 6803. Successful expression and purification of Synechocystis 
Vipp1 from plasmids transformed into E. coli BL21 competent cells has previously been 
documented (Fuhrmann et al., 2009a, Aseeva et al., 2004). Thus, it should be 
straightforward to obtain Vipp1, from our purification system which also uses E. coli BL21.  
Sequence alignments of E. coli PspA and Synechocystis sp. PCC 6803 Vipp1 (shown in Figure 
5.1A) give 32 % sequence identity and 58 % sequence similarity between the first 222 
residues with no alignment gaps. From Figure 5.1A we can see that there is conservation 
across the whole of the PspA sequence. When segmented for analysis, residues 1-25 form 
the region of highest sequence identity at 56% (residues 77–102 are the next most highly 
conserved with 52 % identity). Residues 1-24 contain the putative N-terminal AHs of PspA 
and Vipp1 that have been implicated in their respective membrane binding functions 
(Jovanovic et al., 2014a, Otters et al., 2013). Studies by Jovanovic et al. (2014) on ahA of 
PspA have focused on residues 2-19 and those by Otters et al. (2013) on Vipp1 looked at 
residues 1-21 where an α-helical structure is predicted. Residues 21–25 show the highest 
consecutive run of conserved residues between PspA and Vipp1. The P25 residue is a helix 
breaking residue, segregating ahA and ahB in E. coli PspA. As previously discussed, the 
preceding conserved KAED motif may play a key role in the membrane binding properties of 
the proteins since regions flanking the AH have been shown play a role in modulating bilayer 
association (Chong et al., 2014). Helical wheel projections of residues 1-24 of Vipp1 and 
PspA are shown in Figure 5.1B. The shared amphipathic nature of the two regions is clear. 
Vipp1’s membrane binding properties are less well characterised than PspA. However, it has 
become apparent through in vivo studies that, like PspA, Vipp1 directly binds to 
membranes. This is proposed to locally stabilise them and help to maintain membrane 
integrity (Vothknecht et al., 2012). Though Vipp1 is known to localise at the cytoplasmic and 
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thylakoid membranes in cyanobacteria (Srivastava et al., 2005, Fuhrmann et al., 2009a, 
Bryan et al., 2014), no data on the membrane signals sensed by Vipp1 has been reported. 
Conservation of the putative membrane binding AH region would suggest that the bilayer 
signals sensed by PspA and Vipp1 may also be conserved. By using purified Vipp1 and the 
vesicle binding assays used for PspA we can gain a detailed insight into membrane 
association and hence further the understanding of Vipp1’s function. 
 
 
Figure 5.1 Sequence conservation of PspA and homologue Vipp1. (A) Sequence alignment 
between Synechocystis Vipp1 and E. Coli PspA. The proteins exhibit 32 % sequence identity between 
the conserved residues 1-222. * - conserved residue, : - residues are of similar size and 
hydrophobicity, . – residues are of similar size or hydrophobicity. (B) Helical wheel plots of the N-
terminal AH of Vipp1 and PspA (Residues 1-24). The area of each circle represents the size the AA 
residue side chain with colour coding according to electrostatic and hydrophobic properties. (see 
colour code in figure).  
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5.2 Results and Analysis 
5.2.1 Protein expression and purification of Vipp1 WT and Vipp1∆ahA 
A plasmid expressing Synechocystis sp. PCC 6803 Vipp1 was obtained (a gift from C. 
Mollineux, Queen Mary, University of London) and the gene encoding for wild type Vipp1 
(Vipp1 WT) was cloned into a pET28b+ vector by Goran Jovanovic. This plasmid was used as a 
template for PCR-based site-directed mutagenesis to construct a Vipp1 variant lacking AH 
residues 2-19 (Vipp1∆ahA), also by Goran Jovanovic. Previous in vitro studies of Vipp1 have 
successfully utilized E. coli BL21 strains for expression and purification of both Arabidopsis 
and Synechocystis Vipp1 proteins (Fuhrmann et al., 2009a, Otters et al., 2013). Our 
established protocol for PspA protein expression and purification was deemed appropriate 
for initial purification studies. Expression and purification of (His)6 tagged Vipp1 proteins 
was undertaken using a similar method to that of the PspA proteins with both the soluble 
and insoluble fractions being purified via nickel-affinity chromatography (see Figure 5.2 for 
purification gels). 
For the Vipp1 WT purification, protein was recovered from both the soluble (SN1) and 
insoluble (SN2) fraction, but an approximately four times greater yield was obtained from 
the soluble fraction (210 nM compared with 55 nM). Vipp1∆ahA gave a lower yield than Vipp1 
WT for both soluble and insoluble fractions (soluble fraction - 137 nM, insoluble fraction - 18 
nM). Interestingly, Vipp1∆ahA was still recovered from the insoluble membrane fraction 
despite this mutant form being expected to lack lipid binding activity. However, the 
proportion of Vipp1∆ahA in the insoluble fraction was less than that of Vipp1 WT and may be 
potentially due to interactions between VIpp1∆ahA and integral membrane proteins (possibly 
PspBC). Purified protein stocks were analysed via SDS-PAGE (See Figure 5.2D) and assessed 
for purity using an Agilent 2100 Bioanalyzer (all preparations found to be over 85 % pure). 
Due to the increased solubility observed with Vipp1 it was thought that the protein may be 
stable in solution without low concentrations of the detergent CHAPS being present in the 
assay buffers. Follow up purifications showed that this was the case with a CHAPS free 
purification of the soluble Vipp1 WT fraction, yielding a 30 µM stock solution in CHAPS free 
buffer (20 mM Tris-HCl pH 7.5, 200 mM NaCl, 75 mM NaSCN, 5% glycerol v/v). Despite this, 
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membrane binding assays were undertaken with Vipp1 in PspA buffer to allow for a direct 
comparison with PspA bilayer association. 
 
 
Figure 5.2 Purification of Vipp1 proteins from E. coli. Coomassie stained SDS-PAGE gels showing 
the protein content of eluted fractions (fraction number along the bottom of each image, L - protein 
ladder, WCE – whole cell extract) from nickel chelation chromatography purifications of Vipp1 WT 
SN1(A), Vipp1 WT SN2 (B) and Vipp1∆ahA SN2 (C). SDS-PAGE of purified VIPP1 protein stocks are 
shown in (D), 5 µL of each sample was loaded in triplicate. PspA WT shown for comparison.  
 
5.2.2 Vipp1 secondary and tertiary structure 
Once purified, the Vipp1 was analysed by Circular Dichroism (CD) to allow for comparison of 
secondary structure with preparations from other studies and in silico predictions. In silico 
secondary structure analysis using PSIPRED (Jones, 1999) predicts Vipp1 to be  80 % α-
helical with high confidence in most regions (see Figure 5.3C). CD analysis and spectral 
deconvolution of a purified Vipp1 sample by Furhmann et al. (2009) gave an 83 % α-helical 
structure, closely agreeing with the in silico data. The CD spectra of both the soluble (SN1) 
and membrane (SN2) purified Vipp1 is shown in Figure 5.2A. The spectra were processed 
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using the CONTIN and CDSSTR programmes (Sreerama and Woody, 2000, Whitmore and 
Wallace, 2008, Whitmore and Wallace, 2004) to estimate the secondary structure of the 
two samples. The SN1 fraction averaged 76 % α-helical and SN2 fraction 72 % α-helical, both 
slightly less than the 83 % observed for the Vipp1 preparation by Furhmann et al. (2009). 
However, both SN1 and SN2 fractions were analysed with their (His)6 tags and linker still 
attached, consisting of 21 random coil AAs. Thus, if this is factored into the secondary 
structure predictions then Vipp1 SN1 is 82 % α-helical and SN2 is 78 % α-helical, in line with 
the in silico predictions and previous experimental data. 
 
 
Figure 5.3 Secondary and tertiary structural analysis of Vipp1.  (A) CD spectra of purified Vipp1 
WT between 180 and 270 nm. All spectra are normalised as mean residue ellipticity [θ] and are an 
average of 3 scans at 25 °C. (B) In silico prediction of the tertiary structure of Vipp1 WT obtained 
from the I-TASSER server (Zhang, 2008) showing a predominantly α-helical protein with coiled-coil 
regions. (C) In silico secondary structural analysis from PSIPRED (Jones, 1999) with accompanying B-
Factors predicting 80 % α-helical and 20 % coli secondary structure.  
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It can also be seen from Figure 5.3A that the ratio of the molar ellipticity at 222 nm to that 
at 208 nm for both samples is >1, indicative of coiled coil structures within the sample 
(Monera et al., 1993). This is in agreement with in silico analysis using COILS (Lupas et al., 
1991), which predicts the formation of coiled coils between residues 26–160 (data not 
shown). The tertiary structure of Vipp1 was also analysed using the I-TASSER server (Zhang, 
2008) with Figure 5.3B showing the predicted structure with the highest confidence score. 
The model also contains a coiled coil region after P25 running to the G157 residue. 
The similarity in secondary structure observed between the Vipp1 purifications in previous 
studies and in silico structural predictions indicate that our Vipp1 preparation has folded 
correctly. As such we can have confidence that observations made with the Vipp1 
preparations in this study should be those of native Synechocystis Vipp1. 
 
5.2.3 (His)6-Tag cleavage and oligomer formation assays 
Purified Vipp1 forms high-order oligomers over 1 MDa in weight (Fuhrmann et al., 2009a, 
Aseeva et al., 2004). To assess the self-association of our Vipp1 preparations they were 
subjected to HPLC gel-filtration through a Yarra SEC-S3000 column (see Figure 5.4A for the 
traces). Both the SN1 and SN2 purified preparations of Vipp1 WT eluted in the void volume, 
indicating the formation of a complex over 1 MDa in weight (and agreeing with previous 
findings). Vipp1∆ahA also eluted in the void volume indicative of a high-order oligomer. It 
therefore appears that residues 2-19 of Synechocystis Vipp1 are not required for oligomer 
formation. Interestingly, a Vipp1 mutant of Arabidopsis thaliana lacking residues 1-21 has 
been found to lose the ability to form high-order oligomers (Otters et al., 2013). This raises 
the possibility that residues 20 and 21 may play a pivotal role in oligomerization. However, 
as we are comparing Vipp1 from two different organisms, further studies would need to be 
undertaken to confirm this. 
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Figure 5.4 Gel filtration and (His)6 cleavage gels of Vipp1 proteins. (A) HPLC gel filtration profiles 
of purified Vipp1 proteins. Each trace is obtained from 15 µL, 20 µM protein samples in gel filtration 
running buffer.  Peaks from the ladder of the following globular proteins: carbonic anhydrase (29 
kDa), BSA (66 kDa), β-amylase (200 kDa), apoferritin (443 kDa) and thyroglobulin (669 kDa) are 
represented by dashed lines on the traces. (B) SDS-PAGE gel of Vipp1 proteins after (His)6 tag 
thrombin cleavage.    
 
In order to remove the (His)6 tags used for purification of the Vipp1 proteins (to be used as a 
control to confirm any observed functionality is not due to the presence of a (His)6 tag), a 
thrombin cleavage capture kit (Novagen) was used. Purified (His)6-Vipp1 proteins were 
treated with increasing concentrations of biotinylated thrombin over different time periods. 
The biotinylated thrombin an cleaved (His)6 tags were removed by passing through a column 
containing streptavidin and Ni-NTA agrose beads. Cleavage was then monitored via SDS-
PAGE (see Figure 5.4B).  As can be seen from Figure 5.4B, complete cleavage of both Vipp1 
WT and Vipp1∆ahA was not able to be achieved under any conditions, even with a large 
excess of thrombin and double (6 h) the recommended incubation time. This suggests that 
when oligomerized, the cleavage site (situated three residues upstream of the N-terminal 
Vipp1 methionine) in some of the Vipp1 monomer units is unavailable to thrombin, possibly 
due to being buried within the complex. Further evidence of this can be found when 
    171 
  
considering the fact that (His)6-Vipp1 was still found in the SDS-PAGE analysis, despite the 
samples being passed through a column containing an excess of Nickel-NTA agarose 
beforehand. As any available un-cleaved (His)6 tagged protein should bind to the column, 
the presence of (His)6-Vipp1 in the flow-through means some (His)6 tags must be buried 
within the complex and not solvent accessible for cleavage and for Ni binding. (His)6 burial 
has been found to occur in other proteins upon oligomerization (Anthony et al., 2014). It can 
be seen in Figure 5.4B that the ratio of cleaved to un-cleaved protein is around 1:1 in Vipp1 
WT and 2:1 in Vipp1∆ahA, thus there may be a higher proportion of accessible thrombin 
cleavage sites per oligomer in Vipp1∆ahA compared with Vipp1 WT.  
 
5.2.4 Vipp1 – PspF interaction assays 
Vipp1 is not thought to be able to interact with PspF (Vothknecht et al., 2012), yet to our 
knowledge there is no experimental work showing this is the case in vitro. A number of 
assays were therefore undertaken to investigate if a Vipp1-PspF1-275 interaction was 
observable and if PspF’s regulatory functionality is affected by Vipp1.  
First native-PAGE band-shift assays were undertaken to probe for any PspF1-275-Vipp1 
interaction. Vipp1 WT was incubated with PspF1-275 before being loaded on a 4.5 % native 
gel. The resulting SYPRO ruby stained gel shown in Figure 5.5A.  Samples containing Vipp1 
incubated with PspF1-275 (lanes 4 and 5 of Figure 5.5A) show no new bands that could be 
attributed to a Vipp1–PspF1-275 complex when compared to the Vipp1 WT and PspF1-275 only 
samples (lanes 1, 2 and 3).  Lanes 3, 4 and 5 contain equal amounts of PspF1-275 so if there is 
no Vipp1–PspF1-275 interaction then the intensities of the PspF1-275 band should be equal in 
all three lanes.  However, when the intensities of the PspF1-275 bands are integrated (Figure 
5.5A), a decrease is seen compared with the PspF1-275 alone sample (lane 3) when equimolar 
Vipp1 is added (lane 4, 74 %). The intensity decreases further when a two-fold excess of 
Vipp1 is used (lane 5, 46 %). The intensities of the Vipp1 bands with and without PspF1-275 
were also compared and a decrease was also observed when PspF1-275 was added. A 
decrease in the amounts of free proteins indicates that an interaction between some of the 
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Vipp1 and PspF1-275 may be occurring, yet it does not appear to be in the form of a defined 
6:6 co-complex that can be defined on a native gel (as with a PspA-PspF1-275 co-complex). 
 
 
Figure 5.5 Vipp1-PspF1-275 interaction assays. (A) Native-PAGE band-shift assays of Vipp1 WT and 
PspF1-275. Contents of each lane are shown on the gel, (+) signifies 10 µM of the specified protein, 
(++) – 20 µM. The relative intensity of PspF1-275 in each band compared with the PspF1-275 only (lane 
3) sample is shown. (B) ATPase activity of PspF1-275 incubated with Vipp1 proteins at a 1:2 PspF1-275-
Vipp1 molar ratio (measured via the NADH-coupled assay). Activity of PspF1-275 alone set as 100 %. 
 
As it is not possible to confirm or rule out a Vipp1–PspF1-275 interaction via the native-PAGE 
assay, PspF1-275 ATPase assays were undertaken to ascertain whether Vipp1 is able to mimic 
PspA’s ability to inhibit PspF’s ATPase activity. The steady state ATPase of PspF1-275 was 
measured, and addition of Vipp1 WT was shown to have a negligible effect on the ATPase 
activity (see Figure 5.2B). It appears that if a Vipp1-PspF1-275 interaction occurs then it is 
unable to inhibit PspF’s ATPase activity and so a PspF negative regulatory role for Vipp1 is 
unlikely. Vipp1ahA was also used to see if removal of the N-terminal AH has an impact on 
ATPase of PspF1-275. As PspAahA has been shown to possess stronger negative control of 
PspF than PspA WT (Jovanovic et al., 2014b), it was thought that the Vipp1ahA mutant may 
be more likely to have a regulatory effect. In the ATPase assay (Figure 5.5B) a slight 
inhibitory effect was observed upon addition of Vipp1∆ahA but only a small proportion of the 
inhibition caused by PspA WT under the same conditions was seen.  
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From the experimental data collected it appears that there may be an interaction between 
PspF1-275 and Vipp1 WT, although this was only inferred from a loss of free PspF1-275 and 
Vipp1 WT from the native-PAGE assay. Further assays that observe a direct interaction 
would have to be undertaken to confirm this (such as HPLC gel filtration). It is apparent that 
whether this interaction occurs or not there is no effect on PspFs ATPase ability, thus Vipp1 
cannot effectively substitute PspA’s negative regulatory function. 
 
5.2.5 Vipp1 - membrane binding assays 
As the purified Vipp1 here has been shown to behave similarly to other published 
preparations (Fuhrmann et al., 2009a), membrane binding studies were next undertaken to 
compare and contrast the proteins bilayer association properties with that of PspA. The only 
in vitro experimental work regarding Vipp1’s interaction with membrane was undertaken by 
Otters et al. (2013), who found that Arabidopsis thaliana Vipp1 is able to bind vesicles made 
from the IM of pea chloroplasts and also interact with E. coli lipids. The observations were 
qualitative and provided no specificity for lipid head group, bilayer stress or any other 
membrane property. By using similar binding assays as utilized for PspA in Chapter 4, much 
greater insight into Vipp1’s interaction with the lipid bilayer was hoped to be gained. To 
allow for direct comparison with PspA WT, the purified membrane (SN2) fraction of Vipp1 
WT was used for all the membrane binding assays.  
 
5.2.5.1 Vipp1 and E. coli total lipid extract vesicles 
Initial studies were undertaken using E. coli TLE vesicles as Vipp1 has previously been shown 
to interact with E. coli lipids via an FT-IR assay (Otters et al., 2013). Vesicles were produced 
via extrusion through 100 nm filters and membrane binding of purified Vipp1 was probed 
via the native-PAGE and sucrose gradient co-floatation assays. Figure 5.6 shows the gels 
from each assay.  
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Figure 5.6 Vipp1-membrane binding assays with E. coli TLE vesicles.  (A) Native-PAGE based 
binding assay of Vipp1 WT with E. coli TLE, 100 nm extruded vesicles. Samples containing 10 µM 
Vipp1 were incubated with vesicles (lipid conc. indicated). Gel was stained with Sypro ruby protein 
stain and bands quantified via their intensity. 5 µM PspA WT shown in lane 1 for comparison. (B) 
Collected fractions of sucrose gradient co-floatation assay (analysed via SDS-PAGE and Sypro 
staining) of Vipp1 WT with and without 100 nm E. coli TLE vesicles. Starred fractions indicate those 
found to contain NBD-PE labelled vesicles (monitored via fluorescence emission at 515 nm).  
 
Both assays show membrane binding by Vipp1. In the sucrose gradient co-floatation assay 
Vipp1 settled in the higher density fractions (similar to PspA). Upon addition of E. coli TLE 
vesicles, some Vipp1 was also observed in the lower density fractions where the vesicles 
settled (see Figure 5.6B). Akin to PspA, the binding levels observed in this assay were low, 
and when the bands were quantified only around 8 % of the total protein sample was found 
to be membrane associated (recall around 20 % of PspA was membrane associated in this 
assay shown in Chapter 3.2.3.2). The native-PAGE assay produced a decrease in the free 
Vipp1 band when the protein was pre-incubated with E. coli TLE vesicles which was 
proportional to the lipid concentration added (see Figure 5.6A). This is indicative of 
membrane binding. Again the level of membrane association appeared to be less than that 
of PspA, as even at a 2.5 mM lipid concentration, 35 % of the free Vipp1 band still remained. 
When the percentage of membrane bound Vipp1 (calculated from the native-PAGE assay) 
was plotted against the lipid concentration of the vesicles added, the lower affinity of Vipp1 
for the membrane compared with PspA becomes apparent (see Figure 5.7).  
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Figure 5.7 Membrane binding of Vipp1 and PspA as a function of E. coli TLE vesicle 
concentration. Graph showing the membrane binding of 10 µM Vipp1 WT and PspA WT to 100 nM 
extruded, E. coli TLE vesicles. Insert shows the linear regression of the first three data points where a 
relative linear binding trend is observed. Gradients of fitted lines were 25 and 78 for Vipp1 and PspA 
respectively. Binding was calculated from the native-PAGE based assay using Equation 3.5 with the 
data shown being the mean and SD of three repeats using different protein and vesicle preparations. 
 
Linear regression was undertaken on the first three data points for each protein (where the 
binding trend is relatively linear) to give an indication of relative affinities and is shown in 
the insert of Figure 5.7. The gradients of the two lines were 25 and 78 for Vipp1 and PspA 
respectively, representative of around a three-fold decrease in the affinity of Vipp1 for E. 
coli TLE vesicle compared with PspA.  
It is also apparent from the error bars in Figure 5.7 that there is a higher degree of variation 
in the Vipp1 binding levels than seen for PspA. It is unlikely that technical error could be 
apportioned to this increase as exactly the same experimental technique was undertaken to 
obtain both data sets. As the same vesicle preparations were used for each protein it is also 
implausible that differences in the membrane properties are responsible. However, 
different protein preparations were used for each data point which could cause the 
increased variation with Vipp1. As Vipp1 has been shown to form oligomeric rings of diverse 
sizes (Fuhrmann et al., 2009a), different protein preparations may vary in the distribution of 
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these rings, resulting in more variable results compared with PspA which only forms one 
ring conformation (36-mer) in vitro (Hankamer et al., 2004). Nevertheless, no overlap of the 
membrane binding levels of PspA and Vipp1 for any data point was observed below 
saturation. We can therefore be confident that the general trends of Vipp1’s reduced 
affinity for the membrane is real, however specific relative affinities must be treated with a 
degree of caution. 
With the available data an approximate calculation of the percentage membrane coverage 
of Vipp1 can be made. As with PspA, Equation 3.6 can be used (with 𝐶𝑃𝑠𝑝𝐴 and 𝐴𝑃𝑠𝑝𝐴 
replaced with 𝐶𝑉𝑖𝑝𝑝1 and 𝐴𝑉𝑖𝑝𝑝1) to give a value for coverage. While 𝐶𝑉𝑖𝑝𝑝1 is known (10 µM 
within the Native-PAGE assay), obtaining a value for 𝐴𝑉𝑖𝑝𝑝1 is more problematic than 𝐴𝑃𝑠𝑝𝐴. 
While for PspA the 36-mer oligomeric ring structure has a defined size in vitro (Hankamer et 
al., 2004), Synechocystis Vipp1 has been found to form at least six different rings with 12-17 
fold rotational symmetry (see Figure 1.12 and (Fuhrmann et al., 2009a)). The Vipp1 rings are 
proposed to consist of 48-68 Vipp1 monomers (Bultema et al., 2010) resulting in a surface 
area per monomer ranging from 10.2 to 12.5 nm2. As the distribution of these rings is 
unknown, for this work an estimated average of 11.35 nm2 per Vipp1 monomer was used 
for 𝐴𝑉𝑖𝑝𝑝1. Taking the average membrane binding for Vipp1 of 47% at 1 mM lipid conc 
vesicles (near 50 % binding saturation so within the relative linear range), the approximate 
membrane coverage of VIpp1 was calculated to be 15.0 % assuming that Vipp1 binds the 
membrane face down in an oligomeric ring conformation.  
 
5.2.5.2 Stored curvature elastic stress binding assays 
The assays detailed in 5.2.5.1 clearly established a binding interaction between purified 
Vipp1 and the membrane of lipid vesicles. Studies therefore switched to probing the effects 
of varying membrane properties and compositions. Chapter 4 has highlighted the 
importance of SCE stress and anionic lipids for PspA binding. Vipp1 was subjected to the 
same binding assays to ascertain if these binding trends are preserved.   
First, Vipp1’s affinity for vesicles as a function of SCE stress was probed. Vipp1 WT (10 µM) 
was substituted into the native-PAGE based assay with the 5 vesicle compositions of 
increasing SCE stress used in Chapter 4.2.5. Initial studies were undertaken to confirm the 
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binding of Vipp1 WT to neutral membranes. Vipp1 WT (10 µM) and vesicle with lipid 
compositions of the highest SCE stress (DOPC/DOPE 6:4) were used at lipid concentrations 
from 0.5 to 2.5 mM. Very little membrane association at concentrations up to 1.5 mM was 
observed. However, at a lipid concentration of 2.5 mM over 50 % membrane binding was 
observed (Data not shown). A phospholipid lipid concentration of 2.5 mM was therefore 
used as a basis for the first SCE stress native-PAGE assay for Vipp1 WT. The resulting SYPRO 
stained gel is shown in Figure 5.8A. Like PspA, a decrease in intensity of the free Vipp1 band 
correlates with increased SCE stress within the vesicles used. Controls after (His)6-tag 
cleavage were undertaken to check for (His)6 mediated binding but the binding trends were 
conserved (see Appendix B).  As such, it appears that the trend of increased membrane 
association as a function of SCE stress within the membrane is conserved between Vipp1 
and PspA. 
 
 
Figure 5.8 Membrane binding of Vipp1 WT as a function of bilayer SCE stress.  (A) Native gel 
after incubation of Vipp1 WT with vesicles (2.5 mM lipid conc.) of increasing SCE stress. Vesicles in 
each lane are as follows; Lane 2 - 4:6 DMPC/DOPC, lane 3 - 2:8 DMPC/DOPC, lane 4 - DOPC, lane 5 - 
2:8 DOPE:DOPC and lane 6 - 4:6 DOPE/DOPC. Red boxes indicate integrated regions and intensity of 
each lane with respect to Vipp1 WT alone band (lane 1) is shown. (B) Bar graph of the membrane 
binding of 10 µM Vipp1 and PspA WT to vesicle of increasing SCE stress and E. coli TLE at 2 mM lipid 
conc. 
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As SCE stress specific binding is a phenomenon shared by Vipp1 and PspA proteins, 
comparative studies gauging the relative affinities of the two proteins for each membrane 
state were undertaken using the native-PAGE assay. A lipid concentration of 2 mM was 
chosen, as it should be sufficient to observe resolvable differences in membrane association 
of Vipp1 without exceeding the saturating levels of binding for PspA (with the majority of 
vesicle compositions tested). The data from these studies is presented in Figure 5.8B. It can 
be seen that for all vesicle compositions probing SCE stress, Vipp1 exhibits markedly less 
membrane association than PspA. It is also worth noting that the difference between the 
binding of the vesicle of highest SCE stress (4:6 DOPE/DOPC) and E. coli TLE is significantly 
larger in Vipp1 than in PspA. Around a two-fold difference in magnitude is observed for 
Vipp1 (see Figure 5.8B, 39 % average membrane binding for 4:6 DOPE/DOPC and 82% 
average for E. coli TLE), while for PspA the difference is consistently below 1.5 orders of 
magnitude. This suggests that the SCE stress binding determinant is, to a certain extent, 
tuned down in Vipp1. It is apparent that SCE stress cannot be the only membrane feature 
recognised by Vipp1. 
 
5.2.4.3 Vipp1 and anionic lipid binding assays 
The effect of anionic lipids on the membrane association of Vipp1 was then investigated. To 
allow for comparison with the results obtained for PspA, the same anionic lipids (DOPG, 
14:0 CL and DOPS) and mole fractions (0.5 %, 2 % and 10 %) were used. Neutral vesicles with 
the lowest levels of SCE stress (DMPC/DOPC 4:6) were again used as the carrier lipids so as 
to minimise the SCE stress binding contribution. Vipp1 WT (10 µM) was incubated with 
vesicles (2.5 mM lipid) and the native-PAGE assay was used to probe membrane binding.  
Gels from the assay using DOPG, 14:0 CL and DOPS are shown in Figure 5.9A, B and C 
respectively.    
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Figure 5.9 Membrane binding of Vipp1 WT as a function of anionic lipid content. SYPRO 
stained native gels after 10 µM Vipp1 WT was incubated with DMPC/DOPC 4:6 vesicles (2.5 mM lipid 
conc.) with DOPG (A), 14:0 CL (B) and DOPS (C) at 0.5, 2 and 10 % (Mol fraction). Red boxes indicate 
integrated regions and intensity of each lane with respect to Vipp1 alone band (lane 1) is shown. (D) 
Bar graph of the membrane binding of 10 µM Vipp1 to DMPC/DOPC 4:6 (2.5 mM lipid conc.), vesicles 
alone and containing 10 % (Mol fraction) anionic lipids. 
 
It is apparent from the native gels in Figure 5.9 that the effects of anionic lipids on 
membrane association of Vipp1 at 0-10 % mole fractions are much less significant than that 
seen for PspA. Indeed for 0.5 and 2 % mole fractions of all three anionic lipids used, no 
consistent, or significant decrease in intensity of the free Vipp1 band is observed when 
compared with the neutral DMPC/DOPC 4:6 vesicles. Only when vesicles containing 10 % 
anionic lipid are considered does a consistent, noticeable decrease in intensity of the free 
Vipp1 band occur. Figure 5.9D shows the membrane binding (calculated from the native-
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PAGE assay) of Vipp1 to vesicles containing 10 % mole fraction the three anionic lipid 
species compared with neutral (DMPC/DOPC 4:6) vesicles. Average binding is increased by 
all three species with DOPG increasing 22 %, 14:0 CL increasing 13 % and DOPS increasing 15 
%. These increases are relatively modest and less than those observed for the SCE stress 
assay at comparable vesicle concentrations. Overlap in the error bars of the neutral and 
anionic species also indicate that the data interpretations must be treated with a degree of 
caution. It is also worth noting that at a 10 % mole fraction the anionic lipid species will to 
some extent positively affect the SCE stress of the membrane (see Chapter 4.3 for 
explanation). This could lead to increases in Vipp1-membrane association that are not solely 
due to the bilayers negative charge.  
Taken together the data suggests that anionic lipids have a negligible effect on the 
membrane binding of Vipp1 at 0.5 % and 2 % mole fractions and provide only a modest 
increase at 10 % mole fractions that may in fact be enhanced by a concurrent change in SCE 
stress. Anionic lipid concentrations over the 10 % mole fraction were not undertaken as it 
would lead to an increase in SCE stress within the membrane. As such, it would be hard to 
decouple the effects that anionic lipids and SCE stress were having on any observed increase 
in Vipp1 membrane association. 
As with PspA, the effects on Vipp1 binding to membranes with high SCE stress in 
combination with net negative bilayer charge was also assayed. DOPE/DOPC 4:6 vesicles 
with 5 % and 10 % mole fraction anionic DOPG were used in the native-PAGE binding assay. 
The resulting SYPRO stained gels are shown in Figure 5.10A. The intensity of the Vipp1 band 
with DOPE/DOPC 4:6 vesicles (lane 3) is similar to those where DOPE/DOPC 4:6 + 5 % DOPG 
and DOPE/DOPC 4:6 + 10 % DOPG vesicles were used (lane 4 and 5). Membrane binding 
calculated from the native-PAGE assay for each vesicle composition (at 2 mM lipid 
concentration) is presented in Figure 5.10B.  Like PspA, membrane binding of Vipp1 WT to 
vesicles of high SCE stress is comparable in the presence and absence of anionic lipids. As 
such, the data implies that there is no cumulative effect of the two properties on VIpp1’s 
association with the membrane when levels of anionic lipids are ≤ 10 % mole fraction.  
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Figure 5.10 Membrane binding of Vipp1 as a function of anionic lipids and SCE stress 
combined. (A) SYPRO stained native gels after 10 µM Vipp1 WT was incubated with DMPC/DOPC 4:6 
vesicles and DOPE/DOPC 4:6 vesicles with and without 10 % DOPG. Red boxes indicate integrated 
regions and intensity of each lane with respect to Vipp1 alone band (lane 1) is shown. (B) Binding 
data calculated from the native-PAGE assay (10 µM Vipp1 and 2 mM lipid conc.) for vesicles with low 
(DMPC/DOPC 4:6) and high (DOPE/DOPC 4:6) SCE stress with 5 % and 10 % anionic lipid DOPG. 
Binding to E. coli TLE vesicles is shown for comparison 
 
It is interesting to note the significant increase in affinity of Vipp1 for E. coli TLE vesicles 
compared to the high SCE stress and net negative DOPE/DOPC 4:6 + 10 % DOPG vesicles in 
Figure 5.10B. Though the SCE stress profile of E. coli TLE vesicles is uncharacterised (but 
probably quite high due to large amounts of PE), the increase in binding is unlikely due to 
this as Vipp1’s SCE stress sensing is relatively low compared to PspA. Anionic lipid content in 
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the E. coli TLE extract is around 25 % mole fraction and thus it may be that higher net 
negative membrane charges than those seen at 10 % anionic lipid mole fraction are required 
to promote membrane association of Vipp1.  
 
5.2.5 Vipp1∆ahA assays 
As with PspA, Vipp1 has a putative N-terminal AH region that has been implicated in the 
protein’s membrane binding function. Purified Arabidopsis thaliana Vipp1 missing the first 
21 N-terminal AA residues has been found to be incapable of binding the IM (Otters et al., 
2013). The Vipp1ahA mutant lacking residues 2-19 was used in the native-PAGE binding 
assay to see if the N-terminal region is necessary for membrane association of Synechocystis 
Vipp1. Initial studies with 10 µM Vipp1ahA and E. coli TLE vesicles (2.5 mM lipid) gave on 
average only 10 % membrane binding compared with complete membrane association for 
Vipp1 WT under the same conditions (see Figure 5.11B). Clearly, removal of residues 2-19 of 
Vipp1 has a significant and large effect on membrane association to the E. coli TLE vesicles. 
To see if the decrease in membrane affinity of Vipp1ahA is conserved for other vesicle 
compositions, membrane-binding Vipp1ahA was also probed as a function of SCE stress. 
Figure 5.11A presents a typical SYPRO stained native gel, and Figure 5.11B the comparative 
membrane binding of Vipp1 WT and Vipp1ahA for vesicle of increasing SCE stress. Binding by 
Vipp1ahA is negligible for all vesicle compositions with no trend of increased association as a 
function of SCE stress observed. In Figure 5.11A an increase in intensity of the Vipp1ahA 
band when vesicles are added is even observed in some cases (lanes 2, 4 and 5). However, 
this is within the range of inherent experimental error in the assay, and can be ascribed to 
pipetting errors resulting in variations in the amount of Vipp1ahA loaded onto the gel. 
Binding of Vipp1ahA to vesicles containing anionic DOPG was also tested with the SYPRO 
stained gel shown in Figure 5.11C. Again, a significant decrease in intensity of the free 
Vipp1ahA band was not observed for any of the three vesicle compositions.  
The inability of Vipp1ahA to bind any vesicle composition within the native-PAGE assay 
correlated well with the observations made by Otters et al. (2013,) and strongly suggests 
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that the N-terminal AH of Synechocystis Vipp1 is required for its direct membrane 
association. 
 
 
Figure 5.11 Membrane binding of Vipp1ahA to vesicles of varying membrane composition. (A) 
native gel after incubation of Vipp1ahA with vesicles (2.5 mM lipid conc.) of increasing SCE stress. 
Vesicles in each lane are as follows: Lane 2 - 4:6 DMPC/DOPC, lane 3 - 2:8 DMPC/DOPC, lane 4 - 
DOPC, lane 5 - 2:8 DOPE:DOPC and lane 6 - 4:6 DOPE/DOPC. Red boxes indicate integrated regions 
and intensity of each lane with respect to Vipp1ahA alone band (lane 1) is shown. (B) Bar graph of 
the membrane binding of 10 µM Vipp1ahA and Vipp1 WT to vesicle of increasing SCE stress and E. 
coli TLE at 2 mM lipid conc. (C) SYPRO stained native gel after incubation of Vipp1ahA with 
DOPC/DMPC 6:4 vesicles (2.5 mM lipid) containing 0 %, 5 % and 10 % mole fraction DOPG in lanes 2, 
3 and 4 respectively. 
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5.2.6 Visualisation of SUV bound Vipp1 
In Chapter 4 we observed a PspA-vesicle co-complex in the form of a high running band 
when undertaking the native-PAGE based assay with sonicated SUVs (see 4.2.4). The same 
assay was undertaken with Vipp1 to find out if a Vipp1-vesicle co-complex is seen. Sonicated 
DOPC/DOPG 8:2 vesicles were titrated into Vipp1 WT and then run on a 4.5 % native gel. 
The resulting SYPRO stained gel is shown in Figure 5.12. As expected, the intensity of the 
unbound Vipp1 WT band decreases as the vesicle concentration increases within the 
sample. This is coupled with the appearance of a new high retardation running band 
attributed to a Vipp1-vesicle complex entering the gel.  
 
 
 
Figure 5.12 Visualising direct membrane binding of Vipp1 WT to SUVs using the native-PAGE 
binding assay.  SYPRO stained 4.5 % native gel of Vipp1 WT (10 µM) incubated with increasing 
concentrations of sonicated DOPC/DOPG 8:2 SUVs.  The appearance of a high running band 
attributed to a Vipp1-SUV co-complex is seen in conjunction with a decrease in free Vipp1 
 
It was noted that significant protein density is observed in the wells of each lane in Figure 
5.12 (labelled as aggregated Vipp1). The Vipp1 WT preparation that was used in this assay 
was 6 months old which may have resulted in a degree of protein aggregation or even rod 
formation. Use of two other Vipp1 preps purified more than six months previously in the 
assay also gave protein density in the well. Due to time constraints a new Vipp1 purification 
could not be undertaken, but as this assay was only used qualitatively to show the protein-
vesicle complex it was felt that the data was sufficient. For any quantitative data to be 
drawn from the assay repetition with a fresh Vipp1 WT purification would be required.  
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5.2.7 Binding of Vipp1 to thylakoid membrane lipids 
The previous work in this chapter shows Vipp1’s ability to bind the membrane of vesicles 
with a number of different phospholipid compositions. However, in the photosynthetic 
thylakoid membranes of plants and cyanobacteria, which Vipp1 maintains and directly 
binds, galactolipids replace phospholipids as the major membrane species (Vothknecht et 
al., 2012). Galactolipids are glycolipids with a galalctose attached to the glycerol backbone. 
The galactolipids monogalactosyldiacylglycerol (MGDG) and digalactosyldiacylglycerol 
(DGDG) are the most abundant lipids in plant and cyanobacterial thylakoid membranes and 
contain one and two galactose residues respectively (see Figure 5.13 for the chemical 
structure of each) (Douce and Joyard, 1990). Both lipids play a crucial role in functionality, 
with depletion mutants in Arabidopsis thaliana exhibiting reduced thylakoid membrane 
content and photosynthetic impairment (Jarvis et al., 2000). The thylakoid membrane also 
contains the anionic lipids PG and Sulfoquinovosyl diacylglycerol (SQDG) as major species, 
and Table 5.1 shows the lipid composition of the thylakoid and cytoplasmic membranes in 
Synechocystis sp. Pcc 6803. 
 
 
Figure 5.13 Structures of the most abundant types of MGDG and DGDG within the lipid 
extracts (spinach) used in this study. Neutral, polyunsaturated 
MGDG(18:3(9,12,15Z)/16:3(7,10,13Z)) and DGDG(18:3(9,12,15Z)/16:3(7,10,13Z)) are shown above. 
 
To mimic the native membrane environment that Vipp1 is exposed to, and to ascertain 
whether the membrane-binding properties of Vipp1 in vitro are preserved with galactolipids 
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as the predominant membrane species, studies were undertaken with vesicles incorporating 
the thylakoid membrane lipids DGDG and MGDG.  
 
Composition (mol %)  
Membrane MGDG DGDG PG SQDG Source 
Thylakoid 37.4 20.0 13.7 28.9 (Sakurai et al., 2006) 
Thylakoid 62 14 6 18 (Gombos et al., 1996) 
Cytoplasmic 56 18 10 13 (Gombos et al., 1996) 
Total 59 17 8 16 (Wada et al., 1989) 
 
Table 5.1 Membrane lipid composition of the four major lipid classes in Synechocystis. SQDG 
stands for sulfoquinovosyldiacylglycerol and is an anionic galactolipid.  Data was obtained from the 
literature where TLC-GC analysis was used.  
 
Ideally one would produce vesicles of pure MGDG and DGDG to study the membrane 
binding properties of each lipid type in isolation. Unfortunately, a number of issues arise 
that prevent this from being feasible. DGDG is a bilayer forming lipid and as such will readily 
form vesicles, but MGDG is a non-bilayer lipid, only forming hexagonal structures in purified 
form. MGDG therefore must be mixed with other lipids (such as DGDG) or transmembrane 
proteins in order to from a lamellar phase (Simidjiev et al., 2000, Sen et al., 1981). Also, 
vesicles formed from pure DGDG and DGDG/MGDG mixtures have been found to aggregate 
in the presence of monovalent or divalent cations (Webb and Green, 1990). Since Na+ is 
present in our protein buffers, one would expect vesicle aggregation of DGDG and 
DGDG/MGDG vesicles to occur if it were incorporated into our assays, which is obviously 
undesirable. Aggregation can be avoided by addition of the anionic lipid PG (also a major 
component of the thylakoid membrane) (Webb and Green, 1990).  
Considering the issues highlighted above (and the small quantity of lipids available), two 
galactolipids containing vesicles were produced; DGDG/DOPG 3:1 and DGDG/MGDG/DOPG 
2:1:1 mixtures. DOPC/DOPG 3:1 vesicles were also prepared to act as a control. Membrane-
binding of Vipp1 WT to these vesicles was then assayed using the native-PAGE based assay, 
the results of which can be seen in Figure 5.14. 
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Figure 5.14 Vipp1-membrane binding to vesicles containing the galactolipids DGDG and 
MGDG. (A) 4.5% gels from the native-PAGE based binding assay. Each lane contains 10 µM Vipp1 
WT either alone or with 1 mM or 2.5 mM of the specified vesicles. Vesicles were extruded through 
400 nm filters with the lipid composition of each as follows: DGDG/DOPG: 3:1, DGDG/MGDG/DOPG: 
2:1:1, DOPC/DOPG: 3:1. Intensities of each band with respect to the Vipp1 WT alone sample on each 
gel are shown. (B) Membrane binding of Vipp1 to each set of vesicles at 1 mM and 2.5 mM lipid 
concentration. Data was obtained from three separate Vipp1 preparations. 
 
As can be seen from Figure 5.14, Vipp1 WT bound all three vesicle sets. While the 
phospholipid DOPC/DOPG vesicles had the highest affinity for Vipp1 WT, significant binding 
was still observed for both of the galactolipids vesicles confirming a direct protein-
membrane interaction in vitro.  DGDG/DOPG vesicle exhibit the lowest vesicle affinity 
(about half that of DOPC/DOPG at 1 mM lipid concentration), with DGDG/MGDG/DOPG 
vesicles possessing binding intermediate of the two other vesicle sets. A possible 
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explanation for the reduction in affinity to the galactolipid vesicles may be attributed to the 
increased polar group thickness of DGDG (16.3 Å compared with 10.5 Å for DOPC). This 
could hinder access of the Vipp1 AH to the hydrophobic lipid interface (O\ki, 1988). The lack 
of any cationic residues within the bilayer of the galactolipid vesicles (compared with the 
(N(CH3)3
+ group in DOPC) may result in the loss of a stabilising electrostatic interaction with 
an anionic AA on, or flanking, the N-terminal AH of Vipp1. The increase in Vipp1 binding 
from DGDG/DOPG to DGDG/MGDG/DOPG vesicles correlates with an increase in the non-
bilayer lipid content of the membrane. MGDG is a type II lipid and thus incorporation into a 
bilayer should result in an increase in SCE stress within the membrane. Thus Vipp1’s SCE 
stress binding determinant described earlier in the chapter may be exploited and 
responsible for the increased membrane affinity. As DOPG had to be incorporated into 
vesicles to prevent aggregation, we cannot rule out purely electrostatic binding between 
cationic AA residues of Vipp1 and anionic PG.  
It must be noted that due to the lack of available DGDG and MGDG lipids only a small 
number of assays were able to be undertaken and as such these results should be treated as 
initial findings. Nonetheless, they do show binding of Vipp1 to lipid compositions more 
similar to thylakoid membranes and provide interesting avenues for further studies (see 
further work section for details).   
    189 
  
5.3 Discussion and Conclusions 
The experimental data in this chapter highlight the similarities and differences between 
PspA and its homologue Vipp1, particularly with respect to their membrane binding 
properties. It was shown that Vipp1 is also able to directly bind lipid bilayers in vitro, 
however its overall affinity for the membrane is less pronounced in comparison to PspA. The 
conserved N-terminal AH appears to be responsible for Vipp1’s membrane interaction as a 
Vipp1ahA mutant is unable to bind to vesicles of any lipid composition. For the first time we 
show that the magnitude of this bilayer association is sensitive to SCE stress within the 
membrane but comparatively less so than for PspA. The work also demonstrates that Vipp1 
can directly bind to vesicles with lipid compositions mimicking the composition of thylakoid 
membranes and chloroplasts. 
We show that Synechocystis Vipp1 protein can be expressed and purified via a similar 
method to that used for PspA. A higher proportion of Vipp1 WT is recovered from the 
soluble (SN1) fraction compared to PspA WT, possibly due to a lower affinity for the 
membrane. Purified Vipp1 WT was considerably more soluble than PspA WT, staying 
dissolved in a CHAPS free buffer at concentration over 40 µM. This increased solubility may 
play a role in reducing membrane partitioning of Vipp1 compared to PspA where the 
solubility is limited to around 20 µM in solution (even with 0.005 % CHAPS). The ability of 
Vipp1 to form high-order oligomers is preserved in our purified Vipp1 preparations and a 
similar secondary structure to in silico predictions and preparations from other studies 
(Fuhrmann et al., 2009a) suggest our expression system produces correctly-folded, 
physiologically relevant protein.  
It can be seen from the membrane binding data in this chapter that Vipp1 can directly bind 
to pure phospholipid bilayers along with those containing predominantly galactolipids. This 
is not surprising given the identification of the lipid head-group unspecific SCE stress and 
anionic lipid membrane binding determinants for Vipp1. As all biological membranes have 
the potential to possess these features the bilayer partitioning of PspA and Vipp1 should be 
possible across a range of lipid compositions. This can help explain why Vipp1 is found 
associated to both cytoplasmic and thylakoid membranes in vivo despite their different lipid 
compositions (Westphal et al., 2001), and why Arabidopsis thaliana Vipp1 can bind to E. coli 
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and thylakoid membrane lipids (Otters et al., 2013). Although not tested (due to low MDGD 
availability), it seems likely that PspA would be able to bind to vesicles containing 
predominantly galactolipids.  
From the data in this chapter and previous studies (Otters et al., 2013), the presence of the 
N-terminal AH of Vipp1 is clearly required for the protein to be able to associate with the 
membrane. It is likely that the binding mechanism proposed for PspA, where upon 
membrane association, the hydrophobic face of the N-terminal AH is inserted into the 
hydrophobic core of the bilayer via lipid packing defects, is shared by Vipp1. This may 
explain why cyanobacterial Vipp1 can substitute for the PspA effector function in E. coli and, 
PspA from E. coli can substitute for Vipp1 in cyanobacteria and act as an effector to resolve 
protein translocation defects (DeLisa et al., 2004). Indeed it seems feasible that insertion of 
Vipp1’s AH into the membrane may lead to the relief of SCE stress, stabilising the membrane 
in a similar manner to PspA. 
Although PspA and Vipp1 each contain putative N-terminal AH’s that are likely responsible 
for membrane association, the AA sequence within these motifs is not strictly conserved. 
This may account for the differences in membrane sensing observed. Notably the Vipp1 AH 
has more charged residues on the polar face than PspA (see Figure 5.1). Increasing the 
charged residues on the polar face has been shown to dampen SCE stress sensing in other 
AHs (Drin et al., 2007, Jensen et al., 2011). This may explain why Vipp1 is less sensitive to 
SCE stress than PspA. 
The differing oligomeric states of the two proteins must also be considered when comparing 
membrane affinity and lipid binding. Both Vipp1 and PspA high-order oligomers will possess 
multiple AH binding domains (one from each monomer). As such, multivalent interactions 
with the membrane will arise so long as they are sterically permitted. The binding energies 
of each AH that associates with the membrane will be additive. By this means proteins with 
an individually weak membrane binding AH may have very large overall aggregate 
membrane affinity as part of a high-order oligomer (Lemmon, 2008). As there is currently no 
crystal structure for either PspA or Vipp1 oligomers, the exact arrangement of the 
monomers within the ring, or any other self-assembly, is not known. Therefore, the number 
of AHs in a conformation able to simultaneously associate with the membrane is also 
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ambiguous. The PspA oligomeric ring (Hankamer et al., 2004) could in theory utilize up to 36 
individual AH-membrane binding interactions. With Vipp1 oligomers, this number could 
range from 48 to 68 with rings of the lowest (12 fold) and highest (17 fold) observed 
rotational symmetry respectively (Fuhrmann et al., 2009a). There is no simple way of 
determining the number of simultaneous membrane interactions made by PspA and Vipp1 
oligomers, however results in this chapter suggest the PspA ring may have proportionally 
more of their AHs available for binding. The incomplete cleavage of the (His)6-tag of Vipp1 
showed that only around 50 % of the N-terminal region of Vipp1 is solvent accessible in the 
protein preparation. Thus, it is likely that at least half of the N-terminal AHs in Vipp1 
oligomers are unable to bind the membrane. In contrast, complete cleavage observed with 
PspA indicates that all N-terminal AHs in PspA protein preparation are solvent accessible. 
Whether the available AHs are all aligned in the same plane (therefore able to interact with 
a lamellar bilayer) and, the effects that any ring stacking might have on AH availability 
creates further uncertainties. This prevents the calculation of a reliable binding constant for 
isolated membrane interactions. Studies in Chapter 6 using the isolated N-terminal AH 
regions of PspA and Vipp1 will negate the effects that differing oligomeric states have on 
membrane partitioning and, allow a direct comparison of the relative membrane affinity 
and sensing ability of each N-terminal AH.   
The anionic lipid assays show that the incorporation of low concentrations of anionic lipids 
(≤ 10 % mole fraction) within vesicles does not appear to significantly promote Vipp1 
membrane-binding. However, several results in this chapter indicate that higher anionic 
lipid concentrations may play a more significant role in Vipp1 membrane association. This 
was suggested as being responsible for the large difference in binding between E. coli TLE 
vesicles and other vesicle compositions. Notably, in the thylakoid lipid assays (section 5.2.5) 
binding of Vipp1 to DOPC vesicles containing 25 % mole fraction anionic DOPG was 
considerably higher than seen for DMPC/DOPC 4:6 + 10 % DOPG and DOPE/DOPC 4:6 + 10 % 
DOPG vesicles in the anionic lipid assays (section 5.2.4.3). The extra 15 % mole fraction of 
anionic lipid content in the DOPC + 25 % DOPG vesicles results in around a two-fold binding 
increase of Vipp1, while the SCE stress profiles of these vesicles should be less than that of 
the DOPE/DOPC 4:6 + 10 % DOPG vesicles. When the binding propensity of DOPC + 25 % 
DOPG vesicles are compared with those of E. coli TLE vesicles (which also contain around 25 
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% mole fraction of anionic lipids) they are remarkably similar. This further suggests that high 
concentrations of anionic lipids ( >10 % mole fraction) may promote membrane association 
of Vipp1. Further experiments using lipid compositions with a larger range of anionic lipid 
concentrations would be worthwhile. However, results with the isolated N-terminal AH of 
Vipp1 in chapter six directly support the inferred importance of a large net negative 
membrane charge.  
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Chapter 6 – Probing the amphipathic helices of PspA and 
Vipp1 
 
Overview 
The work detailed in Chapters 4 and 5 showed that the removal of the putative N-terminal 
AH of PspA and Vipp1 results in the near complete loss of both proteins’ membrane-binding 
ability. This strongly implicates the N-terminal AH region as being directly responsible for 
membrane association of the full length PspA and Vipp1 proteins. However, no data 
showing direct binding between the N-terminal AH PspA or Vipp1 and the membrane has 
been reported on. This chapter focuses specifically on the isolated putative AH regions of 
PspA and Vipp1, aiming to probe and characterise their membrane-interactions and relate 
them back to those of the full length proteins.  
Experiments using synthetic peptides with sequences analogous to the PspA and Vipp1 N-
terminal AHs showed that both regions are able to directly bind vesicles. Bilayer association 
is accompanied by a transition in the secondary structure of the peptides from unordered to 
α-helical; behaviour typical of a membrane binding AH. The binding trends of PspA and 
Vipp1 N-terminal AH peptides are similar to those seen for PspA WT and Vipp1 WT. This 
strengthens the evidence for the specific membrane association through the N-terminal AH 
in the full length proteins. The 18 residue, PspA ahA peptide (PspA2-19) was found to cause 
membrane disruption with formation of large peptide-lipid aggregates for all vesicle 
compositions. This was mitigated by the extra AAs in the 24 residue ahA peptide (PspA1-24). 
On the other hand, Vipp1 ahA peptides had no detrimental effect on the stability of most 
vesicles except those with a large net negative membrane charge, where their potency 
exceeded that of PspA2-19.  
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6.1 Introduction 
In the context of the full length PspA and Vipp1 proteins, the N-terminal putative AH regions 
are clearly required for membrane association of E. coli PspA (Chapter 4 and Jovanovic et al. 
(2014)), Synechocystis Vipp1 (Chapter 5) and Arabidopsis thaliana Vipp1 (Otters et al., 
2013). The amphipathic nature of the AA sequence and segregation of polar and apolar 
residues when in an α-helix conformation, present an attractive model for AH based 
membrane association. Conservation of the regions amphiphilicity across organisms would 
be expected if it acts as an AH membrane sensor for PspA and Vipp1. However, due to their 
recent identification, in silico analysis of the putative AHs conservation across organisms is 
lacking.  
Analysis of the first 24 residues of PspA and Vipp1 (up to the helix breaking P25 residue) was 
therefore undertaken to check whether the amphipathic trends are conserved. Figure 6.1 
shows the residue frequency of the first 24 residues of PspA and Vipp1 across different 
organisms. It can be seen that residues 1-24 show a good amount of conserved in PspA 
across all 10 species. Substitutions that do occur are generally residues with similar 
properties especially in the case of the hydrophobic residues. When the properties of the AA 
sequences are mapped onto a helical wheel, the conserved AH character becomes apparent 
(see Figure 6.1). Vipp1’s first 24 residues are less strictly conserved but, like PspA, the 
amphiphilic α-helical nature is still preserved. Therefore, it is feasible that the N-terminal 
region of both PspA and Vipp1 can act as a membrane binding AH.  
To study how the sequence of an AH influences its membrane binding, three physiochemical 
values: the hydrophobicity (H), hydrophobic moment (µH) and net charge (Z), can be used. 
Hydrophobicity is a measure of the mean hydrophobicity of all the residues within the AH, 
with a higher value enhancing the affinity of an AH for lipids. The degree of polarity 
segregation can be described by the hydrophobic moment, a large value of which shows a 
helix is amphiphilic perpendicular to its axis. This favours a parallel alignment at the surface 
between polar and non-polar interfaces (Eisenberg et al., 1982). Finally, the higher the net 
charge of the AH, the more sensitive it is to negatively charged membranes (Drin and 
Antonny, 2010).  
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Figure 6.1 Conservation of the N-terminal AH of PspA and Vipp1 sequence. Residues are colour 
coded according to their properties: Red – Negative, Blue – Positive, Black – Hydrophobic, Purple – 
Polar, Grey – Neutral. Alignments use PspA from the same organisms as in Figure 4.20 and Vipp1 
from Synechocystis sp. PCC 6803, Arabidopsis thaliana, Thermosynechococcus sp. NK55a, 
Chlamydomonas reinhardtii, Auxenochlorella protothecoides and Synechococcus sp. PCC 7002. 
Helical wheel projections are colour coded to show the properties of each residue with their 
orientation within an α-helix. When AA properties are not completely conserved within the 
alignments, the colour of the residue corresponds to the most conserved property with the border 
colour showing the secondary property (size of border correlates to its level of conservation).  
 
The combination of these values can be indicative of the membrane signals sensed by a 
helix. For example, typically Amphipathic lipid packing sensor (ALPS) motifs have a µH over 
0.35, H between 0.28 and 0.6 and a net charge between -1 and 2, while transmembrane 
regions have a H above 0.5 and µH below 0.2 (Gautier et al., 2008). However, treating the 
parameters as a definitive guide to AH properties is ill advised, as they can average out and 
so mask the effects of a critically detrimental residue in the motif. A single charged residue 
in the middle of the AH face, for example, can prevent membrane association (vanderSpek 
et al., 1994). This may not be represented in the hydrophobic moment if the rest of the AH 
is strongly amphiphilic and for this reason comparison of helical wheel projections is 
necessary. Figure 6.2 gives the values for H, µH and Z for the putative N-terminal AHs of 
PspA and Vipp1 in a number of organisms (along with their helical wheel projections). 
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Figure 6.2 The sequence and macroscopic properties of N-terminal AHs of PspA and Vipp1 
across species. Helical wheel projections of the first 24 residues of PspA  homologues from nine 
organisms and Vipp1 from three organisms. Residues are colour coded according to their properties: 
Red – Negative, Blue – Positive, Yellow – Hydrophobic, Purple – Polar, Grey – neutral. The 
physiochemical values for hydrophobicity (H), hydrophobic moment (µH) and net charge (Z) of each 
AH are listed with the arrow on the helical wheels showing the direction of the µH. The percentage 
identity of the first 24 residues (AH) and full length protein (FL), with respect to E. coli for PspA and 
Synechocystis for Vipp1 are also given. Data obtained using Heliquest (Gautier et al., 2008). 
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It can be seen from Figure 6.2 that all three physiochemical parameters of the PspA AHs are 
comparable. The hydrophobicity of all species has a positive magnitude and is over 0.3 
(averaging around 0.38), indicating the AHs will have an affinity for lipids when in aqueous 
solution (Fauchere and Pliska, 1983). Notably, the hydrophobic moments of all the PspA AHs 
are over 0.35 and the sequences are therefore considered amphipathic (Gautier et al., 
2008)). This correspondence is a strong indication of conserved AH driven membrane 
association of the region, as amphiphilicity has been shown to be far more important for 
interfacial binding than hydrophobicity (Fernandez-Vidal et al., 2007). For Vipp1, net charge 
is conserved between the species but more variation in the hydrophobicity and hydrophobic 
moment is observed (Figure 6.2). Nonetheless, all AHs have a positive mean hydrophobicity 
and have a large hydrophobic moment. AH driven membrane-association is also plausible 
for the three Vipp1 species but their relative bilayer affinities may differ more than for PspA. 
From Figure 6.2 it is also apparent that in all species the first 24 AAs share more sequence 
identity than that of the full length protein (when compared with E. coli PspA and 
Synechocystis Vipp1). This increased conservation is an indication of the region being 
important for a required function. In this case it seems likely to be membrane binding. 
This analysis, in concert with previous results shows that the N-terminal region of both PspA 
and Vipp1 is most likely to be responsible for direct membrane association of these proteins 
through their conserved AH motifs. This could provide a unifying membrane association 
mechanism for these proteins across many, if not all species.  
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6.2 Results and Analysis 
6.2.1 Synthetic Peptide Studies 
6.2.1.1 Choice of peptides 
Studies using synthetic peptides derived from PspA and Vipp1’s N-terminal AHs were 
undertaken to probe membrane-binding functionality of the isolated regions. Peptides were 
purchased from Insight Biotechnology. They were supplied as a lyophilised powder at over 
95 % purity (assessed via HPLC and Mass spec). The names, AA sequences and supplied 
purity of all the peptides used in this study are detailed in Table 2.7. For initial studies, 
peptides with the same sequence as the N-terminal AHs of PspA and Vipp1 were used. 
Peptides consisting of residues 2-19 of PspA (PspA2-19) and Vipp1 (Vipp12-19), corresponding 
to the deletion mutants used in Chapters 4 and 5, were purchased along with extended 
peptides of residues 1-24 of both proteins (PspA1-24 and Vipp11-24). These six extra AAs 
(before the helix breaking P25 residue) were incorporated as it was thought they may also 
contribute to the AHs membrane sensing (Chong et al., 2014) and thus provide a better 
comparison to the binding of full length proteins.  
Single and double AA mutants of PspA1-24, substituting apolar residues on the hydrophobic 
face with polar residues, were also chosen to act as potential negative controls. It has been 
shown in vivo that PspA V11E and PspA F4E mutants both lose their membrane binding 
properties (Jovanovic et al., 2014b). Therefore, ahA peptides with the single V11E 
substitution (PspA1-24 V11E) and double F4E V11E substitution (PspA1-24 F4E V11E) were 
purchased. Figure 6.2 shows the helical wheel projections of all the peptides and their 
related physiochemical properties of H, µH and Z. 
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Figure 6.3 Helical wheel projections of the peptides used in this chapter.  Hydrophobicity, 
Hydrophobic moment and Net charge of each peptide are given. The arrows on each wheel 
correspond to the direction of the hydrophobic moment and the residue size is proportional to AA 
volume. Residues are colour coded as per Figure 6.2. Projection were obtained using Heliquest 
(Gautier et al., 2008). 
 
6.2.1.2 Peptide dissolution and secondary structure studies 
Stock solutions in aqueous buffer (above 2 mg/ml) had to be prepared before membrane-
binding assays could be undertaken. Vipp11-24 and Vipp12-19 readily dissolved in dH2O at 
concentrations of 5 mg/ml and could be stored at -20 °C without precipitation. The other 
peptides were insoluble in dH2O at 2 mg/ml after vigorous vortexing. Sonication of the 
solutions was undertaken in an attempt to improve the rate of dissolution (Filippov et al., 
2010). Using this method PspA2-19 dissolved at a concentration of 2.5 mg/ml but all other 
peptides remained insoluble in dH2O. The remaining peptides were found to dissolve in PBS 
or in 40 mM Tris-HCL (pH 7.5) buffer at 5 mg/ml. However, freezing resulted in precipitation, 
so solutions were prepared fresh for each assay. 
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In most cases AH peptides are unfolded in aqueous buffer (Drin and Antonny, 2010). To 
characterise the secondary structure of the PspA and Vipp1 AH peptides in solution, Circular 
Dichroism (CD) was used. Each of the peptides were dissolved in 40 mM Tris-HCl (pH 7.5) at 
a concentration of 1 mg/ml and the CD spectrum was obtained between 280 to 190 nm. The 
water soluble peptides Vipp11-24 and Vipp12-19 were also scanned at 1 mg/ml in dH2O to 
obtain spectra down to 180 nm. Figure 6.4 shows the spectra obtained for both Vipp1 and 
PspA ahA peptides. 
 
Figure 6.4 Circular Dichroism spectra of PspA and Vipp1 ahA peptides.  (A) CD spectra of PspA1-24 
and PspA2-19 peptides dissolved in 40 mM Tris-HCL (pH 7.5) buffer. (B) Spectra of Vipp11-24 and 
Vipp12-19 peptides dissolved in dH2O. All spectra are normalised as mean residue ellipticity [θ] and 
are an average of 3 scans at 25 °C. 
 
The two PspA ahA peptides have a very different secondary structure in solution. With a 
minimum at 200 nm and no strong positive band, PspA1-24 is predominantly unordered in 
solution (Figure 6.4A). Secondary structure was estimated using CDSSTR and CONTIN 
algorithms (Sreerama and Woody, 2000) and predicted the peptide to be 75 % unordered. 
On the other hand, PspA2-19 gave a significantly different spectrum, showing a very strong 
positive band at 193 nm and a strong negative band at 214 nm (Figure 6.4A). This clearly 
shows the peptide has ordering in solution. The observation of only one negative at 214 nm 
opposed to the expected two at 222 nm and 208 nm for an α-helix, suggests there may be 
some β-sheet conformation or peptide aggregation present. The spectra of peptides that 
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form β-sheet tapes have similar appearance along with equivalent minimum peaks at 214 
nm (Aggeli et al., 2001) so PspA2-19 may adopt this conformation in solution. 
On the other hand, it can be seen from Figure 6.4B that the Vipp1 AH peptides have a much 
similar CD spectra. Like PspA1-24, both Vipp11-24 and Vipp12-19 are mainly unordered in 
solution with negative peaks at 200 nm and 201 nm respectively. CONTIN and CDSSTR 
predicted 72 % unordered structure for Vipp11-24 with 69 % for Vipp12-19. 
 
6.2.1.3 Membrane-binding of Vipp1 ahA peptides 
As there were initial issues with the solubility of the PspA peptides (later solved), the Vipp1 
peptides were first investigated for their ability to bind the membrane. An assay working on 
similar principles to the sucrose gradient co-floatation assay (described in Chapter 4) was 
first utilized to probe for any membrane binding. Briefly, peptides and vesicles were 
incubated before being loaded on the bottom of a three layer sucrose gradient. After 
ultracentrifugation, unbound peptides remain in the bottom high density fractions. Vesicles 
and any associated peptides are recovered from the top low density fractions (see Figure 
6.5A for assay schematic). Fractions were analysed via SDS-PAGE on Tris-Tricine 16.5% gels 
to detect peptide.  
The assay was undertaken on the Vipp11-24 peptide with E. coli TLE vesicles (as Vipp1 WT 
showed the highest affinity for these vesicles). The resulting SYPRO ruby stained Tris-Tricine 
gels are shown in Figure 6.5B. When the fractions of Vipp11-24 with and without E. coli TLE 
vesicles are compared, it is apparent that Vipp11-24 binds to the membrane. Bands that are 
seen in the high density B1 and B2 fractions (corresponding to free Vipp11-24) in the peptide 
only sample disappear and are replaced by a peptide band in the low density T fraction 
when vesicles are added. Unfortunately, the staining quality by SYPRO ruby for peptides is 
generally poor, making band quantification problematic. However, in the case of Figure 6.5B 
it appears that 8 mg/ml of E. coli TLE vesicles is sufficient to sequester the majority of the 
0.8 mg/ml Vipp11-24 to the membrane. This equates to around a 26:1 lipid to peptide (L/P) 
ratio. Bearing in mind that around half of this lipid (the inner leaflet of the bilayer) will not 
be exposed to the Vipp11-24 peptide, it can be appreciated that bilayer coverage is high. 
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Figure 6.5 Monitoring Vipp11-24-vesicle binding using a sucrose gradient co-floatation assay. 
(A) Schematic showing the sucrose layers before centrifugation (left) and the recovered fractions 
after centrifugation (right). The B1, B2, M1, M2 and T labelled fractions within the centrifuge tube 
correspond to those labelled in B and C. (B) SYPRO stained SDS-PAGE gels of collected fractions from 
samples containing Vipp11-24 with and without E. coli TLE vesicles. Assay used 0.8 mg/ml Vipp11-24 
incubated with 6 mg/ml, 100 nm, E. coli TLE vesicles. (C) Fluorescence image of each fraction before 
and after centrifugation for E. coli TLE vesicles labelled with 1 % NBD-PE (monitored at 515 nm).  
 
To confirm that the vesicles were also recovered from the T fraction, 1 % NBD-PE doped E. 
coli TLE vesicles were incorporated into the assay and the fluorescence of each fraction was 
monitored before and after centrifugation (Figure 6.5C). A clear shift in vesicles localisation 
can be seen in Figure 6.5C from the high density B1 and B2 fractions before centrifugation 
to the low density T fraction after centrifugation.  
These results show that the Vipp11-24 peptide, mimicking the N-terminal region of Vipp1, has 
direct membrane-binding properties in vitro. This perfectly complements the results from 
the Vipp1∆ahA mutant, where the membrane-binding function was lost (section 5.2.4.4) and 
essentially confirms that the N-terminal AH is responsible for membrane association of the 
full length Vipp1 protein. 
While peptides comprised of an AH sequence are usually unstructured in solution, they fold 
into α-helixes upon membrane association (Drin and Antonny, 2010). To see if Vipp11-24 
    203 
  
follows this behaviour, CD studies of the peptide with increasing concentrations of E. coli 
TLE vesicles were undertaken. The resulting CD spectra are shown in Figure 6.6. It can be 
seen that adding vesicles has a significant effect on the peptide trace. As the lipid ratio 
increases the 200 nm negative band progressively shifts to a higher wavelength and a new 
negative band around 222 nm begins to appear. A positive band at 195 nm also becomes 
apparent, especially for the two highest lipid concentrations. This shift is indicative of an 
increased average α-helix content of the peptide. Membrane association of unordered 
Vipp11-24 peptide must induce a degree of α-helix formation upon binding.  
 
 
Figure 6.6 AH formation of Vipp11-24 with increasing concentrations of E. coli TLE vesicles. CD 
Spectra of Vipp11-24 incubated with E. coli TLE vesicles in 20 mM Tris-HCL pH 7.5 (lipid: peptide ratio 
given in legend). Spectra are an average of 3 scans and normalised as mean residue ellipticity [θ]. 
 
The α-helix content (using CONTIN, CDSSRT) of each spectrum is shown in Table 6.1. As 
expected, the predicted proportion of α-helical residues in the peptide sample increases 
with the amount of vesicles added. In the absence of E. coli TLE vesicles, an average of 3 % 
α-helix was predicted for Vipp11-24 rising to 41 % with vesicles at a 48:1 L/P ratio. This 
increase in the average α-helix content demonstrates the typical AH behaviour of the 
Vipp11-24 peptide, with a significant proportion of the residues in the peptide adopting a 
helical conformation on association with the membrane.  
    204 
  
The values given for percentage α-helical residues in Table 6.1 are an average of all the 
peptide molecules in solution. The value may therefore represent the helical content of 
each peptide in a homogeneous population or the mean helicity of a heterogeneous 
population. At low L/P ratios, where the concentration of the peptide is greater than the 
concentration of the membrane binding sites, the predicted total helical content will be the 
average of the membrane bound helical and free unordered peptide. To ascertain the 
proportion of the Vipp11-24 peptide that assumes a helical conformation upon membrane 
association, saturation of the spectral shift must be reached (where all Vipp11-24 is 
membrane bound). Unfortunately, the L/P ratio could not be increased any further (due to 
the increased signal noise caused by the vesicles) so the point at which the predicted α-
helical content of the spectra stops increasing could not be reached. However, by adjusting 
the scaling to increase the quality of fit, it is possible to obtain a better estimation of the 
conformation of ordered membrane-bound peptide (Miles et al., 2005, Fernandez et al., 
2013). This resulted in a 55 % helical prediction for the 48:1 lipid to Vipp11-24 sample, 
suggesting over half of the peptide (at least 13 residues) assumes an AH upon membrane 
association. 
 
Peptide 
% α-helical residues in the presence of E. coli TLE vesicles (lipid : peptide) 
0:1 4:1 8:1 12:1 24:1 48:1 
Vipp11-24  3 % 5 % 16 % 20 % 35 % 41 % 
Vipp12-19  5 % ND ND 25 % 34 % ND 
 
Table 6.1 α-helical content of Vipp11-24 and Vipp12-19 peptides with E. coli TLE vesicles.  Values are 
calculated from CD spectra using CONTIN and CDSSTR with the average α-helix content given. 
 
The CD spectrum of the shorter Vipp12-19 peptide with E. coli TLE vesicles also showed a 
similar shift from an unordered to α-helical (see Appendix C) with increasing vesicle 
concentration. The α-helix content is shown in Table 6.1 where the trend seen for Vipp11-24 
is clearly conserved with Vipp12-19. The truncated Vipp12-19 peptide containing only the 
putative ahA region clearly behaves similarly with respect to AH formation upon membrane 
association as Vipp11-24. Vipp11-24 was therefore used for further studies as the surrounding 
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residues of AHs play a role in membrane sensing (Chong et al., 2014), thus Vipp11-24’s 
membrane binding properties should be more comparable to the full length protein. 
 
6.2.1.4 AH formation of Vipp11-24 as a function of membrane lipid composition 
As assays with E. coli TLE vesicles show direct bilayer association of Vipp11-24 with 
concurrent folding into an AH, one can now focus on the effect that lipid composition has on 
membrane binding. Vipp1 WT was shown to have a higher affinity for membranes with high 
levels of SCE stress and also for bilayers with a net negative charge (Chapter 5). Thus, 
Vipp11-24’s affinity for the membrane would be expected to follow similar trends if the AH is 
responsible for bilayer association in the full length protein.  
Vesicles with different lipid compositions were produced and the unordered to helical 
transition observed via CD was used to monitor binding. Unfortunately, due to the poor 
staining quality, floatation assays could not yield any supporting data within the studies 
timeframe. SCE stress sensitivity was first assayed using DOPE/DOPC 4:6 (high SCE stress) 
and DMPC/DOPC 4:6 (low SCE stress) lipid compositions incubated with Vipp11-24 at a lipid 
to peptide ratio of 8:1. The resulting spectra are shown in Figure 6.7A (with those of Vipp11-
24 alone and with E. coli TLE vesicles). Incubation with DMPC/DOPC 4:6 vesicles has very 
little effect on the CD spectra of Vipp11-24. DOPE/DOPC 4:6 vesicles do result in a slight shift 
to an increased helical content. This suggests an AH mediated binding preference for 
vesicles with increased SCE stress, mirroring the binding trend of Vipp1 WT. While a 
preference for AH-membrane association with increased SCE stress is evident, it can be seen 
from Figure 6.7A that the helical content of Vipp11-24 with DOPE/DOPC 4:6 vesicles is still 
significantly less than it is with E. coli TLE vesicles. Again this is similar to observations with 
Vipp1 WT (see Figure 5.9) where it was suggested that the high anionic lipid content of the 
TLE vesicles (over 30 %) could result in the increased membrane affinity. To test this 
inference with Vipp11-24, DOPC vesicles with 40 % mole fraction anionic lipid content were 
produced and incorporated into the CD assay. Both DOPG and DOPS were used as the 
anionic species to rule out any specific headgroup interactions mediating AH formation. The 
resulting spectra with those for net neutral DOPC vesicles and are shown in Figure 6.7B. 
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Figure 6.7 AH formation of Vipp11-24 with vesicles of different lipid compositions. (A) CD 
Spectra of Vipp11-24 alone and incubated with 100 nm vesicles of high (DOPE/DOPC 4:6) and low 
(DMPC/DOPC 4:6) SCE stress at an 8:1 lipid to peptide molar ratio. Spectra of Vipp11-24 with E. coli 
TLE vesicles is shown for comparison (B) CD spectra of Vipp11-24 alone and incubated with 100 nm 
DOPC vesicles with 40 % anionic lipid content. Spectra of Vipp11-24 with E. coli TLE vesicles and net 
neutral DOPC vesicles are shown for comparison. All spectra are normalised as mean residue 
ellipticity [θ] and are an average of 3 scans at 25 °C. 
 
From Figure 6.7B, it can be seen that the effect of the neutral DOPC vesicles on AH 
formation is small, with helix content going from 3 % for Vipp11-24 alone to 5 % for Vipp1 
with DOPC vesicles. However, a stark increase in helical content is observed when DOPC + 
40 % DOPG (40% DOPG) and DOPC + 40 % DOPS (40% DOPS) vesicles are added. The large 
and conserved increase in Vipp11-24 helical content highlight the importance of anionic lipids 
on AH formation. The α-helix content of Vipp11-24 with 40 % mole fraction anionic lipid 
vesicles was 31 % and 33 % for DOPG and DOPS respectively, larger than E. coli TLE, where 
16 % α-helix is seen at the same L/P ration. This may be due to E. coli TLE’s lower anionic 
lipid content (≈ 30%). 
To observe the effects of reducing the anionic lipid content and resulting charge density of 
the membrane, DOPC vesicles with 30 %, 20 % and 10 % mole fractions of DOPG were 
studied. The resulting CD spectra are shown in Figure 6.8A. A clear increase in α-helical 
conformation of Vipp11-24 is observed as the anionic lipid content of the vesicles rises, hence 
higher anionic charge density seems to promote AH formation. Table 6.2 gives the α-helix 
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content for each anionic lipid amount. Interestingly, the trend is not linear, with a modest 
increase in helicity observed going from 10 % to 30 % DOPG before a large increase is seen 
between 30 % and 40 % (see Table 6.2). Vesicles with 20 % DOPS were also assayed and 
compared with the 40 % DOPS vesicles (Figure 6.8B) and a similar trend was observed. It 
appears that at < 30 % anionic lipid Vipp11.24 AH formation is only weakly promoted by an 
increased membrane anionic charge density. However, between 30 % and 40 % anionic lipid 
content a threshold is reached where AH formation is greatly promoted. Whether this 
increase is due to more peptides associated with the membrane, or a just a higher helical 
content of those bound is hard to distinguish. Nonetheless it is clear that anionic lipids cause 
an increase in the total residues associated with the membrane in an AH conformation. 
 
 
Figure 6.8 AH formation of Vipp11-24 incubated with vesicles of varying anionic lipid content. 
(A) CD Spectra of Vipp11-24 alone and incubated with 100 nm DOPC vesicles with increasing DOPG 
content (10 – 40 % mole fraction). (B) CD Spectra of Vipp11-24 alone and incubated with 100 nm 
DOPC vesicles with 20 % and 40 % mole fraction DOPS. All spectra are normalised as mean residue 
ellipticity [θ] and are an average of 3 scans at 25 °C. 
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Anionic Lipid 
Species 
Vipp11-24 % α-helical residues  
10 % AL 20 % AL 30 % AL 40 % AL 
DOPG  8 % 11 % 17 % 31 % 
DOPS ND 10 % ND 33 % 
 
Table 6.2 α-helix content of Vipp11-24 in the presence of vesicles with increasing net negative 
membrane charge. Percentages given are for Vipp11-24 incubated with vesicles compositions of 
DOPC + 10-40 % mole faction of anionic lipids DOPG and DOPS at an 8:1 L/P ratio. Values are 
calculated from CD spectra using CONTIN and CDSSTR with the average α-helix content given. 
 
6.2.1.5 AH formation of PspA1-24 as a function of membrane lipid composition 
Like Vipp11-24, PspA1-24 is predominantly unordered in solution immediately after 
dissolution. However, studies with the peptide dissolved in PBS buffer resulted in the 
formation of a gel like solution, characteristic of a β-aggregates (Aggeli et al., 2001), 
occurred within an hour. This aggregation is obviously undesirable as it disfavours AH 
formation (due to the energetic penalty of breaking the β hydrogen bonds) and does not 
represent the native state of the region in the full length protein. These issues lead to the 
peptide being initially discounted for membrane binding studies. However, later 
investigations found that PspA1-24 was stable in a 20 mM Tris-HCL (pH 7.5) solution for over 
72 h in an unordered, non-aggregation dependent conformation. This difference may be 
attributed to the differing ionic strength of the buffers. Studies have shown that increasing 
ionic strength decreases the critical gelling concentration of some peptides (Lockwood et al., 
2002). Fortunately, 20 mM Tris-HCL buffer is compatible with CD studies. PspA1-24 incubated 
with increasing concentrations of E. coli TLE vesicles was assayed with the resulting CD 
spectra shown in Figure 6.9.  
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Figure 6.9 AH formation of PspA1-24 upon membrane exposure. CD spectra of PspA1-24 incubated 
with increasing concentrations of 100nm E. coli TLE vesicles in 20 mM Tris-HCL pH 7.5 (L/P ratio 
given in legend). All spectra are normalised as mean residue ellipticity [θ] and are an average of 3 
scans at 25 °C. 
 
Upon exposure to E. coli TLE vesicles the CD spectra shifts from unordered to increasing 
helical content as the L/P ratio grows. Like Vipp11-24, PspA1-24 displays typical AH behaviour 
with α-helix formation promoted by membrane exposure. Table 6.3 presents the helical 
content of both PspA1-24 and Vipp11-24 as a function of TLE lipid concentration. PspA1-24 goes 
from only 5 % helical in solution to 51 % with TLE vesicles at a 48:1 L/P ratio. Again the 
helical shift could not be saturated in assays due to lipid scattering effects. The number of 
PspA1-24 residues within the AH of each peptide when membrane bound could therefore not 
be determined, but must be over 12 residues (50 % of the 24 residue peptide).  
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Peptide 
% α-helical residues in the presence of E. coli TLE vesicles 
 (lipid : peptide) 
0:1 6:1 12:1 24:1 48:1 
PspA1-24  5 % 7 % 20 % 33 % 51 % 
Vipp11-24 3 % ND 20 % 35 % 41 % 
 
Table 6.3 α-helical content of PspA1-24 and Vipp11-24 peptides with E. coli TLE vesicles. Values are 
calculated from CD spectra using CONTIN and CDSSTR with the average α-helix content given. 
 
The effects of bilayer composition on the AH formation of PspA1-24 was then studied with 
the same vesicle compositions used for Vipp11-24. The SCE stress vesicles were first 
incorporated into the system with the CD spectra of PspA1-24 with each lipid composition 
shown in Figure 6.10A. It can be seen that SCE stress has a significant effect on the AH 
formation of PspA1-24. The low SCE stress vesicles (DMPC/DOPC 4:6) only cause a slight 
helical shift in the CD spectra of PspA1-24. However, the high SCE stress vesicles (DOPE/DOPC 
4:6) have a large effect on the spectra, eliciting a helical shift similar to that of E. coli TLE 
vesicles. The increased α-helix content with low SCE stress vesicles is only 3 % (5 – 8 %) 
while a 13 % increase (5–18 %) is predicted with the high SCE stress vesicles. The 10 % 
increase in total α-helix content is much more than the 2 % seen for Vipp11-24 under similar 
conditions. This shows that PspA1-24 has a higher sensitivity for SCE stress than Vipp11-24. 
High anionic lipid content vesicle were also tested as they were found to have a significant 
effect on the AH formation of Vipp11-24. The CD spectra of PspA1-24 alone and with 40 % 
mole faction anionic lipid vesicles (40% DOPG) is shown in Figure 6.10B. Again the anionic 
lipid vesicles cause AH formation but the extent is much less marked than in the case of 
Vipp11-24, where they promoted the highest degree of α-helix formation of any lipid 
composition. An 11 % increase in helical content of PspA1-24 is seen with the 40 % mole 
fraction anionic lipid vesicles, less than that of high SCE stress (13 % increase) and E. coli TLE 
(15 % increase) vesicles. Thus PspA1-24 AH formation appears to be primarily driven by SCE 
stress with anionic lipids playing a lesser role.  
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Figure 6.10 AH formation of PspA1-24 with vesicles of different lipid compositions. (A) CD 
spectra of PspA1-24 alone and incubated with 100 nm vesicles of high (DOPE/DOPC 4:6) and low 
(DMPC/DOPC 4:6) SCE stress at a 12:1 lipid to protein molar ratio. (B) CD spectra of PspA1-24 alone 
and incubated with 100 nm 40 % anionic lipid (DOPC + 40 % DOPG) vesicles. Spectra of PspA1-24 with 
E. coli TLE vesicles is shown for comparison. All spectra are normalised as mean residue ellipticity [θ] 
and are an average of 3 scans at 25 °C. 
 
A summary of the α-helix content of PspA1-24 and Vipp11-24 with different vesicle 
compositions is shown in Table 6.4. Unfortunately, different L/P ratios were used for the 
two proteins (12:1 for PspA1-24 and 8:1 for Vipp11-24) so a direct comparisons of AH 
formation cannot be made but general trends in the data can be observed.  
 
Peptide  
% α-helical residues with each vesicle composition 
None E. coli TLE DMPC/DOPC 
4:6 
DOPE/DOPC 
4:6 
DOPC + 40% 
DOPG 
PspA1-24 (12:1 L/P) 5 % 20 % 9 % 18 % 16 % 
Vipp11-24 (8:1 L/P) 3 % 16 % 5 % 8 % 31 % 
 
Table 6.4 α-helical content of PspA1-24 and Vipp11-24 peptides incubated with different vesicle 
compositions. Percentages given are for PspA1-24 and Vipp11-24 incubated with vesicles at a 12:1 
and 8:1 L/P ratio respectively. Values are calculated from CD spectra using CONTIN and CDSSTR with 
the average α-helix content given. 
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Remarkably, the membrane features that promote binding of full length PspA and Vipp1 
(Chapters 4 and 5) also cause increased α-helix content in the PspA1-24 and Vipp11-24 
peptides. PspA1-24 AH induced membrane association is driven by increasing SCE stress to a 
larger extent than Vipp11-24, corresponding well with PspA WT’s higher sensitivity to SCE 
stress than Vipp1 WT. We also see higher sensitivity of Vipp11-24 for anionic lipids 
particularly at concentrations >30 %; an analogous increase was also indicated for Vipp1 WT 
but never directly assayed (see chapter 5.3). 
 
6.2.1.6 The effects of polar substitutions on the hydrophobic face of the AH 
To see if AH formation of PspA1-24 is prevented when apolar residues are substituted for 
polar residues on the hydrophobic face, the PspA1-24 V11E and PspA1-24 F4E V11E peptides 
were used. Both PspA1-24 V11E and PspA1-24 F4E V11E formed gels when dissolved in PBS 
buffer within 1 h. However, like PspA1-24, they remained unordered in 20 mM Tris-HCL (pH 
7.5) buffer for over 72 h. Firstly, CD studies with PspA1-24 V11E were undertaken with the 
peptide incubated with E. coli TLE and DOPE/DOPC 4:6 vesicles at a 12:1 L/P ratio. The 
resulting CD spectra are shown in Figure 6.11A. At the same L/P ratio, PspA1-24 exhibits a 
noticeable spectral shift towards increased α-helix content (see Figure 6.7). However, it is 
apparent from Figure 6.11A that both lipid compositions do not promote any AH formation 
of PspA1-24 V11E since no spectral shift is observed. The assay was repeated with the double 
PspA1-24 F4E V11E mutant and again no shift in the CD spectra was observed when vesicles 
were added to the peptide (Figure 6.11B). The α-helical residue percentage for PspA1-24 and 
the two mutants with each vesicle composition at a 12:1 P/L ratio is listed in Table 6.5. It can 
be seen that neither PspA1-24 V11E nor PspA1-24 F4E V11E forms any detectable α-helices 
upon membrane exposure. 
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Figure 6.11 AH formation of PspA1-24 mutants upon membrane exposure. (A) CD spectra of 
PspA1-24 V11E alone and incubated with 100 nm E. coli TLE and high SCE stress (DOPE/DOPC 4:6) 
vesicles at a 12:1 L/P molar ratio. (B) ) CD spectra of PspA1-24 V11E F4E alone and incubated with 100 
nm E. coli TLE and high SCE stress (DOPE/DOPC 4:6) vesicles at a 12:1 L/P molar ratio. All spectra are 
normalised as mean residue ellipticity [θ] and are an average of 3 scans at 25 °C. 
 
From the data it appears that substituting a single apolar residue with a positively charged 
residue on the hydrophobic face of the AH can prevent its formation upon membrane 
exposure. Unsurprisingly, placing two positive charges on the hydrophobic face has the 
same negative effect on AH formation. This suggests that preservation of the polar and 
hydrophobic residue segregation between two AH faces is important in membrane 
mediated formation. It also strongly implicates the occurrence of a peptide-membrane 
interaction driven by hydrophobic interactions between the apolar face of the AH and the 
phospholipid acyl chains.  
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Peptide  
% α-helical residues with each vesicle composition 
None E. coli TLE DOPE/DOPC 
4:6 
DOPC + 40% 
DOPG 
PspA1-24  5 % 20 % 18 % 16 % 
PspA1-24 V11E 5 % 4 % 5 % 4 % 
PspA1-24 F4E V11E 6 % 6 % 5 % 4 % 
 
Table 6.5 α-helical content of PspA1-24, PspA1-24 V11E and PspA1-24 F4E V11E. Percentages given are 
for peptides incubated with vesicles at an 8:1 L/P ratio. Values are calculated from CD spectra using 
CONTIN and CDSSTR with the average α-helix content given. 
 
6.2.2 Effects of AH peptides on vesicle stability 
When the truncated PspA2-19 peptide was added to lipid vesicles the solution often went 
turbid soon after mixing. A sample containing PspA2-19 incubated with E. coli TLE vesicles 
was subjected to the floatation assay (Figure 6.12A). PspA2-19 alone was found in the B1 and 
B2 high density fractions. When vesicles were added a layer of white precipitate was seen 
between the M2 and T fractions after centrifugation. Analysis of the precipitate by SDS-
PAGE (Figure 6.12A) and phosphorous quantification revealed it contained both peptide and 
phospholipids. These observations suggest that PspA2-19 is disrupting the vesicles resulting in 
large, insoluble lipid-peptide aggregates. In an attempt to visualise this disruption, samples 
of E. coli TLE vesicles before and after addition of PspA2-19 were provided for negative-stain 
EM studies undertaken by Harry Low (ICL). Figure 6.12B shows the negative stain EM 
images. Vesicles can clearly be visualised in the vesicle only sample as spheres around 100 – 
200 nm in diameter and are labelled in the image (Figure 6.12B left panel). When PspA2-19 is 
added to the sample these vesicles disappear and large unstained areas over 1 µm are 
observed (Figure 6.12B right panel); likely to be the lipid-peptide aggregates.     
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Figure 6.12 Vesicle rupturing effect of PspA2-19 on E. coli TLE vesicles. (A) SDS-PAGE gels of 
fractions from co-floatation assays of PspA2-19 with and without E. coli TLE vesicles. Assay used 1 
mg/ml PspA2-19 incubated with 5 mg/ml, 100 nm, E. coli TLE vesicles. PPT fraction is the collected 
precipitate that was found between the M2 and T fraction (resuspended in 40 µl buffer). (B) 
Negative-stain EM images of E. coli TLE vesicles alone and incubated with PspA2-19 at a 2:1 L/P 
ratio. Images obtained by Dr Harry Low. 
 
The vesicle destabilising effect of PspA2-19 is the first recorded example of a part of PspA 
exerting a biophysical effect on the membrane upon binding. As such, further studies 
probing these vesicle disrupting properties were undertaken. To monitor the effects of 
bilayer stability as a function of peptide concentration, the calcein efflux assay described in 
Chapter 4 was used. Initial investigations using calcein encapsulated 100 nm E. coli TLE 
vesicles with PspA and Vipp1 ahA peptides were undertaken. Phospholipid concentrations 
of the dye encapsulated vesicles were determined via the phosphate assay (2.2.9.7). 
Increasing amounts of peptides were added from 1 mM stock solutions. Dye leakage of each 
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sample was monitored via fluorescence. Figure 6.13 shows the percentage fluorescence 
increase (background corrected) over time with the points at which peptides were titrated 
into the vesicle sample indicated.  
 
 
Figure 6.13 Monitoring the release of trapped solutes from E. coli TLE vesicle by PspA and 
Vipp1 peptides. Graphs showing the calcein fluorescence measured over time with titrations of 
peptides indicated. P/L is the peptide to lipid ratio within the sample after the titration. (A) Titrations 
with PspA1-24 and PspA2-19. (B) Titrations with Vipp11-24 and Vipp12-19. Fluorescence was measured 
every 2 minutes and traces have been background corrected by subtracting the fluorescence from a 
vesicle and buffer only sample. 100 % fluorescence corresponds to that when all encapsulated dye 
was released via addition of 0.2M C12E8. 
 
The effects of the PspA ahA peptides on E. coli TLE vesicle stability is shown in Figure 6.13A. 
For the shorter PspA2-19 it can be seen that adding peptide to the vesicles causes a marked 
increase in fluorescence, corresponding to calcein release from the vesicles. When the 
number of lipid molecules is in large excess over peptide molecule (100:1) minimal calcein 
release is seen. However, when PspA2-19 is added to give a 1:20 peptide to lipid (P/L) ratio, 
significant dye release is observed (around 20 % of the total encapsulated calcein 40 
minutes after the titration). Further titrations of PspA2-19 provide sequential increases in dye 
release with around 37 % release at a 1:10 P/L ratio and 66 % release at a 1:5 ratio. From 
this data it is evident that PspA2-19 has a membrane permeabilising effect on the TLE 
vesicles, causing release of the encapsulated calcein.  
Interestingly, it can be seen from Figure 6.13A that PspA1-24 causes significantly less dye 
release with only around 13 % of the encapsulated solutes released at a 1:5 P/L ratio, five 
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times less than that of PspA2-19. Clearly the extra six AA residues mitigate the membrane 
disrupting effect of the peptide. In contrast both Vipp12-19 and Vipp11-24 do not appear to 
have any membrane permeabilising or disrupting effect on the TLE vesicles as even at a 1:2 
P/L ratio no dye release is observed (Figure 6.13B). 
 
 
Figure 6.14 Effect of PspA and Vipp1 peptides on vesicles with high and low SCE stress.  Calcein 
efflux assays using vesicles of high (DOPE/DOPC 4:6) and low (DMPC/DOPC 4:6) SCE stress. Titrations 
with PspA2-19 (A), PspA1-24 (B) and Vipp11-24 (C). Fluorescence was measured every 2 minutes and 
traces have been background corrected by subtracting the fluorescence from a vesicle and buffer 
only sample. 
 
Different vesicle compositions were then used in the assay to ascertain if the peptide effects 
on dye release are modulated by the lipid composition of the bilayer. The stability of high 
(DOPE/DOPC 4:6) and low (DMPC/DOPC 4:6) SCE stress vesicles were probed with PspA2-19, 
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PspA1-24 and Vipp11-24 peptides (Vipp12-19 was not used as was not available at the time of 
undertaking the assay). Figure 6.14 shows the resulting fluorescence graphs. It is evident 
from Figure 6.14A that the addition of PspA2-19 causes dye release from both high and low 
SCE stress vesicles. However, the amount of dye release differs between the two vesicle 
compositions with more seen for high SCE stress vesicles than low ones. Dye release for the 
high SCE stress vesicles is still less than that of E. coli TLE vesicles. PspA1-24 also induces 
greater dye release with high SCE stress vesicles (Figure 6.14B), but again the amounts are 
much less than seen for PspA-19 at similar P/L ratios. As seen with E. coli TLE vesicles, Vipp11-
24 shows no leakage for either vesicle composition (Figure 6.14C). 
The effects of net negative membrane charge on calcein release was investigated by 
increasing the anionic lipid content using 20% DOPG and 40% DOPG vesicles. The PspA and 
Vipp1 ahA peptides were titrated into each vesicle composition and the resulting 
fluorescence graphs are shown in Figure 6.15.  At 20 % mole fraction anionic lipid (Figure 
6.15B) only PspA2-19 was found to cause any significant dye release. The other three 
peptides have no noteworthy effect up to the 1:5 P/L ratio tested.  
At 40 % mole fraction anionic lipid content dye leakage trends are remarkably different. 
Figure 6.15B shows the effects of the peptides on 40% DOPG vesicles. PspA2-19 causes similar 
dye release to that seen for 20 % anionic lipid vesicles and PspA1-24 shows a modest increase 
going from 20 % - 40 % mole fraction anionic lipid. However, despite their inability to cause 
any membrane disruption for other membrane compositions assayed, both Vipp12-19 and 
Vipp11-24 peptides cause a dramatic increase in dye release from the 40 % mole fraction 
anionic lipid vesicles. It can be seen from Figure 6.15B that both Vipp1 peptides are 
markedly more effective at causing dye release than the PspA2-19 peptide. At a 1:10 P/L ratio 
Vipp12-19 causes over 60 % release of the encapsulated dye, with complete dye release from 
the vesicles at a 1:5 P/L ratio. This makes Vipp12-19 and 40% DOPG vesicles the most potent 
combination in terms of membrane destabilisation. Vipp11-24 causes around half the amount 
of dye release to Vipp12-19. Thus, like the PspA peptides, the extra AA residues appear to 
mitigate the peptides membrane disrupting effectiveness.  
    219 
  
 
Figure 6.15 Effect of PspA and Vipp1 peptides on anionic lipid vesicle stability.  Calcein efflux 
assays monitoring encapsulated dye release from DOPC + 20 % DOPG (A) and DOPC + 40 % DOPG (B) 
vesicles upon PspA2-19, PspA1-24, Vipp12-19 and Vipp11-24 peptide titrations. Fluorescence was 
measured every 2 minutes and traces have been background corrected by subtracting the 
fluorescence from a vesicle and buffer only sample. 
 
Interestingly, when Vipp12-19 and Vipp11-24 were mixed at 1:5 P/L ratios with 40% DOPG 
vesicles without encapsulated dye, the solution remained clear. From the above dye leakage 
assays it is clear that complete release of encapsulated solute for Vipp12-19 and over 60 % 
release for Vipp11-24 should occur at this peptide concentration. This is in contrast with 
PspA2-19 where solute release is accompanied by turbidity due to the formation of large 
peptide-lipid aggregates (Figure 6.12). These observations suggest that either PspA and 
Vipp1 peptides induce different lipid structures upon membrane disruption, or the Vipp1 
peptides cause pore formation in the bilayer without affecting the vesicle structure. 
Samples of 40% DOPG vesicles alone and incubated with Vipp11-24 at a 5:1 L/P ratio were 
submitted for EM analysis to see if the effects could be visualised. The resulting images are 
shown in Figure 6.16A. 
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Figure 6.16 Vesicle rupturing effects of Vipp11-24 on 40 % DOPG vesicles (A) Negative stain EM 
images of DOPC + 40 % DOPG vesicles alone and incubated with Vipp11-24 at a 5:1 L/P ratio. 
Arrows in right hand panel indicate possible micelles. Images obtained by Dr Harry Low (B) 
Dynamic light scattering data of 100 nm extruded DOPC + 40 % DOPG vesicles with and without 
Vipp11-24 at a 2:1 L/P ratio. 
 
In Figure 6.16A vesicles are observed both before (left) and after (right) addition of Vipp11-
24. After peptide addition, multiple small spheres measuring around 10-20 nm in diameter 
are seen, three of which are indicated with arrows on the right hand panel of 6.16A. Imaging 
of a sample containing Vipp11-24 peptide only did not show these 10–20 nm spheres, thus 
they are unlikely to be peptide aggregates (data not shown). It was thought that these may 
possibly be micelles caused by detergent like disintegration of the vesicles by the Vipp11-24.  
To further test this hypothesis, DLS studies were undertaken on 40% DOPG vesicles with and 
without Vipp11-24 at a 2:1 L/P ratio. Figure 6.16B shows the measured size distributions for 
each sample.  40% DOPG vesicles are all over 50 nm in diameter but when they are mixed 
with Vipp11-24 a shift to particles with diameters around 10-20 nm is observed, similar in size 
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to those seen in the EM images. As these particles are only seen when 40% DOPG vesicles 
and Vipp11-24 are mixed, it is highly likely that they contain both lipid and peptide, however, 
their precise nature is not known. They may be SUVs or micelles with Vipp11-24 bound 
peripherally or just a disordered peptide-lipid aggregate. Nevertheless, the data from dye 
release assays, EM and DLS highlight a specific difference between the lipid-peptide 
structures formed by PspA2-19 and Vipp11-24.  
 
 
6.3 Discussion and Conclusions 
The results obtained in this chapter establish the isolated N-terminal region of PspA and 
Vipp1 as a membrane sensing AH. Direct vesicle-binding of both PspA1-24 and Vipp11-24 
peptides are observed. Also, the AH mediated membrane sensing trends of the PspA1-24 and 
Vipp11-24 peptides coincide with comparative vesicle-binding levels seen in PspA WT and 
Vipp1 WT. These observations provide very strong new evidence for a direct interaction 
between the N-terminal AH of PspA and Vipp1 being responsible for the specific membrane 
binding trends observed in Chapters 4 and 5.  
Circular Dichroism studies show that the PspA and Vipp1 N-terminal peptides behave 
similarly to a typical membrane sensing AH, being unordered in solution and then folding 
into an α-helix upon membrane association (Drin and Antonny, 2010, Drin et al., 2007). We 
show that at least half the residues of both PspA1-24 and Vipp11-24 can form this α-helix upon 
vesicle binding. A V11E mutation of PspA1-24, placing a charged residue on the hydrophobic 
face, prevents any α-helix formation irrespective of vesicle composition and concentration 
added. This shows the conserved amphiphilicity of the peptide is required for AH mediated 
membrane-binding. This also implies that the V11 residue forms the part of the α-helix upon 
membrane association. Although a similar Vipp11-24 mutation was not tested. It is very likely 
that α-helix formation would again be prevented, however, further studies would include a 
Vipp11-24 V11E mutant for such confirmation. 
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The α-helix content for both PspA1-24 and Vipp11-24 peptides was found to be dependent on 
the composition of the membrane. As bilayer association induces α-helix formation for AHs, 
this can be directly related to the proportion of residues that are membrane-bound with an 
AH conformation. Unfortunately, it is not possible to differentiate between increases in 
helicity due to a higher helical content of the bound peptide fraction or an increase in the 
bound fraction itself. Combining the CD data with floatation assays would enable 
identification of which of the two processes were occurring. However, difficulties in reliably 
staining the peptides for detection in gels meant the required breadth of data from the 
assay could not be obtained within the time frame of the study. However, the literature 
does provide an indication of the processes that may be occurring. Experimental evidence 
shows that higher SCE stress predominantly results in an increase in AH binding sites on the 
vesicle surface with only a small increase in affinity of an AH for vesicles (Hatzakis et al., 
2009). As the nature of each binding site in high and low SCE stress vesicles is energetically 
similar, the helical content of each bound AH should be the same irrespective of SCE stress. 
In this respect helical content should be linearly proportional to the amount of peptide that 
is membrane bound. 
SCE stress dependent AH formation is much more apparent for PspA1-24 than Vipp11-24. The 
data advocates that for PspA1-24, increasing the SCE stress of the bilayer has a significant 
positive effect on membrane-binding through AH mediated association. However, for 
Vipp11-24 the increase in membrane binding, while observable, is much more muted.  The 
same binding trends are seen for full length PspA and Vipp1 (see Figure 5.9B), showing that 
SCE stress sensing of the proteins must be directly mediated by the N-terminal AH region 
(containing PspA ahA and Vipp1 ahA). 
In contrast to the SCE stress sensing trends, Vipp11-24’s AH driven membrane association is 
strongly modulated by anionic lipid content. But this time the effects on PspA1-24 are much 
more muted.  A large increase in Vipp11-24’s helicity as a function of anionic DOPG content of 
the membrane is observed, especially between 30 – 40 % mole fractions. A similar trend is 
observed with anionic DOPS signifying that net membrane negative charge is driving the 
increased AH content rather than a specific head-group interaction. Whether the increased 
α-helix content is due to the increasing negative charge density recruiting more peptides to 
the membrane, or promoting a higher degree of helicity in the peptide, cannot be 
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determined from the experiments. Nonetheless, it is clear that anionic lipids result in more 
AH residues bound to the membrane. Increased specificity for negatively charged 
membranes has been seen for a number of AH peptides including those from N-BAR 
domains and the N-terminal region of GTPase activating protein RGS4 (Fernandes et al., 
2008, Bernstein et al., 2000).   
Like the full length proteins, electrostatics and SCE stress both play a role in the membrane 
association of PspA1-24 and Vipp11-24 through AH formation. The relative strength of these 
contributions differs between the two peptides. PspA1-24 primarily sensing the SCE stress 
with a smaller anionic lipid effect while the reverse is observed by Vipp11-24. Analysis of both 
PspA1-24 and Vipp11-24 sequences and the resulting physiochemical AH properties could 
explain these differences. The net AH hydrophobic moment for both Vipp11-24 and PspA1-24 
are relatively similar at 0.455 µH and 0.467 µH respectively. Thus, little difference in 
partitioning should occur due to favourable polar-apolar segregation of either AH. Helix 
hydrophobicity varies more significantly. PspA1-24’s hydrophobicity is 0.392 H compared with 
0.245 H for Vipp1. This should mean that PspA1-24 has a higher avidity for lipids (especially 
hydrophobic cavities created by lipid packing defects) and as such this may contribute to its 
SCE stress sensing ability in neutral bilayers. AHs that purely sense lipid packing defects 
(caused by SCE stress), such as the ALPS motif are typified by their lack of charged residues 
on the hydrophilic face (Drin and Antonny, 2010). Increasing the number of charged 
residues on the polar face decreases packing defect sensitivity of the AH but can increase 
association through electrostatic interactions (Jensen et al., 2011). In this respect, the lower 
number of charged residues on the PspA AH (6R, 9D) can explain its enhanced sensitivity for 
SCE stress dependent binding compared with Vipp1 (5D, 6R, 9R, 12R, 17D). Positively 
charged residues on the AH encourage the interaction with negatively charged lipids, 
therefore Vipp1’s two extra cationic residues could promote its interaction with anionic 
lipids.  
Vipp1’s AH lipid sensing properties appear to be similar to that of the antimicrobial peptide 
Magainin 2. The peptide is weakly sensitive to membrane curvature (causing SCE stress) 
(Wieprecht et al., 2000) but membrane binding is strongly favoured by the presence of 20-
30 % anionic lipids (Wieprecht et al., 1997). PspA’s AH binding on the other hand is much 
more sensitive to SCE stress with high membrane anionic lipid content seeming to be less 
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important for its binding. In this respect, as stated above, PspA’s AH binding properties 
appear to be more similar to an ALPS motif peptide; where membrane association occurs as 
a function of lipid packing defects cause by SCE stress (Drin and Antonny, 2010, Vamparys et 
al., 2013).  
The peptide assays undertaken in this chapter have the advantage of being compatible with 
more physiologically relevant buffers than the full length proteins, where low levels of 
CHAPS had to be incorporated to maintain solubility. As the membrane binding trends seen 
for the PspA1-24 and Vipp11-24 are similar to those seen for the full length proteins, we can be 
confident that the buffer compositions in both systems do not have a significant effect on 
the membrane sensing of the N-terminal AH regions. 
 
Bilayer association of Vipp12-19 (and to a lesser extent Vipp11-24) was shown to have 
detrimental effects on vesicles at high anionic lipid compositions, causing release of 
encapsulated solutes (Figure 6.15) and micellization of the vesicles (Figure 6.16). This 
disruption is coupled with the significant increase in helical content. Therefore, disruption 
appears to be induced by the amounts of AH that is membrane bound. Mechanisms of 
vesicle disruption by helical peptides have been intensively studied due to the discovery of 
antimicrobial α-helical amphipathic peptides (αAMPs) (Sato and Feix, 2006). These studies 
have shown that the majority of αAMPs initially bind parallel to the membrane forming an 
α-helix (similar to a typical AH). As the number of bound peptides increases it is thought 
that positive membrane curvature is induced, increasing the surface area of outer leaflet 
and thinning of the bilayer. These changes in the biophysical properties of the membrane 
then enable increased penetration of the helical peptides (Lee et al., 2015). From this point 
three different mechanisms of vesicle disruption have been described: the formation of 
barrel-stave or toroidal pores and the detergent like carpet mechanism (Figure 6.17 shows a 
schematic of each mechanism). As rather a high concentration of peptide is required for 
solute release, Vipp1 peptide mediated vesicle disruption is likely to arise via the bilayer 
carpeting mechanism.  
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Figure 6.17 Model of membrane disruption by amphipathic helixes.  Upon folding into an AH 
(cylinders) peptides associate parallel to the membrane disrupting lipid packing and thinning the 
bilayer as their concentration increases (a). Peptides can form barrel stave (b) or torroidal (d) pores 
once at a critical P/L ratio or continued accumulation of membrane bound peptide eventually covers 
the bilayer (c) causing detergent-like membrane disintegration (e). Figure adapted from (Sato and 
Feix, 2006). 
 
Interestingly, a CD assay where PspA2-19 was incubated with E. coli TLE vesicles showed the 
peptide remained in its putative β-strand conformation when associated with the bilayer. 
Therefore, membrane disruption may occur through a β-strand mechanism. There are a 
number of examples of membrane-disrupting peptides that assume a beta structure (Mani 
et al., 2006, Blazyk et al., 2001, Wimley, 2010). However, in comparison to α-helical 
membrane-disrupting amphiphilic peptides, the depth of knowledge in the field is limited 
(Watson and Gillies, 2009). Interestingly, some β-strand amphiphilic peptides that possess 
membrane disrupting properties have been shown to be relatively insensitive to lipid 
composition (He et al., 2010), similar to the activity of PspA2-19 seen in this study. The 
differing peptide secondary structures that appear to promote membrane rupture by the 
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Vipp1 and PspA AH peptides may account for the contrasting lipid-peptide aggregates 
formed upon membrane disruption (Figures 6.12 and 6.16). However, it must be stressed 
that the interpretations in this paragraph are based on preliminary findings from only one 
CD run with PspA2-19 and vesicles. As such, follow up experiments would need to be 
undertaken in order to probe the PspA2-19 peptide structure with different vesicle 
concentrations and compositions before a definite conclusion could be made. 
The vesicle destabilising properties of the peptides show, for the first time, binding of the 
AH region of PspA and Vipp1 has an effect on the physical state of the membrane. However, 
the detrimental nature of this interaction seems rather counterintuitive for a membrane 
maintenance role of the full length proteins in vivo. The data does show that extending the 
AH with charged residues significantly mitigates the vesicle disrupting effects. So in the 
context of the full length protein, negative effects may not be observed (as indicated in 
Chapter 4.2.9). Also, the PspA and Vipp1 high-order oligomer may function as a scaffold 
with AHs regularly spaced as to limit the number of contacts that can be made with the 
membrane. This could provide a sufficient density of binding motifs to stabilise stressed 
membranes, while preventing bilayer carpeting and the resulting detergent like 
disintegration through swamping of the membrane with AHs. If membrane disruption by the 
peptides arises from oligomerization to form a transmembrane pore (Yang et al., 2000) 
(unlikely in light of EM studies) then high-order PspA and Vipp1 oligomers could prevent this 
aggregation by steric separation of the AHs within the scaffold. 
The results from the calcein efflux assays showing vesicle rupture raise the prospect of 
possible antimicrobial effect of the PspA and Vipp1 AH peptides. The truncated PspA ahA 
peptide (PspA2-19) was shown to have significant vesicle rupturing properties for all 
membrane compositions. Thus, it is likely to be detrimental to all cell types. The Vipp11-24 
and especially Vipp12-19 peptides had potent vesicle destabilising properties only when the 
membranes had high anionic lipid content. Bacterial cell membranes have a much higher 
net negative charge than eukaryotic membranes (Blondelle et al., 1999). Hence the Vipp1 
AHs could potentially provide membrane disrupting specificity for microbes. Characterised 
antimicrobial peptides, such a Magainin 2 and Melittin are still more effective than Vipp12-19 
(the most effective membrane disrupting Vipp1 AH peptide) causing membrane disruption 
at more than 5 fold lower concentration (Matsuzaki, 1998). However, preliminary work 
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using a Vipp11-24 G8A mutation to increase the helical propensity of the peptide increased 
the vesicle rupturing properties for 40 % anionic lipids threefold on Vipp12-19 and over 10 
times the amount of Vipp11-24. This mutant still has minimal effect on vesicles with 20 % 
mole fraction anionic lipid or less (data not shown). This G8A substitution brings the 
membrane disrupting potency more in line with other antimicrobial peptides. It seems likely 
that a Vipp12-19 G8A peptide would be even more effective. Interestingly, the N-terminal AH 
of Vipp1 from Arabidopsis thaliana possesses an alanine at position 8 and also has a higher 
hydrophobicity and hydrophobic moment than the Synechocystis AH. This should favour AH 
association and folding on the membrane (see Figure 6.2). These features may naturally 
make it a better antimicrobial candidate than the Synechocystis AH, therefore, probing the 
properties of an Arabidopsis Vipp1 AH peptide would be of great interest for further studies. 
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Chapter 7 – Transcription regulation and in vivo implications  
 
Overview 
The protein-membrane interaction assays undertaken in Chapters 3, 4 and 5 have provided 
a useful insight into both the membrane and protein binding determinants of PspA and 
Vipp1. However, the isolated system omits competing and modifying interactions that are 
present in vivo. PspF, which PspA binds to negatively control transcription of the Psp 
response, is notably absent in the vesicle system. By using a three component system, the 
dynamics between PspA, PspF and vesicles are studied in this chapter. The downstream 
effects this has on transcriptional regulation of the Psp response are also probed. We first 
show that exposure to E. coli TLE vesicles is able to relieve transcription inhibition caused by 
the PspA-PspF inhibitory co-complex. This occurs via disruption of the inhibitory co-complex, 
recruitment of PspA to the membrane and release of PspF from the complex. Relief of 
transcription inhibition through membrane exposure is then probed as a function of SCE 
stress. Interestingly, high SCE stress vesicles effectively relieve inhibition, with low SCE stress 
vesicles having lesser effects. These results show PspBC independent induction of the Psp 
response in vitro for the first time. They also suggest that SCE stress within the membrane 
could be responsible for in vivo PspBC independent induction. Finally, the PspA25-47 peptide 
containing the ahB region of PspA, vital for negative regulation of PspF in full length PspA 
(Jovanovic et al., 2014), is found to repress PspF1-275’s ATPase activity. We show this 
inhibitory effect is through interaction with the same region as for PspA WT, provides strong 
evidence for a hydrophobic interaction between ahB of PspA and the W56 hydrophobic loop 
of PspF.  
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7.1 Introduction 
7.1.1 PspBC independent induction of the Psp response through the membrane?  
The membrane binding studies undertaken in the previous chapters are designed to 
investigate the effector function of PspA. In essence they mimic the system in an induced 
state, where PspA is abundant and in large excess over PspF. However, as mentioned in 
Chapter 1, PspA functions as both the effector and negative regulator of the Psp response. 
Before induction of the response, PspA in the cellular environment exists as a negative 
regulatory co-complex with PspF, preventing its ATPase activity and hence the σ54 
dependent transcription of the psp operon. Upon exposure of the cell to Psp inducing 
signals, the PspA-PspF inhibitory complex is disrupted. The resulting free PspF can use its 
ATPase activity to remodel 54 within closed promoter complexes (RPc), to form the open 
promoter complex (RPo). This activates transcription of the psp operon (Joly et al., 2010b). 
PspA production is then upregulated 100-fold and acts in its effector capacity to maintain 
the integrity of the IM (Lloyd et al., 2004). The mechanism by which the PspA-PspF 
inhibitory complex is disturbed under stress conditions is still not completely defined. Under 
some inducing conditions, PspB and PspC play a key role in sensing the stress signal and 
interacting with PspA, resulting in disruption of the PspA-PspF complex (Weiner et al., 
1991). However, PspB and PspC are not required for induction under other conditions such 
as heat, hyperosmotic and ethanol shock (Kleerbezem et al., 1996, Model et al., 1997). 
Therefore, a second PspBC independent, stress activated signalling pathway must operate 
to disrupt the inhibitory complex. We hypothesised that PspA within the PspA-PspF complex 
may still be able to directly sense SCE stress in the membrane. As the putative PspF 
interacting region of PspA (ahB) is in close proximity to the N-terminal membrane binding 
AH (Jovanovic et al., 2014b), bilayer interactions could easily disrupt the PspA-PspF 
inhibitory complex and cause PspBC independent induction of the Psp response.  
In vitro studies are most suited to test the above hypothesis. They provide an isolated 
system where a PspA-PspF inhibitory complex can be exposed to vesicle membranes, with 
lipid compositions and biophysical properties that can be precisely controlled. There have 
been no in vitro studies on PspA’s regulatory function involving lipids. Thus, any information 
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gained on the PspA-PspF inhibitory complexes behaviour upon membrane exposure will 
provide new insights into the regulation of the Psp response via control of PspF.  
 
7.1.2 The role of PspA ahB in negative regulation of PspF 
The presence of the first three helical domains of PspA (PspA1-186) leads to the most efficient 
regulation of PspF’s ATPase activity and subsequent negative control over σ54 dependent 
transcription initiation (Joly et al., 2009, Elderkin et al., 2005). However, shorter PspA 
fragments have also been shown to possess regulatory function, with previous studies in 
vitro highlighting the importance of PspA’s HD1 (residues 1-68) in formation of the 
regulatory PspA-PspF co-complex (Joly et al., 2009). Recent work probing specific regions of 
HD1 has identified a key regulatory role of the second putative amphipathic helix ahB 
(residues 25-42) (Jovanovic et al., 2014b). A PspA25-40 mutant, although potent for IM 
binding, was unable to interact with PspF and lost its negative regulatory function in vivo. 
Evidence for interaction of the hydrophobic face of ahB with PspF came from single AA 
substitutions of hydrophobic residues. Placing a hydrophilic residue on the hydrophobic face 
(PspA V29E) perturbs regulatory function yet, substitution for another hydrophobic residue 
(PspA V29F) has little regulatory effect (Jovanovic et al., 2014). 
These findings are complemented by the recent identification of a surface-exposed ‘W56 
loop’ of PspF that’s primary role is to serve as a docking site for PspA (Zhang et al., 2013). 
Three conserved hydrophobic residues of the loop (Y51, L52 and W56) form a tightly packed 
hydrophobic cluster term the ‘YLW’ patch. All three AAs are required for effective regulation 
via PspA. The two aromatic residues serve as direct binding sites for PspA, while the leucine 
has an association with the ATP hydrolytic site and increases the hydrophobicity of the 
patch. These two studies, taken together, strongly suggest a hydrophobic interaction 
between ahB of PspA and the W56 loop of PspF1-275 being responsible for negative 
regulation. However, the specific nature of the interaction is not characterised and a direct 
interaction between the ahB of PspA and the W56 loop of PspF has yet to be observed.   
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7.2 Results and Analysis 
7.2.1 Studying the effect of membrane exposure on PspA’s negative regulatory 
function  
In order to characterise the effects of membrane exposure on PspA’s regulatory role, a 
suitable assay must be used to monitor both the integrity of the PspA-PspF inhibitory 
complex, and the downstream transcriptional repression that it imparts. The PspA-PspF1-275 
complex was successfully visualised using Native-PAGE band shift assays in Chapter 3. 
Simply incorporating vesicles into the assay should allow the study of the stability of the 
complex in the presence of the membrane. Investigating the effect of the membrane on the 
negative regulatory function of the complex is more complex. However, a short primed RNA 
(spRNA) assay has shown to be an effective method for probing the ability of Eσ54 to form 
transcriptionally competent open complexes via the action of the activator PspF1-275 in vitro 
(Burrows et al., 2010). By adding PspA and vesicles to this assay, the aim was to recapitulate 
the transcription regulatory role PspA plays within the Psp response in the presence of lipid 
bilayers. 
  
7.2.1.1 Developing the assays and initial results with E. coli TLE vesicles 
The spRNA assay uses the Sinorhizobium meliloti nifH test promoter and the 54 RNA 
polymerase holoenzyme in the presence of an RNA dinucleotide primer UpG, radiolabeled 
GTP (pG*), and cold dATP (for PspF ATPase action). Addition of PspF1-275 activates 
transcription producing the small primed RNA product, UpGpG*pG*, that can be visualised 
on a 20 % sequencing gel. The spRNA signal is proportional to transcriptional activity. 
Therefore the level of transcriptional output as a function of PspF concentration and 
upstream regulators (e.g. PspA) can be quantified. The assay has yet to be used for 
investigating PspA’s effect on PspF1-275 and the resulting repression of σ
54 transcription. 
Initial experiments were undertaken with various concentrations of PspA WT, aiming to first 
observe its negative regulatory role with the spRNA assay. The results of the assays are 
shown in Figure 7.1.  
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Figure 7.1 Probing PspA’s ability to repress σ54 dependent transcription via an spRNA assay. 
PspA WT and PspF1-275 were pre-incubated in a 4 µl reaction volume for 10 min at 25 C to allow for 
complex formation before being added to the assay mix (10 µl final vol). Concentrations of PspA WT 
and PspF1-275 shown are those in the 10 µl final reaction volume. 
 
It is apparent from the decreasing intensity of the spRNA product that when the PspA WT 
concentration is increased (see Figure 7.1) it is able to repress transcription within the assay. 
With a 1:1 molar ratio of PspA to PspF1-275, transcription is slightly repressed, with 83% the 
transcriptional activity of PspF1-275 alone still occurring. Increasing the molar ratio of PspA 
leads to increased transcriptional repression. At 4:1 PspA to PspF1-275, transcriptional activity 
is down over three-fold at 27 % and with an 8:1 ratio only 9 % of the uninhibited PspF1-275 
signal is seen. While complete repression of transcription was not achieved at any tested 
excess of PspA WT, this is in line with previous in vitro studies. A minimal latent level of 
ATPase and transcription activity is generally observed even at a high excesses of PspA WT 
(Joly et al., 2009, Elderkin et al., 2002).  
Figure 7.1 shows the spRNA assay can monitor PspA’s negative regulatory function. 
Incorporating vesicles into the system should allow observation of the effect that 
membrane exposure has on this regulation. A 6:1 PspA WT to PspF1-275 molar ratio was 
chosen for these assays as this was the lowest excess of PspA WT that caused near complete 
inhibition of transcription (see 1.5:0.25 µM PspF1-275 to PspA WT sample in Figure 7.1). Initial 
assays were undertaken with 100 nm extruded, E. coli TLE vesicles. PspA WT and PspF1-275 
were pre-incubated for 10 min to allow for complex formation, before addition of vesicles to 
give final assay concentrations of 0.25 µM PspF1-275, 1.5 µM PspA WT and 0.5 mM vesicles 
(lipid conc.). The resulting spRNA signals from the assays are shown in Figure 7.2A. 
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Figure 7.2 Vesicles relieve transcription repression by PspA through disruption of the PspA – 
PspF1-275 inhibitory complex. (A) spRNA synthesis with incorporation of E. coli TLE vesicles. 0.25 µM 
PspF1-275 pre-incubated with 1.5 µM PspA WT before addition of 0.5 mM vesicles (lane 4) (B) SYPRO 
ruby stained 4.5 % Native-PAGE gel showing formation of the PspA-PspF1-275 complex (lane 3) and 
the increase in free PspF1-275 upon addition of vesicles (lane 4). In lane 4 PspF1-275 (5 µM) was pre-
incubated with PspA WT (10 µM) before addition of E. coli TLE vesicles (2.5 mM lipid conc.). (C) 
Denaturing gel showing the spRNA (UpGG*G*) product and free GTP from the spRNA assay. 
Synthesis of the spRNA product occurs in the presence of PspF1-275 (lane 2, 3), is inhibited upon 
addition of PspA (lane 5, 6) and restored again with addition of vesicles (lane 7, 8).  
 
Importantly, the transcription inhibition seen when PspF1.275 is incubated with PspA WT 
(lane 3, Figure 7.2A) is relieved upon addition of E. coli TLE vesicles (lane 4, 7.2A). The level 
of transcription relief is almost complete, with activity retuning to 95 % that of the PspF1-275 
alone reaction. Controls confirmed that vesicles were not having an effect on spRNA 
production in the absence of PspA WT (Figure 7.2C, lane 4 and 9 show the effects of vesicles 
in the absence of PspA WT, with and without PspF1-275 respectively). Thus, it appears that 
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exposure of the PspA-PspF1-275 inhibitory co-complex to the vesicle membrane results in a 
change that makes PspF1-275 transcriptionally active. It cannot be ascertained from the 
spRNA assay alone what the mechanism is by which transcription relief occurs. PspA WT 
within the inhibitory complex may bind the vesicles causing a disruption of the PspA-PspF1-
275 complex. This would allow free PspF1-275 to carry out its ATPase function, enabling 
transcription. Equally, it is possible that binding between PspA and the membrane somehow 
alters the inhibitory complex conformation, reactivating PspF1-275 and allowing transcription 
to occur on the membrane. A direct PspF1-275-membrane interaction through the PspA-
PspF1-275 complex is unlikely as PspF1-275 alone is unable to bind the membrane (see Chapter 
3.2.3.3.2). 
In an attempt to distinguish between the two possible mechanisms of transcription relief by 
E. coli TLE vesicles, native-PAGE analysis was used.  The technique allows for visualisation of 
the PspA-PspF1-275 inhibitory complex via a band shift (described in section 3.2.1.3). The 
stability of the complex upon addition of vesicles can therefore be probed. PspA WT and 
PspF1-275 were pre-incubated to allow for complex formation before E. coli TLE vesicles were 
added. The samples were then run on a native gel. Figure 7.2B shows the resulting gels, 
where lane 3 contains PspA WT incubated with PspF1-275 and lane 4 is with the subsequent 
addition of vesicles. Adding vesicles to the PspA WT–PspF1-275 sample results in a clear 
increase in the amount of free PspF1-275. This proves that disruption of the PspA-PspF1-275 
complex must be occurring. A concurrent increase in free PspA WT is not observed, 
presumably due to it binding to the vesicles and being unable to enter the gel matrix. It 
appears likely that when the PspA-PspF1-275 complex is exposed to the membrane, PspA 
binds the bilayer while PspF1-275 is released and is free undertake its ATPase function. This 
results in the activation of transcription seen in the spRNA assay. 
 
7.2.1.2 The effects of lipid composition and pre-incubation of PspA with vesicles 
To ascertain if de-repression of transcription can occur when the PspA-PspF inhibitory 
complex is exposed to vesicles of different phospholipid compositions, the assay was 
repeated using vesicles made from synthetic phospholipids DOPC and DPPC. Sonication was 
used to prepare the vesicles due to the unavailability of an extruder heating block at the 
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time of undertaking the experiment (preventing extrusion of DPPC above Tm). Sonicated TLE 
vesicles were also used to allow for comparison between similar vesicle preparations. Again, 
PspA WT (1.5 µM) was incubated with PspF1-275 (0.25 µM), before vesicles were added (0.5 
mM lipid conc). Figure 7.3A shows the resulting gel image with the transcriptional activity 
with respect to a PspF1-275 only sample for each lane. It can be seen that different vesicle 
sets vary in their ability to relieve transcription inhibition. E. coli TLE vesicles average 88 % 
activity (lanes 4, 5 of Figure 7.3A), DPPC vesicles 55 % (lanes 6, 7) and DOPC vesicles 45 % 
(lanes 8, 9); compared with the PspA-PspF1-275 inhibitory complex averaging only 19.5 % 
activity (see lanes 2 and 3). 
 
 
Figure 7.3 Effects of sonicated E. coli TLE, DPPC and DOPC vesicles on transcription relief.  (A) 
Denaturing gel showing the spRNA product and free GTP from the spRNA assay with sonicated E. coli 
TLE, DPPC and DOPC vesicles (0.5 mM lipid conc.) added to the preformed A-F complex. Percentage 
spRNA production with respect to the PspF1-275 only (lane 1) is shown. (B) Average percentage 
recovery of spRNA production for the three vesicle compositions.  
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To more accurately gauge the effect of each vesicles composition on transcription, the 
spRNA production from the PspA-PspF1-275 samples (lanes 2 and 3, Figure 7.3A) were used as 
a background and subtracted from each data set. The data was then used to calculate the 
percentage recovery of spRNA production for each vesicle composition (compared with the 
background corrected PspF1-275 only sample). The values are plotted in Figure 7.3B. All 
vesicle compositions were able to recover spRNA production to some extent with E. coli TLE 
vesicles being the most effective, leading to almost complete recovery. Addition of both 
DPPC and DOPC vesicles lead to significant spRNA production recovery (42 % and 30 % 
respectively) but markedly less than E. coli TLE. From these results it is clear that net neutral 
vesicles are also able to relieve transcriptional inhibition of the PspA-PspF complex.  
All previous assays have been undertaken with the addition of vesicles to a pre-formed 
PspA-PspF1-275 inhibitory complex to probe the transcriptional recovery from an inhibited 
state. To compare these transcriptional levels to those when PspA is exposed to the 
membrane prior to addition of PspF1-275, the assay was adapted. PspA WT (1.5 µM) was 
incubated with vesicles (0.5 mM lipid conc.) for 10 min before PspF1-275 (0.25 µM) was 
added to the sample. Figure 7.4A shows the denaturing gel from the assay with the 
calculated transcriptional activity for each lane. The background transcription was again 
subtracted and the average percentage recovery of spRNA production was calculated for 
the vesicle containing samples. Recovery of transcription for each of the three lipid 
compositions with PspA WT-vesicles pre-incubation and PspA WT-PspF1-275 pre-incubation is 
plotted in Figure 7.4B. For PspA-vesicles pre-incubated samples, all three lipid compositions 
also provide an increase in transcriptional activity compared with the PspA-PspF1-275 
complex alone. E. coli TLE vesicles again give the highest level of spRNA production, showing 
levels similar to uninhibited PspF1-275. spRNA production for DPPC vesicles is 24 % higher 
with PspA-vesicle pre-incubation than PspA-PspF1-275 pre-incubated assay. A more modest 
10% increase was observed for DOPC. However, these quantitative observations must be 
treated with caution due to the presence of significant error bars overlap between the data 
sets.   
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Figure 7.4 spRNA production with PspA-vesicles pre-incubation. (A) Denaturing gel showing the 
spRNA (UpGG*G*) product and free GTP from the spRNA assay with sonicated E. coli TLE, DPPC and 
DOPC vesicles (0.5 mM lipid conc.) incubated with PspA WT (1.5 µM) before addition of PspF1-
275(0.25 µM). Percentage spRNA production with respect to the PspF1-275 only assay (lane 1) is shown. 
(B) Average percentage recovery of spRNA production for the three vesicle compositions with PspA 
WT-vesicle and PspA WT-PspF1-275 pre-incubation. 
 
From the results obtained so far we can be confident that relief of transcription repression 
can occur through expose of the PspA-PspF1-275 inhibitory complex to the membrane. The 
resulting increase in spRNA production is most pronounced with E. coli TLE vesicles 
compared to DPPC and DOPC vesicles. These differences in transcription recovery correlate 
well with the membrane-binding trends of PspA WT observed in Chapter 4. The native-PAGE 
analysis (Figure 7.2B) indicates increased spRNA production is through disruption of the 
PspA-PspF1-275 inhibitory complex, with PspA being sequestered to the membrane and a 
concurrent increase in free PspF1-275. It therefore seems logical that vesicles with lipid 
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compositions that have a higher affinity for PspA will result in increased spRNA recovery 
when added to the PspA-PspF1-275 inhibitory complex. 
 
7.2.1.3 SCE stress and transcription relief 
To further probe the correlation between increased transcription recovery in the spRNA 
assay and lipid compositions that have a higher affinity for PspA, vesicles of increasing SCE 
stress were incorporated into the assay. To allow for direct comparison, vesicles of the same 
lipid compositions (DMPC/DOPC 4:6, DMPC/DOPC 2:8, DOPC, DOPE/DOPC 2:8 and 
DOPE/DOPC 4:6) and size (400 nm extruded) as in Chapters 4 and 5 were produced. A 6:1 
molar ratio of PspA WT to PspF1-275 was again used and the synthesised spRNA from the 
assay is shown in Figure 7.5A. The % spRNA recovery for three replicates of each SCE stress 
lipid composition (with E. coli TLE vesicles) is plotted in Figure 7.5B. 
 A clear difference in recovery of spRNA production is observed. The two lipid compositions 
of highest SCE stress behave similarly to E. coli TLE vesicles, causing almost complete 
recovery of spRNA production (averaging 84 % for DOPE/DOPC 2:8 and 89 % for DOPE/DOPC 
4:6). However, the three lipid composition of lowest SCE stress cause only a minimal 
increase in spRNA synthesis (6, 24 and 17 % average recovery for DMPC/DOPC 4:6, 
DMPC/DOPC 2:8 and DOPC respectively. As such, it appears that increased SCE stress within 
the vesicles membrane is sufficient to activate σ54 dependent transcription through PspF1-275 
from an initial PspA WT dependent inhibited state.  
In Chapter 4 we showed membrane binding of PspA varies monotonically as a function of 
SCE stress within a two component protein-vesicles system. Here, the same trend is not 
observed with respect to spRNA production in the presence of the membrane. In the case of 
transcription activation, incremental increases with SCE stress (seen in membrane binding) 
is apparently replaced by a binary on/off system with transcription predominantly 
suppressed until the SCE stress threshold is exceeded with DOPE/DOPC 2:8. These 
differences can be rationalised by the changes in binding dynamics that will occur when 
PspF1-275 is introduced into the system. These results are in agreement with observations 
that only severe IM stress is able to bypass the PspBC-dependent activation of Psp response, 
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leading to direct PspA-PspF interaction with the stressed IM and release of PspF inhibition in 
vivo (Joly et al., 2010). 
 
 
Figure 7.5 Probing the effect of SCE stress on transcription relief  (A) spRNA production with 
addition of increasing SCE stress vesicles(1 mM lipid conc) to pre-incubated PspA WT (1.5 µM) and 
PspF1-275 (0.25 µM). Increasing membrane stored energy compositions from left to right were 
DMPC/DOPC 4:6, DMPC/DOPC 2:8, DOPC, DOPE/DOPC 2:8, DOPE/DOPC 4:6.  (B) Recovery of spRNA 
production for each vesicle composition with data from three independent vesicle preparations. 
 
It is also worth pointing out the differences in recovery of spRNA production for sonicated 
DOPC vesicles (Figure 7.4) and 400 nm extruded vesicles (Figure 7.5) where average 
recoveries are seen of 30 % and 17 % respectively. The increase in transcriptional recovery 
seen for the sonicated vesicles may be due to their smaller diameters. This results in higher 
SCE stress within the membrane, especially at the lower end of the size distribution. 
    240 
  
7.2.1.4 Exposing the PspA1-186 – PspF1-275 inhibitory complex to vesicles 
To compare the effects of the oligomeric state of PspA on the dynamics of transcriptional 
activation in the presence of vesicles, PspA1-186 was incorporated into the spRNA assay. 
PspA1-186 is able to form a complex with PspF1-275 inhibiting its ATPase activity (Chapter 
3.2.1.2) and also directly bind the phospholipid bilayer (Chapter 4.2.8.1) but is unable to 
form a high-order oligomer instead existing as a monomer dimer (Joly et al., 2010b).  
The spRNA assay was undertaken with 0.6 µM PspF1-275 pre-incubated with 3 µM PspA1-186 
before addition of E. coli TLE vesicles. Like PspA WT, a six-fold excess of PspA1-186 over PspF1-
275 sufficiently inhibited spRNA synthesis (Figure 7.6A, lane 5), however, no relief of 
transcription was observed upon addition of E. coli TLE vesicles up to a 2.5 mM lipid 
concentration (Figure 7.6A, lane 8). Native-PAGE analysis (Figure 7.6B) showed that E. coli 
TLE vesicles were unable to bind or disrupt the PspA1-186-PspF1-275 co-complex. In contrast, 
for PspA WT (at the same molar conc.), TLE vesicles at 1 mM lipid concentrations were able 
to completely relieve transcription inhibition, with a concurrent disruption in the PspA-
PspF1-275 inhibitory complex. This data indicates a distinct difference between the vesicle 
binding affinities of PspA WT and PspA1-186 interacting with the PspF1-275.  
Finally, spRNA assay was undertaken but with PspA1-186 pre-incubated with E. coli TLE 
vesicles before addition of PspF1-275. Again spRNA synthesis was completely suppressed by 
PspA1-186, irrespective of the amount of vesicles (data not shown). At the PspA1-186 to vesicle 
ratio used, complete membrane association of the protein should occur. Hence, it appears 
that PspF1-275 is able to effectively sequester PspA1-186 from the membrane to form the 
PspA1-186-PspF1-275 inhibitory co-complex. 
 
.  
 
    241 
  
 
Figure 7.6 Membrane exposure cannot relieve transcription repression by PspA1-186 (A) spRNA 
(UpGG*G*) product and free GTP from the spRNA assay with E. coli TLE vesicles (0.5-2.5 mM lipid 
conc.) added to a PspA1-186 – PspF1-275 inhibitory complex. Percentage spRNA production with respect 
to the PspF1-275 only assay (lane 1) is shown. (B) Native-PAGE gel showing formation of the PspA1-186-
PspF1-275 complex without (lane 3) and with addition of E. coli TLE vesicles (lane 4).  
 
 
7.2.2 Repression of PspF’s ATPase functionality by peptides 
The putative ahB (AA residues 25-42) of PspA has been implicated in the negative regulation 
of PspF (Jovanovic et al., 2014b) but a direct interaction between the regions has yet to be 
shown. To see if we could demonstrate this direct role, we purchased a peptide with the AA 
sequence of residues 25-47 of PspA (PspA25-47). This incorporates the putative ahB.  
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To ascertain if the PspA25-47, ahB containing, peptide possessed any negative regulatory 
effects on PspF, it was incorporated into the NADH-coupled ATPase assay (Norby, 1988). 
Equimolar and 2:1 ratios of PspA25-47 to PspF1-275 had no apparent effect on the ATPase 
activity of PspF1-275 (data not shown). However, at a five-fold excess of PspA25-47 inhibition of 
ATPase began to occur, with activity dropping to around 80 % that of PspF1-275 alone. 
Further increases in PspA25-47 concentration gave a linear decrease in ATPase activity until 
near complete inhibition was achieved at around a 24:1 PspA25-47 to PspF1-275 molar ratio 
(Figure 7.7A, 18 µM PspA25-47). To see if the inhibitory effect of the PspA25-47 peptide is 
through the same mechanism as PspA WT, the ATPase activity of PspF1-275 W56A (a PspF 
mutant that is unable to interact with PspA (Elderkin et al., 2002)) incubated with the 
peptide was also probed. PspA25-47 was unable to inhibit ATPase of PspF1-275 W56A even at a 
50 fold molar excess (Figure 7.7A). This provides strong evidence for inhibition through 
interaction with the W56 loop of PspF, akin to full length PspA (Zhang et al., 2013). 
To see if inhibition is specific to PspA25-47, other PspA peptides were also assayed for their 
effects on ATPase activity of PspF1-275. Figure 7.7B presents the ATPase activity for PspA1-24 
(containing ahA) and PspA1-40 (comprised of ahA and ahB), with that of PspA25-47 for 
reference. While ahB containing PspA25-47 exhibits the largest reduction of ATPase activity, 
PspA1-24 is also able to impart a degree of inhibition on the system. At a molar excesses of 
five-fold and above over PspF1-275, reduction of ATPase activity is observed proportional to 
peptide concentration (Figure 7.7B). At a 24 fold excess of PspA1-24 activity is down 
regulated to 38% of PspF1-275 alone. This is noticeably less than the almost complete 
repression observed at similar concentrations of PspA25-47, yet significant none the less. 
PspA1-24 was unable to impart any ATPase inhibition of PspF1-275 W56A (data not shown), 
suggesting that inhibition is again through interaction with the W56 hydrophobic loop. 
PspA1-24 and PspA25-47 have very different AA sequences but are both amphiphilic in nature. 
Reduction of ATPase activity by both peptides shows that regulation of PspF1-275 is not 
exclusively through a specific AA sequence. Rather, it indicates that inhibition may be 
through non-specific hydrophobic interactions between the W56 hydrophobic loop and the 
hydrophobic face an AH.  
Surprisingly, PspA1-40 was unable to inhibit ATPase of PspF1-275 at any concentration assayed 
despite containing ahA and ahB. Both of these regions cause a significant decrease in 
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ATPase activity individually at similar concentrations (Figure 7.7B). CD studies on the PspA1-
40 peptide showed a predominantly helical secondary structure (see Appendix C). This lack of 
negative regulatory function must be due to the tertiary structure of PspA1-40 either 
preventing access to the PspF1-275 binding site through steric hindrance or intramolecular 
interactions shielding the two AH binding sites of the peptide.  
 
 
Figure 7.7 PspA and Vipp1 peptide effects on PspF1-275 ATPase activity.  PspF1-275 and PspF1-275 
W56A were used at a final concentration of 0.75 µM in all assays with ATPase activity determined by 
the NADH-coupled ATP regeneration system. Results are expressed as the percentage of the PspF1-
275 activity in the absence of peptides. (A), (B) and (C) ATPase activity of PspF1-275 as a function of 
increasing concentration of PspA and Vipp1 peptides. (D) Bar graph of PspF1-275 ATPase activity for all 
PspA and Vipp1 peptides at 18 µM (point at which complete inhibition is seen for PspA25-47).  
 
As ahA containing PspA1-24 was also able to impart an ATPase repressing effect on PspF1-275, 
the effect of other N-terminal AH peptides were assayed. PspA2-19 also reduced ATPase 
activity of PspF1-275 but to a lesser extent than PspA1-24 (Figure 7.7C). ATPase was supressed 
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by 40 % at a 24 fold excess (Figure 7.7D). Vipp1 AH peptides Vipp11-24 and Vipp12-19 were 
also able to repress ATPase activity of PspF1-275 to an extent showing a 30 % and 46 % 
reduction respectively at a 24 fold excess (Figure 7.7D). Again all the AHs were unable to 
inhibit ATPase of PspF1-275 W56A (data not shown). 
It appears that a degree of ATPase repression can be obtained by all AH peptides, likely 
through non-specific hydrophobic interaction, yet the ahB containing PspA25-47 is noticeably 
the most potent. The ATPase activity of PspF1-275 as a function of hydrophobicity, 
hydrophobic moment and net-charge for all isolated peptides was plotted, however, no 
correlation was observed in any of these properties (Figure 7.8). It is apparent that the 
magnitude of regulation imparted by the peptides cannot be solely attributed to any of 
these physiochemical properties.    
 
Figure 7.8 Peptide effects on PspF1-275 ATPase activity as a function of hydrophobicity (A), 
hydrophobic moment (B) and net-charge (C). Data points are from assays with 0.75 µM PspF1-275 
and 18 µM peptide. Results are expressed as the percentage of PspF1-275 activity in the absence of 
peptides. 
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7.3 Discussion and Conclusions 
The results from this chapter show for the first time that the negative regulatory function of 
the PspA can be modulated by exposure to the membrane, with a resulting effecting on 
downstream transcriptional output. We show that the PspA-PspF1-275 inhibitory co-complex 
is unable to survive when exposed to vesicles of certain lipid compositions and this results in 
relief of transcription repression in vitro. This validates our hypothesis that PspBC 
independent induction of the Psp response is possible with a phospholipid bilayer acting as 
the direct inducer (at least in vitro). It also suggests that direct IM sensing could be vital in 
PspA’s regulatory function along with its effector role. Assuringly, the phospholipid 
compositions that result in transcription relief correlate to those that were found to be most 
effective at promoting binding of PspA (Chapter 4). Notably, vesicles with low levels of SCE 
stress were unable to affect PspA’s negative regulation, however, those with high SCE were 
effective at causing transcription recovery. The in vitro identification of a membrane stress 
specific signal that is both sensed by PspA as a negative regulator and, targeted by PspA in 
its effector function raises the prospect of the Psp response maintaining the integrity of the 
IM by sensing and responding to areas of high SCE stress. 
PspA WT can inhibit PspF1-275 from a membrane bound state and can also associate with the 
membrane from a PspF1-275 bound state. It would appear that PspA’s two binding targets 
(PspF and the membrane) recognise different binding motifs yet any stable simultaneous 
binding is not possible. This agrees with the findings in Chapter 6.2.2.3 (and (Jovanovic et al., 
2014a)), where the N-terminal AH (residues 1-24) was identified as being responsible for 
membrane association and, in Chapter 7.2.2 (and (Jovanovic et al., 2014a) where ahB 
(residues 25-47) was shown to inhibit PspF’s ATPase function. While these are distinct 
regions of PspA, the AHs are located adjacent to one another in the primary sequence. It 
therefore seems feasible that steric hindrance or structural remodelling upon binding could 
prevent concurrent association of PspA WT to PspF1-275 and the bilayer. 
These results suggest that the relative affinities of PspA for both PspF1-275 and the 
membrane are important when considering the negative regulatory effects of the protein. In 
this respect, the SCE stress results could be explained as follows: PspA has a higher affinity 
for PspF1-275 than membranes with low SCE stress, forming a PspA-PspF1-275 inhibitory 
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complex, preventing ATPase and subsequent σ54 dependent transcription. However, as the 
SCE stress increases in the bilayer, so too does PspA’s affinity for it (presumably due to the 
increased density of lipid packing defects providing more sites for multidentate oligomer 
binding). At a certain point, the affinity of PspA for the membrane becomes higher than for 
PspF1-275. This results in bilayer association of complexed PspA and a concurrent dissociation 
of PspF1-275, leaving it free to initiate transcription via ATPase. An affinity based mechanism 
can be extended across all membrane signals and so anionic lipids could also play a role in 
negative regulation of PspA. The in vivo implications of these finding may not be straight 
forward as a number of other factors need to be considered, such as interactions with 
PspBC and the effect of the DNA binding domain of PspF (residues 276-330) (Joly et al., 
2010b). 
Interestingly, PspA1-186, lacking HD4 and unable to form high-order oligomers, formed an 
inhibitory co-complex with PspF1-275 that could not be disrupted when exposed to any 
vesicles composition.  PspA1-186 has previously been reported to have a higher affinity than 
PspA WT for PspF1-275 (Elderkin et al., 2005, Joly et al., 2009), a phenomenon that was also 
observed in the native-PAGE band shift assays carried out in Chapter 3.2.1.2. In this respect, 
the affinity of PspA1-186 for PspF1-275 may be higher than its affinity for any membrane 
composition. This would explain why exposure to the membrane is unable to disrupt the 
PspA1-186-PspF1-275 inhibitory complex, while PspF1-275 was also able to sequester PspA1-186 
pre-incubated with vesicles to form an inhibitory co-complex. The inability of PspA1-186 to 
form high-order oligomers could also be a factor favouring PspF association over the 
membrane. PspA WT may exist as a hexemer in the PspA-PspF regulatory complex and so be 
able to form multi-dentate interactions with the membrane, favouring association. Equally, 
complex disruption may be driven though self-association of PspA WT on the membrane. 
Both these interactions are not possible with monomer/dimer PspA1-186.  
This chapter also presents direct evidence for the region of PspA involved in repression of 
PspF’s ATPase activity. While the putative ahB of PspA was implicated in negative regulation 
of PspF (Jovanovic et al., 2014b), a specific interaction had yet to be directly shown. It was 
demonstrated that the PspA25-47 peptide containing ahB is able to repress PspF1-275’s ATPase 
activity, causing almost complete repression at a 24-fold excess over PspF1-275. Results 
showing that the ATPase activity of a PspF1-275 W56A mutant cannot be supressed by PspA25-
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47 demonstrate that the peptide is likely using the same inhibition mechanism as PspA WT 
(through the W56 hydrophobic loop of PspF (Zhang et al., 2013)). While PspA25-47 is the most 
effective suppressor, the ability of other PspA (and even Vipp1) N-terminal AH peptides to 
repress ATPase activity suggests that a strictly conserved sequence is not required for this 
functionality. All the peptides share an amphiphilic nature when in an α-helical 
conformation so hydrophobic interactions between the apolar face of the AHs and the W56 
loop of PspF could be a prime candidate for ATPase inhibition.  
Full length PspA (and PspA1-186) is much more effective at repressing PspF1-275’s ATPase than 
the PspA25-47 peptide. A 24-fold molar excess of PspA25-47 is required for complete PspF1-275 
ATPase inhibition, but in similar assays only a 3-fold excess of PspA WT can cause the same 
level of inhibition (Joly et al., 2009). PspA WT and PspF1-275 demonstrate a strong propensity 
to self-assemble into a single defined heteromeric regulatory complex but isolated PspA 
helical domains have a low affinity for PspF1-275 (Joly et al., 2009). Considering that PspA HD2 
and HD3 also contribute to negative control upon PspF1-275 (Joly et al., 2009), it is likely the 
case that PspA WT (and PspA1-186) makes multiple interactions with PspF1-275. These 
interactions can co-operate to form a tightly bound complex where the ahB region is held in 
the correct location and orientation to associate with the W65 loop. This is clearly not 
possible for the PspA25-47 peptide, where presumably only a single interaction with the W56 
loop is possible. The binding affinity of the peptide for PspF1-275 will therefore be much 
lower than PspA WT, so a much higher concentration of the peptide will be required for a 
similar level of ATPase inhibition. 
Taking the results of this peptide study in isolation, it is feasible that residues 1-24 or 
residues 25-47 could be responsible for binding the W56 loop and causing repression of 
PspF1-275’s ATPase activity in PspA WT. However, in combination with the work undertaken 
by Jovanovic et al. (2014a), where a PspA25-40 mutant was inactive for negative regulation 
but a PspA2-19 mutant retained negative regulatory function, we can be confident that 
residues 25-47 make the inhibitory interaction in PspA WT. 
Jovanovic et al. (2014a) showed that a hydrophobic to charged AA substitution on the 
hydrophobic face of PspA’s ahB strongly reduces negative control in the context of the full 
length protein. As PspA1-24 imparts a degree of negative regulation on PspF1-275, further 
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studies incorporating the PspA1-24 V11E and PspA1-24 F4E V11E mutants (from Chapter 6) 
would be useful to see if a similar substitution has the same effect with peptides. If it does 
then the case for a non-specific hydrophobic interaction between the apolar face of an AH 
and the W56 loop of PspF being responsible for inhibiting ATPase would be very strong. 
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Chapter 8 – Discussion  
 
This work described in this thesis establishes a quantitative technique employing the use of 
native-PAGE to study the membrane binding of PspA and Vipp1 (Chapter 3). In combination 
with previously established sucrose gradient co-floatation assays, this work presents the 
first detailed study of the membrane binding properties of PspA and Vipp1 in vitro, 
providing new insights into the protein and membrane contributions to membrane 
association. SCE stress and anionic lipids are shown to modulate PspA and Vipp1 bilayer 
partitioning, a property that is lost when the putative N-terminal AH is removed from both 
proteins (Chapters 4 and 5). By using isolated peptides a direct interaction between the 
membrane and N-terminal region of both PspA and Vipp1 is demonstrated. This association 
is found to be driven by AH α-helix formation, establishing a mechanism of membrane 
association. Vipp1 peptides were also able to impart micelle formation in bilayers with high 
net-negative charges (Chapter 6). Finally, by developing an in vitro transcription assay 
incorporating vesicles, it is shown that the negative regulatory role of PspA (on PspF) can be 
modulated by direct PspA-membrane interactions independent of PspB and PspC. This 
regulation was also shown to be SCE stress specific, suggesting that SCE stress may act as a 
signal for Psp induction and a target for effector PspA (Chapter 7). 
All the data acquired in this study are from in vitro assays. It is therefore important to 
consider the physiological relevance of the observations made and how they fit in with 
phenotypes observed from in vivo studies. While the results of each chapter have been 
comprehensively discussed individually (see discussion section of Chapters 3-7), the work 
must also be considered as a whole and placed within the context of the appropriate 
research fields. The following sections look to update the current models for the Psp 
response (8.1) and of Vipp1 function (8.2) with the progress made in this thesis. 
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8.1 A key role for SCE stress in the induction and effector function of the Psp 
response? 
This discussion section looks at the Psp response in vivo with respect to the findings of this 
study. Emphasis is placed on the effects of SCE stress, which has so far not been considered 
in the context of the Psp response. 
Based on the findings of this study, new additions to the working model of the Psp response 
regarding PspBC independent induction under severe stress and the effector function of 
PspA based on SCE stress can be proposed (Figure 8.1). Many of the documented inducing 
signals of the psp response in E. coli affect the physical state of bilayers and are therefore 
likely to affect SCE stress levels within the IM. It seem likely that in severe (and possibly 
global) stress, PspA’s ability to directly sense the state of the membrane when undertaking 
its regulatory role, can result in release of PspF from the PspA-PspF complex and hence 
induction of the Psp response. Increased lipid packing defects coupled with SCE stress 
(caused by various Psp inducing agents) provide energetically favourable sites for insertion 
of PspA’s AH at the IM that overcome the repressive PspA-PspF interaction (Chapter 7). This 
effectively bypasses any stress sensing by PspB and PspC. Induction probably results from 
conformational changes in PspA upon membrane-binding, as a competitive binding site for 
PspF seems unlikely since PspAwithout ahA can still regulate PspF (Jovanovic et al., 2014b). 
Once induced, the upregulated PspA forms 36-mer high-order oligomeric rings (either on 
the membrane or in the cytoplasm) that could target areas of the membrane with high 
levels of SCE stress through the N-terminal AH (Chapter 4 and 6). Interfacial membrane 
insertion of multiple PspA AHs within the high-order oligomers could facilitate the reduction 
of SCE stress through a chain splay mechanism (see Figure 4.19) whilst also acting as a 
protein scaffold to further stabilise the IM.  
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Figure 8.1 Model of the PspBC independent induction and effector function of the Psp 
response of E. coli in vivo informed by findings of this study. The PspA-PspF inhibitory complex 
detaches from the nucleoid and diffuses to the IM. PspA can sense the state of the IM via its N-
terminal AH directly binding at locations of SCE stress and resulting lipid packing defects. This results 
in disruption of the PspA-PspF complex, allowing PspF to initiate transcription of the psp operon 
through ATPase and thus expression of the Psp response. The upregulated PspA forms high-order 
oligomers that directly bind the IM in areas of high membrane energy, or PspA may self-assemble at 
the IM itself from lower order assemblies. Multiple N-terminal AH insertions into the IM from PspA 
high-order oligomers reduce the membrane energy status and so stabilise it. PspA high-orders may 
also act as a scaffold mechanically stabilising the IM and preventing non-lamellar phase transitions. 
 
As noted in Chapter 1, a plethora of inducing conditions have been identified for the Psp 
response. While a unifying signal manifested by all the inducers has been proposed to be 
variations in the IM properties (Darwin, 2005, Joly et al., 2010b), a specific chemical or 
physical change has not been identified nor proposed. The results from this work 
highlighting the ability of SCE stress to modulate PspA’s negative regulatory function 
(Chapter 7), suggest that SCE stress or the resulting lipid packing defects within the IM could 
be this signal. Many, if not all Psp inducing conditions will likely result in local, or global 
changes in the SCE stress within the IM. For example, mislocalization of OM proteins 
(Darwin and Miller, 2001) could well cause hydrophobic mismatch due to differences in 
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length of the membrane spanning segment of proteins and thickness of the bilayer. This has 
been found to cause large changes in the lateral stress profile of the surrounding bilayer 
(Nielsen et al., 1998). High temperature could increase the SCE stress within the IM through 
increased acyl chain trans-gauche rotation and osmotic shock could cause increased lipid 
packing defects through bilayer expansion. Another inducer of the Psp response; free fatty 
acids have also been shown to increase the SCE stress within membranes (Seddon et al., 
1997). However, if SCE stress is the unifying signal for induction of the Psp response, it does 
not explain the requirement of PspBC for induction during secretin mislocalization unless 
SCE stress also activates PspBC (Weiner et al., 1991).  
Whether or not SCE stress or the resulting lipid packing defect are specifically sensed when 
the Psp response is induced, its potential as a target for the effector function of PspA is 
certainly an attractive one. It is vitally important for biological membranes to maintain their 
SCE stress within a critical range to prevent phase transition into a porous state (Attard et 
al., 2000). One of the obvious detrimental results of a transition of the IM into a porous 
state is the dissipation of the PMF. As PspA has been shown to prevent dissipation of the 
PMF both in vivo (Kleerebezem et al., 1996) and in vitro (Kobayashi et al., 2007), it seems 
logical that this could be through controlling SCE stress levels to maintain an impermeable 
lamellar bilayer. A number of features would appear to make PspA effective in this 
capability. PspA’s association with vesicles, through the N-terminal AH, increases as a 
function of SCE stress (Chapter 4 and 6). AH mediated interactions with the bilayer are 
proposed to reduce SCE stress via the chain splay mechanism (Attard et al., 2000). This 
mechanism could be particularly effective when combined with PspA’s high-order oligomer 
formation which would provide multiple, structured AH insertions over a large IM area that 
can act as a scaffold physically resisting membrane phase transition to a porous state. Data 
showing that a psp null mutant’s membrane can be permeablised to large molecules upon 
secretin production (Horstman and Darwin, 2012), and that low-order oligomer PspA1-186 
can bind the membrane (Chapter 4) but does not have an effector function (Jovanovic et al., 
2014)  support this proposition. 
On balance, it seems likely that under a number of conditions that result in high levels of 
SCE stress, the Psp response can be directly induced through a direct interaction between 
the PspA-PspF inhibitory complex and the membrane. This sensing may have formed the 
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basis of the core mechanism (consisting of just PspA and PspF) from which the response in 
its current form is proposed to have evolved from (Huvet et al., 2011). Addition of PspB and 
PspC into the response may have enhanced its sensing capabilities allowing other inducing 
signals to be recognised, or, perhaps amplifying small increases in SCE stress that PspA alone 
is unable to sense. PspB and PspC are both integral membrane protein with recent studies 
suggesting that PspC is polytopic and has a, PspA interacting, C-terminal AH  (Darwin, 2012). 
It is logical that PspB and PspC could sense lateral and SCE stress that increase the 
propensity for phase transition of the bilayer but cannot be sensed by PspA’s N-terminal AH. 
This could be stress induced by positive spontaneous curvature or bilayer compression, SCE 
stress in outer leaflet of the IM, or both. In these conditions PspB and PspC may also be 
required as effectors in the response as lipid packing defects will not be present on the 
inner-leaflet of the IM at a high enough density for PspA to bind. Accordingly, upon psp 
induction, PspB and PspC are upregulated 60 and 40-fold respectively (Lloyd et al., 2004). 
They have also been shown to have an effector function in Yersinia enterocolitica under 
certain conditions (Maxson and Darwin, 2006). Membrane insertion of the upregulated 
PspB and PspC into the membrane could provide anchor points for the PspA high-order 
oligomers to bind, creating a scaffold that physically resists any transition of membrane 
non-lamellar phases. This agrees with findings from Yamaguchi et al., (2013) where PspA, B 
and C were found to co-localise in stationary regions of the membrane upon induction of 
the Psp response (through overproduction of secretins).  
Anionic lipids within the IM could have a dampening effect on the SCE stress sensing of PspA 
(seen in Chapter 4). However, SCE stress sensing was seen even at 40 % anionic lipid content 
for the PspA1-24 AH peptide (Chapter 6). This is higher than the physiological levels of net 
negative charge seen in the IM. As such, an SCE stress sensing component of PspA would be 
expected in vivo within the IM of E. coli. 
In this respect the Psp response may have evolved from a core PspAF system that only 
prevent membrane phase transitions to a porous inverse-hexagonal (HII) phase; to a 
PspABCF system which can act to prevent membrane phase transition to both hexagonal 
(HI) and inverse-hexagonal (HII) under stress.  
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8.2 Dual membrane signals impart dual Vipp1 maintenance and biogenesis 
function? 
Vipp1’s precise function has yet to be determined, yet there is no doubt of its importance in 
plastids. Current research suggests that Vipp1 is a multi-functional protein related to the 
biogenesis and maintenance of thylakoid membranes (Zhang and Sakamoto, 2015). The 
following paragraphs will consider the implications that the results of this study have on 
both these functions in vivo.  
This work showed that Vipp1 is able to sense membrane SCE stress through its N-terminal 
AH (Chapters 5 and 6). This stress sensing may play an important role in the membrane 
maintenance function of Vipp1 that has been recently discovered (Zhang and Sakamoto, 
2013, Zhang and Sakamoto, 2015). The study of Vipp1’s maintenance function has been 
driven by the observation that Vipp1 in Arabidopsis thalniana prevents the formation of 
balloon-like swollen chloroplasts caused by membrane stress (Zhang et al., 2012). It was 
suggested that this occurs through localisation and oligomerization of Vipp1 on the 
membrane of the affected area  (Zhang et al., 2012). Membrane swelling will increase the 
lateral stress in the bilayer and most likely induce lipid packing defects, both of which should 
favour membrane association of Vipp1 via its N-terminal AH. Thus, the N-terminal AH of 
Vipp1 may act as both a sensor of membrane stress in chloroplasts and as a lipid anchoring 
region, relieving some of the stress of bilayer swelling through the presentation of its 
hydrophobic face at the membrane facilitating the bilayer expansion (Zhan and Lazaridis, 
2013). Vipp1 high-order oligomer formation could allow multiple AH insertions into the 
bilayer from one rigid self-assembly, then act as a scaffold to stabilise the membrane and 
prevent further swelling. This membrane maintenance function could be extended to Vipp1 
in cyanobacteria, where it may function to maintain the integrity of the thylakoid or even 
the cytoplasmic membrane under stress conditions. 
Aside from SCE stress sensing, Vipp1 N-terminal AH peptides possess increased affinity for 
vesicles with high anionic lipid content (not seen for PspA N-terminal AHs). Association with 
the membrane through AH formation causes results in peptide-lipid particles around 10-20 
nm in diameter (Chapter 6). Anionic lipids SQDG and PG are found in thylakoid and 
cytoplasmic membranes. Both are essential lipids in Synechocystis and are involved in 
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functional integrity of the photosystems (Sato, 2004). The average concentration of anionic 
lipids in both the thylakoid and cytoplasmic membranes are around a 25 % mole fraction 
(see Table 5.1). This is lower than the 30 – 40 % threshold that appears to promote a 
significant increase in Vipp1 AH association and the concurrent formation of small lipid-
peptide structures (Chapter 6). If this functionality is conserved in full length Vipp1, the 
membrane disrupting properties seem unlikely to be imposed on most of the membrane 
compartments but rather the AH region could selectively target sub sets of membrane 
areas, specifically those with elevated levels of anionic lipids (e.g. regions of PG or SQDG 
synthesis). This modality does not provide obvious benefits in terms of a maintenance 
function but in terms of thylakoid biogenesis this sensing could be vital.  
Thylakoid lipids are not synthesised at the thylakoid membrane but at the chloroplast 
envelope in plants and the cytoplasmic membrane in cyanobacteria. Therefore, there must 
be a transport system in photosynthetic organisms to supply lipids to the thylakoids 
(Benning, 2008). Early experimental evidence implicated Vipp1 as playing a role in this 
transport through vesicle budding from the cytoplasmic membrane (Hugueney et al., 1995, 
Kroll et al., 2001). This proposed role for Vipp1 had been disfavoured for one of 
maintenance. However, findings of Vipp1 interacting with Alb3.2 (responsible for 
photosystem assembly) (Gohre et al., 2006), photosystems in Vipp1 depletion mutants 
being sensitive to high light (Nordhues et al., 2012), and PG knockdowns exhibiting similar 
phenotypes as Vipp1 depleted strains (Gao and Xu, 2009, Sato, 2004), lead to a proposed 
role for Vipp1 in trafficking PG to the thylakoid membrane (Nordhues et al., 2012). The work 
suggested that in planta, PG is directly loaded onto Vipp1 at the chloroplast inner-envelope 
with its subsequent release into an Alb3.2-containing photosystem assembly complex at 
thylakoid origins (Nordhues et al., 2012). Our experimental data could supplement this 
model in Synechocystis where Vipp1 may also be responsible for supplying PG to the 
thylakoid membrane. First, targeting of areas of the cytoplasmic membrane with high 
densities of anionic lipids, such as the site of their synthesis through association of the Vipp1 
N-terminal AH could occur (Benning, 2008). The high density of AH insertions provided by a 
Vipp1 high-order oligomer could induce local membrane disruption resulting in formation of 
Vipp1-lipid complexes enriched in PG. Vipp1 could then deliver these lipids to the thylakoid 
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membrane by interacting with Alb3.2 located in the thylakoid membrane (Gohre et al., 
2006).  
This work shows that Vipp1 can sense two different membrane signals: SCE stress, and high 
membrane net-negative charge. These signals are for most part non-cooperative. It 
therefore seems possible that Vipp1 would be able to undertake both a membrane 
maintenance function based on its SCE stress sensing properties, and a role in thylakoid 
biogenesis through its anionic lipid determinant. The relatively low sensitivity for SCE stress 
and requirement of high anionic lipid content for enhanced membrane binding could mean 
that Vipp1 is inactive for either function in normal conditions. However, up-regulation of 
anionic lipid production at the cytoplasmic membrane could promote Vipp1’s thylakoid 
biogenesis function, while exposure to stresses that increase the SCE stress in the 
membrane could cause Vipp1 to act in a membrane maintenance function.  
 
8.3 Future Work 
This study has led to a number of novel discoveries. Nonetheless, like any scientific 
investigation, there are some questions still to be addressed, and indeed others that have 
been raised by the findings of this study. 
Perhaps the major unanswered question is regarding the effector functions of PspA. This 
study identifies membrane binding signals sensed by PspA and shows that membrane 
association is mediated by the conserved N-terminal AH. The effect of this association on 
the physical state of the membrane has not yet been probed. It seems logical that under 
stress, AH insertion could target and relieve SCE stress in the membrane and, in 
combination with the PspA high-order oligomer, form a scaffold that stabilises the 
membrane. Being able to demonstrate a stabilising effect of PspA on vesicles would be the 
first steps to showing this is the mechanism by which PspA achieves its effector function. 
Calcein efflux assays using vesicles pre-incubated with PspA then exposed to different 
membrane stresses could be used to see if PspA can prevent or limit vesicle rupture. Use of 
fluorescent dyes such as Merocyanine 540 and dipyPC, which acts as a sensor for curvature 
related packing stress (van den Brink-van der Laan et al., 2004, Templer et al., 1998), could 
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also be used to ascertain if SCE stress in the membrane is reduced by PspA binding. Finally, 
fluctuation analysis (Karamdad et al., 2015) could be undertaken to characterise the 
bending rigidity of vesicles with and without PspA, allowing quantification of the changes in 
the physical properties of membranes that occur as a result of PspA association.   
Once these methods have been established for PspA, Vipp1 can readily be substituted into 
the assays to investigate its proposed maintenance function and provide a comparison of 
the membrane stabilising effects of the proteins. It would also be useful to follow up the 
effects of a high membrane net-negative charge and Vipp1 association. The ability of Vipp11-
24 to form peptide-lipid particles could be important in a thylakoid biogenesis function if 
maintained in full length Vipp1. Negative stain EM and DLS studies with high concentrations 
of purified Vipp1 WT and 40 % anionic lipid vesicle could be one way of investigating this. 
Assuming a physical effect on the state of the vesicles could be observed in vitro, being able 
to experimentally link this back to the effector function of PspA in vivo would substantially 
enhance characterisation of the Psp response. One approach would be to expose vesicles to 
stresses in vitro that induce the Psp response in vivo such as phage pIV. It can then be 
ascertained if they illicit membrane recruitment of PspA with a concurrent stabilising effect. 
Also, observing membrane dissociation of PspA when SCE stress in the bilayer is reduced 
could indicate a mechanism of response termination. Some insights may also be achieved 
through a recently established collaboration with Dr Gerald Larrouy-Maumus. Here 
collaborative plans are to adapt a number of metabolic and lipidomic techniques (including 
a novel MALDI-TOF setup for detailed lipid analysis (Bouvrais et al., 2013)) used for 
characterisation of the membrane response to stress in Mycobacterium tuberculosis, to seek 
insights into any differing lipid composition in E. coli under Psp inducing conditions with, and 
without PspA.  
The work undertaken in Chapter 6 on peptides establishes the N-terminal regions of E. coli 
PspA and Synechocystis Vipp1 as membrane sensing AHs. CD and co-floatation assays using 
peptides of the putative N-terminal AH regions of PspA and Vipp1 from other organisms 
would hope to rapidly establish the region as a conserved membrane binding domain. The 
Arabidopsis thaliana Vipp1 N-terminal AH would be a fascinating comparative study due to 
its particularly large hydrophobic moment and increased hydrophobicity compared to 
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Synechocystis Vipp1. It would then be of interest to make targeted mutations in the PspA 
and Vipp1 N-terminal AH peptides, observing how they impact on their membrane sensing 
properties. Reducing the charged residues on the polar face of Vipp1 should curtail the 
sensing of high membrane net-negative charge in combination with increasing the SCE 
stress sensitivity. The opposite should be the case for PspA.  
An interesting side project would be to investigate any possible antimicrobial effect of the 
PspA and Vipp1 N-terminal AH peptides. The Vipp11-24 and especially Vipp12-19 peptides had 
potent vesicle destabilising properties only when the membranes had a high anionic lipid 
content. Prokaryotic cell membranes have a much higher net negative charge than 
eukaryotic membranes (Blondelle et al., 1999) thus, the Vipp1 AH could potentially provide 
membrane disrupting specificity for microbes. The PspA ahB peptide (PspA25-47) was found 
to cause inhibition of PspF’s ATPase activity and therefore is most likely to be able to inhibit 
the downstream σ54 dependent transcription of the psp operon. Future work could probe 
the ahB region with an aim to develop effective inhibitors of the Psp response in the form of 
synthetic peptides. This could be of interest for controlling pathogens where Psp response is 
important and conserved. For example, in drug tolerant persister cells the Psp system is 
strongly up-regulated (Keren et al., 2004a). More recently, the Psp response was shown to 
be up-regulated in pathogenic E. coli in a macrophage environment, and PspA was shown to 
be important for E. coli intramacrophage survival (Mavromatis et al., 2014). In these cases 
peptide inhibition of PspF could prove to be lethal to cells. 
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Appendix A – Sizing of vesicles via Dynamic Light Scattering 
 
 
Figure A.1 Dynamic light scattering data of vesicles used within this study.  Intensity of 
scattered light is plotted against particle size. (A) E. coli TLE vesicles produced via extrusion through 
100nm filters and 400nm filters. (B) Vesicles from cell extracts produced via extrusion through 100 
nm filters. (C) SCE stress assay vesicle set, 400 nm extrusion. (D) 400nm extruded DMPC/DOPC 4:6 
vesicles with inclusion of 10 % anionic lipids. (E) Galactolipid vesicles (100 nm extrusion) 
DGDG/DOPG 3:1 and DGDG/MGDG/DOPG 2:1:1. (F) Vesicles made in 20 mM Tris-HCl (pH 7.5) buffer 
used for CD studies (100 nm extrusion). 
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Appendix B – PspA and Vipp1 (His)6 tag cleavage and pH vesicle-
binding controls 
 
 
 
Figure B.1 Native-PAGE based binding assay controls for PspA and Vipp1. Controls undertaken 
to ensure that membrane association of PspA and Vipp1 is not mediated by the (His)6 tag and also, 
to check that the running buffer pH does not significantly affect the SCE stress via de-protonation of 
DOPE. Red boxes indicate integrated regions and intensity of each lane with respect to a protein 
alone sample is shown. (A) SYPRO stained native gel after incubation of (His)6 tag cleaved PspA WT 
with high SCE stress vesicles (DOPE/DOPC 4:6) and E. coli TLE vesicles. (B) Native gel of PspA WT (10 
µM) incubated with vesicles (2 mM lipid conc.) of increasing SCE stress after electrophoresis 
undertaken in a pH 7.5 running buffer. (C) Native gel after incubation of (His)6 tag cleaved Vipp1 WT 
(10 µM) with vesicles of increasing SCE stress (2.5 mM lipid conc.). (D) Native gel of Vipp1 WT (10 
µM) incubated with vesicles (2.5 mM lipid conc.) of increasing SCE stress after electrophoresis 
undertaken in a pH 7.5 running buffer.  
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Appendix C – Circular Dichroism spectra of Vipp12-19 with E. coli TLE 
vesicles and PspA1-40 Peptides 
 
 
 
Figure C.1 CD spectra of peptides. (A) CD Spectra of Vipp12-19 incubated with E. coli TLE vesicles in 
20 mM Tris-HCL pH 7.5 (lipid: peptide ratio given in legend). (B) CD spectra of PspA1-40 peptide 
vesicles in 20 mM Tris-HCL pH 7.5. All spectra are an average of 3 scans and normalised as mean 
residue ellipticity [θ]. 
 
 
 
